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Abstract 
Microfluidic cell culture has been a research area with great attention the last decade due to its 
potential to mimic the in vivo cellular environment more closely compared to what is possible by 
conventional cell culture methods. Many exciting and complex devices have been presented pro-
viding possibilities for, for example, precise control of the chemical environment, 3D cultures, 
controlled co-culture of different cell types or automated, individual control of up to 96 cell culture 
chambers in one integrated system. Despite the great new opportunities to perform novel experi-
mental designs, these devices still lack general implementation into biological research laborato-
ries. 
In this project, the usability and applicability of microfluidic cell culture systems have been in-
vestigated. The tested systems display good properties regarding optics and compatibility with 
standard laboratory equipment and procedures. Such highly usable systems were achieved by inte-
gration of fluidic actuation, liquid reservoirs, liquid interconnections and cell culture chambers in a 
single portable unit. However, improvements regarding robustness of individual system parts and 
thereby reliability of the systems are shown to be needed. This is possibly one of the reasons for the 
lack of implementation of microfluidic cell culture systems into biological research laboratories. 
Procedures to perform long-term microfluidic perfusion cell culture experiments have been es-
tablished. Furthermore, successful application of the microfluidic perfusion cell culture system is 
shown by investigation of adipose-derived stem cell (ASC) differentiation into adipocytes, where 
we have revealed that paracrine/autocrine signaling is involved in differentiation of a population of 
ASCs into adipocytes. We have thereby demonstrated that microfluidic perfusion cell culture sys-
tems are a more powerful and a useful tool to investigate paracrine/autocrine signaling within a cell 
population compared to conventional static cell culture. Thus, we have been able to perform novel 
biological research by the use of our developed microfluidic perfusion cell culture systems. 
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Resumé 
Mikrofluid celledyrkning har det sidste årti været et forskningsområde med stor opmærksomhed 
på grund af dets potentiale for nøjere at kunne efterligne de in vivo cellulære omgivelser i forhold 
til hvad, der er muligt ved konventionelle celledyrkningsmetoder. Mange spændende og komplekse 
devices, som giver mulighed for, for eksempel, præcis kontrol af de kemiske omgivelser, 3D kultu-
rer, kontrolleret samdyrkning af forskellige typer celler eller automatiseret individuel kontrol af op 
til 96 celledyrkningskamre i ét integreret system, er blevet præsenteret. Til trods for de storartede 
nye muligheder for at udføre hidtil ukendte forsøgsopsætninger mangler disse devices stadig at 
blive generelt implementeret i biologiske forskningslaboratorier. 
I dette projekt er brugervenlighed og anvendelighed af mikrofluidiske celledyrkningssystemer 
blevet undersøgt. De testede systemer udviser gode egenskaber angående optik og kompatibilitet 
med standard laboratorieudstyr og procedurer. Sådanne meget brugervenlige systemer er opnået 
ved integration af fluid aktivering, væskereservoirer, væskeforbindelser og celledyrkningskamre i 
en enkelt transportabel enhed. Imidlertid er det vist at forbedringer angående robusthed af individu-
elle systemdele og dermed driftsikkerhed af systemerne, er nødvendig. Dette er muligvis en af 
grundene til den manglende implementering af mikrofluide celledyrkningssystemer i biologiske 
forskningslaboratorier. 
Procedurer for at udføre langtids-mikrofluide perfusions celledyrkningseksperimenter er blevet 
fastsat. Ydermere er en succesfuld anvendelse af mikrofluid perfusions celledyrkningssystemet vist 
ved undersøgelse af fedt-afledte stamcellers differentiering til fedtceller, hvor vi har afsløret at 
parakrin/autokrin signalering er involveret i differentiering af en fedtstamcellepopulation til fedt-
celler. Vi har dermed demonstreret at mikrofluid perfusions celledyrkningssystemer er et mere 
kraftfuldt og brugbart redskab til at undersøge parakrin/autokrin signalering indenfor en cellepopu-
lation i forhold til konventionel statisk celledyrkning. Vi har således været i stand til at udføre ny 
biologisk forskning ved brug af vores udviklede mikrofluid perfusions celledyrkningssystemer. 
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Chapter 1 
 
Introduction 
In vitro cell culture is a central method within biological/biomedical research that has formed 
the basis for most of the knowledge obtained about cell biology during the last century. For exam-
ple, in vitro cell culture has been of great value in unraveling signaling pathways, studying cytoske-
letal arrangements/rearrangements, and drug screening. In general, cell culture is performed by the 
use of petri dishes, flasks or well plates of different sizes, in which adherent cells are cultured in a 
2D-monolayer covered with roughly 1.5 to 2 mm of cell culture medium. Except for optimizations 
of cell culture medium compositions and improvements of the substrates, the method of in vitro 
cell culture has not changed significantly since its introduction. 
One advantage of the existing method is that it keeps the experimental conditions simple and 
fairly well-controlled with respect to parameters that can affect the cellular response. Often a sti-
mulating or inhibitory factor is added to the cell culture medium, and the cellular response is as-
sayed on average conditions. In addition, replicates can be obtained for statistics using a reasonable 
amount of time and effort. However, the present method of in vitro cell culture mimics the in vivo 
cellular environment poorly. In vivo, the cells are in a complex 3D environment in which they are 
influenced by many different soluble factors, cell-extra cellular matrix (ECM) interactions, and 
direct cell-to-cell contacts. Interpretation of the results using the existing cell culture method and 
transfer of the results to what is happening in in vivo situations must therefore be made with cau-
tion. 
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However, during the last decade a new innovative approach to in vitro cell culture has emerged 
in the form of microfluidic cell culture. 
1.1 Microfluidic cell culture 
Microfluidic technology is the ability to control and manipulate very small volumes of liquids in 
channels and chambers in the micro scale [1]. The technology has been widely applied to mamma-
lian cell culture [2], leading to the term microfluidic cell culture. The geometries in the micrometer 
scale and volumes in microlitres by themselves mimic the in vivo cellular environment more close-
ly than conventional cell culture methods and thereby probably increase the biological relevance.  
Furthermore, one very important advantage is the ability to control the chemical composition of the 
near-cell environment, also called the cellular microenvironment. This precise control has made it 
possible to stimulate cells at the sub cellular level [3] and generate stable continuous gradients of 
soluble factors for cell exposure [4]. 
The research in microfluidic cell culture can be divided into a few main focus areas. In addition 
to high accuracy flow control systems as mentioned above, many scientific groups strive to develop 
high-throughput cell culture systems, which are either very complex or simpler in design. Quake et 
al. [5] presented an integrated automated system with mixers, peristaltic pump, pneumatic valves, 
and 96 cell culture chambers that could be controlled individually. A simpler approach to high-
throughput was demonstrated by Beebe et al. [6] in the form of a tubeless array of 192 cell culture 
chambers in standard micro titer plate format and with flow control by passive pumping. 
In an attempt to mimic the in vivo cellular microenvironment further, many studies aim to cul-
ture and analyze cells in 3D ECM-like environments. A device presented by Toh et al. [7] enabled 
cell-cell interactions through cell seeding in an array of micropillars capturing the cells. Further-
more, cell-ECM-like interactions were obtained by the formation of 3D collagen matrices sur-
rounding the cells. Another study [8] investigated proliferation and differentiation of human me-
senchymal stem cells embedded in 3D poly(ethylene terephthalate)(PET) scaffolds under static and 
perfusion culture conditions. 3D cell culture and high-throughput experimentation were combined 
on a microfluidic passive perfusion array in a 96-well format consisting of 32 independent flow 
chambers, presented by Chen et al. [9]. 
Similar to 3D culture systems, co-culture devices have been presented that allow the study of 
one cell type behavior in relation to another cell type. Intravascular adhesion of flowing metastatic 
breast cancer cells to chemokine activated endothelium has been investigated by using a membrane 
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integrated device [10]. Endothelial cells were cultured on the membrane and activated from the 
basolateral side through the membrane by chemokines, and attachment of the floating cancer cells 
to the apical side was assayed. 
Most recently, the trend in microfluidic cell culture research has moved towards tissue engineer-
ing, with the aim of mimicking in vivo conditions even further. For example, by co-culturing 
stromal cells and endothelial cells under physiological interstitial flow conditions in a microfluidic 
device, a vascular network with perfused capillaries was shown to be created within 18 days of 
culture [11]. Another recent study demonstrated the formation of proximal-distal patterning of 
mouse epiblast by spatially micro patterning two different cell types, thereby creating two different 
extraembryonic environments [12].  
 Overall, the ultimate goal of the microfluidic cell culture research community has been and still 
is to develop devices/systems that mimic the in vivo cellular microenvironment as much as possible 
and at the same time enable controllable dynamic cell stimulation and high-throughput cell analy-
sis. 
1.2 Motivation 
As described in section 1.1, the development of microfluidic cell culture has been rapid and has 
already provided many new possibilities for in vitro cell culture, by mimicking in vivo conditions 
more closely and/or by improving the control of the cellular microenvironment. Despite these great 
new opportunities for bringing more biological relevance into biological/biomedical research, the 
methods have not been adopted by biologists and biological/biomedical labs in general. In my opi-
nion, most biologists do not even know about the possibilities that are offered by the microfluidic 
research community. This lack of implementation is well known within the microfluidic research 
community and has been discussed in a few reviews/letters [1, 13, 14]. It is therefore of crucial 
importance that systems/devices are developed in close collaboration with the biologists and finally 
evaluated by the biologists. In addition, papers presenting new devices and applications, in general, 
only describe the successful experiments, but lack the reporting of failure rates and time consump-
tions. Although not described, this is however of great significance for the end users and the im-
plementation into biomedical research. For example, in a presentation of a microfluidic cell culture 
device, it can be emphasized that the device is applicable to long-term cell culture experiments (the 
cell culture has been running for up to two weeks). But how many cell culture experiments have 
been tried to be run for two weeks, and how many of those failed before the two weeks. If the suc-
cessful experiments are only three out of ten, for example, then the device is almost useless. Such a 
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high failure rate can normally not be accepted by a biologist. Thus, in this project, we want to in-
vestigate the usability and the applicability of microfluidic cell culture within biological/biomedical 
research. 
1.3 Project objectives 
This project had two main objectives: 
1. Evaluation of microfluidic cell culture systems, system components, and handling pro-
cedures seen from an end user’s point of view. Based on obtained working experiences, 
design considerations and handling procedures for microfluidic cell culture systems are to be 
discussed. 
 
2. Application of microfluidic cell culture to investigate a biological issue. Most previously 
presented work is proof-of-concepts. However, the aim of this project is to move a step fur-
ther and employ microfluidic cell culture as a method/tool in biological/biomedical research. 
 
1.4 Project basis 
1.4.1 The ProCell project 
This project is a part of the ProCell project (Grant No. 2106-08-0018 "ProCell", under 
the Programme Commission on Strategic Growth Technologies, the Danish Agency for Science, 
Technology and Innovation) and has been performed within the framework of the ProCell project. 
The ProCell project is a highly interdisciplinary collaboration between biology, mi-
cro/nanotechnology and information technology, with its main partners from the Department of 
Micro- and Nanotechnology and the Department of Informatics and Mathematical Modeling, both 
from Technical University of Denmark. ProCell is an abbreviation of „Programmable cell culture 
chip‟ and the goal of the project has been to design and fabricate a device for parallel and combina-
torial cell culture experiments with the capability of real-time monitoring and manipulation of the 
cells (Fig. 1). The experimental design and performance were aimed to be aided by the develop-
ment of computer-assisted user-programmable control programs and theoretical models for the 
physical and chemical properties of the microfluidic environment.  
In relation to this PhD project in particular, one of the ProCell objectives regarding evaluation 
was to test the developed device for investigation and optimization of the differentiation of stem 
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cells in collaboration with the external academic partner, Professor Philippe Collas, University of 
Oslo. The design and fabrication of the microfluidic cell culture device has mainly been performed 
by Peder Skafte-Pedersen, and this work is presented in his PhD thesis entitled “Microfluidic Cell 
Culture Systems for Real-time Studies of Cells” [15]. The system developmental work has been 
carried out in parallel with the biological testing/ application of the system and in close collabora-
tion and sparring with the author of this thesis. For example, the cell loading has been improved by 
a suggestion to reduce the pathway from the cell loading well to the cell culture chamber. 
 
Fig. 1. Overview of the proposed ProCell platform combining biology, micro- and nanotechnology and 
information technology. From www.nanotech.dtu.dk/ProCell. 
 
1.4.2 The FAST research group 
This project has been carried out within the Fluidic Array Systems and Technology (FAST) 
group, headed by Associate Professor Martin Dufva. During the last decade, the research focus area 
of the FAST group has moved towards microfluidic cell culture and analysis, initiated with the 
development and characterization of a biocompatible single chamber cell culture chip by Michael 
Stangegaard [16-18]. Fluidic interconnections have been improved by the development of ball joint 
interconnection features by David Sabourin [19, 20] and integrated fluidic actuation has been ob-
tained by the design and fabrication of a peristaltic micropump, carried out by Peder Skafte-
Pedersen and David Sabourin [21]. Additional engineering has resulted in a whole library of com-
ponents for the creation of various modular microfluidic systems tailored to specific applications 
(Appendix 4) (manuscript in preparation). The ProCell project has been based on the initial devel-
opments and has been a continuation of this research line. 
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1.5 Approaches and methodology 
1.5.1 Evaluation of microfluidic cell culture systems 
In general, the evaluation is based on working experiences obtained by the practical use of mi-
crofluidic cell culture systems and components designed and fabricated within the ProCell project 
and the FAST group. 
This part of the thesis is divided into design considerations/performance of microfluidic cell cul-
ture systems as well as system components and evaluation of normal cell culture procedures. The 
evaluation of microfluidic cell culture systems and components has focused on general usability 
such as assembling, portability, robustness, compatibility with standard laboratory equipment and 
sterilization procedures, and reliability. Assessment of normal cell handling procedures in a micro-
fluidic perfusion cell culture system has concentrated on sterilization and coating procedures, cell 
seeding, cell attachment and proliferation, transfection of DNA, as well as cell manipulation in 
terms of regulation of gene expression. Again, attention has been paid to general usability.  
Overall, the evaluation has not focused on biocompatibility issues due to the fact that these have 
been intensively investigated previously by other members of the FAST group. Michael Stange-
gaard has compared cell proliferation and whole genome expression profile in a 
poly(methylmethacrylate) (PMMA) cell culture chamber to conventional cell culture methods [17, 
18]. Biocompatibility of PMMA and poly(dimethylsiloxane) (PDMS) has been assessed with re-
spect to cell viability and proliferation rate, cell morphology, cell cycle states, and DNA microarray 
based transcription profiling by Joanna Lopacinska and is presented in her PhD thesis entitled “Mi-
cro- and Nanoengineering Meets Cell Biology: In Vitro Biocompatibility Testing Concepts” [23]. 
The evaluation part of the work presented in this thesis distinguishes itself from previously pre-
sented work in the literature by being more critical, assessed from an end user‟s point of view, and 
by reporting failure rates/time consumptions. In striving towards showing good performance and 
thereby getting papers accepted for publication, only the successful experiments are presented. 
However, with the poor adoption of microfluidic cell culture by biological/biomedical research labs 
in mind, one could speculate that this could be related to issues such as ease of use, robustness, and 
reliability. By reporting and focusing on these issues, the hope is to contribute to enhancing the 
implementation of microfluidic cell culture methods in biological/biomedical research. 
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1.5.2 Application of microfluidic cell culture to stem cell research 
Stem cells have a promising potential for the generation of tissue models for basic biological re-
search, biomedical research (as for example drug testing), and for regenerative cell therapies [24, 
25].  The fate of the stem cell is controlled by many external cues, such as soluble factors, cell-
ECM and cell-cell interactions, all acting in a complex network [26], which is difficult to copy by 
conventional cell culture methods. In comparison, microfluidic cell culture offers the potential to 
more closely mimic the in vivo conditions and has therefore been widely applied to stem cell re-
search [27, 28]. However, most studies have been proof-of-concepts [29-33], although more recent 
work has moved a step further and tried to investigate issues within the stem cell area [34-36]. In 
this project, we wanted to continue this progress of the application of microfluidic cell culture with-
in stem cell research.  
  Accordingly, one of the objectives of the ProCell project and thereby this project was, in colla-
boration with the external academic project partner, Professor Philippe Collas, to apply the devel-
oped microfluidic cell culture systems to investigate and optimize the differentiation process of 
adipose-derived stem cells (ASCs) into adipocytes (mature fat cells). The established protocol [37] 
for differentiation of ASCs into adipocytes dictates that the cells should be cultured to 90 % con-
fluence and then medium changed to adipogenic medium consisting of 4 different inducers of diffe-
rentiation. The differentiation process continues for up to 3 weeks with medium change twice a 
week. The fact that the cells must be almost confluent at the time of induction of differentiation 
indicates involvement of cell-to-cell signaling, either by direct cell-to-cell contact or by para-
crine/autocrine signaling. Depending on the flow rate, perfusion cell culture may disrupt para-
crine/autocrine signaling by constantly removing cell released factors from the near-cell environ-
ment. In this project, we wanted to investigate the effect of different flow rates and chemical com-
positions of the adipogenic medium on the differentiation process at various cell densities. 
1.6 Main findings 
1.6.1 Usability of microfluidic cell culture systems 
Regarding usability, the tested microfluidic cell culture systems displayed good properties re-
garding optics and compatibility with standard laboratory equipment and cell handling procedures. 
The high usability of the systems was achieved by integration of fluidic actuation, liquid reservoirs, 
liquid interconnections and cell culture chambers in a single portable unit. However, improvements 
Chapter 1 
 
8 
 
regarding robustness of individual parts and thereby reliability of the systems is shown to be 
needed. 
1.6.2 Applicability of microfluidic cell culture systems 
The tested microfluidic perfusion cell culture systems have successfully been applied to investi-
gate adipose-derived stem cell (ASC) differentiation into adipocytes. By microfluidic perfusion cell 
culture, we have revealed that paracrine/autocrine signaling is involved in differentiation of a popu-
lation of ASCs into adipocytes. Furthermore, we have demonstrated that microfluidic perfusion cell 
culture systems are a more powerful and a useful tool to investigate paracrine/autocrine signaling 
within a cell population compared to conventional static cell culture. 
1.7 Thesis outline 
The content of this thesis is selected work performed during the three-year PhD study, presented 
together with an introduction to the different areas and a discussion of the results. The most impor-
tant results are, in addition, presented in the first-author or co-author papers attached as appendices 
to the thesis. Below are listed the chapter headings, a short description of the content of each chap-
ter and a statement of the work presented in first-author and co-author papers: 
Chapter 2: Background/Theory 
Basic concepts and issues related to microfluidic cell culture are presented, as well as the cellular 
environment in vitro contra in vivo and cell-to-cell signaling aspects. In addition, the basic know-
ledge about the differentiation process of stem cells into adipocytes is described.  
Chapter 3: Materials and Methods 
Used methods, protocols, and materials are presented in a condensed form. 
Chapter 4: System Design Considerations and Reliability 
Different approaches to design and fabrication of microfluidic cell culture devices are shortly de-
scribed, followed by an investigation and evaluation of systems and system components developed 
in the ProCell project and the FAST group. The aspects considered are general usability such as 
assembling, portability, robustness, compatibility with standard laboratory equipment and proce-
dures, and reliability. The outcome of the microfluidic cell culture system investigation and evalua-
tion is included in co-author manuscript no. 2. 
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Chapter 5: Microfluidic Perfusion Cell Culture 
Different approaches to normal cell handling procedures related to microfluidic perfusion cell cul-
ture are shortly presented followed by procedures employed and results obtained during this 
project. The procedures include sterilization and coating procedures, cell seeding and perfusion cell 
culture. Furthermore procedures for transfection of DNA and regulated gene expression of a fluo-
rescent reporter protein with real-time detection are presented. The optimization work presented in 
this chapter has been conducted in parallel and in interaction with the system development and 
forms the basis for the system application presented in co-author paper no. 1. 
Chapter 6: Application to Stem Cell Research 
Application of microfluidic cell culture to stem cells is briefly presented. This is followed by re-
sults achieved during this project by investigation of ASC differentiation into adipocytes in perfu-
sion cell culture at different flow rates, adipogenic medium compositions and various cell densities. 
This work has been presented in conference proceeding no. 1 and is going to be further presented in 
a first-author manuscript together with theoretical modeling of fat accumulation in relation to ap-
plied flow rates, diffusible signaling, and supply of nutrients provided by the theoretical partners in 
the ProCell project.  
Chapter 7: Overall Conclusion and Outlook 
A conclusion of achieved results is presented followed by speculations/suggestions for future ap-
plications of microfluidic cell culture. 
1.8 Publications 
Below are presented peer reviewed papers and conference proceedings either as first-author or 
co-author work. The status of the publications is given as published, submitted, prepared for sub-
mission or in preparation. 
1.8.1 Manuscripts and papers for peer reviewed journals 
1. Peder Skafte-Pedersen, Mette Hemmingsen, David Sabourin, Felician Stefan Blaga, Henrik 
Bruus, and Martin Dufva: A self-contained, programmable microfluidic cell culture 
system with real time microscopy access. Published online in Biomedical Microdevices, 
13 December 2011. 
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2. David Sabourin, Peder Skafte-Pedersen, Vasile Coman, Mette Hemmingsen, Jesper Peter-
sen, Jenny Emneus, Jörg P. Kutter, Detlef Snakenborg and Martin Dufva: MainSTREAM: 
a modular and scalable microfluidic platform. In preparation. 
1.8.2 Peer reviewed conference proceedings 
1. Mette Hemmingsen, Peder Skafte-Pedersen, David Sabourin, Rasmus Find Andersen, Ani-
ta L. Sørensen, Philippe Collas, and Martin Dufva: Perfusion cell culture reveals a para-
crine or autocrine signaling pathway involved in adipose-derived stem cell differentia-
tion into adipocytes. Published in Proceedings of the Fifteenth International Conference 
on Miniaturized Systems for Chemistry and Life Sciences, pp. 834-836, 2011. 
2. Wajid Hassan Minhass, Paul Pop, Jan Madsen, Mette Hemmingsen, Peder Skafte-
Pedersen, Martin Dufva: Cell Culture Microfluidic Biochips: Experimental Through-
put Maximization, 5th International Conference on Bioinformatics and Biomedical Engi-
neering, (iCBBE) , 2011. 
3. Peder Skafte-Pedersen, David Sabourin, Mette Hemmingsen, Peter Friis Østergaard, Fe-
lician Blaga, and Martin Dufva: A user-friendly, self-contained, programmable micro-
fluidic cell culture system for high quality microscopy. Published in Proceedings of the 
Fourteenth International Conference on Miniaturized Systems for Chemistry and Life 
Sciences, pp. 166-168, 2010. 
4. David Sabourin, Peder Skafte-Pedersen, Vasile Coman, Mette Hemmingsen, Jesper Peter-
sen, Jenny Emneus, Jörg P. Kutter, Detlef Snakenborg and Martin Dufva: Fast and sim-
ple: Reconfigurable elements and solutions for creating and driving microfluidic net-
works. Published in Proceedings of the Fourteenth International Conference on Miniatu-
rized Systems for Chemistry and Life Sciences, pp. 1433-1435, 2010. 
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Chapter 2 
 
Background/Theory 
This thesis spans microfluidic cell culture systems and stem cell differentiation. It may therefore 
be read by people with a background in physics/engineering or biology. To assist the reading and 
interpretation of the results some background knowledge is presented in this chapter. This includes 
basic knowledge about the cellular microenvironment in vivo contra in vitro. Furthermore, con-
cepts/issues related to microfluidic cell culture are presented, including aspects of soluble factor 
signaling between cells. Finally, some basic knowledge about stem cells and, in particular, the es-
tablished knowledge about the differentiation process of stem cells into adipocytes is presented.  
2.1 The cellular microenvironment 
The human cellular microenvironment and the cellular response hereof are of course best stud-
ied within its natural environment, i.e. the human body. However, due to practical, safety and ethi-
cal issues, this is normally not possible, and instead other biological models have been widely em-
ployed. The most common are experimental animals, tissue slices from the animals, and in addi-
tion, cells isolated from different tissues, such as skin, brain, liver, lung, breast, the intestine or the 
vascular system. The isolated cells are cultured in vitro in a dish/flask with optimized medium 
composition and maintained inside an incubator with proper conditions regarding temperature, CO2 
and humidity. Although simple, and therefore widely used, in vitro cell culture differs significantly 
from in vivo conditions with respect to many parameters that must be taken into account when in-
terpreting the data. This inadequacy of the current in vitro cell culture methods has been the main 
motivator for the development of more in vivo-like methods within the microfluidic research com-
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munity. Below in section 2.1.1 and 2.1.2 are described some important differences between the in 
vivo and in vitro cellular microenvironments. 
2.1.1 The in vivo cellular microenvironment 
In vivo the cells are in a three dimensional configuration adhered to the ECM, with short dis-
tances from one cell to a neighbour cell and with the extra-cellular volume less than the cell vol-
ume [26, 38-40] (Fig. 2a and b). Nutrients are constantly supplied to the cells and waste removed 
from the near-cell environment. Furthermore, the cells are continuously affected by cues in the 
microenvironment, the concentration of which can vary over time and space. The parameters that 
affect the cells can be biochemical, physical or physiochemical in character.  
  
Fig. 2. The in vivo cellular microenvironment. a) Simplified drawing of the in vivo cellular environment 
depicting various ways of cell-to-cell signaling. b) Liver tissue slice showing the tight cell conformation and 
low ratio of external fluid volume to cell volume. Image from www.leica.microsystems.com. 
 
The biochemical signaling can take place via cell-ECM interactions by for example integrins 
that connect the cell to the ECM and transfer signals from the ECM to the interior of the cell. An-
other type of cell-to-cell signaling happens directly through cell-to-cell junctions, and finally a 
major part of the cell-to-cell signaling is carried out by paracrine or autocrine signaling. The cells 
secrete soluble factors such as cytokines, growth factors and hormones that are sensed by the same 
cell (or same cell type, called autocrine signaling) or a neighbour cell (often another cell type, 
called paracrine signaling) (Fig. 2a). The signal to the target cell is sensed by receptor binding, 
endocytosis or diffusion through the cell membrane determined by the nature of the signaling 
molecule. This soluble factor signaling is dependent on diffusion, stability and binding affinity to a 
possible receptor of the signaling molecule. 
The physical effects can be in the form of shear stress, different topographies and substrate 
stiffnesses, which have been shown to influence, for example, the fate of stem cells [39, 41]. The 
pH, oxygen tension, temperature and osmolarity surrounding the cell define the physiochemical 
Background/Theory 
 
13 
 
environment. For example hypoxia in the primary tumour has been observed to be associated with 
cancer metastasis [42]. 
2.1.2 The in vitro cellular environment in conventional cell culture methods 
In the conventional method of in vitro cell culture, the cells are cultured in a two dimensional 
monolayer in a petri-dish or flask, normally made of polystyrene. For most of the culture period the 
cells have no direct cell-to-cell contact, and the cell culture is mostly a mono-culture, i.e. the cul-
ture of one cell type. Instead of a constant supply of nutrients, the cell culture medium is renewed 
periodically (normally every second or third day), and the volume of medium is very high com-
pared to the cell volume. The high culture volume results in a higher dilution of secreted signaling 
molecules compared to the in vivo conditions, which may affect the cellular response in a different 
way. For example, for some signaling a certain threshold may be necessary to induce the cellular 
response. The procedures including a high cell culture volume, incubation and periodic change of 
medium or cell passaging mean that the cell culture conditions, in general, change over time.  
2.2 Microfluidic cell culture aspects 
As mentioned in the introduction to section 2.1, the inadequacy of the current macro-scale in vi-
tro cell culture methods to mimic the in vivo conditions has been the main motivator for the devel-
opment of more in vivo-like methods within the microfluidic research community. The many pos-
sibilities and potentials offered by microfluidic cell culture, such as control of the chemical envi-
ronment, 3D cultures and co-cultures (described in section 1.1), mimic more closely the in vivo 
cellular microenvironment. However, many phenomena and aspects are different from macro scale 
cell culture to microfluidic cell culture. Thus, it is important to be aware of the nature of those dif-
ferences to be able to interpret and evaluate biological data obtained by the use of microfluidic cell 
culture devices. 
2.2.1 Flow  
In microfluidic cell culture systems, the cells are often constantly perfused with cell culture me-
dium. The constant perfusion of the cell culture chambers ensures that nutrients are continuously 
supplied and waste products removed (Fig. 3). However, constant perfusion of the cell culture 
chamber means that signaling molecules, secreted by the cells, are probably washed away, which 
thereby interrupts a possible autocrine/paracrine signaling (Fig. 3b). This issue is further com-
mented on in section 2.2.2 and chapter 6.  
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Whether the flow is laminar or turbulent is described by the Reynolds number, which is defined 
by [43, 44] 
                                                               
    
 
  ,                                                                    (1) 
where ρ is the fluid density, ν is the characteristic velocity of the fluid, µ is the fluid viscosity, and 
Dh is the hydraulic diameter. The hydraulic diameter is a computed value that is dependent on the 
cross-sectional dimensions of the channel. In general, a Reynolds number lower than 2300 [43, 44] 
indicates that the flow is laminar. All the microfluidic cell culture experiments carried out in this 
project have been performed at constant perfusion conditions. The calculated Reynolds number for 
the employed chamber dimensions and flow conditions is in the range from 10
-3
 to 10
-1
 [15], and 
the flow is therefore dominated by laminar flow.  
 
Fig. 3. Simplified sketch of the flow effects on the chemical microenvironment. a) At low flow some small 
cell secreted signaling molecules may be able to diffuse against the flow direction. However, at low flow the 
medium may be depleted for nutrients before new medium supply. b) At high flow the cells are supplied with 
new medium before depletion of nutrients. However, cell secreted signaling molecules will be washed away 
and thereby interrupt a possible paracrine/autocrine cell signaling. 
2.2.2 Diffusion 
Mass transport by diffusion is the dominant mass transport mechanism at long time scales and 
short distances [43]. Diffusion can be characterized by 
        ,                                                                  (2) 
where d is the distance that the particle diffuses in time t and D is the diffusion coefficient of the 
particle. qi is a numerical constant which depends on the dimensionality. qi = 2, 4, or 6 for 1, 2, or 
3-dimensional diffusion. From equation (2) the diffusion time t can be written as 
   
  
   
 ,                                                                     (3) 
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As seen from equation (3), the time it takes a particle to move a certain distance is dependent on the 
squared power of the distance. The diffusion coefficient of a molecule can be estimated by the 
Stokes-Einstein relation 
    
   
    
 ,                                                                     (4) 
where kB is the Boltzmann constant, T is the absolute temperature, η is the medium viscosity and a 
is the hydrated radius of the molecule. The diffusion coefficient D of a protein can be estimated by 
[45] 
               
 
   
 
 
  ,                                                             (5) 
where M is the molecular mass of the molecule and η is the medium viscosity. Because of the small 
dimensions within microfluidic cell culture, diffusion is more important than for macro scale cell 
culture, where diffusion is an extremely slow process. For example, for hemoglobin, with a diffu-
sion constant in water of 7 x 10
-11
 m
2
/s, it takes 10
6
 sec to diffuse 1 cm, but only 1 sec to diffuse 10 
µm [44]. Whether the dominant mass transport mechanism is diffusion or convection can be deter-
mined by the Péclet number defined by [43] 
    
  
 
 ,                                                                    (6) 
where ν is the velocity, l is the characteristic length and D is the diffusion coefficient of the par-
ticle. Mass transport by convection dominates at large Péclet numbers, while diffusion dominates at 
low Péclet numbers. Thus, the mass transport in a microchamber with laminar flow conditions is 
dominated by convective mass transport along the length axis of the chamber and by diffusion 
along the cross-sectional axis (Fig. 4a). As mentioned in section 2.2.1, the constant perfusion of the 
cell culture chamber will probably wash away signaling molecules secreted by the cells and thereby 
interrupt an autocrine/paracrine signaling. However, the removal of signaling molecules will de-
pend on the applied flow rate. At low flow rates small molecules are able to diffuse against the 
flow direction and thereby stay within the near-cell environment (Fig. 3a). The diffusion coeffi-
cient of a molecule is inversely related to the radius of the molecule (equation 4). Thus, the degree 
of interruption of the paracrine/autocrine signaling is dependent on the flow rate and the size of the 
signaling molecule. 
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2.2.3 Surface area to volume ratio 
The surface area to volume (SAV) ratio in microscale cell culture is much higher compared to 
macroscale cell culture. The SAV ratio of the cell culture microchamber dimensions used in this 
project is about 8.5 times larger than in a 6 well plate or a T75 flask (listed in Table 2). One draw-
back of the high SAV ratio in microchambers can be protein absorption or protein denaturation. A 
hydrophobic interior of a protein may be attracted to a hydrophobic surface of the chamber and 
thereby denature [43]. The large SAV ratio can also have an influence on the material/liquid inter-
faces. For that reason hydrophobic surfaces are often coated. In addition, diffusion of hydrophobic 
molecules into PDMS has been observed [46], which can be problematic due to the fact that many 
signaling molecules and drugs are hydrophobic. However, in a perfusion cell culture system quite 
large volumes of media are perfused trough the system, thereby decreasing the total actual SAV. 
Furthermore, it can probably be assumed that the surfaces of the microfluidic network is not an 
endless sink of absorption of molecules, implying that a possible problem about a high SAV is 
probably non existing in microfluidic perfusion cultures. 
2.2.4 The effective culture volume 
The concept „the effective culture volume‟ (ECV) was introduced by Walker et al. [43] and de-
scribes the cells ability to control its environment. It is dependent on the mass transport along the x, 
y and z axes, whether the mass transport is dominated by diffusion or convection, the cell volume 
to culture volume (volume cell density) and possible protein absorption to the surface caused by a 
large SAV.  
  
Fig. 4. Simplified drawing of the effective culture volume in microscale culture and macroscale culture. 
a) In microscale culture the mass transport is mainly by convection in the flow direction x and less 
by diffusion in the y and z direction. b) In macroscale cell culture the mass transport is in all three 
directions by both diffusion and convection. Adapted from [43]. 
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In microscale cell culture the ECV is smaller than in macroscale cell culture (Fig. 4). In the micro 
cell culture chambers, at a seeding cell density of 100 cells/mm
2
, the volume cell density is 4 times 
higher compared to macroscale (Table 1), and the mass transport is mainly by convection in the 
flow direction x and less by diffusion in the directions y and z (Fig. 4a). In macroscale cell culture 
the mass transport is in all three directions by both diffusion and convection, and the ratio of cell 
volume to culture medium volume is low (Table 1 and Fig. 4b). The low ECV in microscale cul-
ture mimics the in vivo conditions more closely than the conventional macroscale cell culture 
methods. 
2.2.5 Perfusion flow rate 
To ensure good cell viability and satisfactory cell proliferation, the cells need regular supply of 
nutrients and removal of cellular waste products. The most important components in the cell cul-
ture medium are growth factors and molecules needed for the cell metabolic processes, such as 
glucose. In static conventional cell culturing this is normally ensured by changing the cell culture 
medium every 2-4 days. In microfluidic perfusion culture, the question is how to determine the 
optimal perfusion flow rate. The concept „the effective culture time‟ (ECT) was introduced by 
Young et al. [1] and describes the time between changes of the cell culture medium in the cell cul-
ture chamber.  ECT is dependent on the initial concentration of a needed molecule, the reaction 
time of the molecule with the cells, the diffusivity of the molecule, the height of the cell culture 
chamber, the cell density, the cell culture area and the medium volume [1]. The diffusion time scale 
and the reaction time scale of a given molecule with the cell can be related by the Damkohler num-
ber Da given by [1] 
     
     
     
    
  
 
  
   
   
    ,                                                          (7) 
where h is the height of the microchamber, D the diffusion coefficient of the molecule, C0 the ini-
tial concentration of the molecule, Km the maximum reaction/uptake rate of the molecule with the 
cell and σ the cell density. In a diffusion dominant system, Young et al. [1] assume that the con-
sumption of nutrients and growth factors is limited by the time scale of the reaction kinetics (τr) 
with the cell rather than the diffusion time scales. Since they assume that τr is equivalent to ECT 
and τr thereby is linearly proportional to the height of the cell culture chamber (h), they suggest that 
ECT can be scaled according to h. Thus, if ECT in a macroscale chamber with a medium height of 
1.5 mm is 48 hours, then ECT in a microchamber of height 0.5 mm is 16 hours.   
Chapter 2 
 
18 
 
To determine the optimal flow velocity in a perfusion system Young et al. [1] further introduced a 
dimensionless parameter к derived from the ratio of the perfusion time scale and the reaction time 
scale: 
     
 
  
  
   
   
    
    
     
   ,                                                         (8) 
where L is the length of the microchamber and Um is the flow velocity of the molecule. The lowest 
possible flow rate (named the critical perfusion rate (CPR)) to ensure replenishment of nutrients 
and growth factors before complete depletion could be estimated for к = 1 and is then given by 
      
 
  
    
 
   
 ,                                                                  (9) 
where L is the length of the chamber and ECT is the time between changes of medium scaled ac-
cording to the height of the microchamber. However, the general assumption that τr is equivalent to 
ECT is a very rough assumption. The time between changes of medium in conventional cell cultur-
ing is based on recommendations from the supplier or personal experiences/opinions, but normally 
not based on experimental results. Thus, an experimental determination of the optimal flow veloc-
ity in a perfusion system based on cell viability and proliferation may be a better method compared 
to the theoretical computation presented by Young et al. [1]. 
2.2.6 Total culture volume 
One of the often mentioned advantages of microfluidic cell culture is reduced costs for reagents 
because of lower cell culture volume. This is however very dependent on the applied/necessary 
flow rate. In a conventional static culture of ASCs, the medium is normally changed every four 
days. The medium consumption for, for example, a 6 well and 48 well plate is then 2 mL and 0.2 
mL, respectively, while a perfusion cell culture of 500 nL/min or 125 nL/min consumes 2.8 mL or 
0.72 mL per chamber after four days of perfusion (Table 1). Thus, the medium consumption is 
actually often greater with microfluidic perfusion cell culture than with conventional static cell 
culture. 
2.2.7 Shear stress 
In constant perfusion cell culture conditions the cells may be affected physically by exposure to 
shear stress. When dealing with simple rectangular cell culture chambers, the shear stress at the 
wall can be estimated as for the flow between two parallel plates by [15, 47] 
     
   
   
 ,                                                                      (10) 
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where µ is the viscosity, Q is the flow rate, h is the chamber height and w is the chamber width. As 
seen from the equation, the shear stress increases as the dimensions of the chamber decrease and 
the flow rate and fluid viscosity increase. The impact of shear stress, reviewed by [47], vary de-
pending on the cell type, but up to 0.65 Pa had no biological impact on most of the cells. At the 
chamber dimensions of the cell culture chips applied here and a flow rate of 500 nL/min, the shear 
stress has been estimated to 10
-4
 Pa [15], i.e. several orders of magnitude below those observed to 
effect shear stress on the cells. Thus, shear stress is not expected to have any effect on the cellular 
behaviour in the experiments performed in this project. 
Table 1 Overview of different dimensions/parameters of microscale to macroscale culture 
Images of devices at  
the same scaling 
   
Devices Microchip 6 well plate T75 flask 
Area of  
cell culture chamber 
0.1 cm
2
 10 cm
2
 80 cm
2
 
Media volume 0.005 mL 2 mL 12 mL 
Media height 0.5 mm 2 mm 1.6 mm 
SAV 56.36 cm
-1
 6.12 cm
-1
 7.15 cm
-1
 
Volume cell density at a 
seeding density of  
100 cells/mm
2
 
200 cells/µL 50 cells/µL 67 cells/µL 
Total culture volume per 
chamber in four days of 
cell culture of ASCs  
(at perfusion culture at 
125 and 500 nL/min) 
0.72 mL/2.88 mL 2 mL 12 mL 
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2.3 Stem cells 
Stem cells have attracted enormous interest and attention because of their great potential. By 
definition, a stem cell has the capacity for self-renewal and the ability to differentiate into various 
functionally specialized cells [48]. Beyond embryonic development, stem cells are responsible for 
growth, homeostasis and repair of many tissues in the body throughout its life [26], such as for 
example homeostasis of the blood cells, the epidermis and the epithelium in the intestine. Besides 
providing information about what is regulating the fate of cells, stem cells have a great potential 
within regenerative medicine by repairing, replacing and/or regenerating damaged tissues. In addi-
tion, within the area of cell therapies, stem cells have the potential for replacing non-functional 
cells, as for example replacement of non-functional insulin-producing pancreatic cells in connec-
tion with diabetes. Gimble et al. [49] have suggested some criteria that should be meet for stem 
cells applied in regenerative medicine: 
 Can be found in abundant numbers (millions to billions of cells) 
 Can be harvested by a minimally invasive procedure with minimal morbidity 
 Can be differentiated along multiple cell lineage pathways in a controllable manner and 
reproducible manner 
 Can be safely and effectively transplanted to either an autologous or allogeneic host 
 Can be produced in accordance with current Good Manufacturing Practice guidelines 
However, investigation of stem cell behaviour and regulation of differentiation is complicated 
due to the fact that it is difficult to copy the in vivo microenvironment to an in vitro system which 
has the ability to support normal stem cell function. 
2.3.1 Types of stem cells 
As mentioned in the introduction to section 2.3, stem cells have the capacity for self-renewal 
and the ability to differentiate into functionally specialized cells. Stem cells can be divided into 
pluripotent and multipotent stem cells (Fig. 5) [48]. A pluripotent stem cell has the ability to divide 
infinitely and generate all the structures in the embryo, i.e. all the three germ layers (the endoderm, 
the mesoderm and the ectoderm) and the thereby derived cell types and tissues. Embryonic stem 
cells (ESC) (the inner cell mass of the blastocyst) are pluripotent stem cells. Due to the ethical con-
cerns and limited availability connected to the use of embryonic stem cells, a method has been 
developed to induce the pluripotency of cells by introducing four defined transcription factors [50]. 
A multipotent stem cell is a committed stem cell (Fig. 5). It originates from one of the three germ 
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layers and is usually restricted in its differentiation to only cell types that are normally derived from 
the same germ layer as the committed stem cell. An example is mesenchymal stem cells (MSC) 
that originate from the mesoderm and have the ability to differentiate into cells of mesoderm origin, 
such as cartilage, bone, muscle and fat cells [51, 52]. A progenitor cell is a non-differentiated cell, 
but a cell that is committed to a specific differentiation pathway (Fig. 5). It is not capable of self-
renewal and is therefore not considered as a stem cell [48]. The term „adult stem cells‟ comprises 
various groups of committed multipotent stem cells, such as for example the hematopoietic stem 
cells, the neuronal stem cells, intestinal stem cells and the mesenchymal stem cells. They are all 
populations of embryonic-derived stem cells in the adult organism, and are localised in different 
so-called stem cell niches [48]. 
 
Fig. 5. Simplified sketch of steps in cell differentiation. A pluripotent stem cell has the ability to self-
renew and differentiate into all cell types. A multipotent stem cell is a committed stem cell which has the 
ability to self-renew and differentiate into a limited number of cell types. A progenitor cell is an undifferen-
tiated cell committed to a specific differentiation pathway. However, it is not able to self-renew and is there-
fore not a stem cell.  
2.3.2 The stem cell niche  
A stem cell niche regulates stem cell proliferation and differentiation [26]. A stem cell niche is 
comprised of the stem cells and the stromal support cells which interact with the stem cells. In ad-
dition, the niche contains ECM proteins, which provide structure, organisation and chemi-
cal/mechanical signals to the stem cells. A possible presence of blood vessels and nerve cells can 
convey systemic signals to the stem cell niche. Different niches exist for different adult stem cells, 
of which some of the most well-known are those located in the bone marrow for the hematopoietic 
stem cells and the bone marrow-derived MSCs, in the brain for the neuronal stem cells, at the base 
of the epidermis for the epidermal stem cells and at the base of the intestinal crypt for the intestinal 
stem cells [26]. In general, the stem cell niches support the development, maintenance and repair of 
the connected tissue. 
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2.3.3 Mesenchymal stem cells 
The mesenchymal stem cells (or also named mesenchymal stromal cells) are a heterogeneous 
group of multipotent adult stem cells with a fibroblast-like morphology [51, 52]. They are isolated 
from the stromal fraction of many adult tissues (initially from the bone marrow stroma) and are 
defined by three criteria which as a minimum must be fulfilled [53]. First, they must be plastic-
adherent when cultured in a standard cell culture dish/flask. Second, they must express and lack 
expression of specific surface antigens. And third, they must be able to differentiate into os-
teoblasts, chondroblasts and adipocytes in vitro. MSCs have received great attention, because of the 
lack of ethical concerns, wide availability and no immunological considerations compared to hu-
man ESCs. Although induced pluripotent stem cells (iPSC) are now available, epigenetic differ-
ences to human ESCs and the risk of tumour formation in the recipient still makes it controversial 
to use iPSCs in clinical trials [54]. Although bone marrow MSCs are the best described MSCs, low 
availability limits the use of those cells in clinical applications. However, another rich source of 
MSCs exists in the form of adipose-derived stem cells (ASC). 
2.3.4 Adipose-derived stem cells 
ASCs are isolated from liposuction aspirates, as first done by Zuk et al. [55]. The procedure is 
less painful for the donor and the yield is much higher compared to isolation of bone marrow stem 
cells (about 500-fold higher) [56]. The isolation procedure normally includes the following steps 
(Fig. 6) [55, 57, 58]: First, the lipoaspirate is washed several times to remove the majority of blood 
cells, which is then followed by a dispersion of the adipose tissue by collagenase digestion. After 
the digestion, the stromal vascular fraction (SVF) is isolated by centrifugation. The SVF forms a 
pellet, while the adipocytes and the lipids float in the supernatant. Besides containing ASCs, the 
SVF predominantly contains erythrocytes, leukocytes, endothelial cells and stromal cells. The 
erythrocytes are removed by using red blood cell lysis buffer. Often the ASCs have not been fur-
ther purified except by the expansion of the cells on plastic surfaces (culture dishes/flasks) and 
thereby selection of the plastic adherent cells [55, 58]. The ASCs used in this project are provided 
by the Philippe Collas lab. In addition to the isolation procedure described above, the stromal cells 
from the Philippe Collas lab have been further purified by removing the endothelial cells (CD 31
+
) 
and leukocytes (CD45
+
) by magnetic cell sorting [57].  
Like the mesenchymal stem cells in general, the ASCs are characterized by expression and lack 
of expression of certain surface antigens, and their ability to undergo adipogenic, osteogenic and 
chondrogenic differentiation [37, 59]. Besides the capacity to differentiate into adipocytes, os-
teoblasts and chondrocytes, the ASCs have been shown to undergo myogenic and neurogenic dif-
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ferentiation [37].  Furthermore, ASCs have been reported to differentiate into endothelial and 
epithelial cells, hepatocytes, pancreatic cells and hematopoietic supporting cells [56, 59]. However, 
the differentiation of ASCs into cells of non-mesodermal origin is controversial [51, 60] due to a 
general lack of globally standardized methods for their isolation, purification, expansion and char-
acterization. This lack of standardized methods complicates the evaluation and comparison of the 
different reported differentiation potentials. 
 
Fig. 6. Overview of the steps which are normally included in the isolation procedure of ASCs. See the text 
for a detailed description. 
 
There are many clinical applications of ASCs within the areas of adipose, bone and cartilage tis-
sue regeneration/repair [52, 59, 60] due to the fact that they are relatively safe in use, easy to access 
and can be isolated in high numbers. The number of clinical trials rose from 9 in 2009 to 18 in May 
2010 [59]. Because ASCs have been shown to display immunomodulatory activity, they have also 
been applied in for example treatment of graft-versus-host-disease, multiple sclerosis and rheuma-
toid arthritis. Furthermore, ASCs have been used in connection with bone tissue repair, cartilage 
regeneration in joint diseases and wound healing. Finally, there has been great interest within cos-
metic surgery and soft tissue regeneration.  Instead of direct fat-grafting, the ASCs have been used 
as a source of adipocytes [60].  
2.3.5 Adipocyte differentiation 
Fat tissue is a large organ that regulates energy homeostasis and works as an endocrine organ 
secreting many adipokines, which regulate, for example, insulin sensitivity, immune function and 
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lipid metabolism [61-63]. Fat tissue consists of either white adipose tissue or brown adipose tissue. 
The tissue is composed of cells of mesodermal origin that are able to accumulate large amounts of 
triglycerides in cytoplasmic vacuoles. Brown adipose tissue is mainly responsible for thermogene-
sis and is composed of brown adipocytes. They are characterized by many small lipid-filled drop-
lets and a large number of mitochondria (Fig. 7). White adipose tissue is composed of white adipo-
cytes, which in vivo are characterized by a single large droplet of stored triglycerides (Fig. 7). 
However, in vitro the fat is accumulated in many small droplets, which have a tendency to fuse 
during long-term cell culture [61]. The following presentation of adipocyte differentiation focuses 
on white adipocyte differentiation, because most fat in the adult human body is composed of white 
adipose tissue and because the white adipocyte differentiation process is the most interesting in 
connection with the use of ASCs within regenerative medicine. The literature is comprehensive and 
has been conducted within various cell types. Not all of it can be presented here; however, the most 
important parts, in particular in relation to the experimental work done in this PhD project, are 
pointed out and described in the following sections. 
 
Fig. 7. Types of adipocytes. MSCs differentiate into white or brown adipocytes. White adipocytes are cha-
racterized by a single large droplet of stored triglycerides. However, in vitro the fat is accumulated in many 
small droplets (immature white adipocyte), which have a tendency to fuse during long term cell culture. 
Brown adipocytes are characterized by many small lipid-filled droplets and a large number of mitochondria. 
 
The differentiation of multipotent stem cells into adipocytes is divided into two steps, like stem 
cell differentiation in general (Fig. 5) [61, 63, 64]. In the first step, the multipotent stem cells 
commit towards the adipogenic cell lineage and differentiate into preadipocytes. The preadipocytes 
cannot be morphologically distinguished from their precursor cells, but they are limited in their 
differentiation capacity to adipocytes only [63]. Upon exposure to adipogenic stimuli, the preadi-
pocytes enter terminal differentiation to become functional adipocytes. During induction of termi-
nal differentiation a transcriptional cascade is induced followed by expression of adipocyte specific 
metabolic genes and adipokines [61]. 
The adipocyte differentiation has mostly been studied in vitro in mouse preadipocyte models, 
such as 3T3-L1 and 3T3-F442A cells. These cell lines are isolated from mouse embryos and have 
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been selected for their ability to accumulate cytoplasmic triacylglycerol [64]. As a consequence, 
most studies have been concentrated around regulation of the terminal differentiation of preadipo-
cytes into adipocytes, the subsequent activation of transcription factors and adipocyte specific 
genes, while less is known about the commitment step of multipotent stem cells towards the adipo-
genic cell lineage. The most commonly used multipotent cells are various human MSCs and the 
cell line C3H10T1/2, which is isolated from mouse embryos. The C3H10T1/2 cells have a fibro-
blast-like morphology and are functionally similar to mesenchymal stem cells [64]. 
Mesenchymal stem cells and preadipocytes proceed through adipocyte differentiation when cul-
tured in growth medium added serum and a cocktail of adipogenic stimuli consisting of dexa-
methasone, isobuthyl-methylxanthine (IBMX), insulin and in some protocols indomethacin [37]. 
The mouse preadipocytes (3T3-L1 and 3T3-F442A) undergo one or two rounds of mitotic cell divi-
sion upon induction of terminal differentiation, while C3H10T1/2 cells and human preadipocytes 
proceed through differentiation without cell division [63]. 
The following description of the knowledge about adipocyte differentiation is divided into three 
sections:  
 Regulation of the commitment step towards the adipogenic cell lineage 
 Regulation of the induction of the terminal differentiation into adipocytes 
 Terminal differentiation. 
2.3.5.1 Regulation of the commitment towards the adipogenic cell lineage 
Little is known about the conversion of MSCs to committed preadipocytes; however some me-
chanical and molecular cues have been shown to be involved in the regulation. An overview is 
presented in Fig. 8. 
High cell confluence (80-90%) has been reported to be required before induction of terminal 
differentiation by adipogenic stimuli [58, 65]. In addition, when cultured in a mixed adipogenic and 
osteogenic differentiation medium, high cell densities of human MSCs have been shown to pro-
mote adipogenesis, while low cell densities favoured osteogenesis [66]. McBeath et al. [66] further 
proposed that the initial plating density alone can affect the cell commitment and can do this sepa-
rately from the downstream differentiation process. They showed that pre-culturing of MSCs in 
normal growth medium at low cell density inhibited later adipogenesis at both low and high cell 
densities, while pre-culturing at high cell density prevented later osteogenesis at both low and high 
cell densities. However, preculturing of MSCs at high cell density still required high cell density 
for efficient later adipogenesis. Furthermore, at normal cell maintenance the cells are regularly 
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passaged to low cell density, which according to our experiences does not prevent adipogenesis at a 
later high cell density condition. Thus, whether cell density determines stem cell fate and/or regu-
lates/improves differentiation of preadipocytes is controversial.  
Besides cell density, cell shape has been found to affect MSC commitment [66]. Cells grown in 
a mixed differentiation medium differentiated into adipocytes when grown on small islands (round 
shape) of pattern fibronectin, while cells grown on large islands (spread shape) differentiated into 
osteoblasts. The fact that the round cell shape promoted adipogenic differentiation correlates with 
the high cell density requirement, because the cells take up a more round shape when they are very 
confluent. The effect of cell confluence/shape on MSC adipogenic commitment has been associ-
ated with increased RHO-GTPase activity and thereby inhibition of actinomyosin formation [66].  
Other parameters that have been observed to influence MSC fate decision is surface substrate 
stiffness. MSCs grown on polyacrylamid gels with different stiffness showed a larger proportion of 
cells differentiating into adipocytes at the lowest substrate stiffness compared to the highest sub-
strate stiffness [67]. Another study [41] investigated the effect of micropost arrays with different 
rigidity on MSC fate decision. When culturing the cells in a mixed osteogenic/adipogenic differen-
tiation medium, the high rigidity micropost array favoured osteogenic differentiation, while the low 
rigidity micropost array favoured adipogenic differentiation. In both studies [41, 67], the low stiff-
ness/rigidity of the substrate correlates with a round cell shape and thereby further supports the 
suggestion that a round cell shape affects the MSC commitment towards the adipogenic cell line-
age.  
Regarding molecular cues, members of the transforming growth factor beta (TGFβ) super-
family, the bone morphogenic proteins (BMPs) BMP2 and BMP4, have been shown to be involved 
in the regulation of MSC commitment towards the adipogenic lineage [61, 64]. Treatment of multi-
potent C3H10T1/2 cells with BMP2 or BMP4, before exposure to the normal adipogenic differen-
tiation protocol, promoted adipogenesis, while exposure to the differentiation protocol alone could 
not lead to adipogenesis [68]. 
Other molecular cues involved in MSC lineage commitment are the wingless-type mouse mamma-
ry tumor virus (MMTV) integration site family members (WNT) signaling molecules, which are 
cell secreted glycoproteins operating in a paracrine/autocrine manner in many developmental proc-
esses [61]. WNT10B has been shown to promote osteogenesis in MSCs through the canonical 
WNT signaling pathway, while inhibiting adipogenesis by suppressing expression of CCAAT-
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enhancer-binding protein alpha (C/EBPα) and peroxisome proliferator-activated receptor gamma 
(PPARγ) [61, 69-71]. 
 
Fig. 8. Overview of regulation of MSC adipogenic commitment and induction of terminal differentiation. 
See the text for a detailed description. 
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WNT10B binds to frizzled1 (FZD1) receptors and low-density lipoprotein receptor-related protein-
5 or -6 (LRP5/6) co-receptors leading to stabilization of β-catenin, translocation of β-catenin to the 
nucleus and transcriptional activation of WNT target genes [72]. Likewise WNT5A inhibits adipo-
genesis by PPARγ inactivation. However, WNT5A signals through the non-canonical WNT path-
way by binding to frizzled2 (FZD2) receptors [61, 69, 71, 72]. 
2.3.5.2 Regulation of the induction of terminal differentiation 
Many studies of adipocyte differentiation have been performed in preadipocytes, which are 
committed to the adipogenic cell lineage, but which have not yet entered the terminal differentia-
tion process into functional adipocytes. An overview of the regulation of the induction of terminal 
differentiation is presented in Fig. 8. Like in MSCs, WNT10B and WNT5A have been shown to 
inhibit adipogenesis in preadipocytes by reducing/inactivating PPARγ and C/EBPα [69, 72-74]. 
Accordingly, the prevention of WNT signaling induced preadipocytes to differentiate into adipo-
cytes [73]. This correlates with IBMX as one of the adipogenic stimuli in the conventional differen-
tiation protocol. IBMX is a cyclic adenosine monophosphate (cAMP) agonist, which has been 
shown to decrease expression of WNT10B by inhibiting cAMP response element-binding (CREB) 
binding to the WNT10B gene promoter [75]. Furthermore, adipocyte differentiation has been asso-
ciated with the secretion of secreted frizzled-related proteins (sFRP) and Dickkopf-1 (Dkk1) [72]. 
sFRPs bind and sequester WNT10B [61, 72] and Dkk1 is an antagonist to LRP co-receptors, 
whereby they both inhibit WNT signaling [76]. In contrast to WNT10B and WNT5A, WNT5B has 
been observed to impede β-catenin nuclear translocation and thereby promotes adipogenesis [77]. 
Thus, WNT signaling may be an important regulator of adipocyte differentiation through a cross-
talk between mature adipocytes and adipose stem cells/preadipocytes, which further may be regu-
lated by energy storage demands [72]. 
Members of the TGFβ superfamily have in addition to MSCs been shown to be involved in 
regulation of preadipocyte differentiation. TGFβ inhibits adipogenesis through SMAD3 signaling 
[61, 63, 78, 79]. Following phosphorylation, SMAD3 binds to C/EBPs and inhibits their transcrip-
tional activity. Another member of the TGFβ superfamily, BMP2, increases differentiation in 
mouse embryonic fibroblasts (MEFs) grown in adipogenic medium [61, 80]. BMP2 signals through 
SMAD1, which mediate nuclear translocation of the transcription activator Schnurri 2 (SHN2) and 
thereby stimulate PPARγ expression.  
Other transcriptional regulators of the induction of adipocyte differentiation are zinc-finger pro-
tein 423 (ZFP423) and transcription factor 7-like1 (TCF7L1) [61]. Both are expressed in adipo-
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genic fibroblasts, but not in non-adipogenic fibroblasts. TCF7L1 acts downstream of the canonical 
WNT signaling pathway and promotes adipogenesis. ZFP423 is necessary for 3T3-L1 adipogenesis 
and can promote adipogenesis in non-adipogenic NIH-3T3 cells [81]. Finally, fibronectin and α5-
integrin signaling have been reported to decrease differentiation of 3T3-F442A preadipocytes into 
mature adipocytes [61, 82, 83]. The fibronectin/α5-integrin signaling increases the levels of the 
active form of the RHO family GTPase RAC (RAC-GTP), which is normally inhibited during dif-
ferentiation [83]. 
2.3.5.3 Terminal differentiation 
A transcriptional cascade is activated upon addition of the adipogenic stimuli (IBMX, dexa-
methasone, indomethacin and insulin) to MSCs and preadipocytes, which ultimately results in ex-
pression of adipokines and adipocyte specific metabolic genes (such as leptin, adiponectin, lipopro-
tein lipase (LPL), fatty acid binding protein 4 (FABP4/aP2) and glucose transporter type 4 
(GLUT4) [61, 63, 84]. Many transcription factors have been shown to influence the terminal adi-
pogenesis process; however, by far the most important and central transcription factors are PPARγ, 
C/EBPα, C/EBPβ and C/EBPδ. PPARγ and C/EBPα have been shown to be present in about 60% 
of all adipocyte specific genes in mature adipocytes [85]. In general, the induction of terminal adi-
pogenesis is a balance between positive and negative regulators of adipogenesis. An overview of 
the most important factors involved in the terminal adipogenic differentiation is described below 
and presented in Fig. 9. 
C/EBPs 
The transcription factors C/EBPβ and C/EBPδ are early markers of terminal differentiation [61]. 
C/EBPδ is induced by glucocorticoids (for example dexamethasone), while C/EBPβ is induced 
within a few hours after stimulation with cAMP agonists (for example IBMX) [86]. C/EBPβ ex-
pression is induced by activation of protein kinase A (PKA) and phosphorylation of CREB [61]. In 
addition, C/EBPβ expression is induced by Janus kinase 2 (JAK2)/signal transducer and activator 
of transcription 3 (STAT3) signaling, and furthermore by the transcription factors KROX20 and 
Kruppel-like factor (KLF) 4 [61]. However, the initial stimuli of the JAK2/ STAT3 signaling, 
KROX20 and KLF4 are unknown, but it could be insulin, some growth factors or BMPs [61]. 
Phosphorylation of C/EBPβ is required for DNA binding and happens through mitogen-activated 
protein kinase (MAPK) and glycogen synthase kinase 3 beta (GSK3β) signaling induced by un-
known stimuli [87]. Furthermore, glucocorticoids regulate C/EBPβ binding and acetylation [88], 
probably through the glucocorticoid receptor (GR) [89]. The early expression of C/EBPβ and 
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C/EBPδ leads to a later expression of C/EBPα, which is a direct transcriptional target of C/EBPβ 
[90]. However, C/EBPβ cannot induce C/EBPα expression in the absence of PPARγ [91]. 
PPARγ  
PPARγ is the key regulator of terminal adipocyte differentiation [61, 63]. As the only factor in-
volved in adipocyte differentiation, PPARγ has been shown to be necessary and sufficient for adi-
pogenesis [92]. PPARγ exists in two isoforms, PPARγ1 and PPARγ2 [61]. PPARγ1 is the highest 
expressed of the two PPARγs in adipocytes, preadipocytes and MSCs, while PPARγ2 is adipocyte 
specific [93, 94]. However, both PPARγs promote adipogenesis equally well. Upon addition of 
adipogenic stimuli, the PPARG2 locus is dynamically and highly regulated by binding of the tran-
scription factors C/EBPs, GR, STAT5 and retinoid X receptor (RXR) during an epigenomic transi-
tion state [61, 95, 96]. However, the specific dynamic DNA modifications are still unclear [61]. 
Furthermore, PPARγ and C/EBPs have been shown to regulate each other in a positive feedback 
mechanism [90, 95, 97]. The endogene PPARγ ligand is not yet known; however, transcription 
factor sterol response element-binding protein 1-c (SCREBP1c) and C/EBPβ increase PPARγ 
ligand production [98].  
 
Fig. 9. Overview of regulation of terminal adipocyte differentiation. See the text for a detailed description. 
 
Other factors involved in terminal differentiation 
GATA-binding 2 (GATA2) and GATA3 inhibit PPARγ activation and must be repressed in 
preadipocytes for induction of adipogenesis [99]. Furthermore, many of the KLFs are involved in 
regulation of terminal differentiation [61, 63]. KLF4 induces C/EBPβ  expression, while C/EBPβ 
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and C/EBPδ induce KLF5 expression, which further induces PPARγ2 expression [84]. In addition, 
KLF6 and KLF15 are pro-adipogenic [84], while KLF2 and KLF7 are anti-adipogenic [63, 84]. 
KLF2 directly inhibits PPARγ2 promotor activity [100]. Insulin promotes adipogenesis partly by 
enhancing SCREBP1c expression, which further increases the production of the PPARγ ligand 
[84]. Furthermore, insulin promotes adipogenesis by suppressing the inhibitory activity of forkhead 
transcription factor Fox01 [84]. 
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Materials and Methods 
3.1 Fabrication 
Design and fabrication of the microfluidic cell culture systems and components have been de-
scribed in detail in [21] and papers attached this thesis as appendix 3 and appendix 4. System and 
system component fabrication have mainly been carried out by Peder Skafte-Pedersen and David 
Sabourin. However, fabrication of cell culture chips and µfluidic ribbons has routinely been carried 
out by the author of this thesis.  
3.1.1 Cell culture chips 
The employed microfluidic cell culture chips (Fig. 16) are made of poly(methyl methacrylate) 
(PMMA) (Plexiglas XT 20070, Röhm GmbH, Germany and Solaris Clear S000, PSC A/S, Den-
mark) and fabricated by micromilling followed by a UV assisted local heat bonding [101]. In short, 
the individual layers of the chip were cleaned with 70% EtOH before being exposed to UV (DY-
MAX, 5000 EC with bulb 36970, CT, USA) for 90 s. Following exposure the layers were sand-
wiched between two glass slides in an alignment setup and bonded for 30 min in a laboratory press 
(PW 10 H, P/O/Weber, Germany) pre-heated to 90°C and at an initial applied pressure of approxi-
mately 8 kN for chips measuring 26 mm (w) x 76 mm (l) (Fig. 16b, c and d) and 12.50 kN for 
chips measuring 52 mm (w) x 76 mm (l) (Fig. 16a). The chips measuring 26 mm (w) x 76 mm (l) 
have a total thickness of 3.5 mm and the chips measuring 52 mm (w) x 76 mm (l) have a total 
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thickness of 2.0 mm. Depending on the specific design, they are composed of individual sheets of 
PMMA ranging from 0.5 mm to 2 mm in thickness. The bottom layer of all chips is 0.5 mm for 
reduced optical path length from the sample to the objective. Inlets are spaced 2.25 mm apart to 
conform with 1536 micro titer well plate standards and placed along each chip side in groups of 8 
to interface pumps and cell loading chips. The cell culture chambers for culturing of HeLa cells had 
a footprint of 1.5 mm (w) x 4 mm (l) capped by isosceles triangles, while the cell culture chambers 
for culturing of ASCs had a footprint of 1.5 mm (w) x 6 mm (l) also capped by isosceles triangles. 
Chamber height is 500 µm.  For the chips measuring 26 mm (w) x 76 mm (l) the inlet and outlet 
channels are connected at the top surface of the chamber. For the chips measuring 52 mm (w) x 76 
mm (l), the inlet are connected to the top of the chamber and the outlet to the bottom of the cham-
ber. 
3.1.2 µfluidic ribbons 
The µfluidic ribbon (Fig. 11c) was monolithically cast from polydimethylsiloxane (PDMS) (Syl-
gard 184, Dow Corning) inside a polycarbonate (PC) (Nordisk Plast, Denmark) mould. PC brackets 
were placed into the μfluidic ribbon moulds prior to PDMS casting and, during curing, integrated 
into the μfluidic ribbon. Mould pieces were aligned by 4 screws.  An assembled µfluidic ribbon 
mould is shown in Fig. 11d. Before injecting PDMS into the mould, 240 µm optical fibres (Po-
lymicro Technologies, Phoenix, Arizona) were threaded through 250 µm holes in the end pieces.  
PDMS was mixed in a 10:1 mass ratio of elastomer to curing agent and placed under vacuum to 
remove air bubbles. Mould vents allowed PDMS injection via a syringe and prevented air from 
being trapped in the finished part. The filled mould was placed in an oven at 60ºC overnight to 
cure. Once the mould had cooled enough to be handled, fibres were removed to yield integrated 
channels and the mould disassembled. 
3.2 Cell culture and functional cell study experiments 
3.2.1 Cells and cell culture medium 
HeLa Tet-On® Advanced cells (631155, Clontech) were cultured in DMEM/F-12+GlutaMax™ 
(31331, GIBCO) supplemented with 10% Tet System Approved Fetal Bovine Serum (FBS) 
(631106, Clontech), penicillin 100 U/mL, streptomycin 100 µg/mL (P4333, Sigma), and geneticin 
(G-418) 100 µg/mL (11811-023, GIBCO). Adipose stem cells (ASC) (a gift from Philippe Collas, 
University of Oslo) were cultured in DMEM/F-12+GlutaMax™ (31331, GIBCO) supplemented 
with 15% v/v newborn calf serum (NCS) (N4762, Sigma), penicillin 100 U/mL, and streptomycin 
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100 μg/mL (P4333, Sigma). At conventional cell culturing the cells were incubated at 37°C and 5% 
CO2. 
3.2.2 General microfluidic cell culture 
To avoid contamination of the cell culture by bacteria or fungi, all system preparations and changes 
of media reservoirs has been performed in a laminar flow bench and by the use of aseptic working 
procedures. 
3.2.2.1 System assembling and priming 
Liquid glass vials, caps, and silicone/poly (tetrafluoroethylene) (PTFE) tubing were sterilized by 
autoclaving before use. Glass vials or vial chips, tubing and connections to pumps were assembled 
onto the system base plate. The cell culture chip and tubes connecting the liquid reservoirs to the 
pumps or vial chips were filled separately with Milli-Q water to remove bubbles, before assem-
bling the cell culture chip to the base plate (Fig. 17).  Inlet and outlet reservoirs were coupled with 
PTFE tubing (BOLA 1810-10, Bohlender GmbH, Germany) and supplied with air supplemented 
with 5% CO2 through a sterile filter (Fig. 19d). To avoid formation of gas bubbles a pressure of 0.3 
bars was put on the flow system during the whole system preparation and cell culture period, only 
interrupted when for instance changing liquid or liquid reservoirs. 
3.2.2.2 Sterilization of the fluidic network 
The connected flow system was sterilized by flushing with 0.5 M NaOH (1.06498.1000, Merck) 
for 20-30 min at a flow rate of 4.5 µL/min followed by washing with sterile water (W3500, Cell 
culture tested, Sigma) for 30 min at a flow rate of 4.5 µL/min to remove all NaOH. At the steriliza-
tion, the reservoirs in the vial chip were completely filled with 0.5M NaOH, and at the following 
removal of NaOH washed three times with sterile water.  
3.2.2.3 Cell culture chamber coating 
Polyethyleneimine 
The surface of the cell culture chambers was coated by passing a 50 µg/mL polyethyleneimine 
(PEI) (408727, Sigma) solution in phosphate buffered saline (PBS) through the chip at a flow rate 
of 4.5 µL/min for 15 min followed by 195 nL/min for 1.5 h at room temperature.  
Fibronectin, laminin or collagen 
The surface of the cell culture chambers was coated by passing the coating solution through the 
chip at a flow rate of 4.5 µL/min for 15 min followed by 195 nL/min for 45 min at 37°C. Fibronec-
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tin (F0895, Sigma) was applied as a 20 µg/mL solution in PBS, laminin (L2020, Sigma) as a 20 
µg/mL solution in PBS and collagen (C3867, Sigma) as a 40 µg/mL solution in sterile water.  
After coating, the flow system was flushed with cell culture medium for 20 min at a flow rate of 
4.5 µL/min or overnight at 33 nL/min before cell loading.  
3.2.2.4 Cell loading 
Prior to cell loading the outlet tubes were removed from the cell loading chip (Fig. 15d). 
HeLa Tet-On® Advanced cells 
 HeLa Tet-On® Advanced cells were resuspended in cell culture medium added 0.025% w/v 
collagen (Sigma C3867) before approximately 10 µL suspension of a cell density of 5×10
5
 
cells/mL, corresponding to an expected surface density of 280 cells mm
-2
, was loaded into the em-
bedded wells in the cell loading chip (Fig. 15f).  
Adipose-derived stem cells 
ASCs were resuspended in cell culture medium added 60% v/v NCS before approximately 10 
µL cell suspension was loaded into the embedded wells in the cell loading chip (Fig. 15f). For sys-
tem 1 (Fig. 10b) was used a cell suspension density of 1.8×10
5
 cells/mL, corresponding to an ex-
pected surface density of 90 cells mm
-2
. Various cell suspension densities have been applied with 
system 2 (Fig. 10c). 
At cell loading with system 1 (Fig. 10b), the system was transferred to the microscope and cells 
were introduced into the cell culture chambers by setting the pumps to run backwards at a flow rate 
of 4.5 µL/min for about 1 min. The flow was stopped when the entire chamber was filled with 
cells. At cell loading with system 2 (Fig. 10c), the cell loading was performed inside the LAF bench 
by activating a LEGO
®
 Mindstorms flow program of 10 rotations in 6 sec (~ flow rate of 65 
µL/min), which has been optimized to enable uniform cell loading.  
After cell loading, the outlet tubings were attached to the cell loading chip again under aseptic 
conditions in a LAF bench (Fig. 15d and e). The cells were perfused with a low flow rate of 33 
nL/min for 4 h to allow cell attachment. Following this attachment phase, the flow was change to 
the given cell culture perfusion rate. 
3.2.2.5 Incubation 
The microfluidic cell culture system was placed inside a conventional CO2 incubator at 5% CO2 
and 37 °C (Fig. 18b). When performing time-lapse experiments, the microfluidic cell culture sys-
tem was incubated inside an incubator (Incubator XL Dark S1, Zeiss) mounted a Zeiss life science 
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microscope (AxioObserver.Z1) at 37 °C (Fig. 18c). To limit the influence of gas permeable mate-
rials on the cell culture medium, a flexible plastic cover was mounted the microfluidic cell culture 
system. The atmosphere inside the cover of the system was supplied with 8% CO2 through a con-
nected CO2 module (CO2 module S1, Zeiss). The percentage of 8% CO2 has been optimized to 
ensure the maintenance of a pH of the cell culture medium inside the microfluidic cell culture sys-
tem of 7.2 to 7.4. 
3.2.2.6 Changes of liquid reservoirs and supply of medium during culture 
Changes of cell culture medium or supply of fresh medium has been performed either by chang-
ing the glass vial or by suction of remaining medium in the vial chips followed by refilling of the 
reservoirs. Cell culture medium has been changed at least every 4 days. 
3.2.3 Regulated fluorescent reporter gene expression 
3.2.3.1 Plasmid creation 
DD-ZsGreen1-DR was cut out from pZsGreen1-DR (632428, Clontech) and cloned in-frame 
with the DD tag sequence in the multiple cloning site in pTRE-Cycle2 (631116, Clontech). Plasmid 
amplification was carried out in One Shot® TOP10 Chemically Competent E. coli (C4040, Invi-
trogen) cultured either in LB Broth (L7275, Sigma) or on LB agar (L7025, Sigma) added Kanamy-
cin 50 µg/mL (K1377, Sigma) or Ampicillin 100 µg/mL (171254, Calbiochem). The plasmids were 
purified by using PureLink™ HiPure Plasmid DNA Purification Kit (K2100, Invitrogen) and di-
luted in TE-buffer to 100 ng/mL.  
3.2.3.2 Transfection of plasmid and regulated gene expression 
HeLa Tet-On® Advanced cells passage 10 were loaded into the cell culture chambers on chip as 
described above. After 20 h of cell culturing and at a cell confluence of approximately 80%, the 
cells were transfected on chip. Briefly, 6.25 µg plasmid DNA (pTRE-Cycle2-ZsGreen1-DR) was 
diluted in 2.5 mL OptiMem medium (31985, GIBCO) and added 15.6 µL of Lipofectamine™ LTX 
(15338-100, Invitrogen) giving a proportion of DNA to Lipofectamine of 1:5. After gently mixing 
and incubation at room temperature for 25 min, the transfection complexes were diluted 1:3.2 in 
cell culture medium and then flushed into the cell culture chambers at a flow rate of 1.0 µL/min for 
20 min. The transfection process was performed without flow for 60 min, followed by a short flow 
period at a flow rate of 0.5 µL/min for 10 min. These two steps were repeated for 6 h in total. Fi-
nally, the transfection complexes were removed by flushing with cell culture medium at a flow rate 
of 1.0 µL/min
 
for 20 min. Cell culture was continued at a flow rate of 500 nL/min for another 18 h, 
before inducing mCherry and DD-ZsGreen1-DR gene expression by switching to cell culture me-
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dium supplemented with doxycycline 0.5 µg/mL. DD-ZsGreen1-DR was stabilized by another 
switch to medium added doxycycline 0.5 µg/mL and Shield1 0.5 µM and perfusion with doxycyc-
line and Shield1 was continued for another 21 h. Finally, a final switch was made to medium with 
doxycycline but without Shield1. Cell culture was continued for an additional 19 h before comple-
tion of the experiment. 
3.2.3.3 Time-lapse imaging and image analysis of regulated reporter gene expression 
The system was equipped with an atmosphere cover, clicked onto the microscope stage before 
reconnected to CO2, pressure and electrical supplies. The system was incubated in an atmosphere 
setting of 37°C and 8% CO2 to keep a pH of the cell culture medium at about 7.0-7.2. Time-lapse 
series of the regulated fluorescent reporter gene expression were recorded every hour by a Zeiss 
Axio Observer.Z1 microscope equipped with a 10x/0.3 Plan-Neofluar objective, Colibri LED light 
source and a Zeiss Axiocam MRm B/W camera. A scan of 6×2 images, all acquired with a z-stack 
of seven slices (5 µm between each slice), were recorded for each chamber. The DD-ZsGreen1-DR 
signal was acquired at 470 nm excitation wave length through a 62HE filter, while mCherry was 
excited at 555 nm and emission light acquired through a 43HE filter. DD-ZsGreen1-DR was ex-
posed for 10 ms and mCherry for 500 ms. The images were processed by stitching the individual 
images together, converting the stitched images to one image and finally applying the AxioVision 
Extended Focus module on the z-stacks to obtain the best focused image. The fluorescent signal 
was quantified by calculating the densitometric sum (DS) based on the individual pixel values of 
the converted 16 bit image in the range between 1000-62955 for DD-ZsGreen1-DR and 1032-
62439 for mCherry. Mean value of densitometric sum based on six individual chambers was calcu-
lated and normalized to the highest recorded value. The normalized averages and normalized stan-
dard error on the mean (SEM) for the regulated DD-ZsGreen-DR were plotted as function of time. 
3.2.4 ASC differentiation experiments into adipocytes 
3.2.4.1 Adipogenic differentiation media 
All differentiation media has been freshly prepared just before use. 
Adipogenic medium (AM) 
Normal cell culture medium supplemented with IBMX (isobutyl-methylxanthine) 0.5 mM (I5879, 
Sigma), dexamethasone 1 µM (D4902, Sigma), indomethacin 0.2 mM (17378, Sigma), and insulin 
10 µg/mL (I9278, Sigma). 
AM diluted 4x 
AM diluted 4 times in normal cell culture medium without serum. 
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1.5x AM + CM 
AM prepared with 1.5 times the concentration of IBMX, dexamethasone, indomethacin and insulin 
compared to the normal concentrations in AM. The 1.5x AM is mixed 1:1 with conditioned me-
dium (CM) (see below). 
1.5x AM diluted 4x + CM 
1.5x AM is diluted 4 times in normal cell culture medium without serum. The 1.5x AM diluted 4x 
is then mixed 1:1 with CM. 
(1.5x AM + CM) diluted 4x 
The 1:1 mixture of 1.5x AM + CM (1.5x AM + CM) is diluted 4 times in normal cell culture me-
dium without serum. 
3.2.4.2 Adipogenic differentiation in static cell culture 
At a cell confluence of approximately 80-90%, the cell culture medium was changed to diffe-
rentiation medium to induce the differentiation. The differentiation was continued up to three 
weeks with normally half of the differentiation medium changed every 3-4 days. However, in the 
static cell culture reference experiment to the perfusion cell culture experiments, the entire differen-
tiation medium was changed every 4 days. As a negative control one flask was grown in normal 
cell culture medium. 
3.2.4.3 Adipogenic differentiation in perfusion cell culture 
Differentiation was induced at a cell confluence of approximately 80-90%. When testing diffe-
rentiation at different cell densities, the differentiation was induced the day after cell loading. The 
cells were perfused with the different tested differentiation media (see above) and different tested 
flow rates. Medium reservoirs were exchanged with fresh medium every 4 days. For each differen-
tiation experiment, one chamber was grown in normal cell culture medium as a negative control. 
3.2.4.4 Collection of conditioned medium 
In static cell cultures ASCs were grown to a cell confluence of approximately 80-90% before, 
the cell culture medium was changed to AM to induce the differentiation. Half of the conditioned 
differentiation medium was collected normally at day 4, 8, 12 and 16 after onset of differentiation 
and stored at 4 °C.  The collections of CM from the 4 days during the differentiation period were 
pooled, aliquoted and stored at -20 °C. 
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3.2.4.5 Imaging and image analysis of ASC differentiation 
Phase contrast images of ASC differentiation were normally acquired every second day by a 
Zeiss Axio Observer.Z1 microscope equipped with a 10x/0.3 Plan-Neofluar objective, and a Zeiss 
Axiocam MRm B/W camera. A scan of each cell culture chamber, all images acquired with a z-
stack of 5 slices (6 µm between each slice), were recorded with a exposure time of 5 ms. The im-
ages were processed by applying the AxioVision Extended Focus module on the z-stacks to obtain 
the best focused image, stitching the individual images together and finally converting the stitched 
images to one image. Differentiation was measured by the total area of lipid-filled droplets using 
ImageJ and normalized to the total cell area at the start of differentiation. The lipid-filled droplets, 
which appear as white pixels, were marked by marking areas of two or more pixels with a gray 
value between 31347 and 65520. The area of cells at start of differentiation was measured by mark-
ing pixels with gray values of 12076 or more. Due to the very low contrast of ASCs, it was not 
possible to mark the whole area of each cell. However, the error was the same for all measure-
ments. 
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Chapter 4 
 
System Design Considerations 
and Reliability 
As described in the introduction, microfluidic cell culture has offered many new possibilities for 
in vitro cell culture experiments regarding control of the cellular microenvironment and, what is 
more, has improved the biological relevance by mimicking in vivo conditions more closely than by 
the use of conventional cell culture methods. Despite these achievements, microfluidic cell culture 
methods have not been widely implemented into biological/biomedical laboratories. Issues like 
requirement of skills not normally held by biologists, lack of scalability and difficulties with inter-
pretation and comparison of results with previous knowledge obtained by conventional cell culture 
methods are obvious reasons for this lack of adoption by biologists. However, other probable ex-
planations could be that the handling of such complicated devices is laborious and time-consuming. 
In addition, the devices may exhibit poor robustness and general reliability resulting in high failure 
rates.  
In this chapter, microfluidic cell culture devices/systems are evaluated with regard to general 
usability within areas such as fabrication, assembling, portability, robustness, compatibility with 
standard laboratory equipment and sterilization procedures, and reliability. In line with the issues 
described above, the good performance as well as the less good performance will be presented and 
finally discussed in the last part of the chapter. The evaluation is based on working experiences 
acquired by the author through the practical use and testing of systems developed within the Pro-
Cell project and the FAST group alongside the testing. 
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4.1 System requirements 
To meet basic requirements for a microfluidic system for mammalian cell culture experiments, 
many aspects should be considered in the design and fabrication process. The most important re-
quirements that should be met in order to provide a usable cell culture system are listed below: 
 
Fluidic actuation and control 
Control of the cellular microenvironment by means of fluidic actuation (for example pumps), con-
trol of the fluidic actuation (setting/changing of flow rate, turning on/off) and maybe valves (to 
selectively be able to open/close different microfluidic channels) should be provided. The cell cul-
ture compartment must be supplied with fresh cell culture medium containing nutrients and growth 
factors to support normal cellular functionality such as cell viability, proliferation, and differentia-
tion. Likewise, cellular waste products have to be removed to maintain the optimal pH value of the 
medium. Finally, the fluidic control is a necessity to be able to perform spatial and temporal differ-
ential cell stimulation with various cues. 
Liquid reservoirs 
The volume of a microfluidic cell culture chamber is normally in the microlitre scale. However, 
dependent of the flow rate, a perfusion cell culture experiment consumes volumes of medium in the 
millilitre scale over a few days. For that reason, liquid reservoirs for fresh medium and waste me-
dium, which are big enough to support at least 1-2 days of experimentation, are necessary. 
Liquid connections 
In order to provide a liquid line between medium/cues supply, cell sample, and waste, it is often 
necessary to have several liquid interconnections. The connections must be tight and robust to 
avoid leakage, bacteria contamination and introduction of bubbles into the liquid system. In addi-
tion, they should be easy to assemble. 
Cell culture chambers 
The central part of a microfluidic cell culture system is a chip with chambers designed to support 
cell growth and analysis. It should be possible to tailor the number and the design of the cell culture 
chambers specifically to different kind of assays. 
Biocompatibility 
When choosing materials and fabrication processes, it is essential to ensure that the materials and 
fabrication processes are not toxic to the cells or influence the general functionality of the cells. 
Compatibility with standard laboratory procedures 
In order to avoid contamination of the cell culture and to support cell adhesion, growth and differ-
entiation, it is necessary that the device allows for sterilization (preferably autoclavation) of the 
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inner surfaces that will be exposed to the cell culture medium. In addition, the device should allow 
for surface coating procedures. Finally, functional cell analysis may require compatibility with cell 
transfection, immunochemistry, and other staining procedures. 
Compatibility with standard laboratory equipment 
For implementation of microfluidic cell culture systems as a tool in biological/biomedical research 
laboratories, the devices/systems must be compatible with existing laboratory equipment such as 
incubators, microscopes, or microplate readers. 
Optical properties 
A very important tool within biological/biomedical research is microscopy imaging, which implies 
a requirement for good optical properties of the cell culture compartment. It should be possible to 
achieve clear phase contrast and fluorescent images of the cells with low autofluorescence from the 
chip material.  
Scalability 
In a cell analysis study, normally, many conditions wanted to be analysed in the same experimental 
set up in a high-throughput manner. Therefore, one or two separate cell culture chambers are nor-
mally not enough for a common biological experiment. Often 10-30 (or even more) separate cell 
culture chambers are required. In addition, when designing a cell culture system that gives the pos-
sibility to analyse many samples at the same time, it is important to consider means to prepare and 
handle the cell culture system in a high-throughput manner not to make the experimental work very 
laborious and time-consuming. 
Portability 
Normally, a cell culture and analysis experiment involves several different working procedures, 
which take place at different locations, for example in a laminar air flow (LAF) bench, on a micro-
scope stage or in an incubator. Accordingly, it is essential that the system easily can be transported 
between the work stations without interrupting the experiment. 
Usability 
In general, biologists do not have special physical and technical skills. For that reason, it is impor-
tant that the ease of use has high priority. In addition, the time required to set up an experiment 
should be reasonable compared to the output. 
Reliability 
To facilitate low failure rates (< 10% in my opinion) and thereby reliable readouts, one of the most 
important requirements is reliability. The system and the components of the system must therefore 
exhibit a high degree of robustness to withstand the many operations of the cell culture system both 
during the experimental set up and during the run of long-term experiments.  
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4.2 Design approaches 
When designing and fabricating a microfluidic cell culture device, the focus can be on the cell 
culture chip level or on the creation of a fully functional system. A very large part of the presented 
devices have been focused on only the chip level [4, 7, 29, 30]. Even though they display for ex-
ample complex gradient generators or allow co-culture of different cell types, they require several 
peripheral components such as fluidic actuation in the form of macro-sized syringe pumps and 
liquid inlet/outlet reservoirs, thereby reducing the portability of the device. Other devices are based 
on passive perfusion and therefore do not require additional components [6, 9, 10]. One of the pas-
sive pumping principles rely on surface tension of small droplets to drive the fluid from the small 
droplet through a microchannel to a larger droplet [6]. The passive flow systems presented in [9] 
and [10] are based on gravidity driven flow. However, the inlet/outlet reservoirs contain only rela-
tively small volumes and as a consequence have to be refilled once or twice a day. Another ap-
proach has been to construct fully integrated devices/systems, either modular [102, 103] or non-
modular [5, 33, 104], with pneumatically controlled valves and pumps. Although presented as inte-
grated systems, they usually still have liquid reservoirs as peripheral components, and thereby yet 
complicate transport between work stations. 
Within the ProCell project and the FAST group the approach has been to design and fabricate a 
reliable, easy to use, transportable, reconfigurable modular microfluidic cell culture system with 
integrated pumps, valves, and inlet/outlet liquid reservoirs. A library of components has been de-
veloped (manuscript in preparation, Appendix 4) with the intention that the library forms the basis 
for the creation of many system variants tailored specifically to the application of interest. 
4.3 System components evaluation 
The developmental work regarding design and fabrication within the ProCell project and the 
FAST group has mainly been carried out by Peder Skafte-Pedersen and David Sabourin. The tested 
microfluidic cell culture devices/systems are illustrated in Fig. 10. The device shown in Fig. 10a 
was the basis for the developmental work during this PhD project. The first system version is 
shown in Fig. 10b and the second version in Fig. 10c. Both systems are modular and consist of vari-
ous parts of the developed component library. The presented and evaluated components of the li-
brary are divided into pumps, motors and controllers, liquid reservoirs, fluidic interconnections, 
cell loading chips, and cell culture chips. The library also contains a valve; however, it has not yet 
been tested and optimized for cell culture experiments. 
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Fig. 10. Overview of tested devices/systems. a) A simple cell culture device with fluidic actuation by a sy-
ringe pump. Constituted the basis for the developmental work performed during this project. b) Microfluidic 
cell culture system, version 1, with up to 24 inlets. c) Microfluidic cell culture system, version 2, with up to 
32 inlets. 
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4.3.1 Pumps 
Like many microfluidic cell culture devices, the first tested cell culture device relied on a 
macro-sized pump (Fig. 11a) for fluidic actuation. This size of pump complicated transport of the 
device and the number of media inlets was very limited. In addition, the pump did not allow for 
pre-programmed change of flow rates, and due to long tubings it had a large dead volume. To solve 
these issues, a micropump has been developed and described by Skafte-Pedersen, Sabourin et al. 
2009 [15, 21, 105]. The micropump (Fig. 11b) enables simultaneous peristaltic pumping of eight 
fluidic channels, and with a food-print of 30 mm (w) x 40 mm (l) x 20 mm (h) it can easily be inte-
grated into a microfluidic system platform. As shown in Fig. 10b and Fig. 10c, three or four micro-
pumps have been integrated into the microfluidic system platforms. The relatively low height of the 
micropump makes it compatible with the working distance between the stage and the condenser in 
a Zeiss life science microscope. The average standard deviation on flow rates between channels has 
been measured to 2.8% - 8.7%, and in addition, the pump has been shown to withstand more than 
63000 rotations [15]. The number of rotations correspond to a volume of 33 mL or 45 days of con-
stant perfusion at 500 nL/min [15], which is more than enough for a long-term cell culture experi-
ment. 
 
Fig. 11. Pumps. a) Macro-sized syringe pump. b) Assembled micropump. c) Parts of micropump. From left: 
Rotor bed, µfluidic ribbon, and multi-roller. d) Mold for casting of µfluidic ribbon. e) Precipitations in the 
cell culture medium after passage through the micropump. 
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As shown in Fig. 11c, the micropump consists of three parts: a rotor-bed, a µfluidic ribbon, and a 
multi-roller. The multi-roller is made of a central brass shaft, eight rolling stainless steel pins and 
end-pieces in aluminium, while the rotor-bed is milled in polycarbonate (PC). These two pump 
parts have been very robust, as the same parts have been used throughout the whole project. How-
ever, the µfluidic ribbon made in polydimethylsiloxane (PDMS) has displayed much less robust-
ness and has accordingly often been replaced. The µfluidic ribbon is casted in PDMS into the 
mould together with the reusable end-brackets made of PC and fibres of 250 µm in diameter form-
ing the microfluidic channels. The mould assembled with end-brackets, fibres and filled with 
PDMS is shown in Fig. 11d. After some practice, the fabrication of four ribbons took approxi-
mately 4-5 working hours. The elastomeric PDMS material in combination with the thin channels 
makes the ribbon quite fragile, which often has caused breaks on the ribbon both during fabrication 
and general use. When removing the very thin fibres after the casting, the risk of breaking the fibre 
inside the PDMS has been quite high. Finally, the introduction of even a small bubble along the 
channels at the casting resulted in a leaking pump. The µfluidic ribbon can withstand sterilization 
by ethanol, NaOH, and autoclavation. However, leakage at connections to chips has been observed 
after autoclavation. Regarding assembly, the micropump is easily put together by four screws and 
the ribbon connected to the cell culture chip or liquid reservoirs by two additional screws (Fig. 14). 
Normally, the end-brackets of the ribbon have been fixed in a small holder to facilitate easy liquid 
interconnections.  
Besides the fragile character of the µfluidic ribbon, precipitations in the cell culture medium 
have been observed in the cell culture chamber in connection with pumping (Fig. 11e). The cause of 
these precipitations was investigated, and a summary of the results is shown in Table 2. To ensure 
that the precipitations were not already present in the medium, the medium was filtered immedi-
ately before pumping. However, precipitations were still observed. The influence of the micropump 
was further studied by comparing the amount of precipitations at different configurations (Fig. 12). 
A lot of particles were observed at forward flow, while almost no particles were observed at back-
ward flow. 
 
Fig. 12. Overview of cell culture chambers, micropump, and flow directions. a) Forward flow with the cell 
culture chamber downstream of the micropump. b) Backward flow with the cell culture chamber upstream 
of the micropump.  
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In order to investigate if the precipitations were caused by the PDMS material or the mechanical 
influence of the peristaltic micropump, the medium was drawn through a µfluidic ribbon before 
flowing into the cell culture chamber. No precipitations were observed, suggesting that the precipi-
tations were caused by the mechanical impact of the peristaltic movement of the micropump or a 
combination of the mechanical impact and the PDMS material. 
In addition to the cause of the precipitations, the source was examined by pumping either water, 
medium without serum, and medium with 10 % or 20 % serum. Pumping with water and medium 
without serum resulted in no precipitations, while the number of particles was shown to increase 
with higher serum content in the medium and higher flow rates. Different types of serum gave the 
same result. Furthermore, all precipitations were dissociated after flushing the chambers with tryp-
sin-EDTA or 0.5 M NaOH, but not when flushing with PBS, again suggesting that the source of the 
precipitates is serum protein. Precipitation of serum protein could possibly affect cell functionality 
and was therefore tested by culturing and differentiating ASCs into adipocytes either by forward 
flow or backward flow. A negative impact on the three-week differentiation process was seen at 
flow rates of 125 and 500 nL/min, while no influence was noticed at low flow rates of 33 nL/min. 
This difference was due to the fact that almost no precipitations were observed at 33 nL/min, 
whereas many precipitations were observed at the higher flow rates. All tests were performed both 
on a completely new ribbon and a reused ribbon and no difference was demonstrated. In conclu-
sion, the results suggest that the particles are precipitations of serum protein and caused by a me-
chanical impact of the peristaltic micropump. 
Table 2  
Formation of precipitates 
 
Pre-
filtering 
Forward 
pumping 
– high flow 
Forward 
pumping 
– low flow 
Backward pumping 
– high flow 
Backward pumping 
– low flow 
Drawing 
through 
ribbon 
Water - - - - - - 
Medium 
- serum 
- - - - - - 
Medium 
+ 10% 
serum 
++ ++ - - - - 
Medium 
+ 20% 
serum 
+++ +++ + - - - 
Dissociation of precipitates 
 PBS Trypsin-EDTA 0.5 M NaOH 
Dissociation No effect Complete dissociation Complete dissociation 
- No precipitates 
+, ++, +++ Indicates the degree of precipitates from few precipitates to many precipitates 
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Finally, PDMS has displayed unwanted properties like absorption of hydrophobic molecules [46, 
106]. However, at differentiation of ASCs into adipocytes no difference has been observed with 
respect to degree of differentiation regardless of the micropump was upstream or downstream of 
the cell culture chamber. This issue is therefore not considered as a problem in the assays per-
formed in this project. 
4.3.2 Motors and controllers 
Fluidic actuation has been provided either by a stepper motor (PRECIstep AM 1524 + 15A 
1:152, Faulhaber) in combination with a custom-built control-box (Fig. 13a and Fig. 13b) and soft-
ware or the LEGO® Mindstorms® MXT 2.0 robotics kit (Fig. 13c and Fig. 13d). The stepper motor 
provides flow rates of up to 5 µL/min and a smooth rotation with an average resolution ~ 20 pL per 
step [15], however the occlusion volume of the micropump is ~ 80 nL. The control system allows 
minimum flow rates of approximately 30 nL/min. Although the maximum flow rate of 5 µL/min is 
sufficient for most cell culture experiments, a uniform cell loading requires higher flow rates (see 
section 5.5.1). Even when increasing the viscosity of the cell loading medium, the cell loading still 
resulted in a gradient of cell densities over the length axis of the cell culture chamber.  
 
Fig. 13. Overview of motors and controllers. a) Stepper motor (PRECIstep AM 1524 + 15A 1:152, Faulha-
ber). b) Custom-built controller and software for flow control of the stepper motors. c) LEGO® 
Mindstorms® motor and controller. d) LEGO® Mindstorms® software for flow control. 
The size of the stepper motor is less than the micropump and the weight only 17.3 g [15], which 
facilitates easy integration into the microfluidic cell culture platform and keeps the system compat-
ible with the working distance between the stage and the condenser in a Zeiss life science micro-
scope. The motors have been robust in use, as only one motor has been replaced during the whole 
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project. The custom-made pump control is based on Visual Basic for Applications (VBA) thereby 
preparing it for automated control through the Zeiss microscope control software AxioVision VBA 
module. However, a first version was developed by Felician Stefan Blaga and directly implemented 
in MS Excel. This first version only allows pump control, but not pre-programming of pump con-
trol, and has been employed for experiments throughout this project. 
The LEGO® Mindstorms® MXT 2.0 robotics kit provides servo motors, a small controller, and 
a software interface (LabView®) for programming of the motors. The lowest rotational resolution 
is 1°, which makes the rotational movement less smooth compared to the stepper motor. The size of 
the motor is much bigger than the stepper motor (80.3 g, 11 cm (l) x 4 cm (w) x 4.5 cm (h)); how-
ever, it is still possible to integrate up to four micropumps and motors into the microfluidic cell 
culture system platform (Fig. 10c). Although the four motor configuration is possible, it does not fit 
into the microscope unless the two middle upright motors are removed before placing the system 
onto the microscope stage. The small size of the control box and the possibility for battery driven 
power supply makes the LEGO® Mindstorms® kit fluidic action and control more portable than 
the stepper motor control system. The pre-programming of the pumping is easily performed (even 
for a biologist) using the associated software with a LabView® interface. With the software it is 
possible to pre-program flow rates, breaks, or changes of flow rates over time. The LEGO® 
Mindstorms® motors have provided average flow rates from 33 nL/min to 30-40 µL/min [105]. 
The option to run at very high flow rates has made it possible to load cells at a uniform density over 
the entire cell culture chamber (see section 5.5.1). Although the LEGO® Mindstorms® kit has 
many advantages, some problems have been observed. The controller has three output ports that 
can be run at the same time. When running at high flow rates (~ 5 µL/min) from more than one 
port, the output has not been the same from both ports, probably due to too slow a response time of 
the control circuit. Furthermore, the motors move a bit while running, which can interfere with 
keeping the focus during time-lapse microscope imaging. Finally, it is important to ensure com-
pletely free space around the motor to avoid blocking of the motor rotation. 
4.3.3 Liquid reservoirs 
The liquid reservoirs are integrated into the microfluidic cell culture platform either in the form 
of glass vials or vial chips (Fig. 14a and Fig. 14b, respectively). The glass vials are placed into a 
holder, integrated into the microfluidic cell culture platform, and are connected to the micropump 
via poly (tetrafluoroethylene) (PTFE) tubings. The glass vials with polypropylene lids with sili-
con/PTFE septa and PTFE tubing all allow for sterilization by autoclavation. However, with a high 
number of liquid reservoirs, the initial assembling of the system and the change of cell culture me-
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dium during an experiment are quite time-consuming. The vial chip consists of a two layer bonded 
bottom chip with integrated fluidic channels, a block in the middle with eight wells of a volume of 
3 mL, and a top lid. They are all made of poly (methyl methacrylate) (PMMA) to withstand NaOH, 
which is used for sterilization of the cell culture chip, also made of PMMA. Due to the fact that the 
vial chip is made of PMMA, it does not allow for sterilization by autoclavation or by ethanol. The 
inner surfaces are therefore sterilized by 0.5 M NaOH, making the sterilization process more com-
plicated and time-consuming compared to autoclavation. The three parts are fixed together with 
screws and sealed at the bottom and the top via a gasket piece casted in PDMS. Changing of liquids 
can easily be performed by unscrewing the lid, removing the remaining liquid by suction and refill-
ing with new liquid. However, the fixing of the lid to the well part by the six screws has to be done 
very carefully to avoid breaks in the well part. Furthermore, the fixing of the bottom bonded part to 
the middle well part with screws makes the bottom part very exposed to breaks in the bonding. The 
risk of breaks compared to a quite time-consuming fabrication is a disadvantage of the vial chips. 
Finally, increasing the number of required liquid reservoirs complicates the compatibility with 
microscopy imaging, due to limited space in the microscope between the stage, condenser and the 
built-in incubator cabinet (Fig. 18c). 
 
Fig. 14. Liquid reservoirs and interconnections. a) Glass liquid reservoirs connected to micropump via 
PFTE tubings and a small gasket of a piece of silicon tube. b) Liquid reservoirs in the form of a vial chip. c) 
End-bracket of the µfluidic ribbon with integrated gaskets and ball joint interconnections casted in PDMS. 
d) Two micropumps with the one end of the µfluidic ribbon connected to the top of a cell culture chip and the 
other end connected to the bottom of a vial chip. 
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4.3.4 Liquid interconnections 
The design of the ends of the µfluidic ribbon with gaskets and ball joint interconnections casted 
in PDMS (Fig. 14c) enables easy connection of eight microfluidic channels to either a cell culture 
chip, a liquid reservoir chip or another connection piece in one step (Fig. 14d). The connections are 
simply fixed by two screws from the top of the microfluidic platform (see also section 4.4) and 
have, in general, been very tight and robust. PTFE tubings connecting glass reservoirs to a micro-
fluidic ribbon are sealed to a connection piece through a small silicone tube (Fig. 14a). Although 
these connections have been tight, they are not completely fixed and care must be taken not to de-
tach the tubing.  
The cell loading chip (Fig. 15c) is also based on the connection of eight fluidic channels in one 
step. For tight connection to the top of the cell culture chip, the bottom of the cell loading chip has 
integrated gaskets casted in PDMS. The channels/wells in the top of the cell loading chip are con-
nected to the liquid reservoirs by PTFE tubing, which is pressed into the channels/wells in the cell 
loading chip (Fig. 15d and Fig. 15e). The connections are kept tight by applying a diameter of the 
PFTE tubing that is a bit larger than the diameter of the PDMS wells, thereby making a sealing. 
However, initially the connections were not fixed and leakages were observed. 
4.3.5 Cell loading chips 
The first version of a cell culture chip was made of PMMA with embedded micromilled wells 3 
mm in diameter and 5 mm in height (Fig. 15a and Fig. 15b). The cell loading chip was connected 
to the cell culture chip through a small µfluidic ribbon and integrated as a part of the fluidic flow 
from inlet reservoirs to outlet reservoirs. The cell loading chip was connected to the liquid reser-
voirs through PFTE tubing pressed into the wells with a small silicone tube as a gasket (Fig. 15b). 
When performing the cell loading, the tubings were removed and the cell suspension loaded into 
the wells by pipetting. The cell suspension was drawn into the cell culture chambers by actuation of 
the micropump. However, it was very difficult to obtain a uniform cell loading, because of sedi-
mentation of the cells during the relatively long pathway from cell loading chip to cell culture 
chamber. In addition, bubbles were easily introduced into the cell culture chambers, due to bubbles 
caught along the edges of the bottom of the milled wells. 
The second version of a cell loading chip is made of PC with a middle piece casted in PDMS 
with embedded wells (Fig. 15c). It is placed directly on top of the inlet holes of the cell culture 
chip (Fig. 15d and Fig. 15e), thereby reducing the loading pathway, and as a result a more uniform 
cell loading is obtained. The wells, casted in the elastomeric material PDMS, allow for direct con-
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nection to PFTE tubing (Fig. 15d and Fig. 15e) and in that way reduce the number of liquid inter-
connections compared to the first version of the cell loading chip. However, the PDMS is not that 
robust, and care must be taken, when removing the PFTE tubing before cell loading, not to break 
the PDMS casted insert. The cell loading is performed almost in the same way as with the first 
version. However, to avoid introducing bubbles during the loading of the cell suspension into the 
thin wells, the suspension is loaded by the use of a syringe and a 0.5 mm needle (Fig. 15f). Al-
though it is difficult to observe any bubbles through the relatively thick and unclear cell loading 
chip, the cell loading has been performed without introducing any bubbles in most cases. 
 
Fig. 15. Overview of cell loading chips. a) First version cell loading chip connected to the cell culture chip 
through a small µfluidic ribbon. b) The wells in the first version cell loading chip were milled in PC. Con-
nected to liquid reservoirs through PFTE tubing and a small piece of silicone tube as a gasket. c) Second 
version cell loading chip with eight wells embedded in a middle piece casted in PDMS. d) The cell loading 
chip is fixed directly on top of the inlets to the cell culture chip. Liquid connections to reservoirs are per-
formed by pressing PFTE tubing into the PDMS wells. e) Cell loading chip assembled onto the cell culture 
chip and connected to reservoirs by PFTE tubings held together in a small collection piece. f) Loading of the 
cell suspension into the wells is carried out by the use of a syringe and a 0.5 mm needle. Images courtesy of 
Peder Skafte-Pedersen. 
Both PC and PDMS are compatible with sterilization by autoclavation. However, shrinking has 
been observed after autoclavation of PDMS, and the inner surfaces of the cell loading chip have 
therefore been sterilized by flushing with 0.5 M NaOH before assembling the system. Another 
drawback regarding the risk of contamination is that the PFTE tubing has to be removed and re-
placed again to perform the cell loading. Although this is carried out in the LAF bench, it gives a 
risk of contamination with bacteria or fungi. 
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4.3.6 Cell culture chips 
The cell culture chips are made of three or four layers of PMMA bonded together by UV-
assisted heat-bonding [15]. However, the UV-assisted heat-bonding should be carried out very 
carefully to be successful and, in addition, the bonding is not that robust resulting in many failures 
due to a broken bonding (Table 3). Regarding possible sterilization methods, autoclavation results 
in a bent chip due to too low a glass transition temperature of PMMA.  PMMA in combination with 
the tensions applied to the material through the bonding is not compatible with sterilization with 
ethanol either. The ethanol causes breaks in the PMMA. Accordingly, 0.5 M NaOH has been used 
for sterilization of the inner surfaces. 
 
Fig. 16. Examples of microfluidic cell culture chips. a) A 16 chamber chip, each chamber with two inlets. 
b) An eight chamber chip, each chamber with three inlets. c) An eight chamber chip, each chamber with one 
inlet. The channels are divided between three micropumps, thereby enabling application of three different 
flow rates in one experiment. d) A 24 chamber chip, each chamber with one inlet. The channels are divided 
between three micropumps, thereby enabling application of three different flow rates in one experiment. 
Images courtesy of Peder Skafte-Pedersen. 
The design of the cell culture chip with respect to the number of cell culture chambers and rout-
ing of the microfluidic channels can be tailored specifically to each application. With the use of the 
first version microfluidic system (Fig. 10b) up to 24 inlets can be routed to the cell culture cham-
bers in different ways. For example, 24 inlets can be routed to 24 separate chambers (Fig. 16d), 3 
inlets routed to each of 8 chambers (Fig. 16b) or in principle 24 inlets routed to one chamber. Re-
garding the second version system (Fig. 10c) up to 32 inlets can be applied in the same way. An 
example of a cell culture chip for the second version system with 16 separate chambers each with 
two inlets is shown in Fig. 16a. The routing of more than one channel from different pumps to the 
same chamber enables flow from different liquid reservoirs at the same time, switching between 
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different liquid reservoirs over time or creation of gradients of cues over time by differential flow 
rates. Furthermore, routing from different pumps to different chambers allows for different flow 
rates in the same experiment (Fig. 16c and Fig. 16d). 
4.4 Systems evaluation 
As presented in section 4.3 and Fig. 10, three microfluidic cell culture devices/systems have 
been applied/tested during this PhD project. The first device shown in Fig. 10a formed the basis for 
the developmental work, mainly performed by Peder Skafte-Pedersen and David Sabourin, result-
ing in the creation of the component library, from which the main components were presented and 
evaluated in section 4.3.1 to 4.3.6. The two microfluidic cell culture systems, shown in Fig. 10b and 
Fig. 10c, were built by the use of various components from the library.  A detailed characterization 
of the system shown in Fig. 10b is presented in [107]. Assembling, portability, interference by bub-
bles and general reliability of the cell culture systems are presented and evaluated below in section 
4.4.1 to 4.4.4. 
4.4.1 Assembling 
The principle of the assembling of the two microfluidic cell culture systems is the same. The ba-
sis is a system base plate, onto which various components are fixed by screws. The modular system 
and the fixation by screws make it easy to change a broken component without the need to fabri-
cate a whole new system.  
 
Fig. 17. Overview of assembling of cell culture chip to system base plate. a) The cell culture chip is placed 
onto the small support frame in the bottom and the system base plate clicked onto the cell culture chip. The 
recesses of the system base plate fit exactly to the dimensions of the cell culture chip and the support frame. 
b) Finally, the system base plate is fixed to the cell culture chip and the support frame by screws from the top 
of the system base plate. Drawing courtesy of Peder Skafte-Pedersen. 
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A complete system base plate consists of micropumps, motors, liquid reservoirs and liquid con-
nections from the reservoirs to the micropumps. In order to assemble the cell culture chip to the 
base plate, the cell culture chip is placed onto a small support frame and the system base plate 
clicked onto the cell culture chip (Fig. 17a). The recesses of the bottom of the system base plate fit 
exactly to the dimensions of the cell culture chip and the support frame. Finally, the system base 
plate is fixed to the cell culture chip and the support frame by screws from the top of the system 
base plate (Fig. 17b). To obtain a bubble-free liquid network, it is normally necessary to fill the cell 
culture chip with water manually before assembling to the system base plate. A cell culture chip 
with a complicated channel and chamber network can be difficult to fill with water without any 
bubbles. Filling of the channels with CO2 just before filling with water can help to obtain a bubble-
free chip. The CO2 is more easily dissolved in the water than atmospheric air. In addition to pre-
filling the cell culture chip, the PFTE tubings, other liquid channels and the channels in the micro-
pump are pre-filled with water by actuation of the micropumps. When connecting the system base 
plate and thereby the liquid channels to the channels of the cell culture chip, drops of water are 
created at both connection ends to get a connection without introducing any bubbles. The pre-
filling of the system with water and the assembling of the system platform to the cell culture chip 
from the top by screws (Fig. 17) are very user-friendly and has in general resulted in a bubble-free 
liquid network after system assembling. 
4.4.2 Portability 
Normally a cell culture and analysis experiment takes place at many different locations, such as 
for example a LAF bench for system assembling, preparation and medium change (Fig. 18a), a cell 
culture incubator to maintain the required environment (Fig. 18b) and a microscope for imaging 
and cell analysis (Fig. 18c). Due to the integration of all components into a single system base 
plate, both systems are very easy to transport between the different work stations. 
 
Fig. 18. Portability enables easy movement between different work locations. a) Change of medium in LAF 
bench. b) Placed into an incubator for cell culture. c) Placed into a Zeiss life science microscope for imaging 
and cell analysis. Images courtesy of Peder Skafte-Pedersen. 
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Especially the small controller of the LEGO® Mindstorms® MXT 2.0 robotics kit (Fig. 13c), 
which, in addition, allows for battery driven actuation of the micropumps, makes the transport very 
easy. The control system of the stepper-motors requires a small trolley for transportation (Fig. 13b). 
However, because the control system can easily be disconnected by unplugging the electrical wire 
at the system base plate, the transport of this first version system is still unproblematic. 
4.4.3 Bubbles 
Air bubbles are a common problem when working with microfluidic systems. They are un-
wanted, because they cause cell death, interfere with cell analysis and can affect the flow. The bub-
bles can be introduced into the system either during filling or assembling of the fluidic network. 
Furthermore, changes in pressure and temperature affect the amount of air that can be dissolved in 
water, which can lead to outgassing of air from the liquid in the fluidic system. Finally, air can be 
introduced during operation of the system through air permeable components, such as the µfluidic 
ribbon made of PDMS, which is a part of the peristaltic micropump. As shown in Table 3, section 
4.6, air bubbles in the microfluidic system were a major problem during the first period of the sys-
tem testing.   
 
Fig. 19. Bubbles and ways to avoid bubbles in microfluidic systems. a) A bubble trap filled with bubbles at 
the inlet triangle. b) The same bubble trap as in a) six hours later and now filled with even more air. c) A 
cell culture chamber filled with air bubbles. d) Microfluidic cell culture system assembled with a pressure 
network. A T-piece at the inlet divides the air pressure into two, routing to the inlet and the outlet of the 
system. All glass vials are connected in series via PFTE tubings to the inlets and the outlets of the microflui-
dic system thereby applying the same pressure to both the inlets and the outlets of the microfluidic network. 
e) The inlet of the air-network is mounted with a 0.22 µm filter to avoid any contamination of the system. 
Image e) courtesy of Peder Skafte-Pedersen. 
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There are several ways to avoid bubbles in microfluidic systems. The liquid can be degassed be-
fore use and thereby be able to absorb more air during operation. However, this is not an option for 
microfluidic cell culture systems, due to the fact that the cells require O2 and CO2 in the cell culture 
medium to be viable. Passive bubble traps [108] and combined bubble traps and bubble removal 
features [109, 110] have been demonstrated in the literature. In this project, a passive bubble trap 
was applied in the first part of the project (Fig. 19a and Fig. 19b). However for long-term cell cul-
ture experiments, the capture volume of the passive bubble traps was insufficient. Fig. 19a shows a 
bubble trap filled with air bubbles in the inlet triangle to the left. Six hours later, shown in Fig. 19b, 
the bubble trap was filled with even more air. The insufficient trapping volume finally resulted in 
cell culture chambers filled with air bubbles as shown in Fig. 19c. Other drawbacks of the bubble 
traps are that they make the fabrication process of the cell culture chip much more complicated and 
time-consuming and that they take up a lot of space of the already rather limited area of the cell 
culture chip.  
To finally solve the problem of air bubbles destroying the cell culture experiments, the gas per-
meable characteristic of the PDMS components was exploited. The whole microfluidic system has 
been applied a pressure of 0.3 bar ~ 3 x 10
4
 Pa of atmospheric air, added 5% CO2 to maintain a 
proper pH of the cell culture medium. After applying pressure onto the microfluidic network, the 
microfluidic cell culture system has been operated successfully without introduction of any bubbles 
during up to three weeks of cell culture. The pressure is thought to cause the air to diffuse through 
the PDMS and thereby disappear. The same principle has successfully been used by Gómez-
Sjöberg et al. [5]. 
In practice, the microfluidic network has been pressurized by applying atmospheric air added 
5% CO2 to all the inlet and outlet liquid reservoirs at a pressure of 0.3 bar ~ 3 x 10
4
 Pa. The com-
pressed air network has been created through PFTE tubing, which from one inlet tube was divided 
in two through a T-piece and then connected to either the inlet reservoirs or the outlet reservoirs. 
With respect to the glass vials, they were connected in a series via small pieces of PFTE tubing; 
however, if there were many glass vials, this assembling process could be rather time-consuming. 
This issue has been solved by the use of the vial chip, because the wells in the vial chip are con-
nected through a channel-like recess in the lid of the vial chip. In this way, all the wells in the vial 
chip are pressurized by connecting one single PFTE tube to the lid of the vial chip. The connection 
to the lid is sealed by the use of a small piece of silicone tube as a gasket, but the connection was 
not fixed and care should be taken not to detach the PFTE tubing. 
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4.4.4 Compatibility with microscopy imaging 
Both microfluidic cell culture systems are compatible with microscopy imaging using a Zeiss 
life science microscope (Axio Observer.Z1). The system base plates are designed to exactly fit into 
the recess on the microscope stage, originally made for fixation of well plates. In addition, it is 
possible for both systems to perform cell culture experiments with time-lapse microscopy imaging 
by the use of a microscope mounted incubator (Incubator XL Dark S1, Zeiss) and a CO2 module 
(CO2 module S1, Zeiss). However, due to limited space between the condenser and the microscope 
stage and the larger size of the LEGO® motors, it is only possible to run with up to two integrated 
micropumps and LEGO® motors with the second version microfluidic system. 
4.4.5 System reliability 
As described in section 4.1, general reliability is a very important requirement for a microfluidic 
cell culture system to be successfully implemented as a tool within biological/biomedical research. 
In Table 3 an overview is presented of the failures registered during operation of the tested devic-
es/systems and the time consumed to set up an experiment. Each experiment is labeled by the date 
of the setting up of the experiment. The listed types of failures and parameters are described below: 
Broken chip bonding 
A broken bonding of the cell culture chip, at or near the microfluidic channels or cell culture cham-
bers, results in a leakage in the microfluidic network, loss of pressure and finally introduction of air 
into the cell culture chambers. 
Broken µfluidic ribbon  
A leak in a µfluidic ribbon results in a leakage in the microfluidic network, loss of pressure and 
finally introduction of air into the cell culture chambers. 
Leakage at lid/septum of glass vial 
A leakage at the lid or the septum of one of the glass vials results in loss of pressure and finally 
introduction of air into the cell culture chambers. 
Leakage at cell loading chip 
A leakage at the liquid connections to the outlet chip results in a leakage in the microfluidic net-
work, loss of pressure and finally introduction of air into the cell culture chambers. 
Broken cell loading chip 
The inner part of the cell loading chip is casted in PDMS with embedded wells for cell suspension 
loading. When removing the PFTE tubings to perform the cell loading as described in section 4.3.5, 
the PDMS part is very exposed to breaks, if not done carefully. 
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Broken vial chip – bottom part 
The bottom part of the vial chip with microfluidic channels is a two layer bonded chip, which is 
fixed to the well part of the vial chip by screws. The tension applied to the bonded bottom part 
result in a high risk of breaking the bonding, giving rise to a leakage in the microfluidic network, 
loss of pressure and finally introduction of air into the cell culture chambers. 
Broken vial chip 
The bottom part and the lid are fixed to the well part of the vial chip by screws and embedded nuts. 
The fixing has to be quite tight to maintain the pressure; however this can cause the PMMA to 
break. 
Other leakage 
Other leakage can be leakages at liquid connections not listed above or a leakage resulting in a loss 
of pressure, for which the cause could not be found. 
Contamination of microorganisms 
Incidences of contaminations with either bacteria or fungi due to insufficient sterilization or aseptic 
handling during preparation and culture of the cells. 
Chambers with bubbles during cell culture 
Bubbles caught or formed during setting up of the experiment were normally removed before con-
tinuation of the experiment. The bubbles listed in this table are bubbles caught or formed during the 
running of the experiment. 
Time spent to set up the experiment 
The approximate time spent to set up the experiment in hours is listed. 
Days of cell culture 
The days of cell culture for each experiment are listed to be able to compare the failure rate to the 
duration of the experiment. 
Errors during set up or run of the experiment 
For each experiment is given if errors have occurred and the number of errors encountered. The 
errors are divided between during set up of the experiment and during run of the experiment. 
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Table 3. Overview of failures during operation of the tested devices/systems 
Cell culture device with fluidic actuation by syringe pump 
Experiment 
Errors 
during set up 
of experi-
ment ab 
Errors 
during run 
of experi-
mentb 
Broken 
chip 
bond-
ing 
Broken 
µfluidic 
ribbon 
Leakage at 
lid/septum 
of glass 
vial 
Leakage 
at cell 
loading 
chip 
Broken 
cell 
loading 
chip 
Broken 
vial 
chip – 
bottom 
part 
Broken 
vial 
chip 
Other 
leakage 
Contamina-
tion of 
micro-
organisms 
Days 
of cell 
culture 
Chambers 
with bub-
bles during 
cell culturec 
Time spent 
to set up 
experiment 
(hours) 
2009.07.15  x (1)  - - - - - -   5 1/1 13 
2009.09.23    - - - - - -   4 0/1 12 
2009.09.30    - - - - - -   5 0/1 11 
2009.10.07    - - - - - -   5 0/1 9 
2009.10.14  x (1)  - - - - - -   4 2/4 8 
2009.12.09 x (1) x (1)  - - - - - - x  4 3/4 11 
2009.12.17  x (1)  - - - - - -   4 2/4 11 
Error rate in % of 
total numbers of 
experiments/samples 
14 57 0 - - - - - - 14 0 - 50 - 
System 1 not pressurized 
Experiment 
Errors 
during set up 
of experi-
ment ab 
Errors 
during run 
of experi-
mentb 
Broken 
chip 
bond-
ing 
Broken 
µfluidic 
ribbon 
Leakage at 
lid/septum 
of glass 
vial 
Leakage 
at cell 
loading 
chip 
Broken 
cell 
loading 
chip 
Broken 
vial 
chip – 
bottom 
part 
Broken 
vial 
chip 
Other 
leakage 
Contamina-
tion of 
micro-
organisms 
Days 
of cell 
culture 
Chambers 
with bubbles 
during cell 
culturec 
Time spent 
to set up 
experiment 
(hours) 
2010.02.22  x (1)   -   - -   1 3/5 10 
2010.03.12  x (2) x  -   - -   3 8/8 10 
2010.04.16  x (1)   -   - -   3 8/8 9 
2010.04.23 x (1) x (1)  x -   - -   1 8/8 12 
2010.05.19  x (1)   -   - -   6 7/8 10 
2010.05.27  x (1)   -   - -   4 6/8 8 
2010.06.18  x (1)   -   - -   4 3/8 11 
2010.06.22  x (1)   -   - -   2 4/8 9 
2010.06.25  x (1)   -   - -   3 3/8 7 
Error rate in % of 
total numbers of 
experiments/samples 
11 100 11 11 - 0 0 - - 0 0 - 72 - 
- Not relevant. 
 a 
In general, bubbles were frequently acquired during set up of the experiment and removed before continuing.  bThe number in brackets is the number of errors. Bubbles in cell culture 
chambers are set to one error no matter how many chambers that were observed with bubbles.  c The given number is the number of experiments with bubbles caught/formed during run of the experiment 
out of the total number of experiments. 
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Overview of failures during operation of the tested devices/systems continued 
System 1 pressurized 
Experiment 
Errors 
during set up 
of experi-
ment b 
Errors 
during run 
of experi-
mentb 
Broken 
chip 
bond-
ing 
Broken 
µfluidic 
ribbon 
Leakage at 
lid/septum 
of glass 
vial 
Leakage 
at cell 
loading 
chip 
Broken 
cell 
loading 
chip 
Broken 
vial 
chip – 
bottom 
part 
Broken 
vial 
chip 
Other 
leakage 
Contamina-
tion of 
micro-
organisms 
Days 
of cell 
culture 
Chambers 
with bubbles 
during cell 
culturec 
Time spent 
to set up 
experiment 
(hours) 
2010.08.12        - -   6 0/8 10 
2010.09.02  x (2)   x   - -   11 2/8 10 
2010.09.16        - -   8 0/8 11 
2010.10.04 x (1) x (1) x     - - x  4 0/5 11 
2010.10.26 x (4)  x x  x  - - x  0 - 15 
2010.11.03 x (1)  x     - -   5 0/6 16 
2010.11.16  x (1)      - -   13 1/8 9 
2011.03.08  x (1)      - -   19 1/8 10 
2011.04.05  x (3) x x    - -   1 8/8 10 
2011.04.12 x (1)   x    - -   19 0/8 13 
2011.05.12 x (1) x (2) x  x   - -   3 2/24 18 
2011.05.24        - -   17 0/24 10 
2011.06.14  x (2)      - - x  16 8/24 9 
2011.07.04        - -   20 0/24 11 
2011.08.31 x (1)     x  - -   17 0/8 12 
2011.09.17        - -   21 0/8 10 
2011.10.18 x (1)   x    - -   21 0/8 8 
2011.11.28 x (4)  x xx x   - -   24 0/8 12 
Error rate in % of 
total numbers of 
experiments/samples 
44 39 33 33 17 11 0 - - 17 0 - 12 - 
- Not relevant  
bThe number in brackets is the number of errors. Bubbles in cell culture chambers are set to one error no matter how many chambers that were observed with bubbles.   
c The given number is the number of experiments with bubbles caught/formed during run of the experiment out of the total number of experiments. 
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Overview of failures during operation of the tested devices/systems continued 
System 2 pressurized 
Experiment 
Errors 
during set up 
of experi-
ment b 
Errors 
during run 
of experi-
mentb 
Broken 
chip 
bond-
ing 
Broken 
µfluidic 
ribbon 
Leakage at 
lid/septum 
of glass 
vial 
Leakage 
at cell 
loading 
chip 
Broken 
cell 
loading 
chip 
Broken 
vial 
chip – 
bottom 
part 
Broken 
vial 
chip 
Other 
leakage 
Contamina-
tion of 
micro-
organisms 
Days 
of cell 
culture 
Chambers 
with bubbles 
during cell 
culturec 
Time spent 
to set up 
experiment 
(hours) 
2011.08.23 x (6) 0 x xx  x x  x   12 0/8 28 
2011.09.14 x (2) 0   x   x    14 0/16 21 
2011.10.25 x (2) 0    x  x    26 0/15 13 
2011.11.27 0 0          22 0/16 10 
Error rate in % of 
total numbers of 
experiments/samples 
75 0 25 50 25 50 25 50 25 0 0 - 0 - 
bThe number in brackets is the number of errors. Bubbles in cell culture chambers are set to one error no matter how many chambers that were observed with bubbles.   
c The given number is the number of experiments with bubbles caught/formed during run of the experiment out of the total number of experiments. 
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4.4.5.1 System failures 
The system failures encountered when working with the first simple syringe pump device (Fig. 
10a) and system 1 without pressure (Fig. 10b) were mainly observed during the run of the experi-
ment, with a percentage of failed experiments of 57% and 100%, respectively (Table 3 and Fig. 
20c). These high system failure rates during the run of the experiments were mostly caused by 
catching/formation of bubbles in the cell culture chambers (Table 3 and Fig. 20c). After setting 
pressure to the systems, the frequency of catching/formation of bubbles felt dramatically and there-
by the system failures during the run of the experiments (Table 3 and Fig. 20c). The 13 earliest 
experiments with system 1 had a bubble error rate of 16%. However, no bubbles were observed 
during the run of the five latest experiments with system 1 and all four experiments run with sys-
tem 2. In fact, the experiments have been performed without encountering any errors during the run 
of the experiments the last six months of the project (Table 3 and Fig. 20c). Notably, the decrease 
in bubbles observed in the cell culture chambers is inversely correlated to the number of days of 
cell culture, which increased from 4-6 days to 14-21 days (Table 3 and Fig. 20a).  
 
Fig. 20. Analysis of reliability. a) Time spent to set up the experiment and days of cell culture are shown in 
relation to the different tested devices/systems.  b) The number of custom made parts each system consists of 
is related to the number of component errors during an experiment. c) The percentage of system failures 
during set up and during the run of the experiment as well as the fraction of chambers, which caught/formed 
bubbles during the run of the experiment, are related to the different tested devices/ systems. n is the number 
of experiments. 
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However, after setting pressure on the systems the percentage of experiments with errors during 
set up of the experiments increased from 14-22% to 44-75% of the experiments (Table 3 and Fig. 
20c). The high percentage of experiments with errors during set up of the experiments was mainly 
due to broken system components, especially broken chip bondings and µfluidic ribbons (Table 3). 
Furthermore and not unexpected, the number of custom made system components, a system con-
sists of, correlates with the number of component errors during an experiment (Table 3 and Fig. 
20b). Contaminations of microorganisms in the microfluidic cell culture systems have not been 
observed, i.e. the materials and the design allows for efficient sterilization. 
4.4.5.2 Time consumptions 
The average time spent to set up an experiment without encountering any significant problems, 
was from 9-11 hours (Table 3 and Fig. 20a). Interestingly, the time spent to set up an experiment 
with the simple four chamber syringe pump device was also about 10 hours (Table 3 and Fig. 20a). 
Thus, the time consumption per chamber was 2.5 hours for the simple four chamber syringe pump 
device and 25 minutes for a 24 chamber complex system. However, the setting up of experiments 
with many incidents of errors caused by broken system components considerably increased the 
time spent to set up an experiment (Table 3 and Fig. 20a).  
4.5 Summary 
Table 4 is a summary of the advantages and drawbacks pointed out in the evaluation of the micro-
fluidic cell culture systems and systems components in sections 4.3 and 4.4. 
Table 4. Summary of system components and systems evaluation 
System components evaluation 
Pumps Advantages Drawbacks 
Syringe pump 
 
- No formation of precipitates 
- Robust 
- The macro size complicates transport 
- Limited number of liquid inlets 
- Large dead volume 
- No pre-programming of changes of flow rates 
Micropump 
 
- Simultaneous pumping of eight fluidic    
channels 
- The small size allows easy integration 
into a system platform 
- Compatible with life science micro-
scope 
- Easy assembling of pump and liquid 
interconnections 
- µfluidic ribbon quite fragile 
- Complicated fabrication of µfluidic ribbon 
- Shrinkage observed at autoclavation 
- The mechanical influence of the peristaltic pumping 
causes serum proteins in the cell culture medium to 
precipitate 
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Summary of system components and systems evaluation continued 
System components evaluation 
Motors and controllers Advantages Drawbacks 
Stepper motor 
 
- Smooth rotation 
- The small size of the motor makes it easy to 
integrate into system platform 
- Size of the motor compatible with micros-
copy imaging 
- Robust 
- Flow rates no higher than 5 µL/min 
- The highest flow rate not high enough for uni-
form cell loading 
- The size of the control elements requires a small 
trolley for transport 
- Currently not possible to pre-program changes in 
flow rates or breaks 
Lego motor 
 
- Placement of up to two motors compatible 
with time-lapse microscopy imaging 
- Easy portable controller 
- Possibility for battery driven power supply 
- User-friendly controller software with 
LabView® interface 
- Pre-programming of changes of flow rates 
and breaks possible 
- Possible to run at very high flow rates (30-
40 µL/min) 
- The high flow rate possibility enables 
uniform cell loading 
 
- Size larger than stepper motor, but still allows 
for integration into system platform 
- Less smooth rotation compared to stepper motor 
- The controller has three output ports. However at 
high flow rates, the output has been observed not 
to be the same from all ports 
- The motor moves a bit while running. Can 
interfere with keeping the focus during time-
lapse microscopy imaging 
- The motor can be blocked if the space around the 
motor is not completely free 
Liquid reservoirs Advantages Drawbacks 
Glass vials 
 
- Allows for sterilization by autoclavation - At a high number of inlet vials, the assembling 
and change of medium are quite time-consuming 
 -Pressurising the system is time-consuming at a 
high number of liquid inlets 
Vial chip 
 
- Easy change of medium 
- A channel-like recess in the lid enables 
pressurising of the vial chip by connection 
of only one PFTE tube 
 
- Cannot be sterilized by autoclavation 
- The fixing of the chip parts with screws makes 
the vial chip very exposed to breaks of the mate-
rial or the bonding 
- Time-consuming fabrication 
- Many liquid inlets complicate compatibility with 
microscopy imaging 
 
Liquid interconnections Advantages Drawbacks 
Ball joint connections 
 
- Easy connection of eight fluidic channels in 
one step 
- Tight connections 
- µfluidic ribbon quite fragile 
- µfluidic ribbon complicated to fabricate 
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Summary of system components and systems evaluation continued 
System components evaluation 
Liquid interconnections Advantages Drawbacks 
Loading chip connections 
 
- Eight connections made in one step - The connections are not fixed and leakages have 
been observed 
Cell loading chips Advantages Drawbacks 
First version 
 
- Easy to load cell suspension into mi-
crowells by micropipetting 
- Easy cell loading by actuation of micro-
pump 
- Long loading pathway leading to cell sedimenta-
tion and uneven cell loading 
- Bubbles easily caught at the edges of the wells 
leading to bubbles in the cell culture chambers 
during cell loading 
- Difficult to observe if any bubbles are caught in 
the wells 
Second version 
 
- Short loading pathway with less cell 
sedimentation. Enable uniform cell load-
ing 
- Fewer liquid interconnections compared 
to the first version 
- Easy cell loading by actuation of micro-
pump 
- The PDMS insert is fragile and very exposed to 
breaks when removing the tubings before cell 
loading 
- The narrow wells require cell suspension loading 
using a syringe and 0.5 mm needle, which are 
more complicated compared to micropipetting 
- Difficult to observe if any bubbles are caught in 
the wells 
- Shrinkage of the PDMS insert has been observed 
after autoclavation 
Cell culture chips Advantages Drawbacks 
PMMA chips 
 
 
- Good biocompatibility 
- Good optical properties 
- Allows for adhesive and chemical free 
UV-assisted heat-bonding 
- The design of the cell culture chambers 
and routing of the channels can be tai-
lored to the specific application 
- Routing of more than one channel to the 
same chamber enables flow from differ-
ent liquid reservoirs at the same time, 
switching between different liquid reser-
voirs over time or creation of gradients of 
cues over time by applying differential 
flow rates 
- Routing from different pumps to different 
chambers allows for application of dif-
ferent flow rates in the same experiment 
- Complicated and time-consuming to achieve 
successful bonding 
- Bonding very exposed to breaks 
- Low glass transition temperature of PMMA does 
not allows for sterilization by autoclavation 
- PMMA in combination with tensions in the 
material does not allow for disinfection by etha-
nol 
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Summary of system components and systems evaluation continued 
Systems evaluation 
Cell culture systems Advantages Drawbacks 
Simple device 
 
- Simple assembling 
- Low failure rate of components 
- Low portability 
- The percentage of cell culture chambers with 
formation/capture of bubbles during run of ex-
periment high (50 %) 
- Limited scaling properties 
First version 
 
- Easy assembling of cell culture chip to 
system base plate 
- Good portability 
- Pressurized system leads to low percent-
age of cell culture chambers with forma-
tion/capture of bubbles during run of 
experiment (11 %) 
- Compatible with microscopy imaging 
- Compatible with time-lapse microscopy 
imaging 
- Scaling properties good with up to 24 
parallel cell cultures 
 
 
- Assembling of system easy but quite time-
consuming 
- Pressurized system leads to high failure rates of 
system components 
- Pre-programming of the motors currently not 
possible 
- Controller elements require a small trolley for 
transport 
- The flow rate range is below 5 µL/min. Makes 
uniform cell loading impossible 
- Change of medium relatively time-consuming 
Second version 
 
- Easy assembling of cell culture chip to 
system base plate 
- Excellent portability 
- Pressurized system lead to low percent-
age of cell culture chambers with forma-
tion/capture of bubbles during run of 
experiment (0 %) 
- Compatible with microscopy imaging 
- Compatible with time-lapse microscopy 
imaging with up to two integrated motors 
- User-friendly controller software 
- Pre-programming of motors possible 
- Easy change of medium 
- Possibility for applying high flow rates 
enables uniform cell loading 
- Scaling properties good with up to 32 
parallel cell cultures 
 
 
 
- Assembling of system easy but quite time-
consuming 
- Pressurized system leads to high failure rates of 
system components 
 
4.6 Discussion 
4.6.1 Pumps 
The developed micropump has many advantages over the conventional syringe pump, such as 
the small size and thereby easy integration into a system platform, and the simple one-step assem-
bling and pumping of eight fluidic channels simultaneously. Originally, the µfluidic ribbon was 
meant as a disposable part of the micropump. However, as a result of the complicated fabrication 
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procedure, the µfluidic ribbons have been used until breaks or leakages in the ribbon are observed. 
This reuse has probably increased the failure rate, though breaks or leakages have also been noticed 
in new ribbons. A serious problem, in the form of precipitations in the cell culture medium, has 
been detected when pumping cell culture medium through the µfluidic ribbon. The precipitations 
were found to have a negative impact on the optical properties and the cell viability. Investigations 
showed that the particles were precipitations from the serum in the cell culture medium, which 
were formed due to the mechanical influence of the peristaltic micropump. Integrated peristaltic 
pumps made of PDMS have been employed in previously presented microfluidic cell culture sys-
tems [5, 104], so the precipitation problems were not expected. The inner dimensions (i.e. the sur-
face to volume ratio), the way that the pump presses the channel and the occlusion volume may 
affect the tendency to form precipitates. The problem has currently been solved by running the 
pump in a backward direction with the cell culture chamber upstream of the micropump (Fig. 12b). 
However, to be able to switch between different pumps, and thereby to have the possibility of pro-
grammed cell stimulation with different cues and different concentrations over time, the configura-
tion has to be forward flow with the cell culture chamber downstream of the pump (Fig. 12a and 
Fig. 16a and b). Work is currently going on in our lab to solve the problem. New materials and 
different inner channel dimensions are being investigated. 
4.6.2 Motors and controllers 
With respect to smoothness in rotation and size, the stepper motor is preferred to the LEGO® 
motor. The small size eases integration into the system platform and together with the rotational 
smoothness improves the compatibility with time-lapse microscopy imaging. The step-wise move-
ment of the LEGO® motors can disturb the focus of the microscope. However, the low flow rate 
range (< 5 µL/min) of the stepper motor hinders uniform cell loading, which in connection with 
cell differentiation assays, for example, is an important parameter that has to be controllable. The 
LEGO® motor is favoured regarding the possibility of applying high flow rates, thereby enabling 
uniform cell loading, and the accompanying very user-friendly controller and software with pre-
programming possibilities. However, signs that indicate that it is originally a kid‟s toy have been 
noticed in the observation that the output from the three output ports on one controller is not the 
same at high speeds (actually a factor of two in difference). But this issue can easily be solved by 
using two separate controllers.  
The ultimate goal of the ProCell project was to be able to perform conditional experiments. By 
means of automatic time-lapse microscopy imaging and image analysis, a signal should be sent to 
the pump controller and adjust the flow according to pre-programmed commands related to the 
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read-out of the image analysis. To enable these conditional experiments, the pump control system 
must be compatible with the Zeiss microscope control software AxioVision VBA module, which 
currently can only be fulfilled with the custom-made control system of the stepper motors.  
Thus, none of the two tested motors meets all the requirements of an optimal motor. However, 
the LEGO® motor and the accompanying control system satisfy the most important requirements. 
Despite this, the LEGO® motor, to our knowledge, has not been utilized for fluidic actuation in 
other presented microfluidic cell culture systems outside the FAST group. Most fully integrated 
microfluidic cell culture systems presented in the literature utilize pneumatically controlled peri-
staltic pumps [5, 104], where the entire cell culture system, including the peristaltic pump, is casted 
in PDMS. However, the pneumatic control of micropumps usually requires more technical/physical 
skills than are normally held by a biologist. 
4.6.3 Liquid reservoirs 
Liquid reservoirs in the form of glass vials connected to the micropump by PFTE tubing are 
easy accessible and can be sterilized by autoclavation. On the other hand, a microfluidic cell cul-
ture system with many fluidic inlets and outlets, all connected to a glass reservoir, makes the as-
sembling and change of liquid time-consuming and, furthermore, gives an impression of a very 
complicated system (Fig. 10b). In contrast, the application of the vial chip makes the overall im-
pression of the system simpler and enables easy assembling and liquid change (Fig. 10c). However, 
the drawbacks of the vial chip are the fragile character caused by the design and fabrication proce-
dure. The bonding of the bottom chip part is not robust and therefore very exposed to breaks when 
fixing the vial chip together with screws. In addition, the fixing of the lid part to the well part by 
screws and embedded nuts exposes the well part to breaks in the PMMA material. This can be 
solved by using longer screws and embedding of the nuts more deeply into the well part. Finally, 
sterilization by autoclavation is not possible. 
In other presented microfluidic cell culture devices or systems the liquid reservoirs exist either 
as peripheral components [5, 7, 103, 111-113] or imbedded in the system in the form of small wells 
[6, 9, 10, 114]. A configuration with the liquid reservoirs as a peripheral component complicates 
transport, while the size of the embedded wells normally requires supply of medium once or twice 
a day, which is not user-friendly, especially not with long-term cell culture experiments. In a modu-
lar system approach, a vial chip, like the one tested in this project, is preferred. However improve-
ments are needed with respect to robustness and sterilization possibilities. The optimal solution 
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would be a well part with embedded microfluidic channels, fabricated in one piece, and a lid part 
with a gasket, all fabricated in a material that allows for sterilization by autoclavation. 
4.6.4 Liquid interconnections 
The ball joint interconnection principle of the µfluidic ribbon allows, in one step, easy and tight 
connection of eight microfluidic channels from pump to cell culture chip, from pump to vial chip or 
from pump to a small connection piece for further connection to PFTE tubings (Fig. 14c and d). 
The connections from pump and cell loading chip to PFTE tubings are both based on press-fitting 
(Fig. 15b, d and e). The connections to the pump are not completely fixed, and therefore care 
should be taken not to detach the tubing. However, this has not been noticed as a problem. Liquid 
connections demonstrated in the literature are in general micro-to-macro connections, i.e. connec-
tions via tubings from chip/device to peripheral components such as pumps and/or liquid reservoirs 
normally by press-fitting [5, 7, 32, 103, 104, 113]. Through the system development in the ProCell 
project and the FAST group, the PFTE tubing connections have been eliminated by the develop-
ment of the tubing-free vial chips at the connections to the micropumps, as shown in the second 
version microfluidic cell culture system (Fig. 10c). Likewise, the not unproblematic PFTE tubing 
connection to the cell loading chip (Fig. 15d and e) can be changed by the design of an additional 
vial chip fitting into the system platform at the cell loading chip location. 
4.6.5 Cell loading chip 
The development from the first version cell loading chip to the second version was based on a 
general requirement of as few liquid interconnections as possible and experiences that showed that 
the cell loading pathway should be as short as possible to avoid cell sedimentation, and thereby 
enable a uniform cell loading. By the use of the second version cell loading chip and the LEGO® 
motors for fluidic actuation, a uniform cell loading has been performed successfully (shown in 
section 5.5.1). However as described in section 4.6.4, the liquid connections from the cell loading 
chip to the liquid reservoirs have caused some problems in the form of leakages and, in addition, 
breaks in the PDMS well part insert, when removing the tubings before cell loading. Furthermore, 
it is difficult to properly sterilize the inner surfaces of the cell loading wells. When the PFTE tub-
ings are pressed into the wells, as they are during the system sterilization by flushing with 0.5 M 
NaOH, the inner surfaces of the wells are not exposed to the NaOH solution. However, the change 
of the tubings to a vial chip would solve the connection problems as well as the sterilization prob-
lems. Solutions for cell loading presented in the literature are normally infusion/withdrawal from 
various, mostly not integrated, cell reservoirs by manual use of a syringe [32, 36, 113, 115, 116], or 
by peristaltic pumping/ differential pressure application [5, 7]. Currently work is going on in the 
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FAST group to develop a cell loading feature in the form of an integrated septum through which 
cells can be loaded manually by a syringe. 
4.6.6 Cell culture chips 
The modular system approach enables fast changes of the cell culture chip with respect to the 
chamber size and routing of channels, and thus provides the possibility of tailoring the design of 
the cell culture chip to a specific application. Regarding choice of material, complicated structures, 
pumps and valves can be fabricated relatively easily by the use of PDMS, and it is cheap and does 
not break [106].  Therefore, the majority of the devices/systems presented in the literature are made 
of PDMS. However, PDMS has displayed unwanted properties like absorption of hydrophobic 
molecules [46, 106], and due to the fact that many signaling molecules and drugs are hydrophobic, 
the decision within the ProCell project and the FAST group was to use PMMA as the material for 
fabrication of the microfluidic cell culture chips [15]. Furthermore, PMMA has been chosen as the 
material, because it has shown good biocompatibility [17, 18] , good optical properties and in con-
trast to other materials it allows for adhesive-free and chemical-free bonding. The use of adhesives 
and chemicals may influence the biocompatibility. However, the employed UV-assisted heat-
bonding has not been robust and reliable enough in use (Table 3). The rather low robustness in 
combination with a quite time-consuming fabrication process makes improvements with respect to 
the bonding process necessary. Work is currently going on in the FAST group to investigate other 
bonding procedures. 
4.6.7 Microfluidic cell culture systems 
In section 4.1 were listed the most important requirements that should be met to create a useful 
microfluidic system for mammalian cell culture experiments. But, do the tested microfluidic cell 
culture systems (Fig. 10b and c) fulfil these requirements? When evaluating a whole system, many 
aspects are related to specific components, which have already been discussed above in sections 
4.6.1 to 4.6.6. However, overall, the requirement to develop a system with integrated fluidic actua-
tion, liquid reservoirs, liquid interconnections and cell culture chambers, which at the same time 
displays good properties regarding optics, compatibility with standard laboratory equipment, port-
ability and usability has been met. One missing feature is integrated valves to control the routing of 
the liquid network and thereby the cell manipulation. In the systems presented in this project, the 
routing from different inlets has been performed by switching between different pumps by turning 
on/off the pumps. Creation of concentration gradients over time can be performed by changing 
flow rates from two or more pumps over time. A valve has been developed in the FAST group 
System Design Considerations and Reliability 
 
73 
 
(Appendix 4), but it has not yet been tested into a microfluidic cell culture system. Biocompatibil-
ity and compatibility with standard cell culture procedures are considered in chapter five. 
Regarding scalability, it is possible to perform up to 24 or 32 parallel cell cultures in one ex-
periment, which in most cases is enough to investigate a biological issue. Notably, the scaling from 
a four chamber simple syringe pump device to a complex 24 chamber system did not increased the 
time spent to set up an experiment. In fact, the time spent to set up an experiment per chamber de-
creased from 2.5 hours to 25 minutes per chamber. It is important that scaling up the number of 
samples do not increase the time consumption more than reasonable, which for the system pre-
sented in this thesis has been shown to be possible. However, of course higher scalability, than 
shown here, would broaden the application‟s possibilities, such as for example for drug testing. 
The performance with respect to reliability must be improved to be satisfactory (Table 3 and 
Fig. 20c). As expected, the error rate due to component failures increases from working with a 
simple device to working with a more complex system. Thus, it is important to design a system as 
simple as possible, i.e. with as few components as possible. Furthermore, the many failures noticed 
during the experimental work with the second version of the cell culture system (Table 3 and Fig. 
20c), may probably be due partly to teething problems, as only four experiments have been carried 
out in this project. The trend for the use of system 1also shows more failures in the initial phase of 
the use of the system, suggesting that some practice is needed every time some components are 
changed or the system reconfigured. In the initial phase the user of course learns how to handle the 
components/systems, but also very importantly learns how to track errors.  
By pressurizing the microfluidic cell culture system, the common problem of bubbles in micro-
fluidics systems has been almost eliminated. Solving this bubble problem was very important, be-
cause no read-out was obtained as long as bubbles destroyed the cell viability, and in fact the sys-
tems were useless before setting pressure to the systems.  However, the rise in component failures 
after applying pressure to the systems suggests that pressurization makes higher demand on the 
robustness of the system and system components. Even a small leakage is observed in a pressurized 
system. The leakage is observed already during set up of the experiment instead of during run of 
the experiment (in the form of bubbles). This change made it possible to run successful cell culture 
experiments with a biological read-out, see chapter 6. The weaknesses of the system components 
and the fabrication procedures has been discussed in sections 4.6.1 to 4.6.6 and most of the prob-
lems can be related to weak bondings (i.e. the fabrication method) and fragile µfluidic ribbons.  In 
many cases the problems can be further related to the limited possibilities of fabrication methods 
and access to equipment during the developmental and prototyping process. Furthermore, most of 
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the fabrication of for example cell culture chips, vial chips and µfluidic ribbons has been carried 
out by me (a biologist). A possible commercialization of the system by the industry, and thereby 
availability of „on the self components‟, would provide much more advanced fabrication methods, 
more uniformity and robustness of the components, and thereby probably solve most of the reliabil-
ity issues.  
The usability issue in the form of the time-consumption to set up an experiment is partly related 
to the failure rate. A high system component failure rate significantly increases the time that is 
spent to set up an experiment and, in general, makes the time-consumption unpredictable. Nor-
mally, the time-consumption for conventional biological methods is quite well-known for a trained 
person, and this unpredictability is therefore very frustrating. In general, an average of 10 hours has 
been spent to set up an experiment of eight to 24 parallel cell cultures. This would normally have 
taken approximately 1 hour when performed as a static cell culture experiment in a well plate. To 
accept such a big difference as a biologist, it is obvious that the microfluidic cell culture system 
must provide some experimental possibilities that are not achievable by the use of a conventional 
static cell culture method, such as a more in vivo-like environment, co-culture possibilities and the 
study of paracrine and/or autocrine signaling. However, if new biological assays are possible, then, 
in my opinion, an experimental set up time of ten hours is reasonable and acceptable to a biologist. 
The modular system approach improves the usability by making it easy to change a broken sys-
tem component without the need to fabricate a whole new system. This is especially useful during 
the developmental process and prototype testing, where the fabrication possibilities are more lim-
ited. In addition, the modular approach allows for easy reconfiguration of the system. 
Mammalian cell culture requires sterile laboratory utensils and work under aseptic conditions. A 
biologist is used to meet this requirement for sterile utensils by means of autoclavation, dry-
sterilization or radiation, because it is easy and does not require any after-treatment before use, as 
for example sterilization by ethanol or NaOH does. Therefore, the ultimate goal for a microfluidic 
cell culture system would be that every component, exposed to the cell culture medium, allows for 
one of these sterilization methods. This goal is, however, difficult to fulfil, because many of the 
commonly-used materials do not withstand autoclavation or dry-sterilization, and due to the fact 
that a normal laboratory does not have access to sterilization by radiation. 
4.6.8 Implementation of microfluidic cell culture into biological research 
In the introduction of this chapter, it was questioned whether the lack of implementation of mi-
crofluidic cell culture into biological/biomedical research laboratories was partly due to issues like 
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poor usability, robustness and general reliability. The demonstrated performance of the microflu-
idic cell culture systems tested in this project makes these issues very probably one of the reasons 
for their lack of adoption by biologists. As with other microfluidic cell culture systems, the first 
version of the developed and tested systems in this project (Fig. 10b) has recently been published 
[107]. The publication describes the good performance of the system in the form of a detailed de-
scription of the physical properties and the system operation, and it demonstrates an application 
within regulated cellular gene expression. As shown in this chapter, the system performance has an 
additional dimension, which is not described in the paper. In general, this kind of information, such 
as the number of experimental tests, failure rates and time-consumption, is never shown in these 
device/system publications, although, this information is very relevant. The extent of the failures 
and problems, encountered during the testing of the systems in this project, is most probably simi-
lar to what is encountered in relation to other presented devices/systems in the literature. Many 
presented systems are much more complicated than the ones tested in this project and may there-
fore display even more problems and higher failure rates. 
However, if the issues about the low robustness of the system components were solved, I would 
find the microfluidic cell culture systems, tested in this project, easy to use and acceptable to im-
plement as a novel cell analysis tool. All the frustrations and the negative thoughts about the tested 
microfluidic cell culture systems, experienced during the project, have been related to bubbles (in 
the first phase of the project) and the low robustness of the system components.  
4.7 Conclusion and outlook 
The evaluation of the tested microfluidic cell culture systems, developed in the ProCell project 
and the FAST group, has shown that the requirement to develop a system with integrated fluidic 
actuation, liquid reservoirs, liquid interconnections and cell culture chambers, which at the same 
time displays good properties regarding optics, compatibility with standard laboratory equipment, 
portability and usability, has been met. Improvements regarding robustness and thereby reliability 
is shown to be needed, and these issues are probably one of the reasons for the lack of implementa-
tion of microfluidic cell culture systems into biological/biomedical research laboratories. Regard-
ing the microfluidic cell culture systems tested in this project, the most important issues to be im-
proved are the bonding of chips and the robustness of the µfluidic ribbon. 
Based on experiences gained through the practical work in this project, general properties re-
garding the system design, as listed below, are suggested to be considered in addition to the re-
quirements listed in section 4.1: 
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 The overall impression of the microfluidic cell culture system should be as uncompli-
cated as possible, so as not to „frighten away‟ the biologist. 
 The system and each system component should consist of as few sub-components as 
possible to reduce the failure rate. 
 Much effort should be put into the creation of robust system components and thereby a 
reliable system. 
 More efforts should be put into finding materials and fabrication methods that can 
withstand sterilization by autoclavation and thereby ease and reduce the time needed to 
prepare the system for cell culture experiments. 
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Chapter 5 
 
Microfluidic Perfusion                 
Cell Culture 
Many practical issues must be considered when cell culture experiments want to be conducted into 
microfluidic perfusion cell culture systems. This project is only dealing with culture of adherent 
mammalian cells. The practical concerns involve assembling and priming of the system with liquid 
without introduction of air bubbles, sterilization of the inner surfaces of the liquid network and 
often surface coating of the cell culture chambers to allow/enhance cell attachment. Furthermore, 
the practical concerns include loading of the cells into the microfluidic cell culture chambers in a 
controllable manner and assessment of optimal flow conditions to support cell viability, prolifera-
tion and other cellular processes important for the study. Solutions to various practical issues are 
numerous, however some practical guidelines have been presented by Kim et al. [47].  
Cell culture can be divided into cell culture maintenance and functional studies of the cells. This 
project has focused on establishment of procedures to be able to perform long-term functional stud-
ies of cells by the use of our developed microfluidic cell culture systems, while normal cell culture 
maintenance has been conducted by conventional cell culture methods. To avoid contamination of 
the cell culture by bacteria or fungi, all system preparations and changes of media reservoirs has 
been performed in a laminar flow bench and by the use of aseptic working procedures, which is 
normal procedure for conventional cell culture as well. 
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5.1 Cells 
Diverse cell types behave differently with respect to for example surface attachment, prolifera-
tion and requirements to medium composition and renewal. Some cells require coating of the sur-
face to enable or enhance cell attachment. Fast proliferating cells have a need for more frequent 
changes of cell culture medium to ensure sufficient supply of nutrients and removal of waste prod-
ucts. Thus, as in static cell culture the procedures for coating and medium renewal probably are cell 
type dependent.  
Two different cell types have been employed in this project. HeLa cells (HeLa Tet-On
®
 Ad-
vanced cells, Clontech) were used for initial establishment of the microfluidic perfusion cell culture 
procedures. In addition, the HeLa Tet-On Advanced cells, transient transfected with a fluorescent 
reporter plasmid, have been used as a model system to demonstrate the possibility of the microflu-
idic perfusion culture system to perform regulated differential gene expression of a gene of interest. 
In connection with the application of the microfluidic perfusion cell culture systems within stem 
cell research, adipose-derived stem cells (ASCs) have been cultured and induced to differentiate 
into adipocytes over a three week culture period. 
5.2 Assembling and priming of the system 
For assembling and priming of the microfluidic cell culture system is referred to section 4.4.1. 
5.3 Sterilization 
In order to avoid contamination of the cell culture by bacteria of fungi, it is necessary that the 
device is sterilized at the inner surfaces, which will be exposed to the cell culture medium. A bi-
ologist is used to sterilize by autoclavation or dry-sterilization, because it is an easy and biocom-
patible procedure, which does not require any after-treatment before use. Glass vials, PTFE tubings 
and vial lids were therefore sterilized by autoclavation before assembling. However, the PMMA 
used for fabrication of the cell culture chips, and as many of the materials generally used for fabri-
cation of microfluidic systems, do not withstand autoclavation or dry-sterilization. The most com-
monly-used sterilization methods for microfluidic cell culture systems are therefore UV-radiation 
or flushing of the system with ethanol. However, PMMA exposed to tensions, as for example when 
bonded, cracks at contact with ethanol. Flushing with ethanol was therefore not an option for ster-
ilization of our microfluidic cell culture system. Instead, 0.5 M NaOH was chosen as sterilization 
agent of the microfluidic network. Concentrations of 0.5 M to 1.0 M NaOH are commonly used to 
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clean and sterilize chromatography equipment [117]. The ability of NaOH to dissolve proteins has 
the additional effect of cleaning the system, when reusing system components. 
After assembling and liquid priming of the system, the procedure for sterilization was flushing 
of the whole microfluidic network by 0.5 M NaOH at a flow rate of 5 µL/min for about 20-30 min-
utes, followed by a washing step with sterile water for at least 30 minutes to ensure removal of the 
NaOH.  
 
Fig. 21. Effect of NaOH sterilization on HeLa cell viability. The microfluidic system was flushed with 0.5 
M NaOH for either 20 minutes or 2 minutes. As a reference the system was flushed with sterile water sup-
plemented 1% penicillin/streptomycin for 20 minutes. Following perfusion with either NaOH or sterile wa-
ter, the system was flushed with sterile water for 30 minutes, coated, and flushed with cell culture medium 
for 30 minutes before cell loading. 10x phase contrast images of the cells were acquired at day 1, day 2, and 
day 4. 
 
To test the effect of NaOH sterilization of the microfluidic system on cell viability and prolifera-
tion, the system was flushed with 0.5 M NaOH for either 20 minutes or 2 minutes. As a reference 
the system was flushed with sterile water supplemented 1% penicillin/streptomycin for 20 minutes. 
Following perfusion with either NaOH or sterile water, the system was flushed with sterile water 
for 30 minutes, coated with polyethyleneimine (PEI) (see section 5. 4.1), and flushed with cell cul-
ture medium for 30 minutes before loading of HeLa cells. As shown in Fig. 21, the sterilization by 
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0.5 M NaOH seemed to have no negative impact on cell viability and proliferation. Sterilization by 
NaOH has therefore been used at all microfluidic cell culture experiments performed during this 
project. The sterilization effect of 0.5 M NaOH has been satisfactory due to the fact that no conta-
minations of bacteria or fungi have been observed in a total of 38 conducted experiments. 
5.4 Coating 
As mentioned in the introduction to this chapter some cells may require a coating of the cell cul-
ture chamber surface with ECM proteins, such as fibronectin, laminin or collagen to allow or en-
hance cell attachment. Furthermore, many of the materials used to fabricate microfluidic cell cul-
ture devices are quite hydrophobic, which may interfere with cell attachment. 
5.4.1 Coating for HeLa cell culture 
Culture of HeLa cells has previously been performed in a microfluidic cell culture chamber 
made of PMMA in the FAST group [118, 119]. Satisfactory cell attachment was achieved by coat-
ing with polyethyleneimine (PEI) [119] or even without any coating [118]. PEI is a cationic syn-
thetic polymer, which has been shown to enhance cell attachment of various cell types [120]. The 
effect of PEI coating on HeLa cell attachment was tested and compared to fibronectin coated 
PMMA surfaces. The cell culture chambers were either coated with PEI (50 µg/mL) for 1.5 hours 
at room temperature or fibronectin (100 µg/mL) for 10 minutes at 37 ºC, followed by flushing with 
cell culture medium for at least 30 minutes. After loading of the cells, the cells were allowed to 
attach at very low flow (33 nL/min) for four hours before changing to a flow rate of 250 nL/min. 
Coating of PMMA with fibronectin showed a slightly better and faster cell attachment compared to 
PEI (Fig. 22). However, PEI coating was chosen for coating at HeLa cell culture, because PEI is 
much cheaper, and because the HeLa cells were only used in the initial phase of establishment of 
microfluidic perfusion cell culture procedures and not for investigation of a biological question. 
 
Fig. 22. HeLa cell attachment in microfluidic perfusion cell culture at different coatings. Cells were cul-
tured on PMMA coated with polyethyleneimine 50 µg/mL for 1.5 h or fibronectin 100 µg/mL for 10 min. 10x 
phase contrast images acquired 24 hours after cell loading. a) PMMA coated with PEI. b) PMMA coated 
with fibronectin. 
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5.4.2 Coating at ASC culture 
ASC culture on polystyrene surfaces in conventional cell culture in flasks or well plates does 
not require any coating of the surface prior to cell culture. To test ASC attachment on PMMA sur-
faces, preliminary tests were conducted on PMMA in static cell cultures. As shown in Fig. 23, cell 
attachment was very poor on PMMA without any coating (Fig. 23a) and on PMMA coated with 
PEI (50 µg/mL) (Fig. 23b), while a good cell attachment, similar to the reference on polystyrene 
(Fig. 23d), was observed on PMMA coated with laminin (10 µg/mL) (Fig. 23c). Thus, the prelimi-
nary results in static cell cultures suggested that a coating of PMMA with ECM proteins was 
needed to allow proper cell attachment. 
 
Fig. 23. Cell culture of ASCs on PMMA with or without coating in static cell culture. a) PMMA without 
coating. b) PMMA coated with PEI (50 µg/mL). c) PMMA coated with laminin (10 µg/mL). d) As reference 
polystyrene without coating. 10x phase contrast images acquired at day 1 after cell seeding. 
 
To further investigate the effect of different coatings with ECM proteins on ASC attachment, 
proliferation and differentiation in microfluidic perfusion cell culture, the cell culture chamber was 
coated with fibronectin (20 µg/mL), collagen (40 µg/mL), laminin (10 µg/mL) or not coated 
(flushed with PBS). This work was performed together with special course student Rasmus Finn 
Andersen. During coating, the chambers were flushed with the coating solution at a flow rate of 5 
µL/min for 15 min followed by a flow rate of 200 nL/min for 45 min at 37 °C. After achievement 
of 70-80% cell confluence, the ASCs were induced to differentiate into adipocytes in adipogenic 
medium.  
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Fig. 24. ASC attachment, proliferation and adipogenic differentiation at different coatings of PMMA in 
microfluidic perfusion cell culture. The cell culture chambers were coated with fibronectin (20 µg/mL), 
collagen (40 µg/mL), laminin (10 µg/mL) or not coated (flushed with PBS). After achievement of 70-80% 
cell confluence, the ASCs were induced to differentiate into adipocytes in adipogenic medium. 10x phase 
contrast images acquired 4 hours after cell seeding. Cell attachment on PMMA coated with collagen a), 
fibronectin b), laminin c) and non-coated d). e) ASC proliferation. Measured by the percent of the area of 
the cell culture chamber covered by cells by using ImageJ. f) ASC differentiation into adipocytes. Number of 
cells with lipid-filled droplets counted manually over time after start of adipogenic differentiation. Data 
analysis done by Rasmus Finn Andersen. 
 
A satisfactory cell attachment was observed with all coatings (Fig. 24). Even without any ECM 
coating the cell attachment was quite good (Fig. 24d). However, the fastest cell attachment was 
observed by coating with fibronectin (Fig. 24b). The ASC proliferation was almost similar at all 
coatings and without any coating (Fig. 24e), while large differences were seen with respect to dif-
ferentiation efficiency (Fig. 24f). The differentiation efficiency was greatly reduced at fibronectin 
coating compared to laminin and collagen coating (Fig. 24f), which resulted in an almost similar 
differentiation efficiency. Likewise, less differentiation was observed at non-coated PMMA com-
pared to laminin and collagen coated PMMA (Fig. 24f). Because similar cell attachment, prolifera-
Microfluidic Perfusion Cell Culture 
 
83 
 
tion and adipogenic differentiation was observed at laminin and collagen coating, and because col-
lagen is cheaper than laminin, collagen coating was chosen as the standard coating procedure for 
the ASC adipocyte differentiation experiments performed in this project. 
5.5 Cell loading 
After assembling, priming the liquid network with water, sterilization of the inner surfaces and 
coating of the cell culture chamber surfaces, the cells have to be loaded into the chambers in a con-
trollable manner without introducing bubbles into the liquid network. Two methods have been 
tested in this project. In preliminary experiments using the first simple microfluidic device shown 
in Fig. 10a cell loading was performed via direct infusion through the inlet tubing by the use of a 
syringe. However, it was very difficult to introduce the cells without introducing any bubbles, and 
bubbles are almost impossible to remove again at this point in the experiment without interfering 
with the cells or the sterility of the system. Another tested method, which has been employed in 
connection with both microfluidic cell culture systems developed in the ProCell project (Fig. 10b 
and c), is pumping of the cell suspension from a cell loading well into the cell culture chamber, as 
described in section 4.3.5 and Fig. 15. By this method, the cell suspension is loaded into a narrow 
cell loading well by a syringe and needle to avoid introduction of bubbles, whereupon the cell sus-
pension is drawn into the cell culture chambers by activation of the micropump. After loading of 
the cells, the cells were, in general, allowed to attach at very low flow (33 nL/min) for four hours 
before changing to a flow rate supporting culture of the cells. 
5.5.1 Uniformity of cell loading over the entire chamber surface 
To obtain a uniform cell loading the flow of the cell suspension must be faster than the rate of 
cell sedimentation. However, by the use of system 1(Fig. 10b) and thereby pump actuation by the 
stepper motors (Fig. 13a), with a maximum flow rate of 5 µL/min, it was not possible to obtain a 
uniform loading of HeLa cells (Fig. 25a). Another way to reduce the cell sedimentation during cell 
loading is to increase the viscosity of the suspension medium by, for example, addition of collagen 
[47]. To test the effect of collagen on the ability to obtain a uniform cell loading, HeLa cells were 
resuspended in cell culture medium (DMEM + 10% FBS + 1% penicillin/streptomycin) with dif-
ferent concentrations of collagen and loaded into the cell culture chambers by maximum flow rate 
(5 µL/min) using system 1. As shown in Fig. 25b, c and d, a concentration of 0.025% w/v collagen 
resulted in almost a uniform cell loading. Loading of HeLa cells has therefore been performed in 
normal cell culture medium with 0.025% collagen. 
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Fig. 25. Effect of increased cell suspension viscosity by collagen on HeLa cell loading. HeLa cells were 
resuspended in normal cell culture medium a) or cell culture medium with increasing concentrations of 
collagen, b) 0.005% w/v, c) 0.01% w/v and d) 0.025% w/v. 5x phase contrast images acquired immediately 
after cell loading. 
 
With respect to cell loading of ASCs, the cell loading was likewise optimized by investigating 
the cell loading in increasing concentrations of serum (60%, 80% and 100%) in the normal cell 
culture medium (DMEM + 20% NCS + 1% penicillin/streptomycin). This work was performed 
together with special course student Rasmus Finn Andersen. 
 
Fig. 26. Effect of increased cell suspension viscosity by serum on ASC loading. ASCs were resuspended in 
normal cell culture medium (20% NCS)  or in normal cell culture medium with increasing concentrations of 
NCS (60%, 80% and 100%) and loaded into the cell culture chambers. 5x phase contrast images were ac-
quired immediately after cell loading, and number of cells counted in three regions of the chamber by using 
AxioVision (Zeiss). Region 1 is the one third of the chamber at the outlet end, region 2 the middle third of 
the chamber and region 3 is the one third of the chamber at the inlet end of the cell loading. The number of 
cells is normalized to the number of cells in region 3 at the inlet end of the chamber. The error bars indicate 
standard error of the mean of 4 independent chambers in two independent experiments. The distribution of 
cells is shown for 20% NCS a), 60% NCS b), 80% NCS c) and 100% NCS d). Data analysis performed by 
Rasmus Finn Andersen.  
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None of the tested serum concentrations resulted in complete uniform cell loading (Fig. 26). How-
ever, an almost uniform cell loading was obtained in 60% serum (Fig. 26b) compared to 20%, 80% 
and 100% serum (Fig. 26a, c and d). The lower uniformity at 80% serum and 100% serum com-
pared to 60% serum was probably due to clumping of the cells at the high serum content. Cell load-
ing of ASCs has consequently been performed in normal cell culture medium with 60% NCS. 
When increasing the chamber length from 4.4 mm to 6.6 mm, the loading of ASCs in 60% se-
rum by the use of system 1 did not result in complete cell density uniformity (data not shown). 
However, the development of microfluidic cell culture system 2, with pump actuation by the 
LEGO
®
 motors, offered the possibility to apply a much higher flow rate for the cell loading. By the 
use of the motor controller software LEGO
®
 Mindstorms a flow program was optimized to enable 
uniform cell loading by pump actuation by the LEGO
®
 motors. 10 rotations in 6 sec (~ flow rate of 
65 µL/min) resulted in a uniform loading of ASCs, as demonstrated by loading of ASCs at six dif-
ferent cell suspension densities (Fig. 27).  
 
Fig. 27. Cell loading by LEGO
®
 motor pump actuation. Green fluorescent ASCs (infected with a lentivirus 
bearing a GFP expression cassette) at six different cell suspension densities were loaded into the cell load-
ing wells by a syringe and needle (Fig. 15c and f) and pumped into the cell loading chambers by  LEGO
®
 
motor actuation by 10 rotations in 6 sec (~ 65 µL/min). Cell loading uniformity shown at cell suspension 
densities of 0.6x10
5
a), 1.6x10
5
 b), 2.6x10
5
 c), 3.6x10
5
 d), 4.6x10
5
 e) and 5.6x10
5
 f). 
 
5.5.2 Controllability of actual seeding density 
As demonstrated in the application of the microfluidic perfusion cell culture systems in stem 
cell research (chapter 6), it is not only necessary to be able to perform uniform cell loading over the 
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entire cell culture chamber. Besides uniformity, many functional cell studies, such as differentia-
tion of ASCs into adipocytes (chapter 6), require an ability to control the actual seeding density. To 
compare the actual seeding density to the expected seeding density, ASCs, loaded at six different 
cell loading suspension densities by LEGO
®
 motor pump actuation (Fig. 27), were counted imme-
diately after cell loading. As shown in Table 5, only minor deviations (2-4%) from the expected 
cell seeding density to the actual cell seeding density were seen at the highest cell loading suspen-
sion densities of 3.6x10
5
, 4.6x10
5
 and 5.6x10
5
 cells/mL. However, higher deviations (11-53%) 
were observed at the lower cell loading suspension densities, with a deviation of 53% at the lowest 
cell loading suspension density of 0.6x10
5
 cells/mL. These results demonstrate that it is possible to 
control the actual seeding density in the cell culture chamber at high cell densities, whereas it is 
more difficult at low cell densities. The results in Table 5 are from one experiment. 
Table 5.  
Actual seeding density compared to expected seeding density 
Cell loading  
suspension density 
[cells/mL] 
0.6x105 1.6x105 2.6x105 3.6x105 4.6x105 5.6x105 
Expected cell 
seeding densitya 
[cells/mm2] 
30 80 130 180 230 280 
Actual cell seeding 
densityb  
[cells/mm2] 
14 71 103 177 223 290 
Deviation from 
expected seeding 
density 
53% 11% 21% 2% 3% 4% 
a Expected cell seeding cell seeding density calculated from the cell loading suspension density. 
b Actual cell seeding density determined by manual counting of the cells in 1 mm2 in the middle of the chamber. 
 
To further evaluate the cell loading controllability, the cell density of ASC cultures at onset of 
differentiation (1 day after cell loading) in two independent ASC differentiation experiments (Fig. 
40 and Appendix 2) was determined in two parallel chambers for each of the three cell loading 
suspension densities. The cell number was determined by manual counting of the cells in 1 mm
2
 in 
the middle of a cell culture chamber. To compare the cell density at day 1 to the expected seeding 
density, the cell density at day 1 is divided by a factor of 1.8, corresponding to an approximate 
division rate of ASCs the first 24 hours after cell seeding (Fig. 31b). As shown in Table 6, large 
variations are observed from experiment 1 to experiment 2 and within each experiment. These var-
iations can be due to manual dilution errors or a different extent of cell sedimentation in the cell 
loading well before pumping in the cell suspension. In addition, the actual seeding density is, in 
general, higher than the expected cell seeding density, which further suggests a certain degree of 
cell sedimentation in the cell loading well before pumping the cell suspension into the cell culture 
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chambers. Thus, the results indicate that it is not possible to satisfactorily control the actual seeding 
density, in particular not at the low cell densities. 
Table 6.  
Variations in actual cell densities of ASC cultures at onset of differentiation 
Cell loading  
suspension density  
[cells/mL] 
0.5x105 2.x105 4.0x105 
Expected cell seeding densitya 
[cells/mm2] 
25 100 200 
 Experiment 1 
Actual cell density day 1b 
 Chamber 1 
[cells/mm2] 
76 438 898 
Actual cell density day 1b 
 Chamber 2 
[cells/mm2] 
54 370 950 
Estimated cell seeding density c 
 Chamber 1 
[cells/mm2] 
42 243 499 
Estimated cell seeding density c  
Chamber 2 
[cells/mm2] 
30 206 528 
 Experiment 2 
Actual cell density day 1b 
 Chamber 1 
[cells/mm2] 
61 248 550 
Actual cell density day 1b 
 Chamber 2 
[cells/mm2] 
103 351 346 
Estimated cell seeding density c 
 Chamber 1 
[cells/mm2] 
34 138 306 
Estimated cell seeding density c  
Chamber 2 
[cells/mm2] 
57 195 192 
a Expected cell seeding cell seeding density calculated from the cell loading suspension density. 
b Actual cell seeding density determined by manual counting of the cells in 1 mm2 in the middle of the chamber. 
c Estimated cell seeding density is determined by dividing the cell density at day 1 by a factor of 1.8, corresponding to an approximate 
division rate of ASCs the first 24 hours after cell seeding. 
5.6 Cell culture incubation 
For cell culture incubation, the microfluidic cell culture system was placed inside a convention-
al CO2 incubator at conditions of 5% CO2 and 37 °C (Fig. 18b), which ensured proper conditions 
with respect to temperature and pH of the cell culture medium. When performing time-lapse expe-
riments, the microfluidic cell culture system was incubated inside an incubator (Incubator XL Dark 
S1, Zeiss) mounted a Zeiss life science microscope (AxioObserver.Z1) at 37 °C. To limit the influ-
ence of gas permeable materials on the cell culture medium, which at preliminary experiments was 
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observed to change the pH of the medium, a flexible plastic cover was mounted the microfluidic 
cell culture system. By a connected CO2 module (CO2 module S1, Zeiss) atmospheric air with 8% 
CO2 was supplied to the covered microfluidic system. The percentage of 8% CO2 had been opti-
mized to ensure the maintenance of a pH of the cell culture medium inside the microfluidic cell 
culture system of 7.2 to 7.4. 
5.7 Cell morphology and proliferation 
Another important parameter regarding microfluidic perfusion cell culture is determination of 
the optimal perfusion flow rate. An optimal perfusion flow rate should support cell attachment, 
viability, normal morphology and cell proliferation. However, to restrict the consumption of rea-
gents and avoid shear stress, the flow rate is wanted to be kept as low as possible. Due to the fact 
that different cell types behave differently with respect to cell division rate and display different 
sensitivities in in vitro cell cultures, the optimal flow rate is probably cell dependent. Consequently, 
morphology and proliferation at different flow rates have been investigated for both cell types ap-
plied in this project. 
5.7.1 HeLa cell morphology and proliferation 
In microfluidic perfusion cell culture performed previously in the FAST group by Michael 
Stangegaard [17, 118], a flow rate of 1.67 µL/min in a 1.5 mm deep chamber, with inlet and outlet 
at the top of the chamber, was shown to support HeLa cell proliferation. This flow rate corres-
ponded to an exchange rate of the medium in the cell culture chamber of 0.7/hour. The dimensions 
of the cell culture chambers used in this project for HeLa cell culture experiments were 4.5 mm (l) 
x 1.5 mm (w) x 0.5 mm (h). As a first approximation of a possible optimal flow rate, the flow rate 
applied previously by Michael Stangegaard was divided by a factor of three according to the re-
duced height of the cell culture chamber, which then corresponded to a flow rate of 500 nL/min. As 
follows, HeLa cell morphology and proliferation were investigated at four different flow rates, 125, 
250, 500 and 750 nL/min, which correspond to an exchange rate of the cell culture medium in the 
cell culture chambers of 2.2, 4.4, 8.8 and 13.3 per hour, respectively. After cell loading, the cells 
were allowed to attach at very low flow (33 nL/min) for four hours before change of flow rate to 
125, 250, 500 or 750 nL/min. The cells were cultured in DMEM supplemented with 10% FBS and 
1% penicillin/streptomycin. As shown in Fig. 28, the HeLa cells in perfusion cell cultures dis-
played similar morphology at all tested flow rates (Fig. 28a to d) and a similar morphology to the 
static culture reference (Fig. 28e). 
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Fig. 28. HeLa cell morphology in microfluidic perfusion cell culture at different flow rates. After cell 
loading and an attachment phase at a flow rate of 33 nL/min for 4 hours, the cells were perfused at four 
different flow rates. As a reference the HeLa cells were cultured in static culture in a conventional cell cul-
ture flask. 10x phase contrast images demonstrating HeLa cell morphology were acquired after 24 hours of 
culture at a flow rate of 125 nL/min. a), 250 nL/min. b), 500 nL/min. c), 750 nL/min d) and in static cell 
culture e). 
 
However, with respect to cell proliferation, only perfusion at the two highest flow rates of 500 
nL/min and 750 nL/min resulted in exponential growth of HeLa cells (Fig. 29b) with coefficients 
of determination R
2
 of 0.993 and 0.999, respectively. Almost no cell division took place at flow 
rates of 125 nL/min and 250 nL/min, and many apoptotic cells were observed (data not shown). 
The cell doubling times at flow rates of 500 nL/min and 750 nL/min were 30.24 hours and 30.85 
hours, respectively, whereas the cell doubling time in the static cell culture reference was 22.78 
hours. Phase contrast images of cell proliferation at a flow rate of 500 nL/min at 24, 48, 72 and 96 
hours after cell loading are shown in Fig. 29a. 
 
Fig. 29. HeLa cell proliferation in microfluidic perfusion cell culture. HeLa cells were grown in DMEM 
+10% FBS+1% P/S in microfluidic perfusion cell culture for 4 days at four different flow rates, 125, 250, 
500 and 750 nL/min, corresponding to an exchange rate of the medium in the cell culture chamber of 2.2, 
4.4, 8.8, and 13.3 times per hour. a) 10x phase contrast images acquired 24, 48, 72 and 96 hours after cell 
loading. Cells cultured at a flow rate of 500 nL/min. b) HeLa cell proliferation in an area of 2 mm
2
 at flow 
rates of 125, 250, 500 and 750 nL/min. HeLa cell proliferation in static cell culture shown as reference. 
Exponential growth fitting made by GraphPad Prism. The results are from two independent experiments, 
with flow rates of 125 and 750 nL/min from one experiment and flow rates of 250 and 500 nL/min from 
another experiment. 
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The results are from two independent experiments, with flow rates of 125 and 750 nL/min from 
one experiment and flow rates of 250 and 500 nL/min from another experiment. Thus, the results 
suggest that flow rates of 500 nL/min and 750 nL/min support normal cell morphology and satis-
factory cell proliferation. 
5.7.2 ASC morphology and proliferation 
ASCs are slowly growing cells with a fibroblast-like morphology. As for HeLa cells, ASC mor-
phology and proliferation were investigated at three different flow rates, 33, 125 and 500 nL/min, 
which correspond to an exchange rate of the cell culture medium in the cell culture chambers of 
0.4, 1.5 and 6.0 per hour, respectively. The dimensions of the cell culture chambers used in this 
project for ASC culture experiments were 6.6 mm (l) x 1.5 mm (w) x 0.5 mm (h).  
 
Fig. 30. ASC morphology in microfluidic perfusion cell culture at different flow rates. After cell loading 
and an attachment phase at a flow rate of 33 nL/min for 4 hours, the cells were perfused at three different 
flow rates. As a reference the ASCs were cultured in static culture in a conventional cell culture flask. 10x 
phase contrast images demonstrating ASC morphology acquired after 24 hours of culture at a flow rate of 33 
nL/min. a), 125 nL/min. b), and 500 nL/min. c) and in static cell culture d). 
 
After cell loading, the cells were allowed to attach at low flow (33 nL/min) for four hours be-
fore no change or change of flow rate to 125 or 500 nL/min. The cells were cultured in DMEM 
supplemented with 20% NCS and 1% penicillin/streptomycin. As shown in Fig. 30, the ASCs in 
perfusion cell cultures had an almost similar cell morphology at the three tested flow rates (Fig. 
30a to c) and a similar morphology to the static culture reference (Fig. 30d). However, at a flow 
rate of 33 nL/min more of very flat, spread cells were observed, whereas more elongated, slim cells 
were observed at 125 and 500 nL/min. However, both the much spread but still elongated mor-
phologies and the long slim morphologies are observed at all three tested flow rates and in static 
cell cultures. 
Regarding ASC proliferation, similar proliferation curves were observed at all three tested flow 
rates, and in addition, the proliferation curve for microfluidic perfusion cell cultures was similar to 
static cell cultures (Fig. 31). The approximate cell doubling time was 28-30 hours the first two days 
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of cell culture, however, the division rate decreased after two days of cultures, when a certain cell 
density was reached. Phase contrast images of cell proliferation at a flow rate of 125 nL/min at 4, 
24, 48, and 72 hours after cell loading are shown in Fig. 31a. The results are from one experiment. 
Thus, all three tested flow rates of 33, 125 and 500 nL/min supported satisfactory growth in micro-
fluidic perfusion cell culture compared to static cell cultures. 
 
Fig. 31. ASC proliferation in microfluidic perfusion cell culture. ASCs were grown in DMEM+20% 
NCS+1% P/S in microfluidic perfusion cell culture for three days at three different flow rates, 33, 125, and 
500 nL/min, corresponding to an exchange rate of the medium in the cell culture chamber of 0.4, 1.5, and 
6.0 times per hour, respectively. a) 10x phase contrast images acquired 4, 24, 48, and 72 hours after cell 
loading at a flow rate of 125 nL/min. b) ASC proliferation in an area of 1 mm
2
 at flow rates of 33, 125, and 
500 nL/min. ASC proliferation in static cell culture shown as reference. 
 
5.8 Regulated gene expression 
A type of functional cell study that fits well in with the possible read-out methods of our devel-
oped microfluidic perfusion cell culture system and, in addition, demonstrate the potential of the 
system is regulated gene expression of a protein of interest attached to a fluorescent reporter pro-
tein. The attachment of the protein of interest to a fluorescent reporter protein enables protein de-
tection by real-time fluorescent microscopy imaging of living cells. 
5.8.1 Creation of a plasmid system for regulated gene expression 
 Thus, to demonstrate the ability of the microfluidic system to temporally regulate gene expres-
sion by external actuation, a plasmid-based system for regulated gene expression was set up. The 
pTRE-Cycle2 plasmid from Clontech consists of a bidirectional tetracycline sensitive promoter, 
which in the one direction encodes the red fluorescent reporter protein mCherry, and in the other 
direction encodes a DD signal peptide that tags a downstream protein for proteasomal degradation. 
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The sequence encoding the green fluorescent reporter protein ZsGreen1-DR was inserted in-frame 
into pTRE-Cycle2 downstream to the DD tag, resulting in a plasmid named pTRE-Cycle2-
ZsGreen1-DR. When this plasmid construct is transfected into HeLa Tet-On Advanced cells, which 
stably express the Tet-On transactivator, gene expression of the fluorescent reporter proteins can be 
regulated at two levels. Addition of doxycycline to the cell culture medium induces gene expres-
sion at the transcriptional level of both mCherry and DD-ZsGreen1-DR, but due to the upstream 
DD-tag DD-ZsGreen1-DR is quickly degraded. By addition of both doxycycline and Shield1, DD-
ZsGreen1-DR is stabilized by Shield1 and thereby protected from proteasomal degradation. Thus, 
Shield1 regulate gene expression of DD-ZsGreen1-DR at the protein level. 
 
Fig. 32. pTRE-Cycle2, a plasmid-based system for regulated gene expression. When pTRE-Cycle2-
ZsGreen1-DR is transfected into HeLa Tet-On Advanced cells, gene expression can be regulated at two 
levels. Doxycycline induces gene expression of both of the fluorescent reporter proteins, mCherry and DD-
ZsGreen1-DR. Due to the DD-tag, ZsGreen1-DR is quickly degraded unless Shield1 is added, which pro-
tects DD-ZsGreen1-DR from degradation. 
 
5.8.2 On chip cell transfection 
To enable the regulated gene expression by use of the created plasmid-based system described 
above in section 5.8.1, HeLa Tet-On Advanced cells were transfected in the microfluidic cell cul-
ture system. The cells were cultured for 20 hours after cell loading to a cell confluence of about 
80% before the cells were transfected with pTRE-Cycle2-ZsGreen1-DR. The transfection com-
plexes were diluted in cell culture medium and then flushed into the cell culture chambers at a flow 
rate of 1 μL/min for 20 minutes to ensure complete exchange of the medium in the cell culture 
chamber with medium containing the transfection complexes. The transfection process was per-
formed without flow for 60 minutes, followed by a short flow period at a flow rate of 500 nL/min 
for 10 minutes to expose the cells to more transfection complexes. These two steps were repeated 
for 6 hours in total. Finally, the transfection complexes were removed by flushing with cell culture 
medium at a flow rate of 1 μL/min for 20 minutes. The cell culture was then continued at a flow 
rate of 500 nL/min for another 18 hours, before induction of mCherry gene expression by pump 
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switching to cell culture medium added doxycycline 0.5 μg/mL. Image of transfected cells acquired 
24 hours after induction of mCherry gene expression shows a satisfactory transfection efficiency of 
approximately 50%. 
 Fig. 33. On chip trans-
fection of HeLa cells. 
HeLa Tet-On Advanced 
cells were transfected in 
the microfluidic perfusion 
cell culture system. A 
merged fluorescent and 
phase contrast image 
acquired 42 hours after 
completion of transfec-
tion and 24 hours after 
induction of mCherry 
gene expression demon-
strate a transfection effi-
ciency of about 50%. 
 
 
 
5.8.3 Regulated gene expression by pump switching 
The use of a cell culture chip with three inlets to each chamber (Fig. 16b) and with each of the 
inlets connected to a different pump, enabled switching of flow into the cell culture chamber from 
one inlet to another inlet channel by pump switching (turning off one pump and at the same time 
turning on another pump). This ability of temporal changing of culture conditions was used to 
demonstrate the potential of the microfluidic perfusion cell culture system for regulated gene ex-
pression experiments by the use of the created plasmid-based system described in section 5.8.1. 
The HeLa Tet-On Advanced cells were cultured and transfected with pTRE-Cycle2-ZsGreen1-DR 
on chip as described in section 5.8.2, and gene transcription of mCherry and DD-ZsGreen1-DR 
was induced by pump switching from an inlet with normal culture medium to medium added doxy-
cycline 0.5 µg/mL. Regulated gene expression of DD-ZsGreen1-DR at the protein level was dem-
onstrated by switching to medium with or without Shield1 0.5 µg/mL in addition to doxycycline. 
As shown in Fig. 34, the fluorescent signal from DD-ZsGreen1-DR gene expression increased after 
switching to medium with Shield1 (turning ON DD-ZsGreen1-DR gene expression) at approxi-
mately the same rate until it stabilizes at about 19-21 hours. After switching back to medium with-
out Shield1 (turning OFF DD-ZsGreen1-DR gene expression), DD-ZsGreen1-DR was quickly 
degraded with a half-life of about 4.5 hours.  This kinetics is similar to DD-YFP expression in 
NIH3T3 cells [121]. 
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Fig. 34. Regulation of gene expression by pump switching. a) DD-ZsGreen1-DR gene expression was in-
creased (turned ON) by switching to medium added Shield1 and decreased again (turned OFF) by switching 
to medium without Shield1. Doxycycline induces gene expression of both DD-ZsGreen1-DR and mCherry, 
but Shield1 regulates DD-ZsGreen1-DR at the protein level by protecting ZsGreen1-DR from degradation. 
Annotations above the images indicate compound composition and annotation below indicate time line. b) 
Fluorescent signal of DD-ZsGreen1-DR gene expression plotted against time. Time points for switching to 
medium with Shield1 and later switching to medium without Shield1 are indicated with arrows. The fluores-
cent signal measurements are based on the densitometric sum (DS) of individual pixel values. The measure-
ments are normalized to highest value (DSmax). Error bars indicate standard error of the mean based on six 
independent cell culture chambers in one experiment. 
 
5.9 Discussion 
Procedures for microfluidic perfusion cell culture have been investigated and established. The re-
sults show that it is possible to culture cells with a satisfactory cell attachment, morphology and 
proliferation. Furthermore, the potential of the system to perform temporal changes in cell culture 
conditions by pump switching has been demonstrated by regulated gene expression of a fluorescent 
reporter protein with real-time microscopy detection. However, some issues are to be discussed 
below. 
5.9.1 Sterilization 
0.5 M NaOH has been used for sterilization of the inner surfaces of the microfluidic network 
without any instances of contaminations. The sterilization procedure takes only about 1.5-2 hours 
in total (including washing to remove the NaOH). In addition, NaOH has the effect of cleaning 
possibly reused components due to the high solubility of proteins in NaOH solutions. For example, 
in connection with the precipitations of serum in the cell culture medium (section 4.3.1 and Table 
2), 0.5 M NaOH was shown to completely dissociate/dissolve the precipitations. However, a disad-
vantage of the use of 0.5M NaOH is the high safety risk of NaOH. Although, the preparation of the 
system is always performed with gloves and behind a glass wall, a less hazardous agent may be 
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preferred. As mentioned in section 5.3, UV and ethanol are the most common employed steriliza-
tion methods for microfluidic cell culture systems. But as also mentioned, PMMA exposed to ten-
sions is not resistant to ethanol, and due to the enclosed surfaces UV-radiation is not an option. 
Another possible sterilization agent could be 0.5% (w/v) hypochlorite, which has been used for 
sterilization of flow chambers for biofilm cultures [122]. However, they used a sterilization period 
of 3-4 hours, which is much more compared to the 30 minutes with 0.5M NaOH. 
5.9.2 Cell loading 
The approach to cell loading in our developed microfluidic cell culture systems has been with-
drawal of the cell suspension from a cell loading reservoir into the cell culture chamber. This me-
thod reduced the risk of introduction of bubbles into the microfluidic network and also ensured that 
the same volume of cell suspension was introduced into each chamber in the cell culture chip. Fur-
thermore, withdrawal by pumping reduced the path to the cell culture chamber and avoided passing 
of the cells through the pump. To achieve a uniform cell loading over the entire cell culture cham-
ber, the flow rate has to be faster than the rate of cell sedimentation. In addition, the ability to ob-
tain uniform cell loading depends on the length of the cell culture chamber; longer chambers makes 
it more difficult than in shorter chambers. Uniform cell loading was satisfactory obtained by resus-
pending the cells in cell culture medium added collagen or high serum concentrations to increase 
the viscosity of the medium (Fig. 25 and Fig. 26) and, furthermore, by applying a high flow rate of 
65 µL/min for 6 seconds (Fig. 27). However, in spite of an increased medium viscosity, it was not 
possible by the use of system 1, with stepper motor actuation and a maximum flow rate of 5 
µL/min, to achieve a uniform loading of ASCs in chambers with a length of 6.6 mm (2 mm longer 
than the chambers shown in Fig. 25) (data not shown). ASC culture experiments by use of system 
1 have therefore been performed in a gradient of cell densities along the length axis of the cell cul-
ture chamber. 
Another issue is the control of the actual seeding density of the cells, which for example has 
been shown to be an important parameter affecting adipogenic differentiation of ASCs (chapter 6). 
One cell loading experiment with green fluorescent ASCs showed satisfactory deviations of the 
actual cell seeding density to the expected cell seeding density at cell loading suspension densities 
of 1.6x10
5
 cell/mL and higher (Table 5). However, the actual cell density of ASCs at onset of diffe-
rentiation from some representative experiments showed large variations between the two shown 
experiments and compared to the expected cell density (Table 6). In general, the actual seeding 
density was higher than the expected, which indicate that uncontrollable cell sedimentation takes 
place in the cell loading wells in the period from loading of the cells into the wells until actuation 
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of the pump. Eight wells have to be loaded before the pump can be actuated to load the cells into 
the cell culture chambers. Methods used in other microfluidic cell culture devices are infu-
sion/withdrawal from various, mostly not integrated, cell reservoirs by manual use of a syringe [32, 
36, 113, 115, 116], or by peristaltic pumping/ differential pressure application [5, 7]. However, the 
actual detailed performance of the cell loading methods is not presented. But a method employing 
direct cell loading by a syringe probably enable better control of the actual seeding density due to 
less cell sedimentation before loading of the cells into the cell culture chambers. 
5.9.3 Cell culture incubation 
For incubation of the cell culture, the entire microfluidic cell culture system was placed inside a 
conventional CO2 incubator. A microfluidic cell culture chamber previously developed within the 
FAST group [16] had an integrated indium-tin-oxide heater, which enabled cell culture outside the 
incubator. However, the embedded heater complicated the cell culture chip fabrication and reduced 
the optical properties of the cell culture chamber. Consequently, the microfluidic cell culture sys-
tem developed in the ProCell project was decided not to have an integrated heater. Due to the de-
sign of the system with integrated pumps and liquid reservoirs, the incubation inside a conventional 
incubator or incubation in the microscope for time-lapse studies has been completely unproblemat-
ic. Furthermore, the cell culture chip fabrication has been much simpler without any integrated 
components. 
5.9.4 Cell proliferation 
Satisfactory proliferation curves of HeLa cell and ASC culture in our microfluidic perfusion cell 
culture systems were observed compared to the curves for static cultures of HeLa cells and ASCs 
(Fig. 29 and Fig. 24). However, the results show that the optimal flow rate is cell dependent, with 
the faster dividing HeLa cells requiring a higher flow rate to support cell division than the slower 
dividing ASCs. Young et al. [1] have presented a way to make a theoretical estimate of the optimal 
perfusion flow rate in terms of a critical perfusion rate (CPR) (se also section 2.2.5, equation (9)). 
According to their suggestions, CPR can be estimated by the length of the cell culture chamber 
divided by the effective culture time (ECT) in microscale culture. ECT is the time between changes 
of the cell culture medium for the respective cell type, and ECT in microscale culture can be scaled 
from ECT at macroscale cell culture according to the height of the cell culture chamber [1]. For 
HeLa cells with a usual interval between changes of medium of 48 hours in macroscale culture 
with a media height of about 1.5 mm, ECT in microscale culture with a chamber height of 0.5 mm 
is about 16 hours. At a length of the cell culture chamber of 6.6 mm, CPR is then estimated to 
1.15x10
-7
 m/s. With a chamber height of 0.5 mm and a chamber width of 1.5 mm, the correspond-
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ing perfusion flow rate is 5 nL/min. However, the results presented in Fig. 29b showed that flow 
rates of 125 and 250 nL/min did not support HeLa cell division, while flow rates of 500 and 750 
nL/min supported an exponential growth of the HeLa cells similar to the HeLa cell division in stat-
ic cultures. As mentioned in section 2.2.5, the presented theoretical estimation of the optimal perfu-
sion flow rate is based on very rough assumptions. Firstly, they assume that ECT is equal to the 
complete consumption (reaction) of a given molecule with the cells. However, at conventional cell 
culture, the time between changes of cell culture medium for a given cell type is normally not expe-
rimentally determined, but in general based on recommendations from the supplier or personal 
experiences/opinions. Furthermore, the presented model assumes that the time scale of diffusion is 
not limiting the accessibility of molecules. But, in perfusion culture the diffusion time across the 
chamber is normally slower than the convection time in the perfusion direction, i.e. the molecules 
in the upper layer will probably just flow through the system. Finally, different molecules in the 
cell culture medium needed for cell division probably have very different reaction time scales with 
the cells. Our results suggest that experimental determination of the optimal perfusion flow rate is 
necessary. However, the theoretical estimate may give a hint about the range of flow rates appro-
priate to investigate. 
5.9.5 Regulated gene expression by pump switching 
By pump switching and thereby changing of cell culture conditions, regulated gene expression 
of DD-ZsGreen1-DR was demonstrated (Fig. 34), with a good correlation between switching of 
flow from one pump to another (at addition and removal of Shield1) and expression of DD-
ZsGreen1-DR.  The time for switching from one liquid to another in the chip has been shown to be 
between seconds to a few minutes depending on the flow rate [107], which by the expression pro-
file of DD-ZsGreen1-DR is demonstrated to be sufficient to resolve the time scale of the gene ex-
pression. By the use of a passive cell culture chip without integrated valves, some leakage from the 
not flowing inlet cannot be avoided. However, this leakage has by theoretical calculations been 
estimated to be insignificant [107], and the reversibility of the DD-ZsGreen1-DR gene expression 
further demonstrated that the leak is too small to influence the biological read-out in this kind of 
assay. 
5.9.6 Limitations of the optimization study of microfluidic perfusion cell culture 
The optimization study of the system preparation and the microfluidic cell culture conditions 
performed in this project is not a complete validation of the developed microfluidic perfusion cell 
culture system with at least three repetitions of every tested condition/parameter. One of the main 
objectives of this project was to reach beyond the proof-of-concept level and apply the microfluidic 
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cell culture system to investigate an issue within stem cell differentiation. However, the results 
presented in chapter 6 about differentiation of ASCs into adipocytes argue very well that the em-
ployed conditions in the microfluidic cell culture system actually were able to support efficient cell 
function of ASCs in terms of adipogenic differentiation. 
5.10 Conclusion and outlook 
In this project, we have established procedures to performed successful long-term microfluidic 
perfusion cell culture of HeLa cells and ASCs with satisfactory cell attachment, morphology and 
proliferation and without contaminations by bacteria or fungi. In addition, we have applied our 
developed microfluidic perfusion cell culture system to demonstrate the potential of the system to 
regulate gene expression of a gene of interest by external actuation and with real-time microscopy 
detection of the gene expression. Further successful application of the microfluidic perfusion cell 
culture system to stem cell research by investigation of ASC differentiation into adipocytes is dem-
onstrated in chapter 6. 
However, further optimizations have to be done to improve the control of the cell seeding. A 
cell culture chip design with a closed microfluidic network for cell loading and then cell loading by 
direct infusion of the cell suspension by a syringe connected to an inlet port could possibly improve 
the controllability of the cell seeding. Another suggestion could be cell loading through a septum 
with a syringe and needle. Work is currently going on in the FAST group to improve the cell load-
ing. 
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Chapter 6 
 
Application to Stem Cell Research 
 
As presented in section 2.1.1 and 2.3.2, cells and in particular stem cells are in a complex mi-
croenvironment in vivo. In the adult stem cell niches, for example, many interactions and thereby 
many means of signaling control the fate of the stem cell. It is therefore very difficult to copy this 
complex microenvironment to in vitro cell culture models, in particular, by the use of conventional 
cell culture methods. As a consequence, the microfluidic cell culture research community has taken 
this issue, in an otherwise high attention research area, as a great opportunity to provide possibili-
ties for new experimental designs, as reviewed in [27, 28, 123-125]. Gradient generating devices 
have been applied to study the influence of a particular soluble factor, which may be present in a 
stem cell niche. For example,  activation of the canonical WNT-signaling pathway has been inves-
tigated in a WNT3A gradient [126], and differentiation of human neuronal stem cells has been 
studied by exposing the cells to a gradient of growth factors [29].  Quake et al. [5] applied a high-
throughput system with integrated automated mixers, peristaltic pumps, pneumatic valves and 96 
individually controllable cell culture chambers to investigate the effect of transient stimulation 
schedules on proliferation and osteogenic differentiation of MSCs. Furthermore, a co-culture de-
vice with an array of cell capture cups enabled the study of interactions between up to 6,000 cell 
pairs of two different cell types [127]. Regarding 3D cultures, the culture of bone marrow MSCs in 
a 3D environment has been performed by cell seeding in an array of micropillars capturing the cells 
followed by formation of collagen matrices surrounding the cells [7]. In this way 3D cell-to-cell 
and cell-to-ECM contacts were enabled. Despite these above-mentioned attempts to more closely 
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mimic the in vivo stem cell microenvironment, it is still a great challenge to copy the in vivo stem 
cell niche microenvironment and, in addition, to perform the experiments in a consistent way from 
one experiment to another [125]. Furthermore, stem cell experiments often require long term cell 
culture for differentiation to occur, putting further demands on the device performance and experi-
mental optimization. 
Besides the above-mentioned possibilities, a general advantage of microfluidic cell culture in re-
lation to stem cell studies is the small cell culture chamber size, which makes it possible to test 
many conditions by the use of a small number of cells. When dealing with primary cell cultures and 
maybe slowly dividing cells, the number of cells required for an experiment is important. 
6.1 Motivation of application 
Within the framework of the ProCell project, one of the objectives regarding evaluation was to 
test the developed device for investigation and optimization of stem cell differentiation in collabo-
ration with the external academic partner, Professor Philippe Collas, University of Oslo. Professor 
Philippe Collas and his group are, among other things, investigating the differentiation capacity of 
MSCs from adipose tissue (ASCs), and, in particular, a possible epigenetic programming of MSCs 
for specific lineages.  
As mentioned in section 2.3.4, ASCs have potential as replacement cells in regenerative medi-
cine. In relation to this application, it is crucial to be able to control the differentiation into adipo-
cytes. Furthermore, the differentiation process of ASCs into adipocytes has great interest in basic 
research. The in vitro differentiation process takes up to two to three weeks. More knowledge about 
the differentiation process would maybe enable an optimization of the process, and thereby speed 
up the differentiation and also the research within the differentiation process. Finally, the differen-
tiation of ASCs into adipocytes has an interest in relation to treatment of obesity. More knowledge 
about the process could provide possible targets in the combating of obesity. 
The focus in the ProCell project and the FAST group has been on developing a library of com-
ponents that enables the creation of fully integrated microfluidic cell culture systems (section 4.2), 
while less focus has been on developing complex cell culture chips providing possibilities for 3D 
culture or co-culture experiments. When a system component library has been established as a ba-
sis for many possible microfluidic cell culture systems, the focus can then move (and is currently 
moving) to the cell culture chip level. Thus, at the system developmental stage during this project, 
we were able to run parallel microfluidic cell cultures in a 2D monolayer with a different number 
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of cell culture chambers and number of inputs, see section 4.3.6. As described in chapter 5, the 
systems employed have been optimized to run long-term cell culture experiments without interrup-
tions caused, for example, by bacteria contaminations or introduction of bubbles into the system. 
Depending on the applied perfusion flow rate, one of the disadvantages of microfluidic perfu-
sion cell culture is that the constant flow of cell culture medium probably would remove cell se-
creted signaling factors, as described in section 2.2.1 and 2.2.2. However, this disadvantage can be 
turned into an advantage. By means of the applied flow rate, the convection in the flow direction 
can be controlled in relation to the diffusion and reaction time of a signaling molecule. This allows 
the study of the cellular response at conditions that disrupt a possible paracrine/autocrine signaling. 
Thus, a microfluidic perfusion culture system can be used to investigate paracrine/autocrine cell 
signaling in a cell population, even though the signaling factor is not known. Previously, microflu-
idic perfusion cell culture has been used to reveal paracrine/autocrine signaling involved in the 
survival of mouse embryonic stem cells (mESCs) [34], and most recently, the use of a microfluidic 
perfusion cell culture device showed that paracrine/autocrine signaling is involved in both prolif-
eration and neuroectodermal commitment of mESCs [35].  Although a condition of reduced 
paracrine/autocrine signaling probably can be obtained by conventional cell culture methods by 
applying low cell density cultures and frequent changes of culture medium, the signaling can 
probably not be completely controlled, and therefore it may be difficult to obtain a condition with 
no background signaling.  
Paracrine/autocrine signaling has not been directly described to be involved in the differentia-
tion process of a population of MSCs into adipocytes [61, 63, 64, 72, 84, 128, 129]; however, this 
type of signaling is involved in many cellular processes including processes in developmental biol-
ogy [48]. Furthermore, high cell confluence (80-90%) has been reported to be required before in-
duction of terminal differentiation by adipogenic stimuli [58, 65], as well as high cell confluence 
has been shown to promote adipogenesis over osteogenesis of MSCs [66]. Accordingly, it is obvi-
ous to speculate that a paracrine/autocrine signaling is involved in the differentiation process of a 
population of ASCs into adipocytes. 
Altogether, this prompted us to apply the developed microfluidic cell culture systems to investi-
gate if paracrine/autocrine signaling actually is involved in the differentiation process of a popula-
tion of ASCs into adipocytes by examining the effect of different flow rates and compositions of 
the adipogenic medium on the differentiation process at various cell densities. 
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6.2 General experimental design 
General aspects especially important for the stem cell experiments and the interpretation of the 
results are described in this section. For more details, see Materials and Methods, Chapter 3. The 
microfluidic cell culture system 1 (Fig. 10b) was the first system developed during this project and 
has therefore been applied to most of the stem cell experiments. In all experiments performed with 
system 1, a gradient of cell density was present along the length axis of the cell culture chamber 
with the highest cell density at the inlet end of the cell loading (Fig. 35).  
  
Fig. 35. Cell density gradient in relation to flow direction in experiments using system 1. a) Flow direc-
tion from the low cell density end to the high cell density end (forward flow). b) Flow direction from the 
high cell density end to the low cell density end (backward flow). 
 
The gradient of cell density was present due to the fact that the highest possible flow rate was 
not fast enough to avoid sedimentation of the cells before the entire chamber was loaded with cells 
(see section 5.5.1). In the first experiments performed, the flow direction was from the low cell 
density end to the high cell density end (Fig. 35a), with the peristaltic micropump upstream of the 
cell culture chamber (forward flow) (Fig. 12a). This configuration allowed switching between dif-
ferent pumps and thereby temporal differential cell culture conditions without a manual change of 
medium in the inlet reservoirs. In addition, this configuration enabled the use of a 24 chamber cell 
culture chip (Fig. 16d). However, due to problems with precipitations of the serum in the cell cul-
ture medium caused by the mechanical influence of the micropump (see section 4.3.1), the configu-
ration was changed to flow from the high cell density end to the low cell density end (backward 
flow) (Fig. 35b) with the micropump downstream of the cell culture chamber (Fig. 12b). This con-
figuration allowed only the use of an eight chamber cell culture chip (Fig. 16c) connected to one, 
two or three micropumps depending on the number of applied flow rates in one experiment Fig. 36. 
 
Fig. 36. Different pump connection configurations by the use of an eight chamber cell culture chip. a) 
One pump connection. b) Two pump connection. c) Three pump connection. 
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The microfluidic cell culture system 2 (Fig. 10c) enabled uniform cell loading over the entire 
cell culture chamber (see section 5.5.1), which eliminated the influence of different cell densities 
over the length axis of the cell culture chamber on the differentiation process/efficiency. 
The employed adipose-derived stem cells (ASCs) have been isolated (see section 2.3.4) and 
provided by the Professor Philippe Collas Laboratory, University of Oslo. The passage of the cells 
used in the microfluidic cell culture differentiation experiments has been between 6 to12. In gen-
eral the cells have been harvested and loaded into the microfluidic cell culture chambers as de-
scribed in section 3.2.2.4, 4.3.5 (Fig. 15), and section 5.5. After an initial attachment phase, the 
ASCs were induced to differentiate into adipocytes the following day in the different tested differ-
entiation conditions by changing the liquid reservoirs with normal cell culture medium to various 
differentiation media. During cell culture the whole system was placed in an incubator at 37 °C and 
5% CO2. The differentiation was followed for approximately 21 days by microscopy imaging of 
the whole cell culture chamber, normally every second day. A differentiation period of 21 days is 
normally needed for efficient and complete differentiation in static cell culture conditions. Due to 
the fact that fluorescent reporter cells of transcriptional markers of differentiation are not readily 
available for human ASCs, the accumulation of lipid in intracellular vacuoles has been used as a 
marker of adipocyte differentiation. In phase contrast microscopy imaging, these lipid-filled drop-
lets appear as white spheres and can therefore easily be marked by imaging analysis software. As a 
measure of differentiation, the total area of lipid-filled droplets in the entire cell culture chamber 
was measured and normalized to the total cell area at initiation of differentiation. 
6.3 Results 
6.3.1 Effect of perfusion on adipocyte differentiation 
To investigate if ASCs were able to differentiate into adipocytes at microfluidic perfusion cell 
culture conditions, the cells were induced to differentiate in normal adipogenic differentiation me-
dium (AM) (DMEM added NCS 15%, IBMX (isobuthyl-methylxanthine) 0.5 mM, dexamethasone 
1 µM, indomethacin 0.2 mM and insulin 10 µg/mL). The cells were cultured in system 1 at back-
ward flow and at a flow rate of 125 nL/min, corresponding to an exchange rate of medium in the 
cell culture chamber of 1.5/hour. The ASCs differentiated and formed lipid-filled droplets (Fig. 
37a) in a similar manner to static cell culture (Fig. 37c). Likewise, the characteristic stress fibre 
formation in the first phase of the differentiation process was observed in perfusion cell culture as 
in static cell culture (Fig. 37d and e, respectively). Importantly, no spontaneous differentiation was 
observed when the cells were perfused in normal growth medium (GM) (Fig. 37b). 
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Fig. 37. Differentiation of ASCs into adipocytes in normal adipogenic differentiation medium (AM) at 
perfusion cell culture conditions. ASCs were induced to differentiate at a flow rate of 125 nL/min ~ ex-
change rate of medium in the cell culture chamber of 1.5/hour. a) Imaging at 7, 12, 16 and 22 days after 
start of differentiation. The cells were able to differentiate and accumulate fat as shown by the lipid-filled 
droplets indicated by arrows. b) ASCs cultured at perfusion in normal growth medium (GM) as a negative 
control. No spontaneous differentiation was observed at day 21. c) Differentiation of ASCs at static cell 
culture conditions at day 21. d) and e). In perfusion cell culture d) the cells formed stress fibers (indicated 
by arrows) characteristic of the first phase of differentiation in a similar manner to static cell culture e).  
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Further examination of the effect of perfusion was performed by inducing differentiation in AM at 
three different flow rates, 33 nL/min, 125 nL/min and 500 nL/min, corresponding to an exchange 
rate of the medium in the cell culture chamber of 0.4/hour, 1.5/hour and 6/hour. Although large 
variations in overall differentiation efficiency were observed between different experiments, the 
differentiation showed a trend, where the efficiency was higher at 125 nL/min than at 33 nL/min, 
while the differentiation efficiency was much lower at 500 nL/min (Fig. 38a and b). The large 
variations in overall differentiation efficiency from one experiment to another were probably 
caused by varying cell densities at the onset of differentiation. It is well known that the cell density 
affects the adipogenic differentiation efficiency [58, 65, 66].  
 
 
Fig. 38. Effect of perfusion flow rate on the differentiation efficiency of ASCs cultured in AM. ASCs were 
induced to differentiate in normal adipogenic medium (AM) at 33 nL/min, 125 nL/min or 500 nL/min, cor-
responding to an exchange rate of the medium in the cell culture chamber of 0.4/hour, 1.5/hour and 6/hour.  
a) Imaging of a representative experiment at day 20 after start of differentiation. 10x phase contrast images. 
b) The total area of lipid-filled droplets is measured at day 13-14 for three representative examples. The area 
of lipid-filled droplets is measured by using ImageJ and normalized to the total cell area at the start of diffe-
rentiation.  
 
Furthermore, the cells grown at a flow rate of 33 nL/min had an almost round cell shape, while 
more elongated cell morphology was observed at a flow rate of 500 nL/min. The differences in cell 
morphology and differentiation efficiency between the flow rates of 33 nL/min and 500 nL/min 
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could be caused by shear effects of the flow or disruption of a possible paracrine/autocrine signal-
ing involved in adipocyte differentiation, which is further investigated in the next section. 
6.3.2 Influence of conditioned medium on adipocyte differentiation 
In order to investigate whether the low differentiation efficiency at 500 nL/min was caused by 
shear effects or by interruption of a possible paracrine/autocrine signaling involved in adipocyte 
differentiation, ASCs were induced to differentiate in either normal adipogenic medium (AM) or a 
1:1 mixture of conditioned medium (CM) (medium from ASCs undergoing adipogenic differentia-
tion in static culture) and AM with 1.5 times the concentration of adipogenic stimuli (1.5x AM). If 
the cells secrete one or more factors involved in adipocyte differentiation, the CM from differenti-
ating cells would contain those cues. The CM was mixed 1:1 with fresh AM to ensure sufficient 
supply of nutrients. 1.5x AM was applied instead of 1x AM to compensate for an expected con-
sumption/degradation of the adipogenic stimuli in the collected CM. Again the cells were induced 
to differentiate at the three flow rates 33 nL/min, 125 nL/min and 500 nL/min either by the use of 
system 1 or system 2. As shown in Fig. 39, the differentiation efficiency was increased when per-
fused with 1.5x AM+CM compared to AM alone. The enhanced differentiation efficiency was 
observed for all three flow rates. However, the effect of the conditioned medium was batch de-
pendent. Fig. 39b) and d) show a representative example of CM batches with a high adipogenic 
effect, while Fig. 39c) and e) show an example of a CM batch with a lower adipogenic effect. Be-
sides variations of CM from one batch to another, the adipogenic effect was only present when 
applying a freshly collected batch (Fig. 39b, d and Appendix 1), suggesting that the secreted 
paracrine/autocrine signaling factor(s) are quite unstable. All collected results from 9 independent 
experiments are shown in Appendix 1. To ensure that the increased differentiation efficiency was 
not due to the higher concentration of adipogenic stimuli in 1.5x AM+CM, 1.5x AM alone was 
tested. However, this resulted in lower differentiation efficiency than 1x AM (data not shown). In 
addition, ASCs grown in GM alone showed no spontaneous differentiation (data not shown). Thus, 
the results suggest that there exist paracrine/autocrine signaling factors that enhance adipogenic 
differentiation. 
Although, the differentiation efficiency was increased when perfusing with 1.5x AM+CM, the 
overall efficiency was still lower when perfusing at 500 nL/min compared to 125 nL/min. This 
lower differentiation efficiency could still be due to shear effects or it could possibly be due to 
higher exposure of the cells to the adipogenic stimuli supported by the fact that 1.5x AM reduced 
differentiation efficiency.  
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Fig. 39. Effect of conditioned medium on adipocyte differentiation. ASCs were induced to differentiate at 
different flow rates, 33 nL/min, 125 nL/min and 500 nL/min in either AM or 1.5x AM+CM (a 1:1 mixture of 
1.5 times the concentration of AM and CM collected from differentiating cells in static culture). Differentia-
tion is measured by the total area of lipid-filled droplets using ImageJ and normalized to the total cell area 
at the start of differentiation. a) Imaging of representative examples at day 20 after start of differentiation. 
10x phase contrast images. b) The differentiation efficiency shown at day 18 after onset of differentiation. 
Fresh batch CM number 2 was used for flow at 33 nL/min, while fresh batch CM number 3 was used for 125 
nL/min and 500 nL/min. c) The differentiation efficiency shown at day 20 after onset of differentiation. Not 
freshly collected CM batch number 2 was used at all three flow rates. d) Differentiation over time shown for 
the same experiments as in b) e) Differentiation over time shown for the same experiments as in c). All col-
lected results from 9 independent experiments are shown in Appendix 1. 
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6.3.3 Effect of concentrations of adipogenic stimuli on adipocyte differentiation 
To examine whether the lower differentiation efficiency at a flow rate of 500 nL/min was caused 
by possible shear effects or too high an exposure of the cells to the adipogenic stimuli, ASCs were 
induced to differentiate at a flow rate of 500 nL/min in AM, 1.5x AM+CM 1:1, AM diluted 4x or 
1.5x AM diluted 4x+CM 1:1. Furthermore, to test the influence of cell density, the cells were 
loaded at different cell suspension densities, 0.5x10
5
, 2x10
5
 or 4x10
5
 cells/mL. All conditions were 
tested in one experiment by the use of a 16 chamber cell culture chip (Fig. 16a, but with only one 
inlet to each chamber) and system 2.  
As shown in Fig. 40, differentiation in medium with a lower level of the added adipogenic fac-
tors, but with a high level of CM factors (1.5x AM diluted 4x+CM 1:1) resulted in a large increase 
in differentiation efficiency compared to the mixture of AM and CM with a high level of the added 
adipogenic factors (1.5x AM+CM) (Fig. 40b, c, d and e). As a reference ASCs were differentiated 
in diluted AM without CM (AM diluted 4x), which resulted in the same differentiation efficiency 
as in 1.5x AM+CM. Thus, the increased differentiation efficiency observed when differentiating in 
a medium with a lower level of the added adipogenic factors, but with a high level of CM factors 
(1.5x AM diluted 4x+CM 1:1) was not due to a dilution of the added adipogenic factors alone. 
Accordingly, the results further suggest a role of paracrine/autocrine signaling factors in adipocyte 
differentiation. Preliminary experiments investigating the effect of a dilution of both the added 
adipogenic factors and the CM factors ((1.5x AM+CM) diluted 4x) showed only a minor positive 
effect on differentiation compared to not diluted AM+CM (1.5x AM+CM) and diluted AM (AM 
diluted 4x) (data not shown). This further indicates an existence of cues in CM having an effect on 
adipocyte differentiation, and that the signaling factors in CM needs a certain threshold concentra-
tion to have an effect on adipocyte differentiation. The increased adipogenic effect of 1.5x AM 
diluted 4x+CM compared to 1.5x AM+CM was approximately 7-fold, 3-fold and 2-fold for the cell 
loading suspension densities 0.5x10
5
, 2x10
5
 and 4x10
5
 cells/mL, respectively. Compared to AM the 
increase was even higher, approximately 13-fold, 17-fold and 4-fold for the cell densities 0.5x10
5
, 
2x10
5
 and 4x10
5
 cells/mL, respectively. As seen in Fig. 40a) the differentiation efficiency at 1.5x 
AM diluted 4x+CM at the highest cell density achieved almost complete differentiation of all the 
cells. Besides the above observations, the overall differentiation efficiency rose in relation to in-
creasing cell density (Fig. 40a and b), further indicating a positive influence from signaling factors 
secreted by the cells during the course run of the experiment. However, an almost zero-background 
differentiation was observed for AM, 1.5x AM+CM and AM diluted 4x at a cell loading suspen-
sion density of 0.5x10
5
 cells/mL and for AM at a cell loading suspension density of 2x10
5
 
cells/mL.  
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Fig. 40. Effect of concentrations of adipogenic stimuli on adipocyte differentiation. ASCs were loaded at 
different cell suspension densities, 0.5x10
5
, 2x10
5
 or 4x10
5
 cells/mL, and induced to differentiate at a flow 
rate of 500 nL/min in AM, 1.5x AM+CM 1:1, AM diluted 4x or 1.5x AM diluted 4x+CM 1:1. All conditions 
were tested in one experiment by the use of a 16 chamber cell culture chip. Differentiation is measured by 
the total area of lipid-filled droplets using ImageJ and normalized to the total cell area at the start of diffe-
rentiation. The results shown are from one experiment out of two independent experiments. Results from the 
other experiment are shown in Appendix 2. a) Imaging at day 16 after start of differentiation. 10x phase 
contrast images. b) The differentiation efficiency shown at day 18 after onset of differentiation. c), d) and e) 
The differentiation shown over time for the cell loading suspension densities 0.5x10
5
, 2x10
5
and 4x10
5
 
cells/mL, respectively. 
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Altogether, the results add more evidence to the suggestion of an existence of para-
crine/autocrine signaling factors involved in adipocyte differentiation. 
Interestingly, AM diluted 4x resulted in an increased differentiation efficiency compared to 
AM, suggesting a negative effect on differentiation caused by too high an exposure of the cells to 
the adipogenic stimuli and not caused by shear stress effects. 
The results shown in Fig. 40 are from one experiment out of two independent experiments. The 
results from the other experiment are shown in Appendix 2. Again a large variation in overall diffe-
rentiation efficiency was observed, however the trend with a great positive effect of 1.5x AM di-
luted 4x+CM on differentiation was similar. The variation in overall differentiation efficiency be-
tween the two experiments was probably again due to differences in cell densities at onset of diffe-
rentiation and CM batch variations employed in the two experiments. 
6.3.4 Static cell culture reference 
As a reference to the shown effect of CM and concentrations of adipogenic stimuli on adipocyte 
differentiation in perfusion culture, ASCs were seeded at a cell density of 40, 160 or 640 cells/mm
2
 
in a T25 cell culture flask and induced to differentiate in AM, 1.5x AM+CM, AM diluted 4x or 
1.5x AM diluted 4x+CM at static cell culture conditions. The entire medium was changed every 4 
days.  
 
 
Fig. 41. Effect of conditioned medium and concentrations of adipogenic stimuli on adipocyte differentia-
tion in static cell culture. ASCs were seeded at 40, 160 or 640 cells/mm
2
 in a T25 cell culture flask and in-
duced to differentiate in AM, 1.5x AM+CM, AM diluted 4x or 1.5x AM diluted 4x+CM at static cell culture 
conditions. All medium was changed every 4 days. a) Imaging at day 16 after start of differentiation. 10x 
phase contrast images. b) The differentiation efficiency shown at day 20 after onset of differentiation. Diffe-
rentiation is measured by the average of the total area of lipid-filled droplets of 4 areas of 7.7 mm
2
each. The 
area of lipid-filled droplets is measured by using ImageJ and normalized to the total cell area at the start of 
differentiation. 
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Overall, the differentiation efficiency as in perfusion culture was observed to be cell density de-
pendent with increasing differentiation at higher cell densities (Fig. 41a and b). Furthermore, both 
1.5x AM+CM and 1.5x AM diluted 4x+CM resulted in an increased differentiation efficiency 
compared to AM (Fig. 41a and b). For 1.5x AM+CM over AM, a 2-fold, 3-fold and 1.4-fold in-
crease was observed at cell densities of 40, 160 and 640 cells/mm
2
, respectively. A slightly higher 
increase was seen for 1.5x AM diluted 4x+CM over AM with a 3.5-fold, 3.5-fold and 2-fold in-
crease at cell densities of 40, 160 and 640 cells/mm
2
, respectively. However, the rise in differentia-
tion efficiency caused by addition of CM was much lower compared to perfusion cell culture (Fig. 
41 and Fig. 40). At the high cell densities, the lower increase of differentiation was due to a larger 
differentiation efficiency in AM in static culture compared to perfusion culture (Fig. 41 and Fig. 
40). This indicates a greater influence of signaling factors secreted by the cells during the experi-
ment in static cell culture compared to perfusion culture. Thus, the results in static cell culture con-
ditions supported the results observed in perfusion cell culture conditions. 
A minor positive effect of AM diluted 4x on the differentiation efficiency compared to AM was 
observed (Fig. 41b). Combined with a slightly higher differentiation efficiency in 1.5xAM diluted 
4x+CM compared to 1.5x AM+CM, these results indicate that a lower concentration of the adipo-
genic stimuli also increases the differentiation efficiency in static cell culture. However, the differ-
ence in differentiation efficiency between AM diluted 4x and normal AM was much lower in static 
cell culture conditions compared to perfusion culture conditions (Fig. 41 and Fig. 40). 
6.3.5 Spatial differences in adipocyte differentiation in relation to flow 
To investigate the spatial adipocyte differentiation efficiency along a gradient of cell densities in 
the cell culture chamber, ASCs were induced to differentiate at different flow directions (forward 
or backward flow) in relation to the cell density gradient obtained by the use of system 1 (see sec-
tion 6.2 and Fig. 35). The cells were induced to differentiate at different flow rates (33 nL/min, 125 
nL/min or 500 nL/min) in either AM or 1.5x AM+CM. Profiles of differentiation along the cell 
culture chamber were created by measuring the sum of white pixels (lipid pixels) across the cell 
culture chamber and along the length axis of the cell culture chamber (x-axis) at different time 
points after onset of differentiation (y-axis) (Fig. 42). The color code indicates the differentiation 
efficiency with the highest differentiation efficiency at the brightest areas. 
At a flow rate of 33 nL/min and a flow direction from the low cell density area to the high cell 
density area (forward flow) (Fig. 42a), a higher differentiation was seen in the high cell density end 
of the chamber compared to the low cell density end. The spatial analysis of differentiation at for-
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ward flow direction has only been analyzed at a flow rate of 33 nL/min due to problems with preci-
pitations from the serum in the cell culture medium at the high flow rates (see section 4.3.1). 
 
Fig. 42. Spatial effect of flow on adipocyte differentiation. ASCs were induced to differentiate at different 
flow directions (forward or backward flow) in relation to the cell density gradient and at different flow rates 
(33 nL/min, 125 nL/min or 500 nL/min) in either AM or 1.5x AM+CM. Profiles of differentiation along the 
cell culture chamber were created by measuring the sum of white pixels (lipid pixels) across the cell culture 
chamber and along the length axis of the cell culture chamber (the x-axis) at different time points(days) 
after onset of differentiation (the y-axis) by ImageJ. The color code indicates the differentiation efficiency by 
the number of white pixels (lipid-pixels). a)Spatial differentiation efficiency at a flow rate of 33 nL/min and 
flow direction in relation to cell density gradient as in Fig. 35a. b) Spatial differentiation efficiency at a flow 
rate of 33 nL/min and flow direction in relation to cell density gradient as in Fig. 35b. c) Spatial differentia-
tion efficiency at a flow rate of 125 nL/min and flow direction in relation to cell density gradient as in Fig. 
35b. d) Spatial differentiation efficiency at a flow rate of 500 nL/min and flow direction in relation to cell 
density gradient as in Fig. 35b. Plots were made in MatLab by Søren Vedel.  
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When changing to a flow direction from the high cell density area to the low cell density area 
(backward flow), a similar degree of differentiation was observed in the low cell density area com-
pared to the high cell density area at flow rates of 33 and 125 nL/min (Fig. 42b and c). The higher 
differentiation efficiency in the low cell density areas at flow direction from the high cell density 
area to the low cell density area may be caused by a flow of cell secreted signaling factors from the 
cells in the high cell density area, which thereby can interact with the cells in the low cell density 
area.  
As observed previously (Fig. 38, Fig. 39, Fig. 40), a very low differentiation efficiency was seen 
in AM at a flow rate of 500 nL/min (Fig. 42d), which indicates that the flow rate of 500 nL/min 
removes most of the cell secreted signaling molecules, and thereby interrupts paracrine/autocrine 
cell-to-cell signaling. The areas, indicating differentiation already from day 0 is not an indication of 
differentiation (Fig. 42d), but an artifact caused by particles in the cell culture chamber.  
An effect of CM on adipocyte differentiation was observed at all three tested flow rates (33, 125 
and 500 nL/min). However, the highest increase in differentiation efficiency caused by CM was 
seen at a flow rate of 500 nL/min (Fig. 42d) and in the low cell density end at forward flow at a 
flow rate of 33 nL/min (Fig. 42a). Thus, as shown in Fig. 40 the highest effect of CM is observed 
at the lower cell density cultures. 
6.3.6 Dependence of nutrient supply on adipocyte differentiation 
The fat accumulation in the form of formation of intracellular lipid-filled droplets is the final 
step in adipocyte differentiation. This is a metabolic process that probably requires a large supply 
of nutrients compared to requirements during normal cell maintenance. To investigate the effect of 
nutrient availability on the adipocyte differentiation in terms of fat accumulation, ASCs were in-
duced to differentiate in 1.5x AM+CM at a flow rate of 33 nL/min or 500 nL/min. Because high 
cell density cultures are expected to require a larger nutrient supply than low cell density cultures, 
the fat accumulation was further examined at three different cell loading suspension densities, 
0.5x10
5
, 2x10
5
 and 4x10
5
 cells/mL. 
The two lowest cell densities (0.5x10
5
 and 2x10
5
 cells/mL) resulted in almost the same amount 
of accumulated fat at both flow rates (Fig. 43b and c). In contrast, a large difference was observed 
at the highest cell loading suspension density (4x10
5
 cell/mL).  
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Fig. 43. Dependence of nutrient supply on adipocyte differentiation. ASCs were induced to differentiate in 
1.5x AM+CM at a flow rate of 33 nL/min or 500 nL/min. Furthermore, the differentiation was analyzed at 
three different cell loading suspension densities, 0.5x10
5
, 2x10
5
 or 4x10
5
 cells/mL. Differentiation is meas-
ured by the total area of lipid-filled droplets using ImageJ. a) Formation of lipid-filled droplets in the high 
cell density culture (4x10
5
 cells/mL) at day 5 and day 20 at a flow rate of 33 nL/min and 500 nL/min. b) 
Differentiation shown over time at a flow rate of 33 nL/min. c) Differentiation shown over time at a flow 
rate of 500 nL/min. One experiment has been performed at each flow rate. 
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At a flow rate of 33 nL/min, the fat accumulation in the high cell density culture rose quickly above 
the level observed for the low cell density cultures during the first 2-8 days after onset of differen-
tiation (Fig. 43a and b), with a high percentage of the cells having accumulated a few lipid-filled 
vacuoles at day 5 (Fig. 43a). This indicates a possible influence of cell secreted signaling factors 
on adipocyte differentiation in the high cell density cultures at low flow rates. 
However, in contrast to the slope of the curve for the medium cell density culture (2x10
5
 cell/mL), 
the slope of the curve for the high cell density culture was almost constant during the whole expe-
riment (Fig. 43b), and in fact the total fat accumulation was lower in the high cell density culture 
(4x10
5
 cell/mL) compared to the medium cell density culture (2x10
5
 cell/mL) at a flow rate of 33 
nL/min at day 20(Fig. 43b). This indicates too low a supply of nutrients for the fat metabolism to 
occur in the high cell density culture at 33 nL/min. Conversely, the slope of fat accumulation for 
the highest cell density cultures (4x10
5
 cells/mL) was much higher when the cells were induced to 
differentiate at a flow rate of 500 nL/min (Fig. 43c) and the total fat accumulation in the high cell 
density culture was 4-fold higher at a flow rate of 500 nL/min compared to a flow rate of 33 
nL/min, shown by more cells with lipid-filled droplets, more lipid-filled droplets in each cell and a 
bigger size of the lipid-filled droplets (Fig. 43a and c). One experiment has been performed for 
each flow rate. 
Thus, as expected the supply of nutrients seemed to have an effect on the fat accumulation effi-
ciency and thereby the adipocyte differentiation as measured by the amount of lipid accumulation 
in the cells. At high cell density cultures, a flow rate of 500 nL/min could sustain a much higher fat 
accumulation rate than 33 nL/min. 
6.4 Discussion 
In this application of the developed microfluidic cell culture systems, we have investigated 
whether paracrine/autocrine signaling is involved in the differentiation of a population of ASCs 
into adipocytes and thereby, also, whether microfluidic cell culture systems can be used as a tool to 
investigate paracrine/autocrine signaling within a cell population. We took advantage of the inhe-
rent property of constant perfusion cell culture, in which, depending on the applied flow rate, se-
creted signaling molecules are washed away, and thereby probably disrupt a possible para-
crine/autocrine signaling. 
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6.4.1 Main findings 
6.4.1.1 Paracrine/autocrine signaling is involved in adipocyte differentiation 
When ASCs were induced to differentiate in AM, a flow rate of 500 nL/min resulted in a lower 
differentiation efficiency compared to flow rates of 33 nL/min and 125 nL/min, which indicated an 
interruption of a possible paracrine/autocrine signaling implicated in the differentiation process 
(Fig. 38). The differentiation efficiency was rescued by differentiation in a 1:1 mixture of AM and 
CM (collected from differentiating cells in a static cell culture), and, in fact, an increase in differen-
tiation efficiency was observed at all three flow rates when perfusing with CM (Fig. 39). This posi-
tive effect on the differentiation by CM suggests an involvement of paracrine/autocrine signaling in 
adipocyte differentiation. Further evidence supporting the participation of paracrine/autocrine sig-
naling in adipocyte differentiation is demonstrated by the observation that a dilution of the normal 
adipogenic factors in the AM+CM mixture increased even further the positive effect of CM (Fig. 
40). In addition, this increased positive effect was not observed when the cells were induced to 
differentiate in diluted AM alone (Fig. 40) or in a dilution of both AM and CM (data not shown). 
The increased differentiation efficiency observed by differentiation in CM was supported by data 
from static cell culture conditions, although the difference in differentiation efficiency was lower 
than that observed in perfusion cell culture (Fig. 41b).  
Besides the positive influence of CM on differentiation, a general increase in differentiation ef-
ficiency was seen at increasing cell densities, which previously has been described in the literature 
to promote adipogenesis [58, 65, 66]. McBeath et al. [66] explained that the high cell densities 
resulted in cells with a round cell shape, and that the round cell shape was the trigger for adipo-
genesis. However after exposure of ASCs to AM, the first sign of differentiation is actually a 
change in cell shape from an elongated, spindle-like shape to a more round or oval cell shape, indi-
cating that the round cell shape is not a trigger of differentiation, but a first step in the differentia-
tion process. Another explanation of the large differentiation efficiency in high cell density cul-
tures, which is supported by the data shown in this study, could be that the high cell density results 
in a threshold concentration of paracrine/autocrine signaling molecules, and that this threshold 
concentration can be sensed by the nearby cells due to the short distances between the cells in a 
dense culture.  
Although adipocyte differentiation has been reviewed/discussed in several publications [61, 63, 
64, 72, 84, 128, 129], paracrine/autocrine signaling within a ASC population has to our knowledge 
not been described to be involved in the differentiation process of ASCs into adipocytes. However, 
in a study by Maxson et al. [130], the effect of conditioned media on adipocyte and osteoblast dif-
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ferentiation has been investigated in static cell cultures by the use of conventional cell culture 
methods (i.e. in petri dishes).  A 1:1 mixture of AM and CM collected from osteoblast differentia-
tion was shown to enhance adipogenic differentiation by a factor of 2.7, which is similar to the 
increase effect of CM on adipocyte differentiation that we observed in static cell cultures (Fig. 41). 
Likewise, a 1:1 mixture of osteogenic medium and CM collected from adipocyte differentiation 
was shown to enhance osteogenic differentiation by a factor of 1.4. However, by the use of a mi-
crofluidic perfusion cell culture system we demonstrated an increased adipogenic effect of CM 
compared to AM of 17-fold (Fig. 40). Later Maxson et al. have shown the same phenomenon be-
tween chondrocyte CM and osteoblast CM [131]. These results, together with the results demon-
strated in this thesis, indicate that there might exist a common paracrine/autocrine factor influenc-
ing/enhancing the differentiation of MSCs towards the mesodermal lineages. 
Based on the knowledge described in the literature and the data presented here, a simplified 
model of exogenous factors influencing adipocyte differentiation can be created, as shown in Fig. 
44. The model shows that an effective concentration of adipogenic stimuli induces adipocyte diffe-
rentiation, which is then further affected/enhanced by paracrine/autocrine signaling. The effect of 
the paracrine/autocrine signaling on the fat metabolism and accumulation may be direct or indirect 
through commitment of differentiation or through activation of the transcriptional cascade in the 
terminal differentiation process. Furthermore, fat metabolism may be dependent on nutrient availa-
bility, as well as the first steps in adipocyte differentiation are possibly dependent on a certain nu-
trient level. 
 
Fig. 44. Simplified model of exogenous factors affecting adipocyte differentiation. An effective concentra-
tion of adipogenic stimuli induces adipocyte differentiation, which is affected/enhanced by para-
crine/autocrine signaling. The effect of paracrine/autocrine signaling on fat metabolism may be direct or 
indirect through commitment of differentiation or through activation of the transcriptional cascade in the 
terminal differentiation process. The fat metabolism may furthermore be dependent on nutrient availability, 
as well as the first steps in adipocyte differentiation possibly are dependent on a certain nutrient availability. 
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6.4.1.2 Optimal concentrations of cues may differ from static culture to perfusion culture 
A shown in Fig. 38, a lower differentiation efficiency was observed at the highest flow rate. As 
maybe expected, this was not caused by shear effects of the flow, but demonstrated to be caused by 
high exposure of the cells to the adipogenic stimuli. A 4 times dilution of the added adipogenic 
stimuli increased the differentiation efficiency both in AM alone and in the mixture of AM and 
CM. Actually, a previous study [130] also showed an enhancement of adipogenic differentiation 
when differentiation was induced in a 1:1 mixture of AM and osteogenic medium (i.e. a 2x dilution 
of the added adipogenic factors). At cell culture under static conditions, the concentration of adipo-
genic stimuli is expected to decrease during the period between changes of medium caused by con-
sumption and degradation of the adipogenic molecules. However, in perfusion cell culture the me-
dium is constantly renewed resulting in a higher total exposure of the cells to the adipogenic cues. 
The used concentrations of the added adipogenic stimuli have been optimized at static cell culture 
conditions and may therefore not be optimal for adipocyte differentiation in perfusion cell culture. 
Thus, the results indicate that concentrations of various factors, in general, possibly cannot be 
transferred to perfusion cell culture without some preliminary validation. Issues related to microflu-
idic cell culture have been described in several reviews [1, 13, 47, 132]. However, when describing 
mass transport the concern is about cell viability/proliferation in relation to flow rate and thereby 
supply of growth factors and nutrients. None of them discuss the concentrations of exogenous 
stimuli in microfluidic perfusion cell cultures vs. macro scale cultures. A too high exposure of cells 
to an exogenous factor may have a negative impact on cell viability, which could be misinterpreted 
as a negative effect caused by other system properties. 
6.4.1.3 Supply of nutrients may affect terminal adipocyte differentiation 
Accumulation of fat in intracellular vacuoles has been used as a marker of adipocyte differentia-
tion in this study. Besides the signaling cascades involved in induction of adipocyte commitment 
and terminal differentiation, the fat accumulation involves metabolic processes, which probably are 
dependent on sufficient nutrient supply. Thus, when investigating the involvement of 
paracrine/autocrine signaling in the adipocyte differentiation process with the use of fat accumula-
tion as a marker of differentiation, it is very important that the fat accumulation is not inhibited by 
nutrient depletion. At a low flow rate of 33 nL/min differentiation of a high cell density culture 
resulted in less fat accumulation compared to a lower cell density culture (Fig. 43b), whereas the 
fat accumulation in a high cell density culture at a high flow rate of 500 nL/min was much higher 
compared to a lower cell density culture (Fig. 43c). Thus, in the microfluidic cell culture systems 
employed here, a flow rate of 500 nL/min can sustain a much higher fat accumulation rate than 33 
nL/min in the high cell density cultures.  
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However, in a constant perfusion cell culture the available nutrients are not linear proportional 
to the applied flow rate, due to the fact that the time for a molecule to diffuse across the chamber 
down to the cells may be slower than the flow of the molecule in the perfusion flow direction. For 
example, in a chamber with a height of 0.5 mm (as in the cell culture chips employed here), it takes 
a sugar molecule with a diffusion coefficient of 5x10
-10
 m
2
/s [133] 250 sec to diffuse from the top 
of the chamber to the bottom. At a flow rate of 500 nL/min (~ velocity of 1.1x10
-5
 m/s), it takes the 
sugar molecule only 45 sec to move 0.5 mm in the perfusion flow direction, implying that the sugar 
molecule moves much faster in the flow direction than by diffusion across the chamber. Thus, at a 
flow rate of 500 nL/min the cells can only take advantage of the nutrients in the lower layer of the 
cell culture medium. Altogether, the results indicate that a flow rate sufficient for normal cell main-
tenance and proliferation is maybe not sufficient for high nutrient demanding metabolic processes 
as extensive fat synthesis to occur. Work is currently going on in the ProCell project by the theo-
retical microfluidics partners to develop a model of fat accumulation in relation to applied flow 
rates, diffusible signaling and supply of nutrients. The effect of nutrient availability on fat accumu-
lation in relation to adipocyte differentiation can be further examined by investigating differentia-
tion in media with high or low glucose content. 
6.4.1.4 Microfluidic perfusion cell culture is a useful tool in investigation of paracrine 
and/or autocrine cell signaling 
To investigate paracrine/autocrine signaling within a population of cells, it is important to be 
able to create a low background signaling level to reveal a possible effect of added 
paracrine/autocrine factors, for example in the form of a conditioned medium. By the use of the 
developed microfluidic systems we demonstrated up to a 13-17 fold increase in differentiation effi-
ciency at the two lowest tested cell densities by perfusion with CM compared to perfusion with AM 
alone (Fig. 40b, c and d). Thus, it was shown that we could remove cell secreted signaling mole-
cules to an extent that resulted in a biological read-out (low differentiation), and that these signal-
ing molecules were reintroduced by perfusion with CM. The increased effect of CM compared to 
AM alone was observed at the same cell density and flow rate and was therefore not due to any 
system effects (Fig. 40). In another recent study [35] using microfluidic perfusion culture device at 
similar flow conditions (see below) to investigate paracrine/autocrine signaling involved in neu-
roectodermal differentiation of mESCs, a 5.6-fold increase in Sox-1 (a marker of differentiation) 
expressing cells was observed at differentiation in CM compared to differentiation in medium 
without CM. However, by the use of microfluidic perfusion cell culture we demonstrated a 17-fold 
increase in adipocyte differentiation by perfusion with CM compared to perfusion with AM (Fig. 
40). Ellison et al. [34] have used a microfluidic perfusion cell culture device to investigate cell 
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viability of mESCs at conditions, were the medium in the cell culture chamber was washed away at 
different defined time intervals (every 0 minutes(constant perfusion) to 720 minutes). They ob-
served a decrease of 50% in cell viability at 0 minutes intervals compared to 720 minutes intervals. 
However, they did not examined cell viability in CM. 
 The corresponding results obtained in this project in static cell culture were an increase in dif-
ferentiation efficiency of only 3.5-fold (Fig. 41b), which is similar to what was observed in a study 
of the effect of osteoblast CM on adipocyte differentiation in a static cell culture by Maxson et al. 
[130]. They observed a 2.7-fold increase in cellular lipid content compared to cells not exposed to 
CM during differentiation. The lower difference in differentiation efficiency between differentia-
tion in CM and AM alone in static cell cultures suggests that the concentration of cell secreted cues 
between changes of medium increases to a level that results in a higher background signaling than 
in perfusion cell culture and thereby a higher differentiation efficiency at differentiation in AM 
alone.  
However, a lower difference between CM and AM was observed at the highest cell densities in 
both perfusion and static cell culture conditions, with a 4-fold and 2-fold increase, respectively 
(Fig. 40a and e, and Fig. 41b). The small differences suggest that the assay at the high cell densi-
ties was “contaminated” by signaling molecules secreted by the cells during the experiment, which 
therefore resulted in a higher background signaling. It should be noted that the actual cell density at 
onset of differentiation at the high cell density in perfusion culture was 900 cells/mm
2
, while the 
corresponding actual cell density in static culture was 640 cells/mm
2
. Thus, the results are therefore 
not fully comparable.  
The higher background differentiation in perfusion cell culture at the high cell density (Fig. 40b 
and e), indicates that a higher flow rate is needed to remove the background signaling during the 
run of the experiment. The relation between the axial convection time and transverse diffusion time 
can be estimated by the Péclet number given by Pe = v · l / D, where v is the fluid velocity, l is the 
characteristic length of the system (here the height of the cell culture chamber) and D is diffusion 
coefficient of a given molecule. As an example of a possible signaling molecule, Dickkopf-1 (MV 
28.672 Da), which has been associated with adipocyte differentiation, is used. Dickkopf-1 is a cell 
secreted molecule that has been shown to inhibit WNT signaling [76], which is involved in nega-
tive regulation of adipocyte differentiation. The diffusion coefficient of an unknown protein can be 
estimated by equation (5) (section 2.2.2) and with the viscosity of the medium set to the viscosity 
of water (1.002 mPa·s), the diffusion coefficient of Dickkopf-1 (MV 28.7 Da) is calculated to 
7.97x10
-11
 m
2
/s. With a flow rate of 500 nL/min (~ velocity of 1.1x10
-5
 m/s) and a cell culture 
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chamber height of 0.5 mm, the Péclet number is calculated to 69, which is indicative of a mass 
transport dominated by convection. In the study by Blagovic et al. [35] using microfluidic perfu-
sion culture to investigate paracrine/autocrine signaling involved in neuroectodermal differentiation 
of mESCs, flow conditions with a calculated Péclet number of 75 was shown to reduce diffusible 
signaling to an extend that negatively affected neuroectodermal differentiation of mESCs. But al-
though the Péclet number at our flow conditions is indicative of convection dominated mass trans-
port, the diffusion times at the very short distances between the cells down at the cell layer in the 
cell culture chamber is much faster, which may be the cause of the observed background differen-
tiation at high cell densities. As mentioned in section 6.4.1.3, work is currently going on in the 
ProCell project by the theoretical microfluidics partners to develop a model of fat accumulation in 
relation to applied flow rates, diffusible signaling and supply of nutrients. 
In addition, the spatial analysis of the effect of changing flow direction on differentiation over a 
gradient of cell densities showed that the microfluidic perfusion cell culture system is useful for 
investigations of cell-to-cell communications between for example high cell density areas and low 
cell density areas. 
Altogether, the results show that the employed microfluidic perfusion cell culture system is a 
more powerful tool than conventional static cell cultures in investigations of paracrine/autocrine 
signaling within a cell population. 
Another way to investigate paracrine/autocrine signaling by the use of a microfluidic cell cul-
ture system could be by a recirculation of the cell culture medium and with no recirculation in the 
references. However, this makes the system design more complex. 
6.4.2 Encountered problems and limitations of the study 
6.4.2.1 Variations in differentiation efficiency 
Large variations in differentiation efficiencies were observed from one experiment to another. 
These variations were primarily caused by the fact that it has not been possible to control the actual 
seeding density in the cell culture chambers with the current design/configuration of the microflu-
idic cell culture system (see section 5.5.2). Previous studies [58, 65, 66] and data shown in this 
project (Fig. 40 and Fig. 41) have demonstrated that the cell density in particular has a great influ-
ence on the adipogenic differentiation efficiency. Thus, for further studies the cell loading method 
needs to be optimized to be able to control the actual cell seeding density. To avoid sedimentation 
of the cells during loading, a direct injection method may be better. However, our experiences have 
shown that it is not an easy task to perform the cell loading by direct injection without introducing 
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bubbles into the microfluidic system. As mentioned in section 4.6.5, solutions for cell loading pre-
sented in the literature are normally infusion/withdrawal from various, mostly not integrated, cell 
reservoirs by manual use of a syringe [32, 35, 36, 113, 115, 116], or by peristaltic pumping / differ-
ential pressure application [5, 7]. These methods often employ a separate microfluidic network and 
integrated valves for the cell loading process, whereby introduction of bubbles into the whole mi-
crofluidic system is avoided [35]. Work is currently going on in the FAST group to improve the 
cell loading. 
Another reason for some of the variations in differentiation efficiencies is that the method for 
normalization of the area of lipid-filled droplets is not optimal. Due to the known influence of cell 
density on differentiation efficiency and general variations in cell number, it has been necessary to 
normalize the area of lipid-filled droplets in relation to the cell density. The most optimal method 
would have been to normalize the area of the lipid-filled droplets to the number of cells. However, 
because of a very low contrast of the ASCs in microscopy imaging and a very spread/spindle-like 
morphology, it has not been possible to perform the cell counting by image analysis software (even 
by specialists) and a manual counting of the cells in all experiments would have been very time-
consuming. Accordingly, the cell area was chosen for normalization, although the area is not al-
ways proportional to the number of cells, in particular at high cell densities, where the area of each 
cell is decreased because of limited space. Cells genetically modified with a fluorescent reporter to 
a nucleus protein would solve the cell counting problem, but fluorescent reporter cells are not read-
ily available for human ASCs. 
A final reason is batch variations of the collected CM. The concentration of cell secreted cues in 
CM is probably dependent on the cell density and thereby also the differentiation efficiency in the 
cultures from which the CM is collected. Furthermore, our experiences showed that a freshly col-
lected batch had a higher adipogenic effect than an older batch, thereby indicating that the 
paracrine/autocrine signaling molecules are quite unstable. The CM was aliquoted and stored at -20 
°C until use. Furthermore, CM stored at 4 °C has been tested, but showed the same effect on differ-
entiation as CM stored at -20 °C (data not shown). 
Although the large observed variations in differentiation efficiencies, the trend when using a 
freshly collected batch of CM was an enhanced effect of CM on adipocyte differentiation compared 
to differentiation in AM alone. 
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6.4.2.2 Markers of adipocyte differentiation 
In this project, the formation of lipid-filled droplets has been used as a marker of adipocyte dif-
ferentiation. At phase contrast microscopy imaging, these lipid-filled droplets appear as white 
spheres and can therefore easily be marked by imaging analysis software. However, this is a very 
late marker of differentiation. Furthermore, as described in section 6.3.6 and 6.4.1.3, the fat me-
tabolism is dependent on sufficient nutrient supply, which potentially can interfere with the investi-
gation of the signaling process involved in the adipocyte differentiation and thereby lead to misin-
terpretations. Despite these disadvantages, the formation of lipid-filled droplets was chosen as a 
first choice for several reasons. In general, the possible read-out methods in relation to microfluidic 
cell culture are more limited than in conventional cell culture studies, mainly due to the fact that the 
small sample size is often incompatible with conventional read-out methods, such as Western im-
munoblotting, flow cytometry and reverse-transcription PCR (RT-PCR). Furthermore, we wanted 
to make a time-lapse study of the differentiation process and not just an end-point study. In addi-
tion to fat accumulation as a marker of differentiation, the optimal solution for a time-lapse study 
of the differentiation process would have been the use of fluorescent reporter cells of some of the 
early markers of the adipogenic differentiation process, such as the transcription factors C/EBPβ, 
C/EBPδ, PPARγ2 and C/EBPα. However, as mentioned before fluorescent reporter cells are not 
readily available for human ASCs. The use of more markers of the adipogenic differentiation 
would add more evidence to the question of the role of paracrine/autocrine signaling in adipocyte 
differentiation. And most importantly, by the use of some of the early transcriptional markers, it 
can be further investigated where a paracrine/autocrine signaling act in the process of adipocyte 
differentiation. 
6.5 Conclusion and outlook 
By the use of our developed microfluidic cell culture systems, we have revealed that 
paracrine/autocrine signaling is involved in differentiation of a population of ASCs into adipocytes, 
and thereby that microfluidic perfusion cell culture systems are a powerful and a useful tool to in-
vestigate paracrine/autocrine signaling within a cell population in general. In addition, the results 
indicated that optimal concentrations of exogenously stimuli in the cell culture medium in perfu-
sion cultures may be different to what is optimal in static cell cultures.  
To enable more controlled experimental conditions and for further studies into adipocyte differ-
entiation, it is necessary to be able to control the cell seeding density by an improved cell loading 
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method. Furthermore, a standardized method for collection of CM should be employed, as well as   
the CM must be freshly collected at use.  
To further investigate the effect of CM on the adipocyte differentiation process, expression of 
the early markers of differentiation, such as the transcription factors C/EBPβ, C/EBPδ, PPARγ2 
and C/EBPα, can be examine by RT-PCR in a time course study of the adipocyte differentiation. 
To obtain enough cells for RT-PCR, cells may be collected from several chambers. 
Analysis of conditioned medium from differentiating ASCs vs. medium from non-
differentiating ASCs by methods such as for example microarray technologies or mass spectrome-
try may be used to identify possible paracrine/autocrine signaling candidates. Our microfluidic cell 
culture system would then be a useful tool to screen possible candidates for influence on the adipo-
cyte differentiation process. 
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Overall Conclusion and Outlook 
7.1 Conclusion 
The main objective of this project was to evaluate the usability and applicability of microfluidic 
perfusion cell culture systems as a tool in biological research. Based on obtained working experi-
ences through establishment of cell culture procedures and application of our developed microflu-
idic cell culture systems within stem cell research, usability and applicability have been investi-
gated and evaluated. 
Regarding system design, the evaluation of the tested microfluidic cell culture systems, devel-
oped in the ProCell project and the FAST group, has shown that the requirement to develop a sys-
tem with integrated fluidic actuation, liquid reservoirs, liquid interconnections and cell culture 
chambers, which at the same time displays good properties regarding optics, compatibility with 
standard laboratory equipment, portability and usability, has been met.  However, improvements 
regarding robustness and thereby reliability has been shown to be needed. As a biologist it is very 
important that the methods and tools are reliable and that the functional cell assays can be repro-
duced with a satisfactory result. The demonstrated issues regarding robustness and reliability are 
probably one of the reasons for the lack of implementation of microfluidic cell culture systems into 
biological/biomedical research laboratories.  
Procedures to performed successful long-term microfluidic perfusion cell culture experiments 
have been established. Microfluidic perfusion cell culture of HeLa cells and ASCs showed satisfac-
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tory cell attachment, morphology and proliferation and has been performed without contaminations 
by bacteria or fungi. However, further optimizations have to be done to improve the control of the 
cell seeding, which can be important in many functional cell studies. In addition to demonstrate 
satisfactory normal cell culture, we have applied our developed microfluidic perfusion cell culture 
system to demonstrate the potential of the system to regulate gene expression of a gene of interest 
by external actuation and with real-time microscopy detection.  
Further successful application of the microfluidic perfusion cell culture system has been shown 
by investigation of ASC differentiation into adipocytes, where we have revealed that 
paracrine/autocrine signaling is involved in differentiation of a population of ASCs into adipocytes. 
In this study, we demonstrated that microfluidic perfusion cell culture systems are a more powerful 
and a useful tool to investigate paracrine/autocrine signaling within a cell population compared to 
static cell culture. Thus, we have been able to perform novel biological research by the use of our 
developed microfluidic perfusion cell culture system.  
7.2 Outlook 
In this project we have demonstrated that simple microfluidic perfusion cell culture chips are a 
powerful tool to investigate paracrine/autocrine signaling within a cell population compared to 
conventional cell culture methods. Investigations of paracrine signaling could be further expanded 
by co-culture experiments of two or more cell types either patterned in the same cell culture cham-
ber or in different cell culture chambers coupled in series in different combinations. With respect to 
differentiation of ASCs into adipocytes, this approach could also be applied to further investigate 
the effect of high density cell cultures on the differentiation efficiency of low density cell cultures. 
However, for the use of simple microfluidic cell culture chips with cells in a monolayer for 
study of the cellular response to different external stimuli to be advantageous compared to conven-
tional cell culture in a well plate, the system has to provide possibilities for automated spatial and 
temporal control of cell culture conditions of many samples in the same experiment. 
Another great potential of microfluidic cell culture systems lies in the possibility to create tis-
sue-like environments. By micro- and nanotechnologies and biochemical engineering, matrices and 
gel structures can be created to provide structural support and ECM-like properties for the cells in a 
3D environment, which is supplied with nutrients and other possible external stimuli trough perfu-
sion with cell culture medium. This could be useful for, for example, to create stem cell niche-like 
environments for co-culture of MCSs, endothelial cells and other stem cell niche cells. If such in 
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vivo-like cellular environments can be realized and later upscaled in a chip with many “tissue” 
samples, microfluidic cell culture would really distinguish itself from what it possible today with 
conventional cell culture methods. 
However, as pointed out in this project, it is very important in the developmental process also to 
keep focus on usability and reliability. Furthermore, if more projects include application of the 
developed device by a biologist to investigate a biological issue, the results may be presented not 
only in the microfluidic research community, but also in the biological research community and 
thereby possible attract more interest for applying microfluidics for research into cell functions. 
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Appendix 1 
Effect of conditioned medium on adipocyte differentiation 
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Fig. 45. Effect of conditioned medium on adipocyte differentiation. The ASCs were induced to differentiate 
at different flow rates, a) 33 nL/min, b) 125 nL/min and c) 500 nL/min in either AM or 1.5x AM+CM (a 1:1 
mixture of 1.5 times the concentration of AM and CM collected from differentiating cells in static culture). 
Differentiation is measured by the total area of lipid-filled droplets using ImageJ and normalized to the total 
cell area at the start of differentiation. Differentiation is shown over time from onset of differentiation. For 
each pair of cultures differentiated in either AM or 1.5x AM+CM is indicated the batch of CM and whether 
it was freshly collected. The shown diagrams are from 9 independent experiments. 
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Appendix 2 
Effect of concentrations of adipogenic stimuli on adipocyte differentiation 
 
Fig. 46. Effect of concentrations of adipogenic stimuli on adipocyte differentiation. ASCs were loaded with 
different cell suspension densities, 0.5x10
5
, 2x10
5
, 4x10
5
 cells/mL, and induced to differentiate at a flow rate 
of 500 nL/min in AM, 1.5x AM+CM 1:1, AM diluted 4x or 1.5x AM diluted 4x+CM 1:1. All conditions were 
tested in one experiment by the use of a 16 chamber cell culture chip. Differentiation is measured by the total 
area of lipid-filled droplets using ImageJ and normalized to the total cell area at the start of differentiation. 
The results shown are from one experiment out two independent experiments. Results from the other experi-
ment are shown in Fig. 40. a)  The differentiation efficiency shown at day 18 after onset of differentiation. b), 
c) and d) The differentiation shown over time for the cell loading suspension densities 0.5x10
5
, 2x10
5
, 4x10
5
 
cells/mL, respectively. 
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Appendix 3 
Paper 1 
Peder Skafte-Pedersen, Mette Hemmingsen, David Sabourin, Felician Stefan Blaga, Henrik 
Bruus, and Martin Dufva: A self-contained, programmable microfluidic cell culture 
system with real time microscopy access. Published online in Biomedical Microdevices, 
13 December 2011. 
A self-contained, programmable microfluidic cell culture
system with real-time microscopy access
Peder Skafte-Pedersen & Mette Hemmingsen & David Sabourin & Felician Stefan Blaga &
Henrik Bruus & Martin Dufva
# Springer Science+Business Media, LLC 2011
Abstract Utilizing microfluidics is a promising way for
increasing the throughput and automation of cell biology
research. We present a complete self-contained system for
automated cell culture and experiments with real-time opti-
cal read-out. The system offers a high degree of user-
friendliness, stability due to simple construction principles
and compactness for integration with standard instruments.
Furthermore, the self-contained system is highly portable
enabling transfer between work stations such as laminar
flow benches, incubators and microscopes. Accommodation
of 24 individual inlet channels enables the system to per-
form parallel, programmable and multiconditional assays on
a single chip. A modular approach provides system versa-
tility and allows many different chips to be used dependent
upon application. We validate the system’s performance by
demonstrating on-chip passive switching and mixing by
peristaltically driven flows. Applicability for biological
assays is demonstrated by on-chip cell culture including
on-chip transfection and temporally programmable gene
expression.
Keywords Programmable . Cell culture . Microfluidic .
Portable . User-friendly .Modular
1 Introduction
Systems based on microfluidic technology have the poten-
tial to be an important future research tool within the cell
biology field (Velve-Casquillas et al. 2010; Wu et al. 2010;
Yeon and Park 2007; Young and Simmons 2009). Among
the advantages of microfluidics compared to conventional
technologies are reduced sample consumption, portability,
parallelization and increased spatiotemporal control of the
sample environment (Liu et al. 2010; Park et al. 2010;
Taylor et al. 2009; Velve-Casquillas et al. 2010) leading to
possibilities for assays not possible with today’s tech-
nology. Despite these advantages and the existence of
highly advanced systems (Gomez-Sjöberg et al. 2007;
Taylor et al. 2009) the microfluidic technology still has not
made its entry as a common everyday tool into the biolog-
ical research laboratories (Whitesides 2011; Young and
Beebe 2010; Young and Simmons 2009). In order to fully
get the microfluidic technology adopted by the biological
society it is time to consider issues such as usability, avail-
ability and conformity to existing standards and protocols as
pointed out elsewhere (Andersson and van den Berg 2006;
Whitesides 2011).
As microfluidic cell culture is still a relatively young field
of research, as a natural consequence the development of
microfluidic systems has to a high degree been technology
driven and focused on implementation and integration of
functionality rather than usability and availability.
Often, microfluidic cell culture systems focus only on a
subset of components or a single functionality without
addressing issues of portability and connectivity to reagents
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and actuation hardware. Typical prototyping configurations
include a microfluidic chip containing the actual cell cultur-
ing and manipulation functions combined with an external
perfusion system based on bulk syringe (Hung et al. 2005;
Kim et al. 2006; King et al. 2006; Stangegaard et al. 2006)
or peristaltic (Wang et al. 2007; Zhang et al. 2009) pumps
attached through glued or press fitted needles and extensive
tubing. This configuration has advantages in terms of rapid
prototyping and device testing without the need for develop-
ment of pumping solutions. However, bulk pumps heavily
restrict system portability and conflict with established work-
ing routines, increase required sample volume and limit the
number of possible individual inlets to the microfluidic chips.
Furthermore, the use of distantly placed pumps connected by
extensive amounts of tubing can be prone to formation and
trapping of bubbles. Approaches to avoid external pumps
include integration of peristaltic pumps on chip using either
pneumatic (Hsieh et al. 2009; Kim et al. 2008; Melin and
Quake 2007; Yu et al. 2009) or Braille display (Gu et al.
2004; Tung et al. 2007) actuation. This has the advantage of
allowing for a large number of pump lines and integration of
reservoirs. However, the integrated approach can set restric-
tions on the possible assays due to a fixed design. Further-
more, actuation of pumps and valves is often still
accomplished by large amounts of tubing to external sole-
noid actuators. Systems allowing for a higher degree of
portability have been explored and demonstrated. Examples
include a fully portable culturing solution (Futai et al. 2006)
and a parallel culturing system with a simple actuation
interface by a single pressure source (Sugiura et al. 2008).
Examples of approaches interfacing established standards
include a passive culture array by Lindström et al. (2009)
containing 672 micro chambers on a chip with dimension of
a standard microscope slide. The chip can be seeded by
FACS instruments and allows for high-throughput single
cell analysis by conventional imaging equipment, but is
not constructed for automated perfusion. Systems using the
well plate standards include a microbiology fermentation sys-
tem with easy interconnection and handling by Buchenauer et
al. (2009). Lee et al. (2007) presented a 96 well plate based
perfusion system optimized for existing equipment and pro-
tocols with simple but limited fluid control by gravitation-
ally driven perfusion. Systems for high throughput cell
culture have been presented by Meyvantsson et al. (2008)
and Puccinelli et al. (2010) combining passive well plate
format microfluidics with external pipetting. This allows for
a high degree of automation by fluid handling robots.
In this paper we present a stable, self-contained system,
which is fully portable and compatible with common work-
ing routines of cell biology labs. Based on previously pre-
sented interconnection standards (Sabourin et al. 2010a) and
improved and further miniaturized near-chip peristaltic
micropumps (Skafte-Pedersen et al. 2009) the construction
of the system facilitates handling without specialized skills
in microengineering as exemplified by the rapid formation
of 32 system-to-chip interconnections formed with only
tightening four screws. Yet, it provides up to 24 inlets to
one single passive chip and in this and other aspects outper-
forms other more advanced systems regarding the number
of individual fluidic inlet lines (Gomez-Sjöberg et al. 2007;
Taylor et al. 2009). The 24 inlets are pumped with three
peristaltic micropumps each driving 8 liquid streams. The
pumps are programmable in direction and speed over time
using custom designed software to provide automated fluid
handling. We validate the system by determining switch rate
between one reagent and another and mixing in the passive
chip. Finally we control and monitor gene expression in
living cells.
2 Materials and methods
2.1 System base
The entire system is based on modular components previ-
ously described which negate the use for adhesive based
permanent assemblies (Sabourin et al. 2010b). With few
exceptions all components are custom made in-house by
direct mechanical micromilling (Mini-Mill/3, Minitech Ma-
chinery Corporation, GA, USA). An overview image of the
system with mounted culture medium vials is shown in
Fig. 1 and a conceptual system component sketch including
peripherals is given in the electronic supplementary material
(ESI), (ESI Fig. 1). System components are assembled on a
pair of 5 mm thick polycarbonate (PC) base plates. The
outer base plate (OBP) rests on the microscope stage and
supports the reservoir holders, electrical connector, and in-
ner base plate (IBP). Inlet reservoir holders accommodate up
to twenty-four 4 mL glass vials (13090222, La-Pha-Pack
GmbH, Germany) with silicone/poly(tetrafluoroethylene)
(PTFE) sealed screw caps (13150815, La-Pha-Pack GmbH,
Germany) and outlet reservoir holders contain up to six
10 mL glass vials (18091306, La-Pha-Pack GmbH, Ger-
many) with butyl/PTFE sealed screw caps (18031416, La-
Pha-Pack GmbH, Germany). The IBP supports three peri-
staltic micropumps with motors, three inlet adaptors for
connecting pumps and reservoirs through tubes, a combined
outlet and cell loading block (OCLB) and a support frame
for the microfluidic chip (Fig. 2). The IBP is mounted below
the OBP in order to fit directly into the central recess of the
scanning stage (Scanning stage 130×85 mot; CAN, Carl
Zeiss, Germany) for secure mounting by a spring loaded
click-on approach. The pumps have integrated, reversibly
sealing ball joint interconnections with a self-aligning fea-
ture (Sabourin et al. 2010a). The same type of interconnec-
tions is integrated in the bottom of the OCLB. These
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integrated ball joint interconnections, which are firmly se-
cured by the IBP are used to interface the microfluidic chips
directly to the OCLB and outlet side of the pumps, respec-
tively. The 32 system-to-chip interconnections are estab-
lished by snapping chips in place and tightening four
screws, one in each corner of the chip support frame
(Fig. 2). The self-aligning ball joint interconnections and
corresponding inlet holes on the chip create interconnec-
tions with high sealing strength (Sabourin et al. 2010a). The
inlet sides of the pumps have mounted inlet adaptors con-
taining cylindrical cavities with a volume of ~30 μL. These
can be used either directly as pipetting reservoirs for short
assays or a connection base for connecting the pumps to the
glass vials via PTFE tubing. In the latter case a piece of
silicone tubing (1×3 mm, 228–0701, VWR, Belgium) is
mounted in the hole to serve as a gasket for PTFE tubing
(BOLA 1810–01, Bohlender GmbH, Germany). The outlet
block is a combined structure of PC and poly(dimethylsi-
loxane) (PDMS) containing eight integrated ball joint inter-
connections and eight ~15 μL chambers, which serve as
both socket for PTFE outlet tubing and reservoirs for load-
ing up to eight different cell suspensions.
The entire system is enclosed in an incubator (Incubator
XL Dark S1, Carl Zeiss, Germany) when mounted in the
microscope. To limit the influence of gas permeable materi-
als on the liquid the entire system is equipped with a flexible
atmosphere cover during long-term cell culture. The cover is
reversibly attached by Velcro® tape and fed with a
Fig. 2 Exploded view of the interconnection principle for chip mount-
ing. A chip support frame secures and aligns the chip to the inner base
plate. The inner base plate supports the 32 ball interconnections, which
are directly integrated in the OCLB and pums, respectively. By tight-
ening four screws the 32 interconnections to the chip are established.
The inner base plate is cut along the center for visualization and pumps
are not shown. The interconnections are visualized by the four blocks
each containing eight ball joint interconnections at the bottom side
Fig. 1 Complete system including microfluidic chip, 16 inlet vials and 4 outlet vials. Electrical and gas interconnection is seen in upper right corner
and the microfluidic chip (highlighted) is attached in the center surrounded by three pumps
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humidified CO2 enriched gas mixture (CO2 module S1, Carl
Zeiss, Germany).
2.2 Chip design and fabrication
The employed microfluidic chips are based on PMMA
(Plexiglas XT 20070, Röhm GmbH, Germany and Solaris
Clear S000, PSC A/S, Denmark) and fabricated by micro-
milling followed by a UV assisted local heat bonding
(Truckenmüller et al. 2004). In short, the individual layers
of the chip were cleaned with 70% EtOH and Milli-Q water
before being exposed to UV (DYMAX, 5000 EC with bulb
36970, CT, USA) for 90 s. Following exposure the layers
were sandwiched between two glass slides in an alignment
setup and bonded for 20 min at an initial bonding pressure
of 2.3 MPa in a laboratory press (PW 10 H, P/O/Weber,
Germany) pre-heated to 85°C. All chips have a total thick-
ness of 3.5 mm and are, depending on the specific design,
composed of individual sheets of PMMA ranging from
0.5 mm to 2 mm in thickness. The bottom layer of all chips
is 0.5 mm for reduced optical path length from the sample to
the objective. A total of 32 fluidic inlets and outlets are
implemented as 800 μm holes in the top of the chip. Inlets
are spaced 2.25 mm apart to conform with 1,536 microtiter
well plate standards and placed along each chip side in
groups of 8 to interface pumps and OCLB. The chip for cell
culture and programmable gene expression (Fig. 3(a)) con-
tains eight parallel fluidic networks each having three inlets
meeting in a common intersection upstream a mixer and
culturing chamber. The chamber has a footprint of 1.5 mm
width by 4 mm length capped by isosceles triangles. Cham-
ber height is 500 μm and inlet and outlet channels are
connected at the top surface of the chamber.
Characterization of switching and mixing of liquids is
made with chips containing four T-junctions with inlets routed
from either the same or two neighboring pumps in order to test
different flow combinations (Fig. 3(b)). Each mixer has an
outlet channel length of 88 mm and a cross sectional area of
400 μmwidth and 150 μm height. Since the diffusive leak is
dependent on the fluid velocity and thus intersection geom-
etry the influence of geometry is tested through two variants
of the intersection, one with 400 μm by 150 μm intersection
and another with a constricted 200 μm by 70 μm intersec-
tion. 3D images of these can be found in ESI Fig. 2.
2.3 Pump construction
The pump construction is an upgraded and furtherminiaturized
version of a previously presented work (Skafte-Pedersen et al.
2009) based on the three central components highlighted in
Fig. 4. A peristaltic multi roller (MR) consisting of a central
brass drive shaft encircled by eight stainless steel pins
secured in nylon holders and connected to ball bearing end
pieces occludes a monolithic PDMS microfluidic ribbon
(μFR) with eight integrated channels against a static, sup-
porting rotor bed (RB). The μFR is bookended by handling
pieces in PMMA and integrated ball-joint interconnections
for direct chip attachment.
The footprint of the central pump elements, including
two sections for fluidic interconnections of all eight chan-
nels is 30×40 mm2 and the total height is 20 mm excluding
bolt heads. By rotating the MR, fluid volumes occluded
between two pins are transported through the integrated
tubing in the direction determined by the rotation of the
MR. Due to a symmetric construction of the pumps their
action is bidirectional with the same flow characteristics in
either direction. A detailed description of pump operating
principles is provided in Skafte-Pedersen et al. (2009).
For perfusion flow rates on the order of 100 nL min−1 per
fluidic channel low rotational speeds on the order of
10−1 min−1 are required. To achieve a smooth motion at
such low speeds combined with a minimum footprint and
weight for microscopy compatibility a geared stepper motor
is used. The chosen model, which has a cross sectional area
smaller than the remaining pump parts, is a 24 step miniature
stepper motor (PRECIstep AM 1524, Faulhaber, Germany)
equipped with a planetary precision gearhead of reduction
ratio 152:1 (15A, Faulhaber, Germany). Including motor and
(a)
(b)
Fig. 3 (a) Photo of programmable cell culture chip running 8 parallel
assays. Three sets of inlets are each coupled to a pump and combined
on the chip in a passive T-junction. Each of the 24 inlets can contain a
unique compound although actuation is coupled in groups of 8. An
intermediate passive mixing section ensures homogeneous sample
exposure in the downstream cell culturing chambers. (b) Photo of
characterization chip containing four different T-junctions for investi-
gating peristaltic switching and mixing with different combinations of
peristaltic pumps and syringe pumps. Red and blue food coloring is
used for visualization of the individual fluidic networks
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gearhead the total length of a complete eight-channel pump is
100 mm and the mass limited to approximately 50 g.
2.4 Peripheral components
A custom built control box powered by an external power
supply (KY-05036S-12, Leadman Electronic Company,
Inc., Taiwan) contains three stepper motor circuits (Stepper
Motor Driver TA8435HQ CNC, Markus Mechatronics, Ger-
many) and a USB I/O card (LabJack UE9, LabJack Corpo-
ration, CO, USA) as the main components. The system is
connected to the control box through 12 electrical phases in
a single ribbon cable terminated by a standard multipin
connector. For long term cell culture the inlet and outlet
reservoir caps are coupled with PTFE tubing (BOLA 1810–
10, Bohlender GmbH, Germany) and pressurized with an air
and 5% CO2 mixture through a sterile filter with a single
Luer-Lok fitting.
2.5 Software control
The fluidic actuation is controlled by custom-built software
based on Visual Basic for Applications (VBA) for direct
integration of the pump control in the AxioVision micros-
copy software (AxioVision 4.8.2, Carl Zeiss, Germany). For
advanced long term assays such as temporal cell program-
ming requiring changes in perfusion settings over time, a
module integrating each pump setting with a corresponding
acquisition and automated image analysis sequence has
been developed. The module is fed with an external MS
Excel file containing the predefined perfusion, acquisition
and analysis settings for each phase of the experiment. A
simpler software version containing only pump control
without pre-programmed sequences has been implemented
directly in Excel. All data in this article has been produced
using the latter software version.
2.6 Numerical mixing model
Numerical finite element method (FEM) simulations are
implemented in Comsol (Comsol 3.5, Comsol AB, Sweden).
A 2D FEM model combining an incompressible Navier–
Stokes model with a convection-diffusion model in steady
state is made for determination of steady state mixing. The
Navier–Stokes model includes a volume force to account for
the top and bottom surface of the channel identical to the built
in Comsol shallow-channel approximation. The geometry is
restricted to include the first 2 mm of the inlet channels and
56.5 mm of the outlet channel.
Boundary conditions (BC) for the Navier–Stokes model
are normal inflow velocity at inlets, pressure with no vis-
cous stress at the outlet and a no-slip condition at side walls.
BCs for the convection-diffusion model are fixed concen-
tration at inlets, convective flux at outlet and no-flux sym-
metry conditions at side walls. Concentration data are
extracted for further processing from 360 μm long cross
sectional plots sampled with a distance of 0.5 mm along the
channel.
2.7 Analytical diffusive leak model
Due to the valveless construction of the chips there will be
an inherent diffusive leak from the intersection when one or
more inlets are stopped. An analytical 1D model based on
the steady-state convection-diffusion equation combined
with a characteristic diffusion time and length relation has
been developed for design guidelines. If we assume a stag-
nant inlet channel to hold a solute with diffusion coefficient
D and concentration c1 connected to an infinite upstream
reservoir of concentration c1 we can find the diffusive leak-
age concentration cB in the outlet channel subject to an
average fluid velocity v1. A constant concentration BC at
the inlet combined with continuity in concentration and
convective-diffusive flux at the intersection and a down-
stream pure convective flux at the outlet is employed to
develop a steady state model. Combining this with the
characteristic diffusion length l ¼ ﬃﬃﬃﬃﬃﬃﬃ2Dtp results in the fol-
lowing time-dependent estimate for the leak concentration
expressed in terms of the characteristic leak ratio χ
c  cB
c1
¼ D
Dþ v1
ﬃﬃﬃﬃﬃﬃﬃ
2Dt
p : ð1Þ
(a) (b) (c)Fig. 4 (a) The three main com-
ponents of the peristaltic micro-
pump showing rotor bed (RB),
microfluidic ribbon (μFR), and
multi-roller (MR). (b) Partly as-
sembled micropump. (c) Close-
up of four interconnections at the
end of the microfluidic ribbon
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Using this as a design parameter it is clear that the
diffusive leakage can be limited by increased velocity at
the intersection and increased time. However, it should be
noticed that the estimate is only valid for
ﬃﬃﬃﬃﬃﬃﬃ
2Dt
p  x1, where
x1 is the distance from the intersection to the infinite
reservoir.
Due to diffusion between the intersection and stagnant
channel there will be a time lag when switching pump
settings due to required flush of the contaminated stagnant
channel. Assuming the intersection to be a constant source
this lag can be estimated by the volume Vp contaminated
during stagnant conditions over time ts from the character-
istic diffusion length lp ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2Dts
p
. Based on this, the lag time
tl required to flush the contaminated volume Vp can be
estimated to be
tl ¼ whQ1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2Dts
p
: ð2Þ
More in-depth derivations can be found in the ESI.
2.8 Numerical time-dependent switching model
2D FEM models are employed to determine the time depen-
dence of the switching in a T-junction including the initial
convection flushing phase and subsequent convection-
diffusion balance leading towards a steady state leak. The
models are implemented by a coupled steady-state Navier–
Stokes and time-dependent convection-diffusion application
mode. The model includes a volume force to take viscous
stress from the top and bottom of the channel into account as
used in the mixing models as well. For the model shown in
Fig. 5 we use the following boundary conditions for the
convection-diffusion equation: Inlet A has a constant con-
centration of unity representing an infinite reservoir and
inlet B concentration of zero as the concentration of the
flushing liquid. At the outlet the flux is assumed purely
convective. All other boundaries are symmetry conditions.
For the Navier–Stokes model, inlet B has a parabolic inlet
velocity dependent on the flow rate. The outlet is a pressure
outlet condition with no shear stress. All other boundaries
are no-slip conditions.
As initial condition the upper inlet channel and the outlet
channel are maintained at concentration c01, whereas the
lower inlet channel is at c00 as illustrated in Fig. 5. The
model containing a constricted junction assumes a constant
channel height of 70 μm in the entire domain, since the
switching dynamics are dominated by the convection-
diffusion balance in the intersection. The convection-
diffusion model is solved with a time dependent solver at
time steps of 1 or 4 s for flow rates of 1,000 nL min−1 or
250 nL min−1, respectively.
2.9 Flow characterization
Flow patterns and characteristics of a separate pump as well
as on-chip convection-diffusion dynamics were determined.
For time-dependent flow pattern determination the outlet
from individual channels of a peristaltic micropump were
connected to a thermal anemometry volume flow sensor
(Flowell, Fluigent, France) by PTFE and polyetheretherke-
tone (PEEK™) tubing (BOLA 1810–10, Bohlender, GmbH,
Germany and Upchurch Scientific 1581, IDEX Health and
Science, WA, USA) via an intermediate PMMA tubing
connector chip. The inlet side of the pump was connected
by PTFE to an open reservoir containing Milli-Q water by
PTFE tubing and connector chip. Custom made software in
Matlab R2010a (The MathWorks, MA, USA) was used to
plot the pattern.
Determination of channel-to-channel and pump-to-pump
variability were made in a separate test setup containing a
chip with sixteen 1×1 mm2 channels addressed by two
individual micropumps, where the advancing fronts of a
water-based dye solution were used to determine pumped
volume per full pump rotation. For this purpose and for
durability tests another motor type (LEGO® Mindstorms®,
Denmark) with higher rotational speed capabilities was
used.
For on-chip characterization of switching rate and mixing
capabilities using the chip shown in Fig. 3(b) the inlets in
each T-junction were discriminated by feeding one inlet
with a combined fluorescent and absorbing solution and
the other inlet with an absorbing solution. For matched
absorbance and excitation wavelengths this technique elim-
inates signal from the upper part of the channel by Lambert-
Beer absorption as described by Bancaud et al. (2005).
Fluorescein sodium salt (FS) (Sigma 46960-25 G-F) was
used as fluorescent dye and Orange G (OG) (Sigma O3756-
25 G) was employed as a matching absorbing dye. Concen-
trations of cFS01 mM and cOG030 mM were used to obtain
the best compromise between fluorescent signal and decay
length based on a parametric scan of concentration
Fig. 5 Overview of initial and boundary conditions for numerical
FEM model. Initial conditions in concentration are c01 and c00 in
the white and grey areas, respectively. Boundary A has a constant
concentration condition and the outlet is assumed convective flux in
the convection-diffusion model. Inlet B has a constant inlet velocity
and the outlet a no stress condition in the Navier–Stokes model. Area
used for numerical analysis of average leak downstream the intersec-
tion is highlighted
Biomed Microdevices
combinations (unpublished results). The two dyes were dis-
solved in a 50 mM carbonate-bicarbonate buffer solution
(CBB) (Sigma C-3041) with a nominal pH of 9.6. As the
nonfluorescent absorbing solution a 30 mM OG solution in
50 mM CBB was used to ensure identical absorption char-
acteristics over the entire channel width. Based on the
theory presented by Bancaud et al. (2005) this gives a
95% intensity reduction over 24 μm with the employed
Zeiss EC Plan-Neofluar 10×/0.3 Ph1 objective.
The fluids for peristaltic pumping were contained in
4 mL glass vials connected by PTFE tubing (BOLA
1810–01, Bohlender GmbH, Germany) and the chip
outlets were connected to 5 mL glass vials through
PTFE tubing. Image acquisition software was AxioVi-
sion and automated analysis was performed by custom
made software in Matlab with the aid of Bio-Formats
(LOCI, UW-Madison, WI, USA) for reading the Zeiss
ZVI file format.
2.10 Switching
For switching characterization a single T-junction was at-
tached to two independent peristaltic pumps. The switching
efficiency was evaluated by switching off the fluorescent
inlet and turning on the nonfluorescent. Two different flow
rates of 250 nL min−1 and 1,000 nL min−1 were used. Prior
to switching, the system had been running at the initial
condition for a minimum of 2 or 8 min at 1,000 nL min−1
or 250 nL min−1, respectively. The flow rates denote aver-
age flow rates.
Time-lapse series with a temporal distance of 2 s or 8 s at
1,000 nL min−1 or 250 nL min−1, respectively, were
recorded using a 10×/0.3 Plan-Neofluar objective, 62HE
filter, 470 nm Colibri LED light source and a Zeiss Axio-
Cam MRm B/W camera. First image was acquired approx-
imately 1 s before change of pump settings to ensure
recording of initial condition. For each geometry and flow
rate combination a total of three repetitions were made.
Fluorescent images were background corrected by a pixel-
to-pixel subtraction of background images recorded with a
pure OG flow before and after the measurement series.
The fluorescent signal was quantified by calculating the
densitometric mean based on the individual pixel values
in a 125 μm wide stripe centered 750 μm downstream
the rear edge of the intersection. The values were nor-
malized to the densitometric mean of the first frame in
each measurement series. The mean and standard devi-
ation for each setting was calculated and plotted against
a time scale, which was shifted 1 s to account for delay
between start acquisition and change of pump settings.
Conversion from intensity to fluorophore concentration
was done by a 1:1 correlation based on a standard curve
(data not shown).
2.11 Mixing
For determination of mixing properties the four T-
junctions of the chip given in Fig. 3(b) were connected
to the nonfluorescent OG and fluorescent FS/OG mixture.
The schematic representation for each junction can be found
in ESI Fig. 3.
To compare the mixing from pulsating peristaltic pumps
to steady flow from syringe pumps a number of combina-
tions were made. Junction A was fed by a single peristaltic
pump in phase, junction B was connected to two peristaltic
pumps with arbitrary phase shift, junction C was connected
to a peristaltic pump and a syringe pump (CMA 400, CMA
Microdialysis, Sweden) equipped with 1 mL syringes (BD
Luer-Lok Tip 1 mL, ref 309628, Becton, Dickinson and
Company, NJ, USA) and junction D was operated by the
same syringe pump. The nominal, average flow rate ratios of
the inlets were 1:1 in all four junctions and the total flow
rate was 250 nL min−1 or 1,000 nL min−1 per junction,
respectively.
Image acquisition was performed using the same equip-
ment as for switching experiments but measured at positions
0, 2, 4, 8, 16, 32 and 48 mm downstream the front edge of the
intersection in order to determine the diffusive mixing as
function of convection distance. At each position, a 20 s
time-lapse series with 2 s intervals was acquired and repeated
2×3 times per setting for a total of 66 images in both bright-
field and fluorescence per position per flow rate setting.
Mixing efficiency was quantified by the mixing index M
as given by Lee et al. (2000). If we introduce the average
pixel intensity I and the standard deviation of the sample σs
on the pixel intensity the mixing index can be expressed as
M ¼ 1 ss
I
: ð3Þ
The fluorescence images were used for statistical evalu-
ation of the mixing index along a line across the channel.
Optical edge effects were eliminated by centering and lim-
iting the analysis segment to 360 μm and a manually deter-
mined background pixel value based on analysis of an OG
filled channel was subtracted and the line segment smoothed
before calculation of the mixing index for each individual
image. Subsequently, the mean and standard deviation of the
mixing index at each position and condition were calculated
and plotted against the distance from the junction.
2.12 Cells and culture medium
HeLa Tet-On® Advanced cells (631155, Clontech) were
cultured in DMEM/F-12 + GlutaMax™ (31331, GIBCO)
supplemented with 10% Tet System Approved Fetal Bovine
Serum (FBS) (631106, Clontech), penicillin 100 U mL−1,
streptomycin 100 μg mL−1 (P4333, Sigma), and geneticin
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(G-418) 100 μg mL−1 (11811–023, GIBCO). At conven-
tional cell culturing the cell line was incubated at 37°C and
5% CO2.
2.13 Microfluidic cell culture
Liquid glass vials, caps, and PTFE tubing were steril-
ized by autoclaving before use. Glass vials, tubing and
connections to pumps were assembled onto the system
base plate. The cell culture chip and tubes connecting
the liquid reservoirs to the pumps were filled separately
with Milli-Q water to remove bubbles, before clicking
on the cell culture chip to the IBP. Inlet and outlet
reservoirs were coupled with PTFE tubing (BOLA
1810–10, Bohlender GmbH, Germany) and supplied
with air supplemented with 5% CO2 through a sterile
filter. To avoid formation of gas bubbles a pressure of
0.3 bar was put on the flow system during the whole system
preparation and cell culture period, only interrupted when
for instance changing liquid reservoirs.
The connected flow system was sterilized by flushing with
0.5 M NaOH for 20 min at a flow rate of 4.5 μL min−1,
followed by washing with sterile water for 30 min at a flow
rate of 4.5 μL min−1 to remove all NaOH. The surface of the
cell culture chambers was coated by passing a 50 μg mL−1
polyethyleneimine (PEI) (408727, Sigma) solution in phos-
phate buffered saline (PBS) through the chip at a flow rate
of 4.5 μL min−1 for 15 min followed by 195 nL min−1 for
1.5 h at room temperature. After coating, the flow system
was flushed with cell culture medium for 20 min at a flow
rate of 4.5 μL min−1 before cell loading. Prior to cell loading
the outlet tubes were removed from the OCLB.
HeLa Tet-On® Advanced cells were resuspended in
cell culture medium added 0.025% w/v collagen (Sigma
C3867) before about 10 μL suspension of a cell density
of 5×105 cells mL−1, corresponding to a surface density of
250 cells mm−2, was loaded into embedded wells in the
OCLB in a LAF bench. The system was transferred to the
microscope and cells were introduced into the cell culture
chambers by setting the pumps to run backwards at a flow
rate of 4.5 μL min−1 for about 1 min. Afterwards, the outlet
tubing and reservoirs were attached to the OCLB under
sterile conditions in a LAF bench. The system was equipped
with the atmosphere cover and clicked onto the microscope
stage before reconnected to CO2, pressure and electrical
supplies. The system was incubated in an atmosphere setting
of 37°C and 8% CO2 to keep a pH of the cell culture
medium at about 7.0–7.2. After cell loading, the cells were
left without flow for 2 h, and then perfused with a low flow
rate of 33 nL min−1 for another 2 h. Following this attach-
ment phase, the HeLa Tet-On® Advanced cells were per-
fused at a flow rate of 500 nL min−1 until completion of the
experiment.
2.14 Regulated fluorescent reporter gene expression
DD-ZsGreen1-DR was cut out from pZsGreen1-DR
(632428, Clontech) and cloned in-frame with the DD tag
sequence in the multiple cloning site in pTRE-Cycle2
(631116, Clontech). Plasmid amplification was carried out
in One Shot® TOP10 Chemically Competent E. coli
(C4040, Invitrogen) cultured either in LB Broth (L7275,
Sigma) or on LB agar (L7025, Sigma) added Kanamycin
50 μg mL−1 (K1377, Sigma) or Ampicillin 100 μg mL−1
(171254, Calbiochem). The plasmids were purified by using
PureLink™ HiPure Plasmid DNA Purification Kit (K2100,
Invitrogen) and diluted in TE-buffer to 100 ng mL−1. HeLa
Tet-On® Advanced cells passage 10 were loaded into the
cell culture chambers on chip as described above. After 20 h
of cell culturing and at a cell confluence of approximately
80%, the cells were transfected on chip. Briefly, 6.25 μg
plasmid DNA (pTRE-Cycle2-ZsGreen1-DR) was diluted in
2.5 mL OptiMem medium (31985, GIBCO) and added
15.6 μL of Lipofectamine™ LTX (15338–100, Invitrogen)
giving a proportion of DNA to Lipofectamine of 1:5. After
gently mixing and incubation at room temperature for
25 min, the transfection complexes were diluted 1:3.2 in
cell culture medium and then flushed into the cell culture
chambers at a flow rate of 1.0 μL min−1 for 20 min. The
transfection process was performed without flow for
60 min, followed by a short flow period at a flow rate
of 0.5 μL min−1 for 10 min. These two steps were repeated
for 6 h in total. Finally, the transfection complexes were
removed by flushing with cell culture medium at a flow rate
of 1.0 μL min−1 for 20 min. Cell culture was continued at a
flow rate of 0.5 μL min−1 for another 18 h, before inducing
mCherry and DD-ZsGreen1-DR gene expression by switch-
ing to cell culture medium supplemented with doxycycline
0.5 μg mL−1. DD-ZsGreen1-DR was stabilized by another
switch to medium added doxycycline 0.5 μg mL−1 and
Shield1 0.5 μM and perfusion with doxycycline and Shield1
was continued for another 21 h. Lastly, a final switch was
made to medium with doxycycline but without Shield1. Cell
culture was continued for an additional 19 h before comple-
tion of the experiment.
2.15 Imaging and image analysis
Time-lapse series of regulated fluorescent reporter gene
expression were recorded every hour by a Zeiss Axio Ob-
server.Z1 microscope equipped with a 10×/0.3 Plan-
Neofluar objective, Colibri LED light source and a Zeiss
Axiocam MRm B/W camera. A scan of 6×2 images, all
acquired with a z-stack of seven slices (5 μm between each
slice), were recorded for each chamber. The DD-ZsGreen1-
DR signal was acquired at 470 nm excitation wave length
through a 62HE filter, while mCherry was excited at 555 nm
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and emission light acquired through a 43HE filter. DD-
ZsGreen1-DR was exposed for 10 ms and mCherry for
500 ms. The images were processed by stitching the indi-
vidual images together, converting the stitched images to
one image and finally applying the AxioVision Extended
Focus module on the z-stacks to obtain the best focused
image. The fluorescent signal was quantified by calculating
the densitometric sum (DS) based on the individual pixel
values of the converted 16 bit image in the range between
1000 and 62955 for DD-ZsGreen1-DR and 1032–62439 for
mCherry. Mean value of densitometric sum based on six
individual chambers was calculated and normalized to the
highest recorded value. The normalized averages and nor-
malized standard error on the mean (SEM) for the regulated
DD-ZsGreen-DR were plotted as function of time.
3 Results
3.1 System
The presented system is self-contained, modular and opti-
mized for programmable long-term cell culture on micro-
scope stages. The system is based on three peristaltic
micropumps and a number of self-aligning interconnections
(Sabourin et al. 2010a; Skafte-Pedersen et al. 2009). The
central part of the system is an exchangeable cell culture
chip equipped with 32 holes for fluidic input/output (I/O).
Ball joint interconnections allowed the central microfluidic
chip to be attached directly to 32 fluidic lines with a simple
snap-on approach by securing four bolts between the chip
support frame and the inner base plate. The system base
plate is capable of holding up to 24 autoclaveable inlet
reservoirs providing sufficient liquid for 5–10 days of cell
culture and stimulation under typical conditions. With the
exception of external pressure and power supply, which are
attached via two standard connectors, all components and
reagents are securely mounted and enclosed on a single,
portable base, cf. Figure 1. Moving the system between
workstation such as LAF benches, incubators and micro-
scopes only required that the pressure source and the pump
control cable were disconnected from the base plate. Discon-
nection and reconnection of the pressure source and control
cable takes less than 1 min to perform. Because the fluidic
connection from inlet vials to outlet vials via pumps and chip
is not broken during disconnection of external control and
pressure cables, this operation entails no risk of introducing
bubbles during transport between work stations.
The base plate design with a lowered IBP ensured that the
system was securely mounted in the microscope stage for
long-term, multi position microscopy. The lowered IBP also
allowed for use of objectives with low to medium working
distance (WD). The compact size of the pumps combined
with the direct chip attachment allowed the pumps and chip
to fit between the condenser and objective of standard life
science inverted microscopes. The current system is opti-
mized for a motorized, inverted microscope (Zeiss Axio
Observer.Z1, Carl Zeiss, Germany) with a motorized con-
denser with WD of 26 mm and objectives with a WD down
to 2.5 mm.
3.2 Flow characteristics
The pumps are based on peristaltic occlusion of confined
fluid volumes between the multi-roller pins and are there-
fore inherently pulsatile. Figure 6 shows an example of the
flow pattern at an average flow rate of 0.36 μL min−1. A
distinct pulse pattern with typical pulse volumes of 0.08 μL
is seen. Two pumps were tested to have average displaced
volumes per full MR revolution ranging between 0.64 μL
and 0.74 μL per revolution. The relative standard deviation
in displaced volume between channels in individual pumps
was tested to be between 2.8% and 8.7% similar to values
for the previously reported pump (Skafte-Pedersen et al.
2009). Durability tests of the pumps were voluntarily
stopped after 63,000 full revolutions. Using the minimum
measured channel volume of 0.52 μL per revolution this
corresponds to a pumped volume of approximately 33 mL
per channel. For a typical culture experiment with average
flow rates of 0.5 μL min−1, the pumped volume corresponds
to more than 45 days of continuous culture.
3.3 Switching
The system operates with passive chips, i.e. chips not con-
taining any movable parts, and three pumps that each func-
tion as a closed valve when stopped. This means that liquid
could be switched using T-junctions on the chip by stopping
one pump and starting another. Since the chip did not
contain a valve at the merging point of the liquid streams,
it was necessary to determine the amount of diffusive leak
from the stopped liquid line into the downstream line.
Effects of switching were investigated for two flow rates
Fig. 6 Excerpt of peristaltic pump pattern showing flow rate Q vs.
time t at an average flow rate of 0.36 μL min−1 measured with a
thermal anemometry flow sensor. Typical pulse volumes are 0.08 μL.
The dashed line indicates the average flow rate
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(Table 1) and geometries at the merging point (ESI Fig. 2).
The experimental, numerical and analytical results of the
passive on-chip switching are summarized in Figure 7. The
diffusive leak ratio decreased more rapidly for the high
flow rate than low flow rate for each cross section geom-
etry and more rapidly for merging point with constricted
cross section compared to large cross section. The finite bit
depth of the employed camera (12 bit) and correction for a
background, which changes slightly over the course of an
experiment, put a limit on the possible resolution of the
measured leak ratio. For this reason, only data points down
to leak ratios of 1% have been included. 1% was arbitrarily
decided to have no or little biological effect. At high flow
rate and with the constricted cross section, the 1% leak was
reached after about 15 s. For high flow rate and large
volume cross section, 1% diffusive leak was reached after
about 90 s. For lower flow rate the 1% diffusive leak ratios
were observed after 0.7 and 7.2 min for constricted and
large volume cross sections, respectively. Diffusive leak
was determined by analytical and numerical models using
a diffusion coefficient of D06×10−10 m2s−1 and a stagnant
channel length of 5×10−3 m. Diffusion coefficient value is
based on data from Rani et al. (2005) scaled with tempera-
ture through the Stokes-Einstein relation. Table 1 summa-
rizes the times for reaching 1% and 0.1% leak ratios based
experiments and analytical and numerical models using the
same modeling parameters as in Fig. 5. The analytical model
uses the average fluid velocity based on flow rate and
channel cross section. For all four combinations of geometry
and flow rate a fair correlation between experiments and
numerical and analytical models is observed.
Lag time due to upstream diffusive contamination after long-
term stagnancy in the stopped inlet channel has also been
estimated. The characteristic lag times tl for flushing the inlet
channel after long-term stagnancy was calculated from
Eq. 2. With typical system values (D06×10−10 m2s−1,
w0400 μm, h0150 μm) the affected volume after 24 h is
0.6 μL. Assuming a typical flow rate at switching of 0.25 μL
min−1, the corresponding lag time tl for clearing the
previously stagnant inlet channel is approximately 2.4 min.
3.4 Mixing
The effect of pumping mechanism on mixing efficiency
was investigated using different combinations of pump
possibilities (ESI Fig. 3). Mixing of pulsatile flow (peri-
staltic micropumps), steady flow (syringe pump) and com-
bination thereof was compared (Fig. 8). There was no
difference of practical importance in mixing between steady
state flows and peristaltically induced oscillating flows. We
also found a fair correlation between measurements and
numerical results based on steady state flow (Fig. 8). The
same overall tendency for mixing with peristaltic pumping
were obtained for flow rates of 0.25 μL min−1 (data not
shown) and 1.0 μL min−1 (Fig. 8). These results indicate
that the peristaltic micropumps essentially perform equal as
pumps generating steady flow in terms of average mixing
with the employed chip and conditions.
Table 1 Time t to reach 1% and
0.1% diffusive leak ratio χ. Two
different flow rates and
intersection designs are used.
For numerical modeling the
reservoir to intersection distance
is 5 mm and diffusion coefficient
6×10−10 m2 s−1
Small intersection Larger intersection
Q (nL min−1) t1% (s) t0.1% (s) t1% (s) t0.1% (s)
Experimental 250 3.9×101 N/A 4.3×102 N/A
Numerical 250 4.0×101 N/A 6.4×102 N/A
Analytical 250 3.3×101 3.4×103 6.1×102 6.2×104
Experimental 1000 1.5×101 N/A 0.9×102 N/A
Numerical 1000 0.8×101 2.3×102 0.9×102 N/A
Analytical 1000 0.2×101 2.1×102 0.4×102 3.9×103
Fig. 7 Experimental, numerical and analytical result for the leak ratio
χ vs. time t, cf. Eq. (1), during passive on-chip switching in T-junctions
with and without constriction. Experiments A correspond to the largest
intersection and B to the smaller, constricted intersection, cf. ESI
Fig. 2. Annotations 250 and 1,000 refer to the flow rate in nL min−1.
Experimental data are averaged values ± standard deviation. Dashed
lines represent numerical results and solid lines the corresponding
analytical estimates. A diffusion coefficient of D06×10−10 m2 s−1 both
analytical and numerical models and a stagnant channel length of 5×
10−3 m was used for numerical modeling
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3.5 Operability of the system
Assembly of the system takes place in a sterile condi-
tion of a LAF bench. The cells were introduced into the
chips by loading a cell suspension into the embedded
wells in the OCLB and sucking them in by reversing
the pump direction. Due to the immediate vicinity to the
culture chip combined with a vertical design, the cell
loading wells eliminated the risk of cell loading failure
due to unwanted upstream sedimentation before loading
as can be experienced by for example loading from
syringe pumps. Rapid input of cells in the system and
increasing the viscosity of cell culture medium by the
addition of collagen enhanced uniform plating densities
along the chamber length.
Bubble formation and accumulation in the system was
initially a serious problem for the low-permeable PMMA
chips (unpublished results). This was solved by coupling the
inlet and outlet reservoir caps with PTFE tubing and pres-
surizing the system with air supplemented with 5% CO2 at
0.3 bar. After pressurizing the system, no air bubbles have
been observed even for long perfusion times (3 weeks,
unpublished results). In addition, the 5% CO2 gas mixture
improved maintenance of internal gas composition and thus
pH of the medium. Since we observed no bubbles in pres-
surized systems, the need for on-chip bubble traps was
eliminated, which eased initial chip filling, simplified chip
design and manufacture and permits a greater number of
other features, e.g. reaction chambers, to be incorporated
within the area of the microfluidic chip.
3.6 Gene expression regulated by pump switching
The doubling time for the HeLa Tet-On® cells in the system
was 32.5 h and in good correspondence with previously
reported values for growth in conventional dish culture of
unmodified HeLa cells and other microfludic systemes
(Petronis et al. 2006; Stangegaard et al. 2006). Figure 9
shows an example of the HeLa cells in one of the chambers
24 h after initial seeding.
We used the pTRE-Cycle2 tetracycline and Shield1 reg-
ulated gene expression system from Clontech to demon-
strate the ability of the microfluidic system to temporally
regulate gene expression by external actuation. HeLa Tet-
On Advanced cells were cultured and transfected with
pTRE-Cycle2-ZsGreen1-DR on chip. Gene expression of
mCherry and DD-ZsGreen1-DR was induced by culturing
in medium supplemented with doxycycline 0.5 μg mL−1.
Regulated gene expression of DD-ZsGreen1-DR was dem-
onstrated by switching to medium with or without 0.5 μM
Shield1 in addition to doxycycline. As shown in Fig. 10, the
fluorescent signal from DD-ZsGreen1-DR gene expression
increased after switching to medium with Shield1 (turning
on DD-ZsGreen1-DR gene expression) at approximately the
same rate until it stabilized at about 19–21 h. After switch-
ing back to medium without Shield1 (turning OFF DD-
ZsGreen1-DR gene expression), DD-ZsGreen1-DR was
quickly degraded with a half-life of about 4.5 h. These
kinetics were similar to DD-YFP expression in NIH3T3
cells (Banaszynski et al. 2006).
4 Discussion
4.1 System
The system was designed for usability and integration with
microscopy. The basic design of the presented system comes
from the library of components previously presented (Sabourin
et al. 2010b). However, in addition to previously presented
Fig. 9 Phase contrast micrograph at 10× magnification of HeLa cells
24 h after seeding to demonstrate the possibility for phase contrast
imaging in the system
Fig. 8 Diffusive mixing index M, Eq. (3), at a total flow rate 1.0 μL
min−1 in a channel of 400×150 μm2 cross section. Combinations A to
D measure different combinations of pulsating peristaltic actuation and
steady state syringe pump actuation (cf. ESI Fig. 3). Each data point is
based on three independent time lapse series, and errorbars indicate the
standard deviation between measurements. Simulation results are
based on a 2D steady state FEM convection-diffusion model. A diffu-
sion coefficient D of 6×10−10 m2 s−1 was employed in the numerical
model
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single functional components (Sabourin et al. 2010a;
Skafte-Pedersen et al. 2009), this paper demonstrates how
the interplay between improved versions of these components
combined with application specific microfluidic chips leads to
the creation of a robust system capable of performing biolog-
ical assays with options of parallelization and automation. An
example of such assays is the demonstrated real-time gene
expression regulation controlled by the system.
Much of the usability of the system is due to the modu-
larity of the individual components and how they are inter-
faced to the chip. A prime example is the formation of all the
32 interconnections between the systems and the chip by
tightening four screws. A second advantage of the system is
its portability, particularly between incubators, flow benches
and microscope. This is enabled by incorporation of pumps,
chips, and vials on common base plates. The only connec-
tions to the plate that is needed for operation is a single
electrical cable equipped with a standard multi-pin con-
nector and a Luer-Lok pressure connector. As the
pumps function as valves when stopped the system
can be decoupled from power and pressure and individ-
ual reservoirs changed in a LAF bench during long-term
experiments, e.g. to limit degradation of fragile com-
pounds with minimal interruption of constant perfusion
assays. Due to the self-contained structure, risk of con-
tamination during transport is furthermore minimized
and the handling of the system is compatible with
existing cell lab work routines and restrictions.
The modular approach for assembly of the system makes
it possible to exchange a wide variety of the individual
system components with the aid of a screw driver and
without having to rebuild the entire system due to contam-
ination, wear or failure of single components. This enhances
yield and general usability of the system.
As the system is designed for automated long term cell
culture with real-time microscopy it is important to ensure a
stable environmental condition. The system itself only
ensures control of the fluidic and thus biochemical near-
cell conditions and therefore thermal and atmospheric con-
trol has to be established by other means. It has previously
been demonstrated that on-chip thermal control can be uti-
lized for stand-alone transmission microscopy of long term
cell culture (Petronis et al. 2006; Stangegaard et al. 2006).
Despite the advantages in terms of portability and demands
on external equipment this feature, however, requires on-
chip integration of the thermal components, which compli-
cates fabrication, raises the costs of the culturing chips and
can give unwanted optical problems such as autofluores-
cence or shadings. To minimize complexity and cost of the
microfluidic system we employed a microscope mounted
incubator (Incubator XL Dark S1, Carl Zeiss, Germany),
which also ensures thermal stabilization of the microscope.
This added feature is especially beneficial for limitation of
focus drift over time.
The software is based on VBA and predefined settings
for controlling pumps are made in Excel sheets. This
(a) (b)
Fig. 10 (a) DD-ZsGreen1-DR gene expression was increased (turned
ON) by switching to medium added Shield1 and decreased again
(turned OFF) by switching to medium without Shield1. Doxycycline
induces gene expression of both DD-ZsGreen1-DR and mCherry, but
Shield1 regulates DD-ZsGreen1-DR at the protein level by protecting
DD-ZsGreen1-DR from degradation. Annotations above micrographs
indicate compound composition and annotation below indicate time
line. (b) Fluorescent signal of DD-ZsGreen1-DR gene expression
plotted against time. Time points for switching to medium with Shield1
and later switching to medium without Shield1 are indicated with
arrows. The fluorescent signal measurements are based on the densi-
tometric sum (DS) of individual pixel values. Normalized by highest
value (DSmax). Error bars indicate standard error of the mean based on
six independent cell culture chambers in one experiment
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ensures an interface familiar to most users, reduces the
requirements on programming skills and facilitates rep-
etition of entire experiments simply by reloading the
file. The simple software version decouples the fluidic
actuation from the microscope and gives a more flexi-
ble, albeit manual, control of the system. Furthermore, it
allows the system to be run from most Windows based
computers making it suitable for portable applications
and work in LAF benches.
4.2 Chips
The microfluidic chips contain only passive microfluidic
networks and conform to the standard microscope slide
format for easy integration with existing scanners, spotters
and other slide handling equipment. Any fluidic control in
terms of switching and pumping is handled by the three
pumps which are immediately adjacent and in contact with
the chip thus minimizing compliance problems. The volume
displacement controlled pumping mechanism eliminates the
requirements for balanced hydraulic resistance as is neces-
sary for pressure controlled parallel flow systems. This eases
the design of chips significantly and allows for rapid proto-
typing, e.g. with micromilling. The presented setup accom-
modates for a plethora of chip designs as long as the
footprint and interconnections comply with the specified
standard. Due to the non-specific mechanical attachment
of PDMS interconnections the chip can be made of a variety
of materials including, but not limited to, glass, silicon and
thermoplastics. The micromilling based chip fabrication
scheme used in this paper enables simple fabrication of
multilayered, three-dimensional microfluidic networks
allowing parallel, serial and combinatorial layouts. For chip
fabrication on a larger scale, methods such as injection
molding could be considered as an alternative method to
produce the individual chip layers.
The chip employed for programmable gene expression
distinguishes itself by both allowing for the demonstrated
binary on/off situation from each of the inlets as well as a
continuous spectrum of mixture ratios. This is possible
because the peristaltic pumps both can act as valves and
independently control flow rate. The speed of the respective
pump is set in the Excel sheet and mixtures of two liquids
can easily be established on chip. Depending on the appli-
cation all three inlets can contain stimulants to be added in
varied ratios. However, letting one of the inlets contain a
buffer solute the system is readily converted into eight
parallel temporal concentration gradient generators each
with two stimulants and one diluter. By a proper control of
the pumps the overall fluid dynamics near the cells can be
maintained through a constant average flow rate while the
concentration is varied through the flow rate ratio of the
inlets.
4.3 Fluidic control for biological assays
Results on the externally actuated fluidic control showed
that the time for switching from one liquid to another in the
chip was between seconds to a few minutes (Table 1). The
speed of exchanging a liquid from one to another is depen-
dent on the flow velocity at the merging point and diffusion
coefficient of the compounds. The flow velocity at the
merging point can be increased by employing even smaller
channels fabricated with other methods and set the pumps to
run at maximum speed (volumetric flow rate 5 μL min−1). It
should be noticed that the leak ratio is measured in close
proximity to the intersection and thus the downstream re-
sponse, e.g. in a downstream cell culture chamber as in the
design shown in chips such as those presented in Fig. 3(a),
will have a natural delay due to channel residence time. The
analytical estimate of lag in switch time after long-term
stagnancy also shows time scales in the minute range,
depending on channel geometry and flow rate. The switch-
ing performance compared to the presented results is thus
not expected to be significantly reduced even after stagnancy
periods on the order of days.
The pumps have a pulsatile flow pattern, which could be
of concern for the on-chip fluid dynamics. However, for the
employed chips and applications a comparison of models
and experiments showed that for both switching and mixing,
simple steady-state flow models can be used for design
guidelines despite the actual peristaltic actuation. This sug-
gests that the construction of similar systems can be based
on corresponding steady-state modeling.
The time to switch one liquid for another with an accept-
able contamination ratio is significantly shorter than the
typical biological time scale of the presented assays. This
has been demonstrated using on-chip transfected HeLa Tet-
On cells where the microfluidic system is capable of con-
trolling on-chip gene expression of mCherry and DD-
ZsGreen-1-DR by externally mounted pumps. The good
temporal correlation between change of pump settings and
alteration of gene expression shows that the microfluidic
system under the given culture conditions have a response
that is sufficiently fast to resolve the time scale of the
employed gene expression. The reversibility of the expres-
sion also demonstrates that the approach of passive micro-
fluidic chips is a viable tool for this type of assays in that the
diffusive leak as expected from the theoretical predictions is
insignificant. This means that the use of integrated and more
complex approaches is not necessary for these assays, and
the experiments can be performed with high cost efficiency
on passive, single-use chips.
Based on models and experiments we can thus conclude
that passive on-chip networks for switching are performing
satisfactory for such biological assays. The time scale of the
gene expression in this experiment, which is also typical for
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biological processes such as differentiation, cell division,
metabolic response and migration, is longer than the fluidic
switch time suggesting that the system can be used for a
large variety of experiments.
Finally, the presented gene expression results are
obtained by fully automated time lapse and the relatively
small variation between the individual cultures demonstrate
the power of multiple parallel microfluidic channels for
gaining data for statistical analysis in a time and cost effi-
cient manner.
4.4 Applications
The presented system is compatible with numerous biological
applications. The particular application is tightly connected to
the design of the chip attached to the system and the fact that
the systems has three motors each controlling eight flow lines
simultaneously. One configuration involves 24 chambers on
the chip, where each chamber is controlled by one flow line. In
such a configuration, it is possible to have well-controlled
treatment of cells. Such configuration would for instance
support research with the goal to understand signaling path-
ways involving a soluble compound released from cells or the
impact of flow induced stress on the cell. These assays are
now being performed in the system for investigation of stem
cell differentiation (Hemmingsen et al. 2011), and examples
of differentiating cells can be found in ESI Fig. 5 and ESI
Fig. 6. In a 24 chamber configuration, it is not possible to
obtain automated switching between factors, since the addi-
tion of factors to the cells is determined by what is added to
the input vials. For temporal control, the system and chip
must support feeding in factors to the growth medium over
time. As demonstrated in Fig. 10 using the chip shown in
Fig. 3(a), the system can support eight independent tests in
parallel for temporal investigations. While the experiments
shown are based on ZsGreen expression, it is possible to
temporally control expression of any gene of interest cloned
into a correct expression vector, in this case responding to
the presence of doxycycline. Each test site (chamber) can be
exposed to two different gradients simultaneously meaning
that timely controlled expression of a gene (as driven by
doxycycline concentration) can be combined with timely
controlled presence of a soluble like cytokine. Due to the
coupled actuation of channels by the three pumps, the num-
ber of different compounds that can automatically be added
per chamber is in the present configuration limited to a
maximum of three different compounds. For each chamber,
however, these compounds can be unique and need not to be
identical with compounds addressing neighboring cham-
bers. Moreover, an expansion of the number of possible
compounds can be implemented by adding compatible com-
ponents capable of routing multiple inlets to the chambers
(Conde et al. 2011).While the system is designed and
validated for experiments involving higher eukaryotic cells,
the system is not limited to such assays. For instance, we
have validated that biochemical assays like DNA microarray
analysis are supported by systems using the same compo-
nents (data not shown). The presented system therefore
would support research of for instance hybridization kinet-
ics. Such analysis would increase the understanding of
hybridization to and from immobilized probes.
5 Conclusions
We have devised and characterized a cell culture system
based on peristaltic micropumps and passive polymeric
microfluidic chips. The system allows for easy handling,
loading, culturing and stimulation of cells with real-time
optical detection. All handling can be performed without
skills in micromechanics and components in contact with
compounds and cells can be reused or discarded at a low
cost through the use of passive microfluidic chips combined
with off the shelf reservoirs on a modular system base. The
portability and standardized construction of the system con-
forms well with established work flows and routines in
standard cell culture labs. Biocompatibility and temporally
controlled exposure has been demonstrated through pro-
grammable gene expression. By combining peristaltic
pumping with a pressurized system we have eliminated the
need for bubble traps in a low-permeable PMMA chip while
retaining the advantages of a volume controlled pumping
mechanism. The use of PMMA chips with a well defined
geometry enables high-quality microscopy with various
contrast and fluorescence techniques and ensures a low-
permeable culturing surface amenable to coating.
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Standardization and simplification of methods to construct microfluidic and use system would greatly benefit end 
users. In this report we explore a holistic approach to building microfluidics system. The approach is based on a 
microfluidic component library and design principles that simplify construction and use of microfluidic system. 
The library of components includes a miniaturized 8–channel peristaltic pumps, valves and sample-to-waste 
liquid management and provides means to connect these components with each other or to chips in a 
standardized fashion. Constructing various systems supporting perfusion cell culture and solid phase assay like 
DNA hybridizations and in situ hybridization tested the library of components. The results showed that 1) 
constructing diverse systems is aided by a standardized component approach, 2) establishing numerous 
interconnections to components and chip is aided by handling eight fluidic lines as aligned blocks instead of 
handling eight fluid lines individually, 3) highly usable systems required that all liquid connections are fixed in 
space on a frame to which a chip can be attached to, 4) highly usable systems required that all pumps, valves 
and liquid management is collected on a portable, 5) the library provides excellent biocompatibility in terms of 
cell culture and cell differentiation, 6) the library can automate multistep processes like in situ hybridization. In 
conclusion, the library of components described here and designated MainSTREAM, supports rapid construction 
of user-friendly microfluidics systems as well as biological experiments carried out in these systems.   
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2 
Introduction 
Microfluidics offers many potential advantages over traditional techniques and can therefore 
enable new research and approaches in a variety of fields such as cell biology, structural biochemistry 
and analytical chemistry (Whitesides 2006). However, practical concerns including reliability, 
accessibility, affordability, portability, ease of use, assembly, integration and control of microfluidic 
devices hinder usability and, ultimately, adoption of microfluidic approaches (Fredrickson and Fan 
2004; Andersson and van den Berg 2006; Whitesides 2006; Young and Beebe; Young and Simmons; 
Whitesides 2011). It is possible that the reason for the existence of these practical concerns is that 
there is little engineering research addressing microfluidics on the system level. There is in contrast 
abundant and excellent literature describing function of only one part of a system, i.e the chip. We 
hypotheses that the majority of the practical concerns raised above must be addressed on the system 
level rather than the single component level such as the chip. We define a system as every component 
to operate a chip as intended including pumps, valves, computer controllers, reagent vials, waste 
containers and means to connect these components together and together with a chip. In this paper we 
explore how components can be designed and be connected together into systems that addresses the 
majority of the practical concerns raised above.  
Modular microfluidic systems of either academic or commercial origin (www.epigem.co.uk; 
www.labsmith.com; www.thinxxs.com; Grodzinski, Yang et al. 2003; Pepper, Palsandram et al. 2007; 
Rhee and Burns 2008; Sun, Wang et al. 2008; Yuen 2008; Yuen, Bliss et al. 2009) are influenced by 
both LEGO® and electronic breadboards aim to provide methods to rapidly assemble sealed 
microfluidic networks by simplifying interconnection formation between microfluidic chips. 
Additionally, modular systems present easily reconfigurable elements that can be assembled quickly 
and allow flexibility in design and construction of fluidic networks (Rhee and Burns 2008; Yuen, Bliss 
et al. 2009; Mark, Haeberle et al. 2010). Though modular approaches simplify interconnection 
formation, they fail to address and resolve fluidic actuation, routing, control and sample to waste 
liquid management (www.epigem.co.uk; www.labsmith.com; www.thinxxs.com; Grodzinski, Yang et 
al. 2003; Pepper, Palsandram et al. 2007; Rhee and Burns 2008; Sun, Wang et al. 2008; Yuen 2008; 
Yuen, Bliss et al. 2009). The resulting systems consist of chips connected to, for example, a syringe or 
peristaltic pumps. Such systems are very hard to place near or within detection instruments and 
incubators. Extended tubing then required to interface to microfluidic chips result in large dead 
volumes, induce compliance, interfere with detection and limits the portability of the systems. This 
suggests the next step to increase system level performance and usability is to provide scalable means 
to integrate pumps, valves and sample-to-waste liquid management within a single movable the 
microfluidic unit.  
A potential and commonly implemented solution to the above is the integration of fluidic 
actuation and routing functions into the microfluidic device. Multi-layer elastomeric approaches 
including microfluidic Large Scale Integration (mLSI) (Unger, Chou et al. 2000; Gomez-Sjoberg, 
Leyrat et al. 2007; Taylor, Falconnet et al. 2009) and Braille display activated microfluidic chips (Gu, 
Zhu et al. 2004; Futai, Gu et al. 2006; Tung, Torisawa et al. 2007) are examples of this approach and 
offer large multiplexing capabilities. However, the actuators, external pressure sources, solenoids, 
computers, and reagent vials and waste vials required to drive mLSI systems are still connected to the 
chip via tubes and cables. Again this limits the portability of the approach (Mark, Haeberle et al. 
2010). Braille display (Gu, Zhu et al. 2004; Futai, Gu et al. 2006; Tung, Torisawa et al. 2007) 
approaches may overcome portability issues but uptake of this approach has been slow and is 
attributed to the complexity of the equipment and the unconventional nature of the platform (Young 
and Beebe 2010). Sample-to-waste liquid management systems are not easily integrated using mLSI 
and Braille display based approaches. While sample-to-waste liquid management seems trivial, it 
requires an array of sample holders, from µL to mL in size, to be directly connected to the chip ideally 
without any tubings.  Combining µm scale features of pumps and valves with the cm scale of sample 
holders on the same chip is not necessary a simple task.  
Another solution to the raised issues of microfluidics is addressed in the point of care (POC) 
system (Mark, Haeberle et al. 2010).  POC systems aim to be highly portable, user friendly and 
typically consist of a custom control box which runs cartridges. The cartridges usually contain the 
reagents and components required for detection and quantification of analytes as well as sample ports. 
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The control box contains the actuators required to move liquids within the cartridge as well as 
detection units and a user interface. POC systems are mainly designed for repetitive, standardized, 
high volume assays, characteristics which is what is required for microfluidics to move into 
mainstream use in biomedical laboratories. However, adaptability of such systems is poor when it 
comes to variety of chips that can be processed and interfacing with various detection equipments.  
With the above in mind, we asked ourselves if it was possible to find a method and design 
components that allow engineers to construct complete microfluidic systems which are scalable, 
flexible, portable, reliable and easy to use and which also resolve the previously described practical 
issues. In particular, the methods and components should provide i) simple and reliable sample-to-
waste interconnections, ii) numerous fluidic inputs and outputs to chips, iii) pumping and iv) 
routing/valving capacity for these inputs, and a high degree of v) portability, vi) 
reconfigurability/flexibility in system design, vii) compatibility with detection equipment, and viii) 
usability in terms of robustness, biocompatible and compatible with biological work procedures. The 
resultant microfluidic platform presented here is designated as MainSTREAM.   
MainSTREAM evolved from two previously described achievements, independently 
addressing interconnection and pumping methods, into a component library which collapses 
microfluidic systems inclusive of chips, reagent and waste vials, pumps and valves, into compact and 
portable experimental units without sacrificing flexibility and scaling of microfluidic system 
construction. Through genotyping, cell culture and in situ hybridization (ISH) applications we 
demonstrate that the platform’s component library is a versatile tool set for building microfluidic 
systems with applicability to a broad range of microfluidic applications within the field of biomedical 
research. Finally, the reliability and usability of system build with MainSTREAM components was 
tested.  
 
 
Materials and Methods 
General fabrication 
Unless otherwise noted, all MainSTREAM components, and elements thereof, were based on 
CNC micromilled components (Skafte-Pedersen, Sabourin et al. 2009; Sabourin, Snakenborg et al. 
2010). Multi-layer PMMA chips were bonded via a UV-assisted bonding process (Truckenmuller, 
Henzi et al. 2004). Bonding faces of the PMMA chips were exposed to UV (DYMAX EC 5000 with 
p/n 36970 bulb, Torrington, Connecticut) for 1 min. and were subsequently bonded between glass 
plates in a bonding press (P/O/Weber, Remshalden, Germany) at 85°C for 10 minutes at an initial 
applied pressure of approximately 8 kN for chips measuring 26 mm x 76 mm (l) and 13.50 kN for 
chips measuring 52 mm x 76 mm. PDMS (Sylgard 184, DowCorning) used for elastomeric 
components was mixed in a 10:1 mass ratio of elastomer to curing agent and placed under vacuum to 
remove air bubbles. PDMS components were cured overnight at 65°C. 
Microfluidic ribbons 
Type I µFRs (Figure 1a) are designed for use in the micropump (Figure 2) and camshaft valve 
(Figure 3) and connect microfluidic elements found on both sides of the micropump and valve. Type I 
µFRs are monolithically cast from PDMS by a method previously described (Skafte-Pedersen, 
Sabourin et al. 2009; Sabourin, Snakenborg et al. 2010) and contain eight integrated circular 240 µm 
diameter channels spaced 2.25 mm centre-to-centre (1536 well plate standard). The raised tubing-like 
features (Figure 1b and c) of the Type I µFRs are occluded during micropump and valve operations. 
Type II µFRs (Figure 1e) are shorter versions of the Type I µFR. All µFR channels end with ball joint 
features (Figure 1d), which provide self-aligning, minimal dead volume interconnections (Sabourin, 
Snakenborg et al. 2010). Polycarbonate (PC) brackets, either square or round in shape, (Figure 1a and 
1e) are placed into the µFR moulds prior to PDMS casting and, during curing, are integrated into the 
µFR. Overall dimensions, inclusive of the PC brackets of the Type I and II µFR are 48 mm (l) x 30 
mm (w) x 5 mm (h), and 20 mm (l) x 30 mm (w) x 5 mm (h) respectively. 
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Fig. 1 µFRs. (a) Type I µFRs are monolithically cast from PDMS and contains eight integrated 240 µm channels 
spaced 2.25 mm centre-to-centre. The central portion of the Type I µFR (dashed box, close-up provided in (c)) 
contains raised tubing like features which facilitate pumping. Channels terminate with ball-joint interconnection 
features (box, close-up provided in (d)).  Terminal polymeric blocks incorporated during the casting process 
facilitate handling, alignment and interconnection formation. (b) Schematic representation of cross-section of 
middle portion (dashed box in (a)) of µFR. Only 2 of 8 channels shown. Tubing-like structures with 0.4 mm radii 
rounded features are raised 0.6 mm above a 0.7 mm above a PDMS support layer. Integrated channels of 0.24 
mm diameter are centered 0.25 mm above the supporting layer. (c) Type I µFR folded over on itself. The raised 
tubing-like features facilitate compression and reduce friction placed on motors during pump operation.  A 
webbed-foot design (arrow) connects tubing features to thicker PDMS blocks. (d) Ball joint interconnection 
features.  Cylinders of 1.8 mm diameter and 0.5 mm height are topped by 0.8 mm diameter hemi-spherical 
features. Integrated channels pass through the center of the ball joint features. Integrated channels of the µFR 
were filled with dye to facilitate visualization (e) Type II µFRs permit connection of microfluidic chips to each 
other using the terminal polymeric blocks and ball joint features.  Unlike the Type I µFRs, they do not contain 
raised tubing like features 
Micropump 
MainSTREAM’s micropump (Figure 2) is a further miniaturized and improved version of a 
multi-channel, mechanically actuated peristaltic pump previously described (Skafte-Pedersen, 
Sabourin et al. 2009). The three main parts of the micropump are a multi-roller (MR), a rotor bed 
(RB), and a Type I µFR (Figure 2a). The MR is made from aluminium blocks which house 4 mm inner 
diameter (ID) ball bearings (VXB Bearings, Anaheim, USA). Nylon discs mounted on a central brass 
shaft align eight free rolling 2 mm stainless steel pins. The RB is made from polycarbonate (PC). 
When attached to the micropump, the RB’s shape results in occlusion of the Type I µFR tubing 
features between the RB and the MR’s rolling pins. This enables peristaltic pumping. The footprint of 
an assembled micropump with Type I µFR attached to microfluidic chips excluding motors is 30 mm 
(w) x 40 mm (l) x 20 mm (h).  
 
 
Fig. 2 Micropump. (a) 3D schematic of micropump assembly. The Type I µFR is placed between the multi-roller 
(MR) and the rotor bed (RB). When the RB is attached to the MR, tubing features of the Type I µFR are 
occluded to permit peristaltic pumping. (b) Assembled micropump. The Type I uFR ‘s square bracket can be 
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seen middle-left protruding from between the RB and MR. Integrated channels of the Type I µFR  filled with 
dye to facilitate visualization 
 
Valve component 
MainSTREAM’s camshaft valve (Figure 3) also uses a Type I µFR (Figure 1a). The camshaft 
(Figure 3a) is fabricated from the same parts as the micropump’s MR except that the stainless steel 
pins are replaced with individual cams that are stacked and aligned along a central 4 mm brass shaft 
and 2 mm alignment pins running between the nylon discs. Cams (Figure 3b) are made from 
aluminium and have a radius of 4.66 mm, a flat cut face, a 4 mm diameter central hole and 2 mm 
through holes. The 4 mm diameter central hole allows the cams to be placed on the camshaft. The 2 
mm through holes allow flat cut faces of cams to be aligned at defined angles and positions relative to 
each other.  
  
 
 
 
 
 
Fig. 3 Camshaft valve (a) Assembled camshaft valve. Individual Type I µFR channels are alternately filled with 
blue dye, green dye, water and red dye to facilitate visualization. (b) Schematic representation of the 3 different 
cams used to build the camshaft used in this report. The central hole in each cam is used for mounting these on a 
central shaft. The two smaller holes in each cam permit alignment of the cams and their flat cut face features at 
set angles to each other. (c) Schematic representation of valve operating principle.  When the flat cut face is held 
parallel to and above a µFR channel, the channel remains open.  Rotation to any point where a circular portion of 
the cam is above the channel results in depression of the PDMS directly underneath the disc and closing of the 
channel 
To operate as a valve component, the µFR is aligned under the camshaft on a base plate via its 
two PDMS blocks (Figure 1a). A camshaft is then attached to the base plate. The height of the 
camshaft is set so that when the flat cut face of a cam is parallel to a µFR channel, the channel remains 
open (Figure 3c). Rotation of the camshaft to a position which places any circular portion of the cam 
above a channel results in contact between the cam and the µFR channels. This depresses the tubing 
wall and closes the channel. The aluminium cams are machined to thicknesses so that each cam is 
centered directly above each of the µFR’s 8 channels (Figure 3a).  
The camshaft used in this report contains eight cams (Figure 3a). The cams were arranged 
such that each 45° degree rotation of the camshaft only allows flow through only one of the µFR’s 
eight channels at a time. The 45° steps continue in the same direction sequentially along the camshaft. 
If the starting camshaft position is assigned as 0° and having channel 1 of the µFR open, sequential 
45° camshaft rotation steps in the same direction as the 45° steps of the cams’ flat faces will permit 
flow through only channel 1, then only channel 2, then only channel 3, etc., up to channel 8. Prior to 
operation, the valve’s camshaft was manually aligned to a pre-determined position. 
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Microfluidic chips 
Microfluidic chips (Figure 4a) must contain the 10 hole patterns matching that of the µFRs 
(Figure 1).  The inner 8 of these 10 holes are inlet or outlet holes with similar diameter and spacing as 
the ball joints (Figure 1d), 0.8 and 2.25 mm respectively. The outer two holes are 2 mm in diameter 
and allow µFRs to be fastened to microfluidic chips via 2 mm screws. Connector chips (CCs) are used 
for linking µFRs together (Figure 4) and are made from 1.5 mm thick PMMA and measure 30 mm (l) 
by 5 mm (w).  The previously described 10 hole pattern is centered within these dimensions.  
 
Fig. 4 (a) Sample microfluidic chip used in MainSTREAM systems. The 10-hole interfacing pattern is shown in 
the dashed box. (b)  Connector chip (CC) with 10-hole pattern used to join two µFRs together. (c) CC (arrow) is 
between and used to connect Type I µFR from micropump (left) to Type I µFR from camshaft valve (right)  
Sample to waste liquid management 
Well arrays (WAs) (Figure 5a and b) are used to store reagents, samples and waste material. 
The WA chips also contain the 10 hole pattern in order to interface to a seal against a µFR. For 
applications requiring small volumes multi-layer PMMA or PC-based WAs were used (Figure 5a). For 
applications requiring larger volumes WAs were made from layers of PMMA sealed by intermediary 
PDMS gaskets (Figure 5b).  When users specify the use of sample vials rather than WAs, tubing 
connectors (TCs) (Figure 5c) are used to connect up to sample vials to microfluidic systems. TC 
construction details are provided in the supplementary information, but in short they are a modified 
version of o-ring based interconnection blocks (Sabourin, Snakenborg et al. 2009) which also 
incorporate press-fitting of PTFE tubing into their PDMS portion and a second polymeric component 
to which interfaces to the PDMS interconnection features of the µFRs.   
 
Fig. 5 Liquid Management. (a) Well array (WA) chip for small sample volumes, approximately  
15 µL is seen attached to one side of a micropump. (b) A larger WA chip capable of holding volumes upwards of 
4 mL is seen attached to two micropumps. (c) Tubing connectors (TCs) (in dashed box) connect tubing from 
sample vials to Type I µFRs. (d) Cell loading chip (CLC).  The monolithically cast PDMS insert (dashed box) 
contains integrated wells bookended by sealing features which allow direct attachment to microfluidic chips and 
facilitate loading of cells into microfluidic systems 
 
For cell culture applications a cell loading chip (CLC) (Figure 5d) is used. The CLC contains a 
PDMS portion integrated within a PC frame. The PC frame contains inset nuts which facilitate 
attachment to other components. The PDMS portion is monolithically cast as previously described 
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(Sabourin, Snakenborg et al. 2009). In this case 1.5 mm diameter pins are used to create eight wells 
with volume of approx. 15 µL each.  The wells are bookended with o-ring sealing features (Sabourin, 
Snakenborg et al. 2009) on the bottom and top side. A lidding piece of PC is fastened and sealed 
against the top of the CLC with screws. This lidding piece contains either a single or eight press-fit 
PTFE tubings to collect waste liquids. To introduce cells into a microfluidic system, the top piece is 
unfastened by removing screws. Cells can then be loaded into individual wells and the top piece 
reattached.   
System Assembly 
All MainSTREAM components interface with each other using 2 mm screws and nuts. Base 
plates (Figure 6), made from PC, contain arrays of 2 mm holes in which 2 mm screws are inserted to 
position micropumps and camshaft valves in place. Base plates also contain recesses matching 
microchip dimensions to guide placement of chips within systems. In some cases, 2 mm nuts were 
press fit into undersized recesses within the baseplate to facilitate attachment of MainSTREAM 
components to each other. Brackets complimentary to the shape of µFR’s end brackets are sometimes 
attached to the baseplate adjacent to micropumps or camshaft valves.  These guide µFR end bracket 
placement prior to the attachment of the µFRs to other components.  
 
Fig. 6 Sample MainSTREAM microfluidic system assembly scheme. (a) MainSTREAM components required for 
system assembly.  Soft elements including Type I µFRs used in the micropump and Type II µFRs are in left 
hand box. Type II µFRs are shown at bottom left. Hard elements including microfluidic chips and well arrays 
(WAs) are in the right hand box. (b) The micropumps’ MRs are attached to the base plate. (c) A WA is placed 
on the left side of the MRs and a test chip is placed to the right. (d) Type I µFRs are connected to the chips and 
bridge the MR. (e) The RBs are attached to the MRs.  Micropump assembly is now complete. (f) Remaining test 
chip and WA(far right) are placed in system. (g) Type II I µFRs are used to connect the microfluidic chips to the 
right of the pumps together. (h) LEGO® motors are mounted to the shafts of the micropumps. (i) The controller 
unit is attached to the motors.  Samples are loaded into the WAs found to the left of the micropumps 
Actuation and control of micropump and camshaft valve 
For microfluidic networks requiring greater levels of automation or for assays of longer 
duration, the LEGO® Mindstorms® NXT 2.0 robotics kit(www.LEGO.com) was used (Figure 6, 
supplementary video 1 and 2). The LEGO® kit provides multiple servo motors with 1 ° angle control, 
a controller (NXT Intelligent Brick), software interface (powered by National Instruments LabView®) 
for programming of motors, and other required components such as connector cables and power 
source. The micropump’s and camshaft valve’s shafts were shaped to attach to the LEGO® 
Mindstorms® motors. For assays not requiring automation, a hand crank (Figure 7, supplemental 
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video 3) made from PC was attached to the micropump’s or valve brass shaft and rotated to deliver 
fluids.   
 
Genotyping in MainSTREAM  
 
Hand crank driven micropumps were used to genotype patient samples for mutations in the 
human β-globin gene [24] (HBB) via an allele-specific hybridization assay. Microfluidically-
addressable microarrays were incorporated within PMMA chips using a UV-activated poly(T)-poly(C) 
probe tag as described in a previously [24]. A PMMA genotyping chip sized identically to a 
microscope slide and containing 16 microfluidic lanes (see Figure 7) was interfaced to two 
micropumps. Each lane of the chip measured 1.5 mm (w) x 0.25 mm (h) x 21 mm (l) and was 
bookended by 0.8 mm inlet and outlet holes. Each lane contained DNA arrays constructed from 
poly(T)-poly(C)-tagged probes.  The DNA microarrays allowed allele-specific hybridization (ASH) 
genotyping of three mutations in the human β-globin (HBB) gene [24]. The probe pairs used for ASH 
genotyping of these three mutations are provided in the supplemental information. Target preparation 
from patient archive material and washing buffers for the genotyping experiments were prepared as 
previously described [24] and were transferred from a loading chip through the pump and into the 
PMMA genotyping chip by turning the hand crank (Figure 7). Solutions were sequentially introduced 
into the PMMA chip. Prior to the introduction of the next required solution, the solution within the 
chip’s lanes was pumped out and absorbed dry with a paper towel. Approximately 12 µL of each 
solution was used at each step. Channels were first filled with 5 µL, of 0.1 × saline-sodium citrate 
(SSC) supplemented with 0.5% sodium dodecyl sulfate (SDS) and incubated for 10 minutes to 
solubilize probes not bound to the surface after the spotting process. The channels were washed with 
additional 5 µL wash of 0.1 × SSC supplemented with 0.5% SDS in order to remove unbound probes. 
Fluorescently Cy3-labelled patient materials were prepared by PCR amplification and subsequent T7 
in vitro transcription. The resulting amplified RNA were diluted 1:1 in hybridization buffer (10 × SSC 
supplemented with 1% SDS) (Sabourin et al 2010) Hybridization was performed at 37°C in a dark 
humid chamber for 2 h. The hybridization solution was then removed to prepare for multi-salinity 
gradient washing. Multi-salinity gradient washing allows genotyping via parallel analysis of identical 
arrays treated with different stringency wash buffers (Petersen et al 2009). In this case, each of the 
four lanes used to genotype a single patient was filled with one of the following four washing buffers: 
2.0 × SSC, 0.55 × SSC, 0.10 × SSC and 0.035 × SSC, all supplemented with 0.1% SDS. These buffers 
correspond to 331.0, 91.6, 17.3 and 6.6 mM Na+ respectively. Lanes were filled for 1 min at room 
temperature to remove excess and unbound target. Following this the lanes were filled with the wash 
buffers and left for 30 min at 41°C. Hybridization reactions were imaged using a Zeiss Axio 
Observer.Z1 microscope. Identical focal and camera setting were used for all images collected. All 
signals were analyzed with GenePix Pro 6.1 (Molecular Devices, Sunnyvale, CA, USA) and analyzed 
according to the multi-salinity gradient washing method, which allow for the use of probes with 
different washing buffer optima in the same microarray (Petersen et al 2009).  
 
Cells and culture medium 
 
HeLa Tet-On® Advanced cells (631155, Clontech) were cultured in DMEM/F-
12+GlutaMax™(31331, GIBCO) supplemented with 10% Tet System Approved Fetal Bovine Serum 
(FBS) (631106, Clontech), penicillin 100 U mL-1, streptomycin 100 µg mL-1 (P4333, Sigma), and 
geneticin (G-418) 100 µg mL-1 (11811-023, GIBCO). Adipose stem cells (ASC) (donated by Philippe 
Collas, University of Oslo) were cultured in DMEM/F-12+GlutaMax™ (31331, GIBCO) 
supplemented with 10 % v/v Foetal Bovine Serum (FBS) (04-007-1A, Biological Industries), 
penicillin 100 U mL-1, and streptomycin 100 µg mL-1 (P4333, Sigma). Rat adrenal 
pheochromocytoma cells (PC12) (ACC 159, DSMZ GmbH) were cultured in DMEM/F-
12+GlutaMax™ (31331, GIBCO) supplemented with 15 % v/v Horse serum (HS) (H1138, Sigma), 3 
% v/v Foetal Bovine Serum (FBS) (F9665, Sigma), Hepes 0.5 % v/v (H0887, Sigma), penicillin 100 U 
mL-1, and streptomycin 100 µg mL-1 (P4333, Sigma). Human Umbilical Vein Endothelial Cells 
(HUVEC)(Lonza) were cultured in M-200 Medium (M200500, Invitrogen) supplemented with 10 % 
v/v FBS (04-007-1A, Biological Industries), and penicillin 100 U mL-1, and streptomycin 100 µg mL-
1. At conventional cell culturing the cells were incubated at 37°C and 5% CO2. 
9 
 
Cell culture in MainSTREAM 
 
A PMMA microfluidic chip containing sixteen separate microfluidic cell culture chambers 
was placed in a MainSTREAM two-pump configuration. PMMA was used due to its biocompatibility 
[26] The microfluidic chip was made from micromilled PMMA and was bonded as described above.  
Each of the sixteen cell culture chambers measured 1.5 mm (w) x 4.5 mm (l) x 0.5 mm (h) and were 
individually addressed.  The LEGO® Mindstorms® kit was used to control and drive the micropumps 
addressing this chip. All flow rates described below are average flow rates. Liquid glass vials, caps, 
and PTFE tubings (BOLA 1810-01, Bohlender GmbH, Germany) were sterilized by autoclaving 
before assembly of the system. Tubes connecting the liquid reservoirs to the pumps and the cell 
culture chip were filled separately with Milli-Q water to remove bubbles, before connecting the cell 
culture chip to the pumps. To avoid bubbles, a pressure of 0.3 bar was put on the flow system during 
the whole system preparation and cell culture period, only interrupted when changing liquid 
reservoirs. The pressure was applied to the system by coupling inlet and outlet reservoirs with PTFE 
tubing (BOLA 1810-10, Bohlender GmbH, Germany) supplied with air supplemented with 5% CO2 
through a sterile filter. The assembled microfluidic system was first sterilized by flushing with 0.5 M 
NaOH for 20 minutes at a flow rate of 5.2 µL/min. The chip was then flushed with sterile water for 30 
minutes at a flow rate of 5.2 µL/min to remove all NaOH. A 20 µg/mL Laminin (L2020, Sigma) in 
phosphate buffered saline (PBS) solution was then passed through the chip at a flow rate of 5.2 
µL/min for 15 minutes, followed by 250 nL/min for 45 minutes in order to coat the surface of the cell 
culture chambers. During coating the system was placed in an incubator at 37 °C. For HUVEC 
culturing the chambers were coated with human Fibronectin (663, YO Proteins AB) 100 µg/mL in cell 
culture medium for 20 minutes at room temperature. The cell culture chip was then flushed with cell 
culture medium for 30 minutes at a flow rate of 5.2 µL/min. Approximately 10 µL of cell suspension 
was loaded into wells of a PDMS loading chip (Figure 5). The cell density for HeLa cells, adipose-
derived stem cells, PC12 cells, and HUVEC was 2 x 105 , 1 x 105, 5 x 105, and 1 x 106 per mL 
respectively. To introduce cells into the cell culture chip, the micropumps were programmed to run 
backwards at a flow rate of 5.2 µL/min for about 1 minute. This introduced cells into the chambers 
from the outlet side. The system was then placed in an incubator at 37 °C and 5% CO2. To allow cell 
attachment to the surface, the cells were left without flow for 2 hours. Following this, the cells were 
perfused at a flow rate of 500 nL/min for HeLa cells, ASC (Isolation, culture and banking of adipose 
stem cells was done according to protocols approved by the Regional Committee for Ethics in Medical  
Research for Southern Norway (approval S-06387a to P.C.)) and PC12 cells and 400 nL/min for 
HUVEC until completion of the experiment.  For time-lapse microscopy the entire system was 
enclosed in an incubator (Incubator XL Dark S1, Carl Zeiss, Germany) at 37 °C when mounted in the 
microscope. To limit the influence of gas permeable materials on the liquid and thereby keep the pH of 
the culture medium at approximately 7.0- 7.2, the entire system incubator was humidified with 8% 
CO2 enriched gas mixture (CO2 module S1, Carl Zeiss, Germany). 10X phase contrast time-lapse 
images of cell proliferation for HeLa cells, ASC, and PC12 cells were recorded every 12 hours by a 
Zeiss Axio Observer.Z1 microscope equipped with a Zeiss Axiocam MRm B/W camera. A scan of 
2×7 images, all acquired with a z-stack of eleven slices (5 µm between each slice), were recorded for 
each chamber. For HUVEC the whole system was incubated in a conventional incubator at 37 °C and 
5% CO2 and then moved to the microscope every day for imaging. 4X phase contrast images acquired 
by a Nikon Eclipse TS 100 equipped with a Nikon Digital Sight DS-2Mv. 
PC12 cells were inserted into and cultured in MainSTREAM for 4 days before initiation of 
differentiation as described above. Medium reservoirs were changed to reservoirs with differentiation 
medium (DMEM/F-12+GlutaMax™ (31331, GIBCO) supplemented with 0.5 % v/v Horse serum 
(HS) (H1138, Sigma), 0.5 % v/v Foetal Bovine Serum (FBS) (F9665, Sigma), Hepes 0.5 % v/v 
(H0887, Sigma), Nerve growth factor (NGF) 0.1 µg/mL, penicillin 100 U mL-1, and streptomycin 100 
µg mL-1 (P4333, Sigma). Cell culture and differentiation of PC12 cells in MainSTREAM were 
continued for further three days and 10X phase contrast images recorded every six hours to follow 
differentiation. 
 
In situ hybridization 
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An in situ hybridization (ISH) assay was performed by attaching the HistoFlex device to a 
MainSTREAM configuration. In brief, HistoFlex encompasses a patterned PDMS insert which upon 
sealing aligns microfluidic reaction chambers to tissue sections fixed on a microscope slide (Søe et al 
2010). Integrated channels in the PDMS insert permit fluid delivery to and from reaction chambers. 
Temperature is controlled using peltier elements. In this report, HistoFlex’s fluidics were driven and 
controlled using MainSTREAM components: the described valve component, a micropump and 
interconnection components (Figure 8). HistoFlex is not part of the MainSTREAM platform and its 
interconnection features are not directly compatible with MainSTREAM components. As such, 
HistoFlex was connected to the MainSTREAM components previously listed through a merging chip 
(MC), and a variation of tubing connector (TC)(Figure 8). The MC merged the output of the eight 
channels; first into groups of 6 and 2 channels, and subsequently into a single channel (Figure 5b). The 
single channel was connected to the HistoFlex using the TC.  Casting techniques are used to create an 
o-ring feature at the end of a 1.6 mm through channel found within a PDMS block housed in a 
polymeric bracket.   The bracket was attached to the MC using 2 mm screws. 0.2/1.7 mm inner/outer 
diameter tubing (Bola/Bolender, Germany) was then press fit into the PDMS block. The other end of 
the tubing was inserted into a similar cavity in the HistoFlex PDMS insert, which connected to a 
reaction chamber. Waste from the reaction chamber was collected through tubing into a vial. 
An ISH assay was performed for detection of microRNA-138 (miR-138) in formalin-fixed 
paraffin-embedded (FFPE), mouse brain tissue sections, by adapting the protocol and solutions 
presented by (Søe et al.2010). Reagents were prepared in 0.2, 1.5 or 9 mL vials and placed in the vial 
rack (Figure 8). Vials, as depicted in Figure 8, were filled as follows: Channel 1 (C1) = PBS, C2 = 
prehybridization buffer (Søe et al 2010), C3 = hybridization buffer (40 nM miR-138 in 1xSSC, 4M 
urea and 1xDenhardt’s), C4 = 0.1 x SSC, C5 = blocking buffer , C6 = Cy3 - tyramide signal 
amplification solution, C7 = antiFITC antibody conjugated to a horse radish peroxidase (HRP) 
enzyme, C8 = PBS.  Merging all channels of the MC at a single point could result in unwanted mixing 
of reagents at this single merging point. In particular, premature reactions between anti-FITC antibody 
coupled to a peroxidase enzyme (C7) and i) probe coupled to a fluorescein (FITC) label (C3), and i) 
tyramide signal amplification substrate (C6). For these reasons, the two point merging structure of  the 
MC was used.  To further avoid the aforementioned reactions, PBS(C8) was always flowed in between 
when switching reagents found from C1 to C6, and from C7 to C8. The MC was primed before 
connecting the HistoFlex to the microfluidic network. The MC was primed by sequentially filling each 
channel through pumping of the respective reagents past the channel merging area. After priming, the 
tubing was removed from the waste vial and connected to the HistoFlex. 
 
Results 
The results of the holistic approach to microfluidics are on two levels. Firstly, the engineering 
level which includes system assembly, pumps, valves and other components. Secondly, 
microfluidics systems were built to address three large groups of biological assays including 
genotyping, in situ hybridization and cell culture. Each of these required different components 
and system design. These examples are used to demonstrate and describe the versatility of the 
components. Pumps and valves were evaluated for robustness and performance parameters. 
Systems were generally evaluated for compatibility with intended assay type. In case of cell 
culturing systems, a detailed usability and robustness analysis was done on the system level 
using a novel cell culturing system described here and a previously reported system (Skafte-
Pedersen et al. 2011).  
System assembly principles  
The MainSTREAM component library is summarized in Table 1. The principle used for 
creation of MainSTREAM microfluidic systems is the alternation of hard (rigid) and soft 
(compressible) components. Specifically, compression of the interconnection features of PDMS-based 
components against microfluidic elements such as microfluidic chips creates sealed microfluidic 
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networks. A sample assembly process of a system demonstrating this principle, inclusive of multi-
channel pumping capability, is shown in Figure 6.  
µFRs (Figure 1) contain aligned banks of 8 short tubes bookended with integrated 
interconnection features, which provide sufficient seal capabilities for most microfluidic applications 
(Sabourin, Snakenborg et al. 2009; Sabourin, Snakenborg et al. 2010).  µFRs provide a simple flexible 
method for establishing chip-to-chip and chip-to-world interconnectivity and withstood system 
handling and moving operations (see below). Dead volumes are 2.5 and 1 µL respectively for Type I 
and II µFRs. A chip is exchanged by releasing the µFRs from chips by loosening screws, a new chip is 
inserted and the screws are then tightened to fasten the µFR. Dependent on chip design and number of 
µFRs attached to it, this usually takes less than one or two minutes. Complete system disassembly is 
thus not necessary to exchange a chip. The interconnections are robust and only seldom, leaks were 
observed from assembled systems despite having up to 96 interconnections (Figure 6, 12). Replacing 
the µFR from the pump only requires that the RB is removed and the ends of µFR are unfastened. The 
access of the parts from the top simplifies replacements of specific parts.  
 
Micropump performance 
The micropump is self-priming, and simultaneously pumps fluids through the Type I µFR’s 
eight channels bi-directionally (supplementary video 1). Average per channel displaced volumes per 
micropump rotation was approximately 0.7 µL (testing described in supplemental information).  
Heretofore, rotation refers to a 360° rotation. Channel-to-channel coefficient of variation for per 
channel displaced volumes ranged between 2.8 % and 8.7 % (Supplementary Information). Durability 
as compared to previously peristaltic pump(Skafte-Pedersen, Sabourin et al. 2009) was improved at 
minimum 30-fold. Testing (supplemental Information) indicated that following 63000 micropump 
rotations Type I µFRs were intact.  Using the minimum observed per rotation channel displaced 
volume of 0.52 µL (supplemental information), 63000 rotations correspond to a minimum total 
displaced volume of 33 mL per channel. A 3-week microfluidic cell culture experiment running at 1 
µL/min would consume 30 mL per channel.  Additionally, given that testing was voluntarily stopped 
this is likely an underestimate of durability.  The compact nature of the micropump allows its 
placement adjacent to microfluidic chips and yields compatibility with detection equipment (Figure 
10d).  
To achieve a given flow rate using the LEGO Mindstorms motors a procedure involving a) the 
use of a calibration chip (to determine per channel displaced fluid volumes per micropump rotation) 
and b) “STEP and WAIT” programming of LEGO® motors (supplemental Information) at powers 
allowing consistent turning of the micropumps is used. STEP and WAIT programs STEP the motor a 
fixed number of degrees and then WAIT a fixed time between steps. STEP and WAIT is enabled by the 
motors’ integrated rotation sensor, to within 1°, and simplified by the provided LEGO® LabView® 
interface. A sample STEP and WAIT procedure is provided in the supplemental information. 
Assuming an average per rotation per channel displaced volume of 0.7 µL, use of the LEGO® motors 
can provide flow rates from sub µL  to 90 µL/min. Though per rotation micropump displaced volumes 
are constant from 25 to 50% motor power, flow rates do not linearly increase with power (data not 
shown).    
 
Valve performance 
Camshaft valve testing (supplemental information) showed that the valve could block 
channels against an upstream pump running at 100% motor power. With an open valve this 
corresponds to a flow rate 89 µL/min, well above that used for the majority of microfluidic 
applications. The pressure buildup between the micropump and valve was automatically relieved by 
backflow towards the micropump. Valve rotation between different positions occurred in less than 2 
seconds. This time was dependent on the degrees of rotation required.  Valve durability testing 
(supplemental information) was voluntarily stopped after 20000 rotations. Each rotation corresponded 
to an opening and closing of each of the µFR‘s eight channels. After 20000 rotations, the µFR was not 
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damaged and all eight channels were still being properly valved. Given that testing was voluntarily 
stopped this is likely an underestimate of durability.  For typical biochemical assays (see discussion) 
this is sufficient for approximately 2000 complete assays. 
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Component Interfacing 
Characteristic 
 
Description Fig 
Microfluidic 
Ribbons (uFRs) 
Type I 
Soft Simultaneous 8 channel through micropump and 
camshaft valve connectivity 
16 self-aligning minimal dead volume 
interconnections 
2.5 µL internal dead volume 
1 
Microfluidic 
Ribbons (uFRs) 
Type II 
Soft Simultaneous 8 channel through micropump and 
camshaft valve connectivity 
16 self-aligning minimal dead volume 
interconnections 
1.0 µL internal dead volume 
 
1 
Micropump 
 
Soft Bi-directional, self-priming, simultaneous 
pumping of 8 channels from nL to approx. 90 
µL /min 
Low compliance, compact, portable, compatible 
with detection methods 
 
2 
Camshaft Valve 
 
Soft Modular, user defined valving patterns of 8 
channels Compact, portable, compatible with 
detection methods 
Valves channels up to 89 µL /min 
 
3 
Microfluidic 
Chip 
Hard Must contain 10 hole MainSTREAM pattern to 
interface to soft elements 
 
4 
Well Arrays 
(WA) 
Hard Sample and waste reservoirs which elimintate 
tubing requirments 
Must contain 10 hole MainSTREAM pattern to 
interface to soft elements 
Can be pressurized for prevention of bubbles in 
MainSTREAM networks 
 
5 
Tubing 
Connector (TC) 
Hard Simultaneous connection of 8 sample vials to 
µFRs 
 
 
5 
Connector chip 
(CC) 
Hard Direct interfacing of µFRs to each other 4 
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Genotyping using MainSTREAM system 
We have previously described incorporation of DNA arrays within PMMA microfluidic 
chips (Sabourin, Petersen et al. 2010) to genotype patients for mutations in the beta-
globin gene (HBB) giving rise to beta-thalassemia. HBB mutations are prevalent in 
resource poor areas.  A key requirement for diagnostics in such areas is to lower costs.  
One way to do so is increasing the tests and patients analyzed per device.  Microfluidic 
lanes of our previous chip were addressed with a pipette and used 4.5 mm channel 
spacings.  Reduction of this spacing would increase risk of cross-contamination. To avoid 
this problem the microfluidic DNA chip (Sabourin, Petersen et al. 2010) was modified 
with MainSTREAM’s standard 10 hole patterns and connected to two handcrank driven 
micropumps (Figure 7 and supplementary video 3).  
 
Fig. 7 MainSTREAM ASH genotyping. (a) MainSTREAM hand crank-driven micropumps 
interfaced to PMMA genotyping chips contained 16 lanes.  Representative system and chip shown 
with alternating lanes filled with red and blue dye to facilitate visualization. Each chip lane 
contained an ASH diagnostic microarray for genotyping HBB mutations. Reservoir chips (arrows), 
made from PC, are mounted to the top side of micropumps and contain wells in which samples and 
reagents can be introduced. Turning of the hand crank drives samples through the microfluidic 
chip. (b) ASH genotyping. The image shows microarray hybridization following processing with a 
hand crank driven MainSTREAM system. ASH microarrays contained Wild Type (WT) and 
Mutant Type (MT) probe spots for HBB mutation sites labelled above as I, II and III above. 
Hybridization of patient-derived target to only WT probes indicates the patient is homozygous 
unaffected. Similarly, hybridization to only MT probes indicates the patient is homozygous 
affected.  Hybridization to both WT and MT probes indicates the patient is heterozygous for a 
mutation at a given site.  In this case, the patient was heterozygous at mutation site I. Patient 
material was fluorescently labelled for detection purposes 
 
WA chips were attached directly to the pumps’ Type I µFRs. The WA’s design provided 
features guiding operators and more suited to introduction of solutions by pipette.  
Genotyping now occurred on chips featuring 16 lanes spaced at 2.25 mm (Figure 7). The 
PMMA chip contained a microarray of DNA probes (Supplementary Table S2) for 
genotyping mutations in the HBB gene. Patient DNA samples were hybridized to the 
DNA microarrays found within the microfluidic chip (Sabourin, Petersen et al. 2010) 
lanes by loading the samples in WA and turning the hand crank. By turning the hand 
cranks, sixteen samples were introduced nearly simultaneously into the PMMA chip 
(supplementary video 2) and four patients were genotyped at once using a multi-
stringency washing protocol (supplementary Figure 5). Four out of four patients were 
correctly genotyped for three mutations in the HBB gene using this highly portable non-
motorized approach (Figure 7).  
In Situ Hybridization (ISH) using valve and pump components 
ISH assays are an example of histological assays. These assays are used in pathology 
investigations and aim to detect the presence of various diagnostic markers, e.g. nucleic 
acid sequences, within preserved tissue sections. At present a lack of reproducibility in 
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histological assays is thought to limit their clinical relevance and potential (Blenkiron, 
Goldstein et al. 2007).  Reproducibility issues stem from variability in processing steps 
such as sample pretreatment and hybridization conditions (Nitta, Kishimoto et al. 2003) 
(Hrabovszky and Petersen 2002).  Additionally, the utility of ISH assays is limited as they 
are typically manually operated and take extended time periods, from a single to several 
days, to complete.  For instance obtain staining of miR-138 (see below) in conventional 
ways requires incubation of the tissue slide with 8 different reagents and totally 18 
incubation and washing steps (Soe, Okkels et al. 2011). 
The HistoFlex device (Soe, Okkels et al. 2011) (Figure 8) has recently been 
described as a tool for generating high performing histological assays. The Histoflex 
encompasses a patterned PDMS insert which upon assembly, seals a microfluidic reaction 
chamber to a tissue section fixed on a microscope slide (Soe, Okkels et al. 2011). The 
HistoFlex enables real time monitoring of flow based assays over tissue sections and 
limits variability related to hybridization conditions. However, as a standalone device it 
still required manual and sequential introduction of reagents. 
 
Fig. 8 In situ hybridization (ISH) assay. (a) System component outline and flow. (b) ISH setup. 
Reagents are stored in the vial rack prior to usage. Reagents flow from the vials through the 
micropump and towards the valve.  They are routed through a merging chip (MC) and then flow 
into the HistoFlex. A program was written and stored on the LEGO® NXT controller which 
automated the assay by co-ordinating and controlling the motors used for micropump and valve 
operation.  For demonstration purposes, micropump and camshaft valve channels have been filled 
with either water or coloured dye solutions (blue, green and red). The HistoFlex reaction chamber 
is filled with red dye. Excluding HistoFlex temperature control components, the system footprint 
is approximately 30 x 20 cm.  
 
To automate reagent introduction and reduce ISH assay times the HistoFlex was 
interfaced to a MainSTREAM system (Figure 8). The reagents required for the ISH assay 
were placed in reagent vials which were connected to the micropump by a TC.  The 
micropump was then connected to the camshaft valve using a CC. As the HistoFlex is not 
part of the MainSTREAM platform, its interconnection features are not directly 
compatible with MainSTREAM components. To solve this, a merging chip with the 10-
hole pattern permitting connection to the camshaft valve was connected to the HistoFlex 
using a variation of TC (supplemental information). The LEGO® Mindstorms® motors 
and software interface were used to control the micropump, camshaft valve, and hence 
gate and automate the introduction of 8 different solutions into the HistoFlex. In brief, the 
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micropump was programmed to run at 89 µL/min (full speed) when filling or replacing 
reagents in the reaction chamber. Once the reaction chamber was filled with a reagent, the 
micropump was programmed to stop for static incubation, to deliver continuous flow at 
41 µL/min, or to introduce approximately 0.6 µL every 15 seconds for discontinuous 
incubation (supplemental information). 
Using the system shown in Figure 8, an ISH assay was performed for detection of 
microRNA-138 (miR-138) in formalin-fixed paraffin-embedded mouse brain tissue 
sections by adapting the protocol previously described by Søe et al (Soe, Okkels et al. 
2011). Results of the ISH assay are shown in Figure 9. Automation of the ISH assay 
using the MainSTREAM network resulted in a reduction of assay times to approximately 
4 hours which is half the time as for conventional methods (Soe, Okkels et al. 2011) and, 
with the exception of initial sample vial fillings, eliminated the need for an operator. Use 
of the LEGO® motors and the provided user interface made co-ordination of micropump 
and camshaft operation a simple task. Use of the camshaft and micropump yielded a 
decrease in assay variability through increased reproducibility of both reagent flow rates 
and reaction times (Soe, Okkels et al. 2011).  
 
Fig. 9 ISH for detection of microRNA-138 in mouse brain tissue sections. Fluorescent images 
show miR-138 in red (cy3) and nuclei in blue (DAPI). (a) Low magnification (2.5x) of 
hippocampus and adjacent cortex. High magnification (20x) images show cell specific detection in 
hippocampus (b), cortex (c) and Purkinje cells of the cerebellum (d) 
 
Cell culture and differentiation using MainSTREAM systems 
Cell culture is a more demanding application of microfluidics. Sterile working conditions 
must be maintained throughout experiments and experimental protocols frequently 
require different workstations: e.g., LAF bench, incubator, microscope/observation tool.  
As such, portable and compact microfluidic systems for cell culture are beneficial.  
Additionally, in order to harness the advantages of microfluidic approaches systems 
should provide higher parallelization, throughput and multiplexing capabilities.  To 
demonstrate that the MainSTREAM approach was suited to microfluidic cell culture, 
several different fluidic systems were built for cell culture and differentiation 
experiments. For these applications, MainSTREAM multi-micropump systems such as 
that shown in Figure 10 were used for the culture of HeLa, adipose-derived stem, and 
PC12 cells over a period of four days (Figure 11) in PMMA microfluidic chips. PMMA 
was used due to its biocompatibility (Stangegaard, Wang et al 2006; Stangegaard, 
Petronis et al, 2006)) 
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Fig. 10 (a) Four micropump MainSTREAM system. This system is highly portable.  Motors are 
easily disconnected and reattached enabling the system to be shuttled between workstations 
including (b) laminar air flow bench, (c) incubator and (d) microscope. This last panel 
demonstrates compability and ability to integrate MainSTREAM systems with detection 
equipment.    
 
 
Fig. 11 Cell adhesion, proliferation, and differentiation. (a) HeLa cells, adipose-derived tem cells, 
and PC12 cells cultured in a PMMA chamber with a height of 500 µm and a volume of 3.37 µL. 
Cells perfused with a flow rate of 500 nL min-1. 10X Phase contrast time-lapse images acquired 
after 1, 2, 3, and 4 days of cell culturing. (b) Differentiation of PC12 cells initiated after 4 days of 
cell culture. 10X Phase contrast time-lapse images acquired after 0, 1, 2, and 3 days of  
differentiation. (c) HUVEC  cultured in a PMMA chamber  with a height of 250 µm and a volume 
of  3.75 µL. Cells perfused with a flow rate of 400 nL min-1. 4X Phase contrast time-lapse images 
acquired after 0, 1, 2, and 3 days of cell culturing  
 
For all cell types the procedures for system preparation, cell loading, cell culture, 
and imaging demanded that the system was moved between a LAF bench, an incubator, 
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and a microscope stage. In the LAF bench the system was assembled, sterilized, coated 
and loaded with cells. The whole system with motors and all was then either placed in a 
CO2 incubator or fixed in the microscope for time-lapse imaging, demonstrating 
portability and compatibility with instrumentation of the system. Moving a system 
required that and four (one for each motor) electrical and then one tube pressurizing the 
whole system was disconnected. Disconnecting the system from the pressure and 
electrical sources took less than 30 seconds. To introduce cells into the microfluidic 
chips, the CLC was used (Figure 5 and 10) and the micropumps were programmed to run 
backwards. All of the cultured cell types adhered and proliferated well compared to 
conventional cell culture, showing that the systems supported cell culture studies (Figure 
11).  Pressurization of the system (Skafte-Pedersen, Sabourin et al. 2010) resulted in 
bubble-free operation. 
PC12 cells respond to nerve growth factor (NGF) that stimulate them to 
differentiate and stop dividing, which makes them useful as a model for neuronal 
differentiation. After 4 days of cell culture of PC12 cells, differentiation was initiated by 
changing liquid reservoirs with normal cell culture medium to differentiation medium and 
differentiation was followed by time-lapse imaging every six hours for three days (Figure 
11b). The growing network of axons demonstrates that the system is usable for PC12 cell 
differentiation and for on-stage time-lapse microscopy. 
Human Umbilical Vein Endothelial Cells (HUVEC) were used as a cellular 
model for primary cell culture in a two micropump MainSTREAM system. This system 
was designed to be compatible with upright microscopy and resembled the system used 
for micropump characterization (supplemental information). As demonstrated in Figure 
11C these primary cells adhered and proliferated, demonstrating the system also could be 
used for even more demanding cell populations. HUVEC cultured in commercially 
available iBIDI chips connected to commercial peristaltic pumps was morphologically 
comparable with HUVEC cultured in the MainSTREAM system (data not shown).   
 
Reliability evaluation 
 
In order to test the reliability and usability of systems made from MainSTREAM 
components, we registered types of failures encountered when using systems for cell 
culturing. Three systems were compared. 1) the most complex system shown here 
containing up to 32 inlets + 16 outlets to and from a single chip, 4 pumps and three WA 
(Figure 10), “Lego system”. 2) A slightly less complex system, “Procell”, presented 
earlier consisting of 24 inputs, 8 outputs, three pumps and large number of individual 
glass vial for liquid managements (Skafte-Pedersen et al 2011) and 3) a single chip driven 
by up to four syringe pumps. Reliability was evaluated for long term (2-3 weeks) of cell 
culture or until failure. An experiment with up to 4 chambers in the chip takes about 10h 
to start when using a simple syringe pump solution  (Fig 12A). It was possible to start a 
24 chambers experiment using Procell system in about 10h leading to a time per chamber 
of 30 minutes. Corresponding values for the Lego system was 16 chambers in 10h or 40 
minutes per chamber. This is far more rapid than the 2.5 h it takes for a syringe pump 
system.  
The failures of the systems were also investigated. Failures were typically of two types - 
leaks and bubble formations. The leaks was mostly due delamination of bonded chips and 
breaks in the uFR (data not shown). Chips driven without over pressurizing the entire 
system leads to bubble formation in the majority of the reaction chambers even after a 
few days of cell culturing (Fig 12C). In systems that where not put under over pressure, 
most of the system failures were observed during the culturing phase. Non pressurized 
system was deemed useless for further use in long term cell culturing due to the problems 
with bubble formation. However, non-pressurized system work acceptably for ISH 
assays. A large drop in bubble formation in chambers was observed when pressurising 
entire systems (Fig 12C). Component failures were then increased during the 
experimental setup phase (Fig 12C) instead of during the run of the experiment. Work 
with pressurized Procell systems was divided into an early learning phase (the 13 first 
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expriments) and a later usage phase (five last experiments). During the learning phase, 
there where many issues with system handling, leaks and broken components during the 
experiment setup, but also during the run. After the learning phase, the Procell system 
was repeatedly used for cell culturing experiment with >20 days of incubation (Fig 12A, 
five last experiments) and there where no issues during the run with bubbles or broken 
parts.  However, there was at least one component failure in about 40% of the 
experiments during experimental setup phase (Fig 12C). Using the more complex Lego 
system (Fig 10) gave the same experience. No bubbles after about three week culture in 
any of the chambers, while three of four experiments gave problems in the experimental 
setup phase. The results indicate that the robustness of each component needs to be 
increased to limit issues during the setup phase. However, assembled systems are robust 
enough to support three weeks cell culturing including handling procedures to switch 
medium and microscopy at least twice a week and microscopy 3-4 times a week. In total, 
system were moved up to 20 times during a cell culturing experiment. It should be noted 
that no contaminations were observed using the systems based on Mainstream 
components.   
 
Figure 12. Analysis of reliability and use paramenters. The analysis concerned a simple 
syringes pump system with up to 4 reaction chambers, a Procell (Skafte-Pedersen et al 
2011) system that where not pressurized, a Procell system that was put under over 
pressure and a Lego system (Fig 10A) containing some improvement in liquid 
management systems. A) Experiment setup time and cell culturing times.  B) Average 
number of component in a system and number of component failures. C) % Chambers 
with bubbles/failures, and % system failures during the setup and during the run of the 
experiment.  
 
 
Discussion 
Our goal was the creation of a platform with wide applicability and whose components 
would provide i) simple and reliable sample-to-waste interconnections, ii) numerous 
fluidic inputs and outputs to chips, iii) pumping and iv) routing/valving capacity for these 
inputs, and a high degree of v) portability, vi) reconfigurability/flexibility in system 
design, vii) compatibility with detection equipment, and viii) usability. Finally, though 
not necessary for all applications, the approach should be biocompatible. The results and 
systems presented above shows that the MainSTREAM component library (Table 1) 
fulfils these criteria. As will be discussed below, the holistic approach taken here to 
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microfluidics makes the system usable enough to be used in profession settings even for 
demanding applications.  
Modular microfluidic systems (www.epigem.co.uk; www.labsmith.com; 
www.thinxxs.com; Grodzinski, Yang et al. 2003; Pepper, Palsandram et al. 2007; Rhee 
and Burns 2008; Sun, Wang et al. 2008; Yuen 2008; Yuen, Bliss et al. 2009), are based 
on a standardized breadboard/baseplate into which everything (usually just chips) is 
plugged in. The underlying assumption in such an approach is that the breadboard’s 
spacing and other design criteria will satisfy the overwhelming majority of microfluidic 
application and assay requirements. MainSTREAM components are modular, 
reconfigurable and provide a method to establish many different fluidic networks suitable 
for many applications. As shown (Figures 6-10), each application requires widely 
different layouts of the systems, suggesting that a standard breadboard is appropriate for 
rapid prototyping of chip functionalities, e.g. by serial connection of standardized chips, 
but not for rapid prototyping of entire microfluidics systems. An overview of system 
(Table 2) that can be build by MainSTREAM components suggest that these components 
can be used in the majority of lab on a chip application.  
The performance of the micropump is sufficient for most biological applications.  
The micropump’s performance is similar to commercial syringe pumps with respect to 
channel-to-channel variability (Skafte-Pedersen, Sabourin et al. 2009) and significant 
durability improvements make it not only generally more applicable but particularly more 
suited to extended experiments such as long-term cell culture than our previous report 
(Skafte-Pedersen, Sabourin et al. 2009). Comparisons to similar PDMS-based, 
mechanically actuated peristaltic pumps is difficult as these i) only present a single 
channel pump (Lim, Kim et al. 2003; Yobas, Tang et al. 2008; Du, Ye et al. 2009; Koch, 
Remcho et al. 2009) or do not provide comparable data (Gu, Zhu et al. 2004; Rhie and 
Higuchi 2008). The MainSTREAM micropump facilitates parallel operations on chip and 
limits dead volumes. This is especially useful for multiplexed experiments where 
conserving samples is desired. The flow rate range, from sub µL/min to near 90 µL/min, 
is appropriate for many applications. For instance, it is possible to pump at 33 nL/min per 
channel resulting in medium exchange rate of 150 minutes in a cell culture chamber that 
is 0.5 X 2 X 5 mm.  The pulsatile flow by the peristaltic pumps is not affecting fluidics 
operation on chip like switch from one liquid to another (Skafte Pedersen, 2011). We 
have no evidence that the pulsatile flow has negative effects on cell or solid phase 
biochemical assays. The ability to drive the micropump at higher flow rates with the 
Mindstorms® motors is advantageous for assays like ISH (Figure 8 and 9). For the ISH 
protocol (supplemental information), delivery of 30 µL to exchange reagents as quickly 
as possible within the reaction chamber took 20 seconds. MindstormsTM motors can also 
be programmed to deliver discreet volumes from the micropumps via the integrated 
rotation sensor and then wait a set time before delivering another similar or different 
volume. This is useful for one-time deliver of reagent packets or low perfusion schemes 
requiring even supply of reagents to benefit reaction kinetics. This is particularly useful 
for even cell loading into chambers. A rapid injection of a cell suspension limits effects of 
sedimentation since the time it takes to draw in a cell suspension is counted in seconds 
using the Lego cell culturing system (Fig 10).   
The novel camshaft valve presented in this report is itself a reconfigurable 
component which co-ordinates opening and closing of all the µFR’s channels 
simultaneously. Unlike many other valves (Unger, Chou et al. 2000; Browne, Hitchcock 
et al. 2009; Hulme, Shevkoplyas et al. 2009; Pitchaimani, Sapp et al. 2009; Zhang, Lin et 
al. 2009; Simone, Perozziello et al. 2010) employing deflection of elastomeric 
membranes, the presented  valve is located outside and apart from the microfluidic device 
it addresses (as is the peristaltic micropump). As compared to the use of screws (Weibel, 
Kruithof et al. 2005; Hulme, Shevkoplyas et al. 2009), the camshaft simplifies operation 
as it co-ordinates valving of multiple channels simultaneously. As an example, for 8 
channel systems passing from an “all open” to an “all closed” configuration with screw-
based valves requires manual adjustment of 8 individual screws. In contrast, the camshaft 
must only be rotated to a new position (Fig 8).  Solenoids or piezoelectric driven tactile 
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pins could have been used to valve individual channels of the µFR rather than a DC 
motor controlled camshaft. However, doing so would add additional layers of actuation 
and control equipment. Additionally, solenoid use restricts system portability (Mark, 
Haeberle et al. 2010). Although not yet tested in cell culture experiments yet, there are no 
reason why  the valve cannot be used for such application to provide large degree of 
flexibility to deliver cues to cell cultures (table 2).  
MainSTREAM design concept enables construction of highly integrated systems 
that are best choice for experimental procedures requiring moving the system between 
laboratory functions as illustrated in the cell culture experiment where the system is 
moved between LAF benches, microscopes and incubators (Figure 10). The exemplified 
systems (Figure 6, 7, and 10) are integrating pumps (including motors) reagents and 
waste into a movable unit after disconnecting the power source. Disconnecting and 
moving MainSTREAM systems is a quick and robust procedure as three weeks cell 
culturing were successful despite moving systems between incubators, LAF benches and 
microscope stations up to about 20 times during the experiment (Fig 12). The reasons for 
the solution being robust are likely 1) the pump function as a valve when stopped, 2) no 
fluidic lines are disconnected, 3) disconnecting a electrical contact stops the pump and 
thereby stops any movement of the liquids, 4) disconnecting a pressure line does not 
perturb the fluidic lines because the pump function as a valve.  
 To provide professional scale analysis systems, systems must contain many 
inputs and outputs to the chip. Number of samples analysed on a chip is limited by 
pumping capacity, efficient methods to connect pumps to the chip and liquid management 
systems. Commercial producers of microfluidic systems and components such as 
ThinXXS and Dolomite provide miniaturized pumps and valving solutions. These 
solutions address only a single channel but occupy the footprint of MainSTREAM’s eight 
channel micropump or valve. Scaling the aforementioned commercial microfluidic 
solutions into multi-step serial systems such as the ISH (Figure 8) and 32-channel cell 
culture applications (Figure 10) would lead to fairly complex, encumbered setups that are 
likely not very portable or compact.  The control equipment and systems required for 
systems built from the commercial systems would likely be equally much larger as 
compared to use of LEGO® modules we have demonstrated. The demonstrated 
integration of pumps, valves, reagent and waste management and motors results in 
systems (Figure 6 through 10) which are portable and scaled enough (up to 32 individual 
reaction sites) to be used in biological applications. MainSTREAM systems cannot likely 
match the multiplexing and throughput capabilities of the multi-layer elastomeric 
approaches including the mLSI (Unger, Chou et al. 2000; Gomez-Sjoberg, Leyrat et al. 
2007; Taylor, Falconnet et al. 2009) and Braille displays (Gu, Zhu et al. 2004; Futai, Gu 
et al. 2006; Tung, Torisawa et al. 2007) methods. For example, a single camshaft valve 
cannot produce as many valve combinations as the MLSI and Braille methods. However, 
for the majority of applications the ability to generate this many combinations is not 
required (Hulme, Shevkoplyas et al. 2009). The simple valve sequence used in this report, 
which gates one of eight liquids at a time through a reaction chamber, suffices for many 
different biochemical and cell-based assays such as sandwich, competitive, and direct 
immunoassays, DNA, protein and small molecule analysis by microarrays, tissue section 
analysis (Figure 7 and 8), affinity-based sample preparation procedures and the stepwise 
addition of compounds required differentiate stem cells (Osakada, Ikeda et al. 2009).  
Table 2 outlines the capacity of a four-motor system to support complex time 
dependent assay. Depending on number of variable parameters, 4, 8 or 16 independent 
factors can be distributed to 8, 2 or 1 reaction sites respectively. We are currently 
exploring the routing capacity of the valve component, which would allow eight 
independent factors to be added to up to 16 reaction sites. With respect to assays featuring 
parallellization, recent mLSI-based microfluidic high content methods employed 16 
fluidic inputs (excluding inputs required for system control) (Gomez-Sjoberg, Leyrat et 
al. 2007; Taylor, Falconnet et al. 2009) that can be routed to different parallelized cell 
culture sites (Taylor, R. J., D. Falconnet, et al., 2009) leading to 256 unique experiments.  
The MainSTREAM system shown in Figure 10 has 32 fluidic inputs. It would be possible 
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to arrange the pumping capacity into similar combinatory fashion also reaching 256 
different unique reaction sites (Table 2). This number of fluidic inputs pushes the 
limitations of microfluidic approaches away from fluidic concerns and towards those 
associated with data capture and analysis.  For example, time-lapse data capture and 
analysis on 32 parallel cell cultures is a demanding task. 
Recently, calls for standardized, cheap, interconnectable, and easy to build 
microfluidic systems that can connect together effortlessly have been made (Whitesides 
2011).  MainSTREAM meets these demands.  The components presented in this report are 
low cost and built from affordable materials (e.g. the material cost for micropump and 
camshaft is approx. 10 USD each). MainSTREAM also uses a standard 10-hole pattern for 
fluidic I/O of 8 channels. Though overall chip dimensions are flexible with this approach, 
the chips presented in this report were single or double microscope slide size to facilitate 
use in standard processing, such as microarray spotters, and detection equipment 
(Sabourin, Petersen et al. 2010). Spacing of µFR channels was set at 1536 well plate 
standards (2.25 mm) in order to simplify future coupling to automated fluidic handling 
machines. This would permit highly dynamic addition and subtraction of compounds and 
agents from test systems and would leverage many of the same advantages described by 
others (Yu, Alexander et al. 2007; Meyvantsson, Warrick et al. 2008; Puccinelli, Su et al. 
2010).  
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Table 2. Applications to up to four motor systems: 
Config. Configuration Suggested/supported applications 
32 pump 
lines  
 
• Cell cultures  
• Homogeneous enzymatic/binding 
reactions e.g. PCR 
• Heterogeneous reactions e.g 
hybridizations 
32 pump 
lines 
 
 
• Programming cell responses over 
time by creating time and 
concentration dependent gradients 
of three soluble factors (one is a null 
buffer). 
• Optimize enzymatic/binding 
reactions as a function of three 
reagents 
• Four steps heterogeneous assay e.g. 
hybridization, washing and 
colorimetric detection of 
microarrays 
16 pump 
lines + 16 
gating 
 
• Eight reagent solid phase assay such 
as in situ hybridization, 
immunochemistry 
•  Complex cell programming  
16 pump 
lines + 16 
gating 
 
• 16 reagent solid phase assay such as 
in situ hybridization, 
immunochemistry 
•  Complex cell programming 
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Conclusion 
 
The component library of the MainSTREAM platform provides interconnection, 
sample-to-waste liquid management, as well as pumping and valving components which 
are flexible, reconfigurable, modular, scalable, and provide a simplified method to build 
microfluidic systems. Accessible and easily implemented methods of controlling and 
automating fluidic networks were also described. Microfluidic systems built from 
MainSTREAM components are compact, portable, user friendly, compatible with 
detection instruments and laboratory workflows and can interface to auxiliary 
components.  The varied applications demonstrate for the platform illustrate that the 
approach can encourage broader adoption of microfluidics as it yields the benefits of 
parallel and multiplexed experiments, scalable fluidic actuation and routing and 
simplified sample-to-waste connectivity and management. 
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Supplemental Information 
 
Tubing Connectors (TCs) 
For applications requiring interfacing to sample vials a tubing connector (TC) 
(Figure S1) can be used.  TCs can connect both Type I or II uFRs to sample or waste vials 
using 1.6 mm outer diameter (OD) / 0.2 mm inner diameter (ID) PTFE tubing 
(Bola/Bohlender, Germany). TCs are made from two PC pieces (Figure S1a). Both pieces 
measure 30 mm (l) x 5 mm (w) x 5 mm (h). The first piece aligns eight lengths of PTFE 
tubing via 1.6 mm through holes and contains a custom-made PDMS gasket insert. The 
PDMS insert contains 1.6 mm channels, each ending with a 1.0 mm wide and 0.5 mm 
high O-ring feature (Figure S1b). The PDMS insert is manufactured similarly to the 
method described in our previous report describing PDMS-based interconnection blocks 
which feature aligned O-ring banks [1]. In this case, 1.6 mm PTFE tubing was used 
during the casting process to create the 1.6 mm channels within the gasket. The second 
PC piece has eight through holes which transition from 1.6 mm to 0.8 mm diameter. 
These correspond to the PTFE and hemi-spherical ball joint feature diameters 
respectively. Alignment and compression by screws results in a sealed interconnection 
between TC’s PDMS gasket and Type I µFR (Figure S1c).   
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Fig. S1 Tubing Connectors (TCs). (a) TCs are made from two polymeric chips. (i) A 
polycarbonate (PC) shell houses a custom-made PDMS gasket insert (dashed box). The PDMS 
gasket contains 1.6 mm diameter channels. At the end of each of these channels a 0.5 mm wide O-
ring protrudes by 0.5 mm. (ii) A PC chip with througholes which transition from 1.6 and 0.8 mm 
diameters. (b) PTFE tubing of 1.6 mm OD is passed through the chip containing the PDMS 
gasket.  Each protruding PTFE tube is thus collared by an O-ring feature (indicated by arrow). (c) 
Using 2 mm screws the TC is interfaced to one end of a Type I µFR. Dashed boxes correspond to 
individual components.  The upper dashed box is the bracket of the Type IµFR. Parts (i) and (ii) 
are aligned such that the tubings enter the 1.6 mm portion of part (ii). Part (ii) is also aligned to the 
bracket of the Type I µFR. The Type I µFR ball joint features thus align with the 0.8 mm channel 
portion of part (ii). With compressive force, the gasket of part (i) forms a seal between part (i) and 
(ii) and the ball joint features form a seal between the Type I µFR and the part (ii) of the TC.  The 
lack of a seal between the 1.6 mm PTFE tubing and the 1.6 mm diameter channels in part (ii) is 
expected  
Micropump Characterization: Displaced Volume and Durability 
Testing 
The microfluidic chip and MainSTREAM configuration used for per channel 
displaced volumes and durability testing is shown in Figure S2.  
 
Fig. S2 Experimental setup for micropump displaced volume and durability testing. (a) Setup. A 
microfluidic chip (MC) with 16 fluidic channels with cross-sections of 1 mm x 1 mm is connected 
to two micropumps. LEGO® motors are not shown. (b) Motors were first run to introduce fluids 
into each channel.  A “before” picture was then taken.  The motors were then activated for 25 
rotations. An “after” picture was taken at this point. Using the “before” and “after” pictures the 
average amount of fluid displaced per pump rotation could be calculated. This was repeated for 
different LEGO® motor power settings and was the procedure used for durability testing.  
 
Two micropumps were tested at different LEGO® motor power settings to verify 
that per channel displaced volumes per pump rotation did not change with different motor 
powers. Micropumps were tested between 25 and 50 % motor power. These values were 
selected since at 20% the micropump did not always consistently turn over, and at 50% 
flow rates exceeded what we gauged to be typical of microfluidic assays (i.e. well above 
10 uL/min). Increased motor power did not result in changes to per channel average 
displaced volumes per pump rotation (Table S1). Average displaced volumes per channel 
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were different between the two micropumps tested.  We estimate that manufacture of the 
microfluidic calibration chip used to measure displaced volumes may impart a channel-
to-channel variability of approximately 1%. 
 
Table S1:  Per channel displaced volumes per micropump rotation at different LEGO® servo 
motor powers 
 
MicroPump 
Power 
Setting 
(%) 
Average 
Displaced 
Volume (µL) 
Maximum 
Displaced  
Volume (µL) 
Minimum 
Displaced 
Volume (µL) 
% 
CV 
1 25 0.71 0.76 0.67 5.1 
 30 0.73 0.78 0.69 4.8 
 35 0.74 0.78 0.70 4.5 
 40 0.74 0.78 0.70 4.5 
 45 0.73 0.76 0.70 3.7 
 50 0.74 0.78 0.68 3.2 
2 25 0.62 0.66 0.60 2.8 
 30 0.64 0.69 0.60 3.9 
 35 0.64 0.67 0.60 3.2 
 40 0.64 0.68 0.62 2.9 
 45 0.66 0.68 0.63 2.6 
 50 0.65 0.68 0.62 2.8 
 
Durability and lifetime testing results are shown in Figure S3. Testing was 
completed using a motor power setting of 30%. A larger disparity in displaced volumes 
between micropumps is initially observed (prior to 23000 rotations), as compared to the 
difference between micropumps noted at 30% power in Table S1. 
At 23000 rotations, the RBs of the micropumps being tested were switched. At 
this point the difference between micropump displaced volumes collapses (Figure S3). 
This indicates that attachment of the RB to a micropump can result in differences in 
average displaced volumes. When testing was deliberately stopped following 63000 
rotations, all 16 channels of the two Type II µFRs used in the micropumps were 
functional and did not show signs of damage.  
 
 
Fig. S3 Micropump durability and displaced volume testing. 
Step and Wait Micropump Flow Programming 
As provided the LEGO® Labview interface does not permit selection or entry of flow 
rates. To achieve a given flow rate a procedure using “STEP and WAIT” programming of 
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LEGO® motors at powers allowing consistent turning of the micropumps (approximately 
30% or higher) was used. STEP and WAIT programs STEP the motor a fixed number of 
degrees and then WAIT a fixed time between steps. STEP and WAIT is enabled by the 
motors’ integrated optical controllers and simplified by the provided LEGO® LabView® 
interface. Knowing the time required to complete a series of STEP and WAIT operations, 
an average flow rate can be determined. The following example is provided for 
demonstrative purposes: 
 
A. Displaced volumes were first determined per micropump using a calibration 
chip (Figure S1). A displaced volume of 0.7 µL per pump rotation is 
assumed. 
B. STEP and WAIT is set up such that the LEGO® motor advances in 5° steps 
and waits 0.05 seconds between steps. 
C. The user programs the LEGO® motor to repeat the STEP and WAIT 
procedure 720 times, for a total of 3600° degrees of rotation, or 10 rotations. 
From A, the displaced volume per rotation is 0.7 µL and as such the total 
displaced volume will be 7.0 µL.   
D. The program is started and the time required to complete the 10 rotations is 
recorded. 
E. Dividing the volume delivered, 7.0 µL from C, and the time recorded to 
complete the test from D, an average flow rate can be determined.  
 
An example STEP and WAIT programming block in the LabView interface provided with 
LEGO® Mindstorms® shown in Figure S4. 
 
 
Fig. S4 STEP and WAIT programming loop. The LabView® interface provided with 
Mindstorms® is shown. A STEP and WAIT program can be constructed using three buttons 
(highlighted boxes) found within the column on the left-hand side: MOVE (meshed gears), WAIT 
(hourglass) and LOOP (circular arrows). Once added to the programming environment, (gridded 
area) parameters for each function can be set in the MOVE, WAIT and LOOP windows shown at 
the bottom of the figure. In this example, the MOVE function is set to activate through a 5° step at 
30% power (red box). The WAIT function requests a 0.05 second wait (blue box) until the next 
operation. The LOOP function repeats the MOVE and WAIT functions a total of 720 times (green 
box), or a total of 720 x 5° = 3600° or 10 rotations. As such, 10 pump rotations are completed in 
5° steps.  
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Camshaft Valve Durability Testing  
To assess durability of the valve, in particular the PDMS µFR, the valve was 
placed in a MainSTREAM-based (Sabourin, Skafte-Pedersen et al. 2010) microfluidic 
system shown in Figure S5. The LEGO® Mindstorms® kit and software interface was 
used to control and co-ordinate both valve and micropump operation during durability 
testing. 
Visual inspection and use of a microfluidic chip (Figure S5) with eight individual 
lanes was used to assess durability. Each channel of the chip connected to a single 
channel of the valve’s µFR. All eight channels of the microfluidic chip (Figure S5) were 
first primed by activating the pump and rotating the camshaft through a complete rotation 
thereby sequentially opening and closing each of the eight channels.  During camshaft 
rotation, the pump was stopped. For durability testing, the camshaft was first rotated one 
rotation clockwise and then one rotation counter-clockwise. This was repeated through 
completion of nine valve rotations. The tenth valve rotation was completed stepwise in 
order to sequentially test each µFR channel. Channels were tested by running the 
micropump at 69 µL/min and verifying whether liquid flowed properly according to the 
camshaft’s valving pattern. For the camshaft shown in this report, this meant that i) flow 
should only be observed through one of the eight channels of the µFR at a time and, ii) 
that leaks resulting from PDMS wear by the camshaft should not be observed elsewhere. 
In a given valve position when the micropump was activated, proper valving was 
indicated by hanging drop formation only at the microfluidic chip channel exit 
corresponding to the µFR channel the camshaft set as open. µFR channels were evaluated 
in this manner after completion of 10, 20, 30, 40, 50, 100, 200, 500, 2.000 and 20.000 
valve rotations. 
 
 
Fig. S5 Camshaft valve durability testing. A MainSTREAM micropump (left) connected to sample 
vials (not shown, off to left) by a TC (left) delivers fluids through the camshaft valve (center) and 
to a microfluidic chip (right).  The eight individual lanes of the microfluidic chip permitted 
assessment of valve functionality. Automation of durability testing was accomplished by 
programming  LEGO® Mindstorms®  motors. The motor controlling the valve is not shown.  
Genotyping in MainSTREAM 
 
Table S2:  Probes used for ASH genotyping 
 
Probe Name Probe Sequence (5’ to 3’) Type of 
Mutation 
CD 17WT CCCCCCCCCCTTTTTTTTTTCCCTGTGGGGCAAGGTG A > T 
CD 17MT CCCCCCCCCCTTTTTTTTTTCCTGTGGGGCTAGGTGA A > T 
31 
CD 26HbeWT CCCCCCCCCCTTTTTTTTTTTTGGTGGTGGTGAGGCCC G > A 
CD 26HbeMT CCCCCCCCCCTTTTTTTTTTAGTTGGTGGTAAGGCCC G > A 
IVS I+5 WT TTTTTTTTTTCCCCCCCCCCGGCAGGTTGGTATCAAGG
TTACA 
G > C 
IVS I+5 MT TTTTTTTTTTCCCCCCCCCCGGCAGGTTGCTATCAAGGT
TACA 
G > C 
 
 
All signals were analyzed with GenePix Pro 6.1 (Molecular Devices, Sunnyvale, 
CA, USA) and analyzed according to the multi-salinity gradient washing method, which 
allow for the use of probes with different washing buffer optima in the same microarray 
(Poulsen, Soe et al. 2008). For each chamber and salinity condition used to genotype a 
patient, a normalized ratio for each probe pair was calculated as the signal from the wild-
type probe (SWT) divided by the sum of the signals from the wild-type and mutant probes 
(SMT). 
RATIO = SWT / (SWT + SMT) 
For an individual with no mutation, homozygous wildtype (WT) at a given mutagenic 
site, at an appropriate stringency during the post-hybridization washing step the 
normalized ratio should approach an ideal value of 1.0. Likewise, the ideal ratio for an 
individual who is heterozygote (HZ) at a given mutagenic site, with one wild-type and 
one mutant allele, should approach 0.5. Finally, the ideal ratio of a homozygous mutated 
(MT) individual should approach zero. A more comprehensive discussion of the multi-
salinity gradient method is provided elsewhere [2].  An example of the analysis of this 
genotyping approach is described in Figure S6.   
 
 
Fig. S6 Multi-salinity gradient washing genotyping in MainSTREAM. In this figure analysis of a 
patient for the mutation site referred to as IVS I+5 is shown (Table S2).  As can be seen, when 
using 2.0 X SSC discrimination between MT and WT probes is not sufficient in order to 
confidently and correctly genotype the patient as being WT at this mutation site as the ratio lies 
between the ideal values for WT and HZ individuals.  Using wash buffers of increasing stringency 
results in correct identification of the individual’s genotype, WT, at the IVS I+5 position as the 
ratio approaches the ideal value of 1.0.  
 
 
Table S3: Reagents used for ISH Assay 
 
Step Channel Reagent Composition Flow Time 
(min) 
Temp. 
(°C) 
32 
1 C1 Washing buffer PBS Continuous 3 25 
2 C2 Prehybridization 
buffer 
5xSSC, 4M urea, 
1xDenhardt's, 
500 mg/mL yeast 
RNA 
Discontinuous 8 45 
3 C3 Hybridization 
buffer 
40 nM FITC 
labeled probe, 
1xSSC, 4M urea 
and 
1xDenhardt’s 
Discontinuous 15 45 
4 C4 Stringency 
washing buffer 
0.1 x SSC Continuous 12 45 
5 C1 Washing buffer PBS Continuous 3 25 
6 C5 Blocking buffer 0.1M Tris pH 
7.5, 0.15M NaCl, 
10% fetal bovine 
serum (FBS) 
Discontinuous 5 25 
7 C1 Washing buffer PBS Continuous 3 25 
8 C7 Antibody-enzyme Cy3 - TSA 
solution 
Discontinuous 10 25 
9 C8 Washing buffer PBS Continuous 3 25 
10 C6 Amplification 
reagent 
0.375 U/mL 
antiFITC-HRP in 
blocking buffer 
Discontinuous 15 25 
11 C1 Washing buffer PBS Continuous 3 25 
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ABSTRACT 
Microfluidic cell culture has advantages compared to conventional static cell culture regarding spatial and temporal con-
trol of near-cell environment.  Differentiation of adipose-derived stem cells (ASC) into adipocytes was studied under micro-
fluidic perfusion culture conditions.  Constant removal of cell released components from a culture had large negative impact 
on differentiation.  Adding supernatant from cells, undergoing differentiation into adipocytes in static culture, to the perfu-
sion medium restored efficient differentiation.  The results suggest that a paracrine or autocrine signalling pathway is in-
volved in differentiation of ASC into adipocytes. 
 
KEYWORDS: Perfusion cell culture, Adipose-derived stem cells, Differentiation, Paracrine, Autocrine 
 
INTRODUCTION 
Microfluidic cell culture is an emerging field in stem cell research [1] owing to advantages compared to conventional 
static cell culture.  By having constant perfusion of medium over the cell culture, the near-cell environment can be precisely 
controlled with respect to for example chemical stimuli via the cell culture medium.  Constant perfusion will remove secreted 
factors from the cells and thereby disturb cell to cell signalling, which normally would be considered as a drawback as com-
pared with static cell cultures.  
ASC are an abundant source of adult stem cells with multipotent differentiation properties [2], no ethical or immunoreac-
tive considerations, and potential for tissue regeneration and engineering.  Differentiation of ASC into adipocytes is regulated 
by a network of transcription factors induced by insulin, glucocorticoids, agents elevating cAMP, and serum factors [3].  
However, little is known about the role of paracrine or autocrine signalling in adipogenesis, and conventional static culture 
systems have been unsuitable for such investigations.  In this study, we use a previously described microfluidic cell culture 
system [4] to disrupt paracrine and autocrine signalling pathways during stem cell differentiation.  The possibility of disrupt-
ing signalling pathways is necessary for identification of cell released factors.    
 
EXPERIMENTAL 
The microfluidic system (Fig. 1a) [4] consists of three miniaturized eight-channel peristaltic pumps, liquid reservoirs and 
an exchangeable microfluidic chip with up to 24 culture chambers (Fig. 1b).  Glass vials, lids, and PTFE tubing (BOLA 
1810-01, Bohlender GmbH) were sterilized by autoclaving before assembling the system.  Tubes connecting the liquid reser-
voirs to the pumps and the cell culture chip were filled separately with Milli-Q water to remove bubbles, before clicking on 
the cell culture chip to the system base plate.  Inlet and outlet reservoirs were coupled with PTFE tubing (BOLA 1810-10) 
and supplied with sterile filtered air added 5% CO2.  To avoid formation of  bubbles, a pressure of 0.3 bar was put on the 
flow system during the whole system preparation and cell culture period, only interrupted when for instance changing liquid 
reservoirs.  
 
  
Figure 1:  Microfluidic system for culture and functional studies of cells.  a) The platform assembled with chip, 24 inlet 
and four outlet reservoirs.  b) PMMA chip containing 24 parallel chambers with a height of 500 µm and a volume of 3.2 µL. 
Prior to cell culture, the flow system was sterilized with 0.5 M NaOH for 20 min at a flow rate of 5.2 µL/min.  NaOH was 
removed by washing with sterile water (W3500, Sigma) for 30 min at a flow rate of 5.2 µL/min.  The surfaces of the cell cul-
ture chambers were coated with collagen (40 µg/ml in sterile water, C3867, Sigma) at 37ºC at a flow rate of 5.2 µL/min for 
15 min followed by 195 nL/min for 45 min.  Finally, the flow system was flushed with medium (DMEM/F-12+GlutaMax™ 
(31331, GIBCO) supplemented with 10% v/v newborn calf serum (N4762, Sigma), penicillin 100 U/mL, and streptomycin 
100 μg/mL (P4333, Sigma)) for 30 min at a flow rate of 5.2 µL/min before cell loading.  Uniform cell density over the entire 
culture chamber was obtained by loading the cells in culture medium supplemented 60% serum.  To allow cell attachment, 
cells were perfused with medium supplemented 10% serum for 4 h at a flow rate of 33 nL/min at 37ºC.  After this attachment 
phase, cells were perfused at a flow rate of either 33, 125, or 500 nL/min at 37ºC until completion of the experiment. 
Differentiation was induced after 3 days of culture at a cell confluence of approximately 80-90%.  The cells were per-
fused with either normal adipogenic differentiation medium (AM) (cell culture medium supplemented with IBMX (isobutyl-
methylxanthine) 0.5 mM (I5879, Sigma), dexamethasone 1 µM (D4902, Sigma), indomethacin 0.2 mM (17378, Sigma), and 
insulin 10 µg/mL (I9278, Sigma), or conditioned medium (CM) (a 1:1 mixture of medium from ASC undergoing adipogenic 
differentiation in static culture and AM with twice concentration of differentiation factors).  Medium reservoirs were ex-
changed with fresh medium every third day. 
Images of ASC differentiation were acquired at 10x phase contrast using a Zeiss Axio Observer.Z1 microscope con-
nected to a Zeiss Axiocam MRm B/W camera.  Quantification of lipid-filled droplets was carried out using ImageJ by mark-
ing areas of four or more pixels within a set range of gray-values and a circularization degree of 0.9-1.0, i.e. almost circular.  
 
RESULTS AND DISCUSSION 
Based on the assumption that constant flow conditions would disrupt a possible paracrine or autocrine signalling, we ex-
amined differentiation of ASC into adipocytes by perfusing ASC cultures with normal adipogenic medium at three different 
flow rates (33, 125, and 500 nL/min).  Formation of lipid-filled droplets was used as an indicator of differentiation into adi-
pocytes.  Flow rates of 125 and 500 nL/min had a negative impact on differentiation compared to 33 nL/min (Fig. 2 upper 
panel and Fig 3).   Flow rates of 33, 125, and 500 nL/min correspond to a resting time of medium in the cell culture chamber 
of 97, 26, and 6 min, respectively.  
 
   
Figure 2: Conditioned medium restored differentiation of ASC into adipocytes.  ASC was induced to differentiate by perfus-
ing the cells at three different flow rates (33, 125, and 500 nL/min) with either normal adipogenic differentiation medium 
(AM) or conditioned medium (CM) (a 1:1 mixture of medium from ASC undergoing adipogenic differentiation in static cul-
ture and adipogenic differentiation medium with twice concentration of differentiation factors).  10x phase contrast images 
of differentiating ASC acquired after 16 days of differentiation. 
 
To investigate whether the decreased formation of lipid-filled droplets was caused by removal of cell secreted signalling 
factors during differentiation, ASC were differentiated by perfusion with conditioned medium (AM added supernatant from 
cells undergoing differentiation into adipocytes in static culture).  Perfusion with CM increased the formation of lipid-filled 
droplets compared to ASC perfused with AM alone, as shown in Fig. 2 and Fig. 3.  Importantly, the effect was dependent on 
flow rate.  Almost no positive effect of perfusion with CM  over AM was observed at 33 nL/min.   By contrast, perfusion 
with CM resulted in up to two times more lipid-filled droplets  than perfusion with AM for flow rates of 125 and 500 nL/min 
(Fig. 3b).  This suggests an involvement of paracrine and/or autocrine signalling factors in differentiation of ASC into adipo-
cytes.  As control to perfusion with CM, cells were perfused with medium added twice the concentration of differentiation 
factors, but this resulted in cell death.  Cells perfused with normal cell culture growth medium led to no differentiation at 
flow rates of 125 and 500 nL/min.  However, some spontaneously differentiated cells were observed by perfusion with 
growth medium at 33 nL/min in the outlet end of the chamber (data not shown).  The presence of differentiated cells only at 
33 nL/min and in the outlet end of the chamber, where released factor concentration would be highest, further point to an in-
volvement of paracrine and/or autocrine signalling factors in ASC differentiation into adipocytes. 
 
  
Figure 3: Effect of conditioned medium (CM) on differentiation of ASC into adipocytes was flow rate dependent.  a) Number 
of lipid-filled droplets over time from cell loading.  Induction of differentiation was started at day 3.  Number of lipid-filled 
droplets were measured using ImageJ by marking areas of four or more pixels within a set range of gray-values and a circu-
larization degree of 0.9-1.0, i.e. almost circular.  b) Number of lipid-filled droplets at perfusion with CM compared to perfu-
sion with AM at flow rates of 33, 125 and 500 nL/min.  Data shown at day 19, i.e. after 16 days of differentiation. 
 
CONCLUSION 
We have shown that perfusion culture at flow rates of 125 and 500 nL/min have a negative impact on differentiation of 
ASC into adipocytes compared to perfusion at 33 nL/min.  Furthermore, differentiation is restored when perfusing with adi-
pogenic conditioned medium.  This demonstrates that ASC differentiation into adipocytes is dependent on a paracrine and/or 
autocrine signalling pathway.  Thus, we have proven that our microfluidic perfusion culture system is suitable for stem cell 
differentiation.  It constitutes a flexible tool to fine-tune stem cell differentiation conditions, as well as investigate signalling 
pathways controlling differentiation. 
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Abstract-Microfluidic biochips offer a promising alternative 
to a conventional biochemical laboratory. There are two 
technologies for the microfluidic biochips: droplet-based and 
flow-based. In this paper we are interested in flow-based 
microfluidic biochips, where the liquid flows continuously 
through pre-defined micro-channels using valves and pumps. 
We present an approach to the system-level modeling and 
simulation of a cell culture microfluidic biochip called ProCell, 
Programmable Cell Culture Chip. ProCell contains a cell 
culture chamber, which is envisioned to run 256 simultaneous 
experiments (viewed as a 16 x 16 matrix). We use an inverted 
fluorescence microscope to observe the experiments in real-
time, allowing kinetic data analysis. We are able to automati-
cally adjust the current experimental setup thus allowing, for 
the first time, conditional experiments. We propose a biochip 
architecture model and a comprehensive fault model that 
captures permanent faults occurring during chip operation. 
Using the proposed modeling and simulation framework, we 
perform an architectural level evaluation of two cell culture 
chamber implementations. A qualitative success metric is also 
proposed to evaluate chip performance in the presence of 
partial failures. Our results show that significant improve-
ments in efficiency can be obtained using redundancy, provid-
ing improved chances to complete an experiment even in the 
presence of faults. This decreases the experiment repetition 
rate while increasing system productivity, saving time and 
reducing costs. 
I.  INTRODUCTION 
During the last decade, microfluidic biochips have be-
come an actively researched area [1]. By miniaturizing the 
macroscopic chemical and biological processes to a sub-
millimeter scale, microfluidic systems enable the integration 
of various assays onto a single chip. The technology is 
referred to as lab-on-a-chip (LoC), as it offers a promising 
alternative to a conventional biochemical laboratory. In 
addition to the reduced geometrical dimensions, this minia-
turization also results in reduced required reagent volumes, 
saving material costs. Moreover, because of the homogene-
ous reaction conditions at the micro level, microfluidic-
based systems provide results of enhanced precision com-
pared to the conventional biochemical analyzers [2]. 1 
                                                 
This work was supported by Grant No. 2106-08-0018 “ProCell”, under the 
Programme Commission on Strategic Growth Technologies, the Danish 
Agency for Science, Technology and Innovation. 
There are two technologies for the microfluidic biochips: 
droplet-based [4] and flow-based [7]. Droplet-based bio-
chips, also referred to as digital biochips, deal with discrete 
droplets on a two-dimensional electrode array and have so 
far been the focus of attention of the design automation 
community [5] [6]. In flow-based microfluidic biochips, the 
liquid flows continuously through pre-defined micro-
channels using valves and pumps [7]. These flow-based 
biochips are fabricated using multilayer soft lithography 
techniques. Although the soft lithography technology has 
advanced faster than Moore’s law [9], the design methodol-
ogy of these biochips is still based on the bottom-up custo-
mized approach involving multiple manual steps with 
minimum design automation. Each new chip is designed by 
creating and connecting the on-chip components based on 
the precise steps of a specific assay [14], thus the chips are 
termed as “Full Custom” biochips. 
As the designs become larger and more complex, the cur-
rent bottom-up full-custom design approach will not scale to 
the new designs, widening the gap between the manufactur-
ing technology capability and the achieved design complex-
ity.  New top-down computer-aided design tools are re-
quired, which can offer the same level of support as the one 
taken for granted currently in the semiconductor industry 
[10]. 
As a first step, we need to model the biochemical applica-
tions separately from the architecture. Thies et al. [12] 
propose a software system called BioStream with two levels 
of abstraction for describing biological assays. The first 
layer consists of a BioStream library, which is used to write 
a program for describing the assay. The second abstraction 
layer, a fluidic instruction set architecture (ISA), interfaces 
the first level with the underlying biochip architecture. 
Their work serves as a first step for decoupling the architec-
ture from the assays.  
Amin et al. [11] propose a general-purpose microfluidic 
architecture called AquaCore and an instruction set (consist-
ing of instructions, such as, <input id2, id1>and <mix id, 
time> where id1 is an input port, id2 is a reservoir and id is 
the mixer) to be implemented on this architecture. Aqua-
Core can be programmed to run any assay, and is thus 
termed as programmable LoC (PLoC). Although such a 
general-purpose PLoC has the obvious advantage of fast 
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turnaround time and lower cost (due to production in larger 
quantities compared to the full custom biochips), it has a 
key concern of reliability (valves operate reliably only for a 
few thousands of actuations), as reported in the paper. 
Furthermore, considering the vast variety in the biochemical 
applications in terms of the biochip architectural require-
ments, it is not possible to run all these applications on one 
architecture. Even if it is assumed that all these applications 
can be run by a generic PLoC, it is very difficult to achieve 
a reasonably high efficiency for all these applications from 
the same architecture.  
Considering the above facts and the low cost of the manu-
facturing process (soft lithography) [8] for the flow-based 
microfluidic biochips, it is more suitable to develop applica-
tion-specific architectures providing a compromise between 
full custom and general-purpose architectures. These appli-
cation-specific programmable LoC (ASPLoC) can be tai-
lored to provide a higher efficiency for a specific set of 
applications bringing it closer to the full custom biochips, 
while retaining the advantages of lower cost and flexibility 
of the general purpose PLoCs.  
Modeling and simulation of the LoC systems are impera-
tive for quickly evaluating design decisions without build-
ing costly prototypes. The simulations can be carried out at 
different levels of abstraction. Chakrabarty et al. [10] pro-
pose hierarchical modeling and simulation framework for 
the LoC systems, from the component-level to the system-
level. The system level involves system performance mod-
eling and behavioral simulation of the system operation. 
The system model needs to be complemented by component 
models in order to characterize the individual microfluidic 
component behavior, and to emphasize the physical proper-
ties and the relationships at the circuit level.  Wang et al. 
[18] present a schematic-based approach to model and 
simulate the LoC systems using theoretical microfluidic 
models for the components. They use parameterized and 
closed-form models of the LoC elements to perform both 
DC and transient analysis of the chip. Using the analyses, 
they propose to capture the influence of topology, element 
sizes, and material properties on the biochip performance. 
Amin et al. [13] propose computer-aided design support 
methods for the microfluidic biochips at the physical design 
level. They propose methods to automatically infer the 
control valve placement, reducing the number of control 
lines needed to drive the valves and for routing these valves 
to the control ports. 
In this paper, we present an approach for the high level 
modeling and simulation of a cell culture microfluidic 
biochip called ProCell, Programmable Cell Culture Chip 
[15]. ProCell is envisioned to run up to 256 experiments 
simultaneously. We use an inverted fluorescence micro-
scope to observe the experiments in real-time. Depending 
on the observed outcome of a particular experiment, we are 
able to automatically adjust the current experimental setup. 
Thus, for the first time to our knowledge, conditional expe-
riments can be performed. 
ProCell can be viewed as an ASPLoC as it can be used to 
implement a specific set of applications with reasonably 
high efficiency, e.g., in vitro drug testing, genomics, stem 
cell analysis, tissue engineering [15]. This would offer the 
possibility of breakthroughs in regenerative medicine, 
cancer research and developmental biology.  
Biochips belong to the class of Micro-Electro-Mechanical 
Systems (MEMS) and exhibit many different types of 
faults. Modeling these faults and their impact is imperative 
in order to perform a realistic system analysis.  
In this paper we propose a biochip architecture model and 
a comprehensive fault model. We model faults that cause 
partial failures in the chip during operation and propose a 
success metric Q , which provides a qualitative measure of 
the chip performance in the presence of partial failures. 
Using the proposed simulation framework, we provide an 
architectural-level comparison of two cell culture chamber 
implementations. Our results show that significant im-
provements in efficiency can be obtained using redundancy, 
providing improved chances to complete an experiment 
even in the presence of faults. This decreases the experi-
ment repetition rate while increasing system productivity, 
saving time (one cell culture experiment can take many 
days to complete), and reducing costs, since the purified 
proteins and compounds used in the experiments are highly 
expensive.  
 The rest of the paper is organized as follows. Section II 
describes the details of the ProCell prototype operation. 
Section III.A presents the architecture model of the cell 
culture biochip and Section III.B gives details of the pro-
posed fault model. Different redundancy schemes are dis-
cussed in Section III.C and Section III.D gives out the 
problem formulation. The simulation framework is pre-
sented in Section IV. Section V describes the experimental 
results and Section VI presents the conclusions. 
II. PROCELL PROTOTYPE OPERATION 
ProCell is a new microfluidic-based device (being devel-
oped at the Technical University of Denmark, DTU) for 
culturing and monitoring of living cells in real-time [15]. 
ProCell is aimed to be a powerful, user-programmable, 
completely self-contained open platform for performing 
high throughput conditional cell culture experiments.  
The ProCell chip contains one large chamber with 16 in-
lets and 16 outlets. There are a total of 32 individual inlets 
carrying soluble compounds (e.g., growth factors), which 
connect to the chamber inputs through 16 independent two-
way valves. ProCell cell culture chamber is a modified 
version of the well characterized single experiment culture 
chamber developed at DTU [16]. Fig. 1 shows an example 
of a large chamber being divided into 8 virtual cell culture 
chambers using the laminar flow property of liquids at 
micro scales (each row can be viewed as a virtual chamber). 
Laminar flow is a distinguished category in the liquid flow 
classification [3]. Laminar flows are defined as the flow of 
fluids in parallel layers without any disruption between the 
layers. To carry out the experiment, first, valve D2 is 
opened and valve D1 is closed, allowing 8 different cell 
types to be pumped into the large chamber and since lami-
nar flow conditions are applied eight corresponding stripes 
of cells are produced. After sedimentation, cells adhere to 
the bottom of the chip.  
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Figure 1: ProCell: Laminar flow-based large chamber 
 
Then, valve D2 is closed and valve D1 is opened, allow-
ing eight soluble compounds to perfuse over the cells in the 
perpendicular direction creating simultaneous experiments 
in the chip. Exposure of a cell colony to the soluble com-
pound and monitoring its reaction is termed as an experi-
ment. Since we have 8 cell colonies in each virtual chamber 
and there are 8 virtual chambers in total, thus we have 64 
simultaneous experiments taking place in the chip. The fluid 
flow is managed by pumps that are controlled by electric 
motors.  
 A.  Large Chamber vs Isolated Chambers  
Fig. 1 shows a large chamber that is divided into 8 virtual 
chambers. Each chamber holds 8 cell colonies. Dividing the 
large chamber in such a way allows the in vitro conditions 
in the virtual chambers to resemble more closely to the 
natural in vivo conditions, since the cells are placed next to 
each other both horizontally as well as vertically.  
A second choice of chamber architecture is to use 8 inde-
pendent chambers physically isolated from each other. Just 
like the virtual chambers in the previous case, each isolated 
chamber also holds 8 cell colonies. The difference in this 
case is that the cells are placed next to each other only 
horizontally. Vertically, the isolated chambers have solid 
boundaries, i.e., each row (representing a chamber) is 
isolated from the rows next to it. Although such a scheme 
may have less resemblance with the natural conditions, it 
may prevent faults in one chamber, such as air bubbles, 
from advancing to the other chambers. We analyze the 
performance of both kinds of chamber implementations in 
this paper. 
B.  Conditional Experiments  
The current ProCell prototype is able to run up to 64 ex-
periments simultaneously. We use an inverted fluorescence 
microscope to observe the experiments in real-time,  allow-
 
Figure 2: Biochip Architecture Model 
 
ing kinetic data analysis. Depending on the observed inter-
mediate outcome of a particular experiment through optical 
feedback, we are able to automatically adjust the current 
experimental setup thus creating conditional experiments.  
ProCell uses the Zeiss AxioObserver Z1 inverted fluores-
cence microscope [19] for real time image capturing of the 
cell culture chamber over extended periods of time. The 
microscope is integrated with a Fujitsu high-end worksta-
tion CELSIUS R650. MCL-D2568 [20].  
III. SYSTEM MODEL 
A.  Biochip Architecture Model 
Fig. 2 shows the biochip architecture model. Each row in 
the model represents a chamber1. The architecture is 
represented by an 8x8 matrix (8 rows representing 8 cham-
bers, where each chamber hosts 8 cell colonies). Each 
element of the 8x8 matrix hosts a cell colony, i.e., a separate 
experiment. 2 
One primary step common to all cell culturing applica-
tions is the placement of cell colonies onto the chambers. In 
Fig. 2, 20 different cell colonies (C1 – C20) are placed on the 
biochip. The cell colonies marked with different patterns 
represent the fault affected regions, see next section. Each 
cell culture experiment requires some sort of controls to 
ensure quality of compounds being inserted into the cham-
ber (which may degrade over time since one experiment 
lasts for many days) and to guarantee that the conditions in 
the chamber (e.g., a certain compound concentration) are 
uniform (some cell colonies might consume the compound 
at a rate fast enough to deprive the cell colonies downstream 
of it, creating undesired non-uniform conditions). Positive 
and negative controls, provided by specific cell colonies 
depending on the application, are used for this purpose [17]. 
Cell colonies serving as positive controls are manipulated to 
give out positive signals (e.g., certain level of fluorescence) 
in the presence of desired conditions (e.g., desired concen-
tration of the compound) and are placed as the last cell 
colony in the chamber as shown in Fig. 2 using notation C+. 
Absence of a positive signal from a positive control means 
                                                 
12In the rest of the paper, the word chamber will be used interchangeably for 
the virtual or isolated chamber (not for the large chamber). 
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that the chamber no longer holds the desired conditions and 
the experimental results of that chamber are no longer 
reliable. Cell colonies serving as negative controls are 
manipulated to give out negative signals (e.g., absence of a 
certain level of fluorescence) in the presence of desired 
conditions (e.g., desired quality/ concentration of the com-
pound) and are placed as the first cell colony in the chamber 
as shown in Fig. 2 using notation C–. A negative control 
giving positive results also renders the chamber experimen-
tal results unreliable.  
Different cell colonies can exhibit different properties in a 
chip and are thus placed at different locations in the cham-
ber, based on the application. Some cell colonies (termed as 
Comm – communicator colonies) secrete compounds that 
are useful for the cell colonies placed downstream. Such 
colonies are placed close to the chamber inlets. It may also 
be possible that these secretions are instead harmful for the 
other cell colonies, in which case the cell colonies secreting 
these compounds are placed close to the outlets ensuring 
that they do not contaminate the chamber. Some cell colo-
nies might be very rare or very expensive (and thus are 
considered high priority – HP) and would hence be placed 
at the location most suited to their requirements, making a 
compromise on the placement of other cell colonies (consi-
dered low priority – LP). HP and LP can also reflect the 
weight of a particular combination of cells and experimental 
conditions in a chamber, since some combinations may be 
more vital than others in order to test a certain hypothesis. 
The cell colony placement scheme (the order in which the 
colonies are placed) on a chamber is thus dependent on the 
properties of the cell colonies and the desired output of the 
experiments being run on the chip. Placement scheme can 
have an impact on the tolerance to faults, e.g., colonies 
placed close to the inlets are more susceptible to air bubbles 
than the ones placed close to the outlets.  
Based on the cell colony properties, the colonies placed 
on the chip in Fig. 2 are categorized as: 
 Negative Control (–): C– 
 Positive Control  (+): C+ 
 Comm:   C2, C6, C12, C17 
 High Priority (HP):            C1, C4, C9, C10, C15 
 Low Priority  (LP): All others 
B.  Fault Model  
As discussed in Section II.B, there are 64 simultaneous 
experiments running on the chip, i.e., each cell colony 
represents a different experiment. Failure of an experiment 
caused by a fault is defined as a cell colony being unable to 
exhibit the reactive response, which it would exhibit other-
wise under the applied conditions in the absence of that 
fault.  
Different kind of faults can occur in a cell culture biochip. 
Some faults (e.g., mechanical pump breakdown, electronic 
motor failure) result in the failure of all the cell colonies in a 
chamber (complete chamber failure), whereas others (e.g., 
air bubbles enclosing one cell colony in the chamber thus 
modifying its conditions) may lead to the failure of some of 
the cell colonies in the chamber, i.e., a partial chamber 
failure. In this paper we model partial failures in the chip 
and propose a metric called Failure Index (FI) which is used 
to provide a qualitative success measure of the biochip 
performance in the presence of partial failures.  
 
TABLE 1 
FAULT TYPES 
 
Cause Fault Error Impact Possible 
Failure 
Grade 
Air 
bubbles 
Cells in 
the 
chamber 
enclosed 
in air 
bubbles 
Cells enclosed in 
air bubbles no 
longer affected 
by the compound 
inserted into the 
chamber 
Complete 
or partial 
chamber 
failure  
 
FC 
C 
PH 
PL 
 
Over-
stressed 
cells 
None or 
partial 
cell 
adhesion 
Some cells in 
some chambers 
flushed out with 
the media 
Complete 
or partial 
chamber 
failure  
FC 
C 
PH 
PL 
Over-
stressed 
cells           
Cells no 
longer 
react in a 
normal 
manner 
None or incorrect 
results which 
will not be 
reproduced upon 
repetition 
Complete 
or partial 
chamber 
failure  
 
FC 
C 
PH 
PL 
 
 
A quantitative measure of success of the biochip can be 
the total number of experiments run on the biochip without 
failure. However, the cell colonies placed on the biochip 
have different properties and failure of one cell colony may 
have a stronger impact compared to the other, e.g., failure of 
the negative control would result in the failure of the whole 
chamber. Thus a qualitative measure of success is required.  
Table 1 presents the three most common faults that occur 
in cell culture biochips together with the corresponding 
errors and possible failure grades. Failure grade assignment 
is done to all 64 cell colonies on the biochip depending on 
the kind and/or number of cell colonies affected by the 
fault. Failure grade PL or PH is assigned if the fault occurs 
on a low priority or a high priority cell colony, respectively. 
If the fault occurs on a communicator colony or on all the 
negative/ positive controls available in a chamber, failure 
grade PH is assigned to all the colonies in the chamber 
marking a complete chamber failure. Failure grade CC is a 
chamber level failure grade marking complete chamber 
failure and FC is a chip level failure grade representing full 
chip failure.  
Table 2 shows the value contributed by the fault type to 
the total Failure Index metric depending on the failure grade 
assigned to the fault. For example, a single PL grade failure 
contributes 1 failure point, whereas a high priority cell 
colony failure resulting in a PH grading contributes 2 
failure points. Failure of the positive or negative controls or 
a communicator colony is ranked as a complete chamber 
failure equivalent to 16 failure points. Last column of 
Table 2 shows the range of PL failure index contribution for 
a chamber as {0-5, 16}. This represents that that if 5 cell 
colonies out of the 6 in a chamber (2 cell colonies are 
reserved for positive and negative controls) undergo partial 
failure, the failure index contribution is 5 points, whereas 
partial failure of all 6 colonies is ranked as a complete 
chamber failure equivalent to 16 failure points. Same ap-
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plies for the failure index contribution of PH failure shown 
in the Table. Using different failure index contributions for 
different impacts allows qualitative evaluation of chip 
failure.  
TABLE 2 
FAILURE INDEX 
 
Fault 
Impact 
Failure 
Grade 
Description Failure Index  
Contribution 
Partial 
Chamber 
Failure  
PL 
3 
Represents partial 
chamber failure, L in PL 
represents failure of low 
priority cells 
1 / Each low 
priority cell 
experiment failure 
in the chamber 
[0 – (M-l-1) 1, 2M] 
PH 
 
Represents partial 
chamber failure, H in 
PH  represents failure of 
high priority cells 
2 / Each high 
priority cell 
experiment failure 
in the chamber 
(0 – 2×(M-l-1), 2M) 
Complete 
Chamber 
Failure 
CC 
 
Represents complete 
failure of a chamber 
(e.g., loss of posi-
tive/negative control or 
the Comm) 
 
 2M 
Full Chip 
Failure 
FC Represents simultane-
ous complete failure of 
all chambers 
 
N1 × 2M 
 
The Failure Index of a chip is calculated by adding the 
failure index contributions (FIC) of all chambers: 
,   
                                   ܨܫ ൌ  ∑ ܨܫܥ݅ே௜ୀଵ                                (1) 
 
where N is the number of chambers. 
 
In order to calculate FIC of a chamber, first the failure 
grade of the fault is determined based on the cell colony 
type at which the fault occurs. Based on the failure grade, 
the FIC for chamber 1 can be calculated as,  
 
                       ܨܫܥଵ ൌ   ඃ∑ ܲܪ݅ ܯ௜ୀଵ ඇ ൅ ڿ∑ ܲܮ݅ ெ௜ୀଵ ۀ                 (2) 
 
where M is the number of cell colonies in the chamber, PH 
represents the failure points contributed by any high priority 
cell failures in the chamber, and PL represents the failure 
points contributed by the low priority cell failures. The roof 
value for the first term is 2M (16 in this case) which is 
applied in case the summation value exceeds (M–l–1), 
where l is the number of cell colonies reserved for the 
positive and negative controls in the chamber. The roof 
value for the second term is also 2M and is applied if the 
summation value exceeds 2×(M–l–1).  
In Fig. 2, chamber 1 (marked with inlet A1) has an air 
bubble failure on C–. Loss of the negative control marks a 
complete chamber failure, thus FIC1 = 16. In chamber 6, 
cell colonies C4 and C8 fail to adhere to the chip and are 
flushed out. C4 and C8 are in categories HP and LP respec-
tively. As per eq. 2, FIC6 is calculated as (2 + 1) = 3.  
                                                 
13N is the maximum number of chambers and M is the maximum number of 
cell colonies per chamber. In this case,   N = M = 8. l is the number of colonies 
used for positive and negative controls per chamber, in Fig. 3 l = 2. 
Similarly, FIC2, FIC3, FIC4, and FIC8 are equal to 16. FIC5 
and FIC7 are equal to 0. Failure Index of the whole chip is 
equal to sum of all FIC (1), i.e., 83 for this case. In the 
worst-case, FI is represented by a full chip failure (FC in 
Table 2).  
The success metric Q  is thus calculated as, 
  
                      Q  ൌ ቂே ൈ ଶெି ிூே ൈ ଶெ ቃ ൈ 100                             (3) 
 
where N and M represent the number of chambers and the 
number of cell colonies in a chamber, respectively. For the 
current case, Q  is (128 – 83) / 128 =  35.15%. 
Note that chamber 6 and chamber 7 in Fig. 2 have the 
same placement scheme. Chamber 6 is affected with partial 
failures, whereas chamber 7 is fault free. The redundancy 
increases the success probability for that particular place-
ment scheme. The redundancy schemes are discussed in the 
next section. 
The faults listed here are permanent faults that occur dur-
ing chip operation and are detected through optical feedback 
in real time. Based on the detection results, the experimental 
setup is adjusted to cater for the caused errors. Fault detec-
tion is not a part of the ProCell simulator since the faults are 
randomly generated and injected into the cell culture cham-
ber during simulation. The simulator is used to architectu-
rally compare two different cell culture chamber implemen-
tations.   
C.  Redundancy Schemes 
Different redundancy schemes can be introduced into the 
chambers in order to improve the chip reliability. Two types 
of redundancy schemes are proposed here: placement re-
dundancy and control redundancy.  
Placement redundancy is defined as placement of the 
same cell colonies in multiple chambers, i.e., the colony 
placement done in one chamber is repeated in multiple 
chambers. The number of chambers in which the same 
placement is repeated is termed as the redundancy level.  
In this paper, two types of chamber implementations are 
under consideration as discussed in Section II.A. The prima-
ry difference between the two implementations, in terms of 
fault impact, is that in the virtual chambers (present in one 
large chamber) the air bubbles can easily spread from one 
chamber to the other.  
 
                         Level = 2                Level = 4                Level = 8 
Figure 3: Placement Redundancy: 8 Isolated Chambers 
 
 
            Level = 2              Level = 3               Level = 4              Level = 8 
Figure 4: Placement Redundancy: Large Chamber (8 Virtual Chambers) 
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However, this is not true for the isolated chambers since 
those are separated from each other using solid boundaries. 
Fig. 3 shows the placement redundancy schemes for the 
isolated chambers implementation. Fig. 4 shows the place-
ment redundancy schemes for the virtual chambers. Maxi-
mum air bubble radius is set to three chambers. For redun-
dancy levels 1 and 2 in Fig. 4, the redundant placements are 
made 2 chambers apart such that the air bubble affecting 
one chamber does not affect the other redundant chambers 
even in the worst-case.  
Control redundancy is defined as placing multiple control 
colonies on a single chamber, e.g., instead of one negative 
control two negative controls can be placed on the chamber. 
Failure of the control marks the failure of the whole cham-
ber. Thus, the placement of redundant controls can increase 
the success probability of the experiment.  
D.  Problem Formulation  
The problem addressed can be formulated as follows. 
Given (1) a cell culture biochip architecture model M 
consisting of an N × M matrix representing the cell culture 
chamber, (2) a set of three different static cell colony 
placement schemes P, (3) a fault model F together with the 
set of occurrence rates of different faults, and (4) a set of 
placement redundancy levels R , the target is to perform an 
architectural level evaluation of two implementations: large 
chamber (with virtual chambers) vs isolated chambers.  The 
evaluation provides qualitative measure of success Q for 
each chamber implementation under the same conditions. 
The evaluation is made at different redundancy levels in 
both cell culture chamber implementations in order to 
determine the variation in Q . 
The architectural evaluation involves mapping the place-
ments P onto the chamber architecture model, conducting a 
property analysis of the placed cell colonies, randomly 
generating different faults according to the given occurrence 
rates (see Section V for details) and calculating the failure 
index FI which is used to calculate Q. The performance 
evaluation is based on the properties of the architecture 
model, the fault model and the cell colonies at which these 
faults occur. The architectural comparison is performed 
independent of any specific application rendering the results 
equally applicable to all applications that can be executed 
on the chip.  
IV. PROCELL SIMULATOR 
The simulation framework is shown in Fig. 5. Cell cham-
ber implementation choice, the placement scheme, fault 
rates and selected redundancy levels are given as an input to 
the simulator.  
The first step in the simulator operation is to map the se-
lected placement onto the selected chamber implementation. 
The chamber implementation is represented as a matrix 
model in the simulator. Different cell colonies have differ-
ent properties and thus different priority levels as discussed 
in  Section III.A. Based on the  properties of these cell colo- 
 
Figure 5: Simulation Framework 
 
nies, a new property matrix is generated next. This property 
matrix is utilized at the time of failure index evaluation 
since the same fault occurring on cell colonies with differ-
ent properties can result in a different failure index contri-
bution. 
Next, using Monte Carlo Simulation (MCS), faults are 
randomly generated based on the chosen fault rates and 
evaluated to generate the Failure Index (FI) and the success 
metric Q . FI calculation takes into account the fault model 
built in the simulator, the generated property matrix, se-
lected chamber implementation and the chosen redundancy 
level. At the end of the MCS cycle (10,000 runs), the aver-
age percentage value of Q is calculated and generated as an 
output.  
V. EXPERIMENTAL RESULTS 
Table 3 shows the results of the architectural comparison 
(as a measure of Q) between the two chamber implementa-
tions using varying fault rates. Only control redundancy is 
utilized for this comparison. The property based description 
of the three placement schemes is as follows: 
 
 P1 =  < –, Comm, LP,       LP, LP, LP,  LP, + >  
 P2 =  < –, Comm, LP, Comm, LP, LP,  HP, + >  
 P3 =  < –,     –     , LP, Comm, LP, LP, HP, + >  
 
As can be seen, P2 and P3 are identical, other than the 
fact that the Comm of P2 is replaced by an extra negative 
control in P3, providing the control redundancy.  
Different fault rates can be chosen for the three types of 
faults discussed in Table 1. Fault rates under which the 
simulation experiments were performed are given in the 
first column in Table 3. Since no statistics on the fault 
occurrence rates are available yet, we base our experiments 
on the limited observations made during the ProCell opera-
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tion. The experiments are carried out at different fault rates 
per experiment and the results are analyzed. Whenever 
more accurate statistics become available, those can easily 
be plugged into the simulator to perform architectural 
evaluation. The notation (10, 5, 5) in the first column of the 
Table means that the air bubble occurrence rate is 10%, rate 
of the faults resulting in cells not adhering to the chamber is 
5% and the rate at which the cells become non-reactive is 
5%, respectively.  
 
TABLE 3 
RESULTS: PERFORMANCE COMPARISON 
 
Fault Rate P1 P2 P3 
8 Isolated chambers 
(10,5,5) 55.14 54.19 58.53 
(20,5,5) 38.08 36.72 41.26 
8 virtual chambers 
(Max air bubble radius = 3 chambers) 
(10,5,5) 44.25 43.15 48.02 
(20,5,5) 23.30 21.58 25.66 
8 virtual chambers 
(Max Air bubble radius = 5 chambers) 
(10,5,5) 36.36 34.96 39.96 
(20,5,5) 15.27 13.93 17.52 
 
TABLE 4 
8 ISOLATED CHAMBERS: REDUNDANCY RESULTS 
 
Fault Rate Redundancy P1 P2 P3 
(10,5,5) 2 79.60 71.40 81.09 
(20,10,10) 2 46.30 32.80 47.11 
(30,15,15) 2 22.97 12.47 23.61 
(40,20,20) 2 10.33 4.25 10.50 
(10,5,5) 4 95.14 91.37 95.86 
(20,10,10) 4 69.86 54.16 71.24 
(30,15,15) 4 40.07 23.41 41.37 
(40,20,20) 4 18.93 7.89 19.31 
(50,25,25) 4 7.75 2.25 7.92 
(10,5,5) 8 99.27 98.80 99.60 
(20,10,10) 8 88.38 78.15 90.01 
(30,15,15) 8 62.53 40.96 64.06 
(40,20,20) 8 33.47 15.25 34.75 
(50,25,25) 8 14.66 4.50 15.19 
 
TABLE 5 
8 VIRTUAL CHAMBERS: REDUNDANCY RESULTS 
 
Fault Rate Redundancy P1 P2 P3 
Maximum air bubble radius is 3 chambers for all cases
(10,5,5) 2 74.46 64.55 75.90 
(20,10,10) 2 37.53 24.69 38.26 
(30,15,15) 2 16.49 8.13 16.92 
(40,20,20) 2 6.45 2.4 6.67 
(10,5,5) 3 83.19 74.20 84.87 
(20,10,10) 3 43.54 28.33 44.44 
(30,15,15) 3 18.45 8.83 19.10 
(40,20,20) 3 7.00 2.46 7.20 
(10,5,5) 4 87.41 79.75 89.27 
(20,10,10) 4 49.08 32.33 50.57 
(30,15,15) 4 21.06 9.89 21.59 
(40,20,20) 4 7.70 2.61 13.64 
(10,5,5) 8 95.82 92.41 96.71 
(20,10,10) 8 66.87 49.16 69.58 
(30,15,15) 8 33.33 16.71 35.02 
(40,20,20) 8 12.85 4.36 13.67 
(50,25,25) 8 4.23 0.97 4.50 
Since the air bubbles are inserted into the chamber 
through inlets, the cell colonies closer to the inlets are more 
susceptible to the air bubble faults than the ones close to the 
outlets. We assume a linear decrease of 1% in the occur-
rence rate when moving from the inlets to the outlets in the 
chamber, i.e., cell colony closest to the inlet has a rate of 
10%, next one has a rate of 9%, and so on.  
As shown in Table 3, the isolated chambers have a higher 
success rate Q compared to the virtual chambers. As the 
fault rates increase, the gap in the success metric also wi-
dens. This is because in the virtual chambers the air bubbles 
can easily spread from one chamber to the other. However, 
this is not true for the isolated chambers since those are 
separated from each other using solid boundaries. Compar-
ing results of P2 and P3, it can be seen that the control 
redundancy provides up to 5% increase in Q. Tables 4 and 5 
show the variations in Q as a result of placement redundan-
cies for the same placement schemes. 
As shown in Table 4, even a level-2 placement redundan-
cy provides up to 24% increase in Q (P1 under (10, 5, 5)) 
compared to the results without placement redundancy in 
Table 3 for isolated chambers. Q is calculated by using the 
average Q calculated over an MCS cycle (10,000 runs). For 
every run, the higher value of Q from the two redundant 
chambers (for level-2) is considered for calculating the 
average Q . The redundancy level can be increased to cater 
for the increasing fault rates. However, for the isolated 
chambers as shown in Table 4, the Q  value falls below 35% 
when the fault rates go up to (40, 20, 20), even with a 
placement redundancy level of 8. For the virtual chambers, 
the results are shown in Table 5. At the placement redun-
dancy level 8, Q  goes as low as 35% at the fault rates (30, 
15, 15).  
The results show that the mixed redundancy scheme (both 
placement and control) provides the best results. 
VI. CONCLUSION 
In this paper we have presented a modeling and simula-
tion framework for the cell culture microfluidic biochip 
ProCell. We have proposed a biochip architecture model 
and a comprehensive fault model capturing permanent 
faults that occur during the chip operation. Using the pro-
posed simulation framework, we have carried out an archi-
tectural level evaluation of two cell culture chamber imple-
mentations. The proposed approach considers the fault 
model, cell placement scheme, fault occurrence rates, and 
the redundancy level and provides a qualitative success 
metric as a measure of performance for both architectures in 
the presence of partial failures. Three different cell place-
ment schemes have been used to evaluate the architectural 
performance under different redundancy levels and varying 
fault rates.  Our results show that significant improvements 
in efficiency can be obtained by using redundancy schemes; 
increasing the system productivity, saving time and reduc-
ing costs. However, evaluation depicts that both architec-
tures have separate limits of maximum tolerable fault rates, 
after which the redundancy is no longer effective in improv-
ing the chip performance.  
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ABSTRACT 
We present a fully self-contained system for long-term cell culture with real-time, high quality microscopic access 
and programming capabilities for constant perfusion live-cell assays.  When assembled, the system constitutes a closed 
unit complete with microfluidic culturing chip, reservoirs, interconnections and flow control without the need for exter-
nal mechanical components.  Being designed especially for use in cell labs and to fit into standard motorized stages in 
inverted life science microscopes the system is user-friendly for operators without a microfluidic background.  To dem-
onstrate the system capabilities we show examples of switching between different liquids and long-term cell culture with 
time-lapse imaging. 
 
KEYWORDS: Long-term cell culture, Microscopy, Microfluidics, Interconnection, Fluid actuation, Cell programming 
 
INTRODUCTION 
The use of microfluidic tools in cell culture is often limited by the complexity and need for peripheral components in 
typical research setups incompatible with standard, sterile cell biology work flows and microscopy [1,2].  This can be 
particularly pronounced in assays requiring high parallelization or multiplexed operation where external fluid actuation 
requiring e.g. large amounts of tubing from syringe pumps or pressure controllers can lead to unwanted dead volumes 
and portability issues thus reducing their suitability for routine work in a laboratory environment.  A common way to 
overcome issues with peripheral components is to integrate fluid actuation directly on the chip [3].  Despite the advan-
tages in reduced total system footprint, response time and swept volume, a drawback of on-chip actuation approach is 
that systems can become highly specialized thereby limiting their versatility and possibly reducing fabrication yield.  
The presented system distinguishes itself from other integrated systems [3,4] by having more fluidic inputs/outputs, 
accepting polymeric and silicon/glass based chips, not relying of pneumatics for fluidic control and being compatible 
with unobstructed, high quality real-time transmission and fluorescence microscopy observation.  We demonstrate how 
the system can be used to switch between different liquid inputs, which is necessary for programming purposes, and that 
cells can be seeded and cultured on-chip in a microscope for several days. 
 
SYSTEM DESIGN 
In the present system we have implemented fluid actuation by miniaturized peristaltic pumps of the type presented in 
[5] modified for direct attachment to a cell culture chip by integrated ball joint interconnection blocks [6] without any 
intermediate fluidic components.  This significantly reduces swept volume and compliance compared to distantly placed 
volume displacement pumps.  Thus, except from the power supply and electrical controller, every component for driving 
the microfluidic chip is on the system.  It can therefore easily be moved from cell culture labs for cell loading to micro-
scopes for observation just by connecting one single electrical cable through a standard DA-15 connector  (Fig. 1).  
 
 
Figure 1: a) The complete platform mounted with chip, eight inlet reservoirs and two outlet reservoirs. Miniaturiza-
tion of pumps and connections allows these and the observation area to fit between life science objectives and a 26 mm 
working distance (WD) condenser in an inverted microscope. b) Schematic side view showing fit of central parts be-
tween 26 mm WD condenser and 2.9 mm WD objective. 
 
The platform (Fig. 1), consists of three miniaturized 8-channel peristaltic pumps [5], inserts with space for up to 30 
reservoirs and a chip holder allowing the exchangeable chip to be readily snapped on to 32 self-aligning fluidic ball joint 
interconnections [6] by tightening four stainless steel bolts.  The exchangeable microfluidic chips are fabricated by direct 
micromilling in poly(methyl methacrylate) (PMMA) and contain passive microfluidic networks.  Depending on the assay 
requirements the chips can make use of all or a fraction of the inlets and contain single or multiple fluid channel layers 
for parallel, serial or combinatorial operation all using the same standardized interconnection and actuation platform. All 
chips are designed with a total of 24 inlets in groups of 8 and a group of 8 outlets and have a microscope slide foot print 
for ease of use and compatibility with standard life science equipment. 
The central element of the pumps containing integrated channels and ball joint interconnections is made of injection 
molded PDMS using a fabrication scheme similar to the ones previously reported in [5] and [6].  This low-cost element 
can be exchanged easily between experiments to avoid cross contamination. 
Pump control is obtained through a single electrical interconnection to a custom-made controller.  A VBA script in 
Zeiss AxioVision 4.8.1 (Carl Zeiss, Germany) has been developed to simultaneously control the pumps and Zeiss Axio 
Observer microscope (Carl Zeiss, Germany) for automated perfusion, imaging and analysis.  
Cell loading is carried out by pipetting cell suspension into integrated wells at the outlet side.  A uniform cell seeding 
is readily achieved upon reversing the flow.  Due to the design of wells and channel system no agitation between pipet-
ting steps is required making it easy to load different cell lines in each well.  When sterilized and assembled the system 
is fully enclosed and can be transferred between equipment without risk of contamination. 
 
EXPERIMENTAL 
Without on-chip valves the switching between compounds must be accomplished by start and stop of the low-
compliance pumps, which entails a diffusion limited leakage from channel intersections to the downstream culturing 
chambers.  This, however, can be controlled by design to be without physiological significance. 
To test the switching capabilities chips containing T-junctions have been fabricated with inlets connected to two 
pumps.  One inlet feeds a fluorescent diluted Streptavidin-Cy3 (S-Cy3) solution (S6402, Sigma-Aldrich) and the other a 
nonfluorescent phosphate buffered saline (PBS) solution (P5368, Sigma-Aldrich).  The switch rate is determined by 
measuring the average pixel intensity of the fluorescent signal downstream the junction after changing pump settings. 
Long-term cell culture directly on a microscope is demonstrated using a PMMA chip with culturing chambers having 
a cross section of 200 m by 1500 m.  HeLa Tet-On cells (Clontech 631155, Clontech Laboratories, Inc.) have been 
cultured at an average flow rate of 250 nL/min to test proliferation and viability.  
To demonstrate gene expression the line has also been transfected with the fluorescent reporter gene ZsGreen1-DR 
and cultured under the same flow conditions with added doxycycline at a concentration of 5000 ng/mL.  During perfu-
sion the setup is mounted in an inverted microscope (Zeiss Axio Observer) equipped with an incubator to ensure stable 
temperature and CO2 conditions. 
 
RESULTS 
Figure 2 demonstrates how two pumps are used to switch between S-Cy3 and PBS with a downstream diffusion lim-
ited leakage.  The fluorescent signal is reduced approximately two orders of magnitude within 3 minutes at a flow rate of 
250 nL/min in channels with 400x150 m2 cross section.   
The result is in fair agreement with time-dependent 2D convection-diffusion finite element (FEM) simulations im-
plemented with a constant inlet velocity in COMSOL Multiphysics 3.4 (COMSOL AB, Sweden). This verifies the sys-
tem’s switching properties.  Switch characteristics can be tailored by changing geometry and flow rate, which has been 
experimentally verified, and proves the system suitable for cell studies with temporally varied exposure profiles. 
 
 
Figure 2: Switching sequence between PBS and fluorescent S-Cy3 conjugate in a T-junction with channel cross sec-
tion of 400x150 m2 at a flow rate of 250 nL/min. Arrows indicate flow settings under a) initial condition and b) 8 s, c) 
16 s and d) 112 s after switching. Quantification by background corrected, relative pixel intensity over three repetitions 
and theoretical data based on a FEM simulations  is given in e). The box annotation in a) indicates the analysis region. 
 
Figure 3 shows a long-term time-lapse series of HeLa Tet-On cells cultured an average flow rate of 250 nL/min per 
chamber. The proliferation and adhesion proves the seeding and perfusion method suitable for the application.  
 
 
Figure 3: HeLa Tet-On Advanced Cell Line  cultured in a PMMA chamber with a height of 200 mm and 3.2 mL vol-
ume perfused with an average flow rate of 250 nL/min. Phase contrast time-lapse images acquired after a) 0 hours, b) 
16 hours,  c) 32 hours and d) 64 hours  of perfusion demonstrate cell adhesion and proliferation. 
 
A gene expression assay is given in Fig 4, which shows a fluorescent time lapse series of transfected HeLa Tet-On 
cells stimulated with doxycycline over 36 hours initiated after 5 hours of low flow without doxycycline. The signal is 
seen to increase during the course of the experiment thus demonstrating a well functioning gene expression. 
 
 
Figure 4: HeLa Tet-On Advanced Cell Line  showing overall increased expression of a transfected fluorescent re-
porter gene ZsGreen1-DR during perfusion at a rate of 250 nL/min with medium containing doxycycline. Images a)-d) 
show fluorescent micrographs of the cells at 0, 8, 16 and 24 hours after stimulation start, respectively. Image e) shows 
the fluorescent signal over 36 hours measured as average pixel intensity in a 3 mm2 area normalized to the first frame. 
 
CONCLUSION 
We have presented a complete, self-contained platform for programmable long-term cell culture with microscope ac-
cess. Using the platform we have demonstrated that two different fluids can be exchanged with two orders of magnitude 
within few minutes at relevant culturing flow rates and that cells can be cultured and stimulated over days with the sys-
tem mounted in a microscope. 
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ABSTRACT 
 Reconfigurable microfluidic elements including multi-channel interconnection and peristaltic pump components are 
described.  The elements form the basis of a modular microfluidic system which features and provides a small footprint, 
unobstructed microscopic observation, portability and supports a wide variety of assays.  Design, fabrication and 
characterization of the elements are described, as are both motorized and non-motorized methods to control and actuate 
fluidic networks supported by the system.  Applications using the approach are also presented.  
 
KEYWORDS: Interconnections, Pump, Modular, Reconfigurable  
 
INTRODUCTION 
 Ease of use, reliability and accessibility remain barriers to the adoption of microfluidic approaches [1, 2]. Practical 
issues including interconnections, pump capacity and control, and suitability to microscopic observation often complicate 
microfluidic setups.  We present modular interconnection and pump components which address these issues and provide 
simple, reliable and multiple parallel chip-to-world and chip-to-chip interconnectivity and pump capacity.  Additionally, 
for non-experts developing microfluidic investigations there is also a lack of accessible and easily implementable control 
and actuation solutions. To circumvent this issue, a hand crank is used for simple applications requiring simple fluidic 
actuation or the commercial LEGO® MindstormsTM kit is used to program and control pumps when higher degrees of 
automation are required.  
 
DESIGN AND FABRICATION 
 Microfluidic ribbons (μFRs) (Figure 1) provide interconnectivity between system components.  Each μFR is cast 
from PDMS and contains eight integrated channels with 240 µm inner diameters spaced 2.25 mm centre-to-centre (1536 
well plate standard).  Three μFR versions eliminate further tubing requirements. Type I μFRs permit direct chip-to-chip 
or chip-to-reservoir connectivity.  Type II μFRs connect microfluidic components through a further miniaturized and 
improved version of an 8-channel micro-peristaltic pump (see below, Figure 2) we previously described [3]. Type III 
μFRs provide chip-to-waste flow (not shown).  Faces and integrated channels of μFRs which link components together 
contain ball joint features (Figure 1) which provide self-aligning, minimal dead volume sealed interconnections [4].  
Screws are used to connect elements together (Figure 2) and provide the compressive force which yields interconnection 
supporting pressures greater than 200 kPa [4], the threshold applicable to most microfluidic applications [5].  All μFRs 
are manufactured from micromilled PMMA moulds in a manner previously described [4].  
 
 
 
Figure 1.  Modular microfluidic system components. i) TYPE I μFR containing 8 integrated 240 um inner diameter 
channels. Channels filled with dye to facilitate visualization. All channels are bookended by Ball Joint interconnection 
features. ii) Ball Joint interconnection feature. iii) Type II μFR used for connecting microfluidic chips through a 
miniaturized peristaltic pump. Channel dimensions and interconnection features are identical to Type I μFR. iv) The 
peristaltic pump’s multi-roller (MR) is made from eight free-rolling 2 mm stainless steel rods. v) A Type II μFR is placed 
across the pump’s multi-roller to deliver fluids. A covering piece compresses the Type 2 MR against the multi-roller to 
pump fluids (not shown). 
 
 Type II uFRs are used in a peristaltic micropump (Figure 1 and 2).  Type II uFR integrated channels run within raised 
tubing-like features.  When the pump is assembled these tubings are occluded between the micropump’s multi-roller 
(MR) and a rigid polymeric piece complementary to the MR, thus permitting peristaltic flow in eight individual channels.  
Pump dimensions, excluding motor, measure only 20 mm (h) x 20 mm (w) x 40 mm (l).For simple microfluidic analyses 
the micropump can be operated with a hand crank (Figure 3).  For more involved assays, motors for and control of 
micropumps can be provided by the LEGO® MindstormsTM kit (Figure 3).  
  
EXPERIMENTAL 
 As interconnection performance was previously assessed [4], the primary concern was pump characterization.  To 
assess Type II μFR durability and micropump performance a microfluidic chip, made from micromilled PMMA, was   
 
 
Figure 2. Assembled fluidic networks in different configurations. i) Two pump configuration with 96 interconnections.  
Motors not shown. A)  Sample reservoirs and outlet chips (made from PMMA), B) miniaturized 8 channel peristaltic 
pump with Type II μFR inside, C) PMMA microfluidic chips, D) Type I μFR (dashed boxes). ii) Side view of network 
shown in i). iii)  Network employing different configuration and chip design.  
 
 
 
Figure 3. Fluidic actuation. i) Two pump system powered by hand cranks.  A handcrank can be attached to the 
micropumps to move fluids through fluidic networks made with system components. ii)  Two pump system showing LEGO 
motors and controller.  The LEGO® controller( top) can be programmed to control the LEGO® motors (leftmost and 
rightmost) and thus also control peristaltic pump flows.  The microfluidic chip shown was used to assess per rotation 
displaced volumes in each of the 16 channels provided by the two micropumps.  
 
interfaced to two micropumps (Figure 3).  The microfluidic chip permitted per rotation displaced volume measurements 
in each of the eight micropump channels. MindstormsTM motors were programmed to complete 20 rotations and per 
rotation displaced volumes were determined by analyzing ‘before’ and ‘after’ photographs.  Between measurements 
motors were programmed to complete 10 000 rotations. 
 
RESULTS AND DISCUSSION 
 System components are reconfigurable and permit many possible configurations (Figure 2) and higher interconnection 
numbers than previous reports [4], i.e. up to 32 interconnections on a 35 mm x 35 mm chip, are possible. The Type I and 
II μFR’s reduce dead volumes between microfluidic chips and within the pump to approximately 1 and 2.25 μL 
respectively. 
 Micropump durability testing indicated that all eight channels of Type II uFRs remained functional following more 
than 63 000 rotations.  For all test points, per rotation displaced volumes averaged near 0.7 uL per channel.  Average 
micropump displaced volumes were stable throughout durability testing and differed by approximately +/- 5%.  The 
average coefficient of variance (%CV) of per rotation displaced volume across the 8 channels of a single micropump was 
6%, with observed minimum and maximum values of 4.2 and 8.7%.  At 63 000 rotations, durability testing was 
deliberately stopped.  Inspection of the Type II uFRs did not reveal any damage.  The micropump can thus support 
extended experiments, such as perfused cell culture, for periods of greater than 3 weeks at flows near 1μL/min.  
Comparisons to similar miniaturized peristaltic pumps are not possible as these do not provide such data or do not 
provide multiple channels [6, 7] 
 For simple experiments or use in resource poor and remote locations, hand cranks are attached to the micropumps to 
deliver fluids. A hand crank system (Figure 3) was used to genotype patients for mutations in the β-globin gene (Figure 4) 
within a disposable microfluidic microarray-containing PMMA device [8].  For more complicated or longer term assays, 
the LEGO® MindstormsTM kit components can be used.  The low-cost product (approximately 350 USD) includes motors, 
a controller, power source and a “child friendly” graphical computer interface.  The LEGO® motors provide large flow 
rate ranges.  Using these motors, we have realized flows between approximately 0.033 and 60 µL min-1.  As motor 
rotation can be controlled to 1°, multiple pumps can be accurately activated to time, meter and flow fluids through chips.  
Cell culture of HeLa cells within a PMMA chip and associated processing steps including, sterilization and loading, were 
performed using a system actuated by the LEGO® components (Figure 4). 
 
 
Figure 4. i) Image of fluorescently-detected allele-specific hybridization (ASH) assay used to genotype a patient for 
mutations in the β-globin gene. A PMMA microfluidic chip containing ASH microarrays and the hand crank system 
shown in Figure 3(i) were used to process patient material. The patient shown was wild-type (WT) for all interrogated 
sites with the exception of site 4, for which they were heterozygous mutant type (MT), and therefore carry a mutation 
associated with a β–globin deficiency. Spot sizes are approximately 250 µm. ii) Image of HeLa cells cultured using a 
PMMA chip and a system configuration similar to that shown in Figure 2(iii). Fluidic control and assorted operations 
including sterilization and cell seeding were achieved by LEGO® MindstormsTM motors and control. 
 
 We believe our approach to be more accessible than similar solutions, including Braille displays [6].  The system’s 
modular components and compact design allows construction of setups that fit on microscope stages or similar life 
science instruments, thus making it suitable for experiments involving kinetic studies of molecular interactions (e.g., 
DNA hybridization) and cells (e.g., growth, migration, gene expression).  As multiple pumps can be connected to the 
same device without extensively increasing system footprint, highly multiplexed assays are possible. 
 
CONCLUSION 
  A portable, modular microfluidic system including methods to actuate and control multiple flow lines has been 
designed and characterized. The system's small footprint, modularity, integration, planar interconnections and simple 
operation make it well suited to a variety of microfluidic applications such as cell culturing and biochemical assays. 
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